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UNRESECTABLE HEPATIC METASTASES FROM COLORECTAL
CANCER: RESULTS OFA COMBINED APPROACH BY CHEMOTHERAPY
AND SUBSEQUENT RESECTION
R. Adam, H. Bismuth, Ch. Farabos, F. L6vi, F. Waechter
Hepatobiliary Surgery and Liver Transplant Center, Paul Brousse Hospital,
Villejuif, France
Resection is the sole curative treatment of hepatic metastases from colorectal
cancer. However, it may be achieved in only 10% of patients(pts) since most pts
have at the first irresectable lesions associated with a poor prognosis. Over the past
6 years, we have managed these pts with a new protocol of chemotherapy with the
aim to perform subsequent curative liver resection. From April 1988 to March
1994, 53 out of 337 pts (16%) with liver metastases initially considered as non
resectable were subsequently submitted to hepatic resection with a curative intent.
All pts have been treated by intravenous chronomodulated chemotherapy
combining 5 Fluorouracil, Folinic acid and Oxaliplatinum, a non nephrotoxic
platinum complex. To optimize dose intensities and tolerance, drug delivery was
sinusoidally modulated along the 24 hour-scale with peak flow rates at 04.00 hours
for 5-FU and Fol and at 16.00 hours for Oxa, using an ambulatory programmable-
in-time pump. Initial non resectability was assessed by the same surgical team and
was related either to technical impediment due to large (n=8), multinodular (n=24)
and central ill-located tumours (n=8) or to the presence of extra.hepatic disease
(n=13 Peritoneum (6), Epiploon (3), Lungs (4)). Pts received 3 to 29 courses of
chemotherapy (mean =10) for 2 to 29 months (mean= 8 months) before surgery.
Results: An objective reduction in tumour size. was observed following
chemotherapy in all pts subsequently submitted to liver resection. A significant
reduction of tumor markers was also demonstrated. A major hepatectomy (_ 3
segments) was performed in 37 pts and a minor resection in 16. There was no
operative mortality within 2 months. Post operative complications included 2
infected collections that needed non operative drainage, transient biliary fistula
and reoperation for bleeding. Chronomodulated chemotherapy was routinely
continued post operatively in all pts for 6 courses at less. Associated procedures
included repeat hepatectomy (15), pulmonary resection (11), hepatic cryotherapy
(8), splenectomy (1) nephrectomy (1), resection of the diaphragm (2), repeat
resection of colon cancer recurrence (2). Twenty eight pts are presently alive (of
whom 16 without disease) with a mean follow of 2.5 years (range 1.3 6.4).
Median survival is 3.2 years with a patient survival rate of61% at years.
Conclusion: Resection may be achieved in some unresectable pts with the help of
an efficient chemotherapy. The benefit in survival seems comparable to that
obtained with liver resection for initially resectable liver metastases. This
therapeutic strategy involves a multimodality approach including repeat
bepatectomy and extrahepatic surgery.
IMPACT OF PREVIOUS VARICEAL BLEEDING ON SUBSEQUENT
LIVER TRANSPLANTATION IN CIRRHOTIC PATIENTS.
R. Adam, J. Raccuia, H. Bismuth.
Hepatobiliary Surgery and Liver Transplant Center, Paul Brousse
Hospital, Villejuif, France
In order to establish a treatment strategy based on the perspective of liver
transplantation, we reviewed 1000 consecutive liver transplants over a 10
year period with special emphasis on prior history of portal hypertension
with variceal hemorrhage.
The impact of bleeding and subsequent therapy was analyzed to integrate
the proper timing of liver transplant in the multimodality therapy of portal
hypertension. Transplantation for fulminant hepatitis (n=148) and re-
transplantation (n=122) were excluded. Of 730 primary transplanted
patients with chronic liver disease, 544 (74%) had no, prior history of
variceal hemorrhage. There were 186 (26%) patients with variceal bleed
prior to transplantation of which 130 (70%) required interventional
therapy to palliate the bleeding. In the two groups of patients with and
without bleed prior to transplantation there were no significant differences
in regards to age, sex, etiology of the liver disease or donor liver
morphology. Sclerotherapy was Ferformed in 93 (50%), surgical portal
diversion in 27 (15%) and TIPS in 10 (5%) patients. Moderate to severe
liver dysfunction (grade B and C of a modified Child classification)
accounted for 91 percent of the patients with bleeding complications. The
overall survival for all patients was 76 percent at five years. Previous
history of variceal bleeding alone or treatment by initial sclerotherapy
demonstrated no significant difference with either graft or patient survival.
The patients who had TIPS to control hemorrhage had lower, but
insignificant, graft and patient survival. The group of patients with
variceal hemorrhage who had prior surgical shunt did, however,
demonstrate a significant increased survival at five years when compared
to the non-shunted group (96% versus 73%, p<0.007). In conclusion, the
impact of variceal bleeding does not seem to be critical to subsequent liver
transplantation. In contrast to sclerotherapy and TIPS, portocaval shunt
demonstrated an improved outcome following liver transplantation. The
perspective of liver transplantation should not be a contraindication to
perform portocaval shunting in properly selected patients.
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ROLE OF NITRIC OXID INACUTE LIVER INJURY ANDTHE
ASSOCIATED BACTERIAL TRANSLOCATION
D. Adawi, 1F.B. Kasravi, 2G. Molin, B. Jeppsson
1Deparanent of Surgery, 2Department ofFood Technology, Lund
University, Lund, Sweden
The effect ofnitric oxid in acute liver injury at different time intervals was
evaluated in an acute liver injury model induced by D-galactosamine (1.1
gm/kg body wt.) intraperitoneally. Rats were divided into 4 groups: normal
control, acute liver injury, acute liver injury+ N-nitroL-arginine methyl
ester (L-NAME) and acute liver injury + L-NAME + L-arginine. After 6
hours ofthe liver injury, the Alkaline Phosphatase (ALP), Bilirubin (B/L),
Aspartate Aminotransferase (ASAT) and Alanine Aminotransferase
(ALAT) increase in the acute liver injury+L-NAME group compared to
the acute liver injury control group with significant difference in ALP (P-
<0.01), BIL (P<0.05) and ASAT (P<0.05). The acute liver injury +
L-NAME + L-arginine group show reduced levels ofALP, B1L, ASAT and
ALAT compared to acute liver injury +L-NAME group, with a significant
difference in ALP (P<0.05). After 12 hours the inhibition ofnitric oxid
increase the level ofliver enzymes and translocated bacteria but without
significant difference. After 24 hours in the acute liver injury + L-NAME
group there is a significant increase in B/L (P<0.05) compared to acute
liver injury group. The acute liver injury + L-NAME + L-arginine show
significant reduction in the level ofALP (P<0.05) compared to acute liver
injury + L-NAME group. The number ofthe transloeated bacteria to
arterial blood, portal blood, liver and mesenteric lymph nodes at all time
intervals increased in acute liver injury + L-NAME groups compared to
acute liver injury group with a significant difference in the arterial blood
after 24 hours (P<0.05) and a decreased number in acute liver injury +
L-NAME+ L-arginine groups compared to acute liver injury+ L-NAME
groups with a significant difference in the arterial blood after 24 hours
(P<0.05). These show that inhibition ofnitric oxid increase the number of
the translocated bacteria and potentiate the liver injury.
PREOPERATIVE ALBENDAZOLE TREATMENT FOR LIVER
HYDATID DISEASE DOES NOTAFFECT THE VIABILITY OF
THE CYST
AKTAN A.O., YALIN R.
Marmara Univ. School ofMedicine,Dept.ofGeneral Surgery,
lstanbul, TURKEY
The treatment of hydatid cysts of the liver is still primarily
surgical. The surgica treatment of this disease, however, is far from
ideal. Intraoperative spillage and postoperative recurrence around
10 % are yet unresolved problems. Although in experimental models
the efficacy of albendazole has been demonstrated, clinical data are
still lacking. In addition to the gross appearance of the cyst, the
intracystic pressure (ICP) has also been found to be a reliable guide
for the assessment ofviability. High intracystic pressures are found in
viable cysts.
In this study a three week course of preoperative albendazole
(10 mg/kg) was given to patients with liver hydatid cysts and the
intraoperative viability ofthe cyst assessed.
The study consisted of two groups and the first group had 15
patients (5male, 10 female)with a median age of 31 (21-75). All cysts
were located in the liver. In two patients the cysts were grossly
degenerated and the ICP was 0. In two others the cysts were partly
degenerated and the ICPs were 4 and 5.5 era. In the remaining
patients the mean ICP was 27 em H20 (range 8-42 cm H20). Direct
microscopy with eosin exclusion test revealed viable scolices in four
patients in whom the test was performed.
The second group consisted of 40 patients with liver hydatid
cysts without any preoperative treatment. In this control group, there
were 9 non-viable (mean ICP 0era H20) and 31 viable cysts (mean
ICP 35cm H20). The differences among the groups were not
significant (p< 0.05).
It is concluded that a three week course of preoperative
albendazole treatment does not effect the viability ofthe hydatid cyst.F005 F006
IN-VITRO ASSESSMENT OF UPTAKE AND CYTOTOXICITY OF
LIPIODOL AND OTHER FATTY ACIDS IN PRIMARY AND METASTATIC
LIVER CANCERS
Re &. 1YL Ai- Mufti, J. LEWIN, M. C. WINSLET, K. E. F. HOBBS
University Department of Surgery, Royal Free Hospital School ofMedicine,
Pond Street, London NW3 2QG, ENGLAND
Lipiodol, an iodinated poppy seed oil, has been shown to be taken up and
retained selectively by primary and some metastatic liver cancers, following
injection into the hepatic artery. The mechanism of uptake, retention and
cytotoxicty of Lipiodol, constituent and non-constituent fatty acids by primary
and colorectal hepatic metastases in tissue cultures were assessed using growth
curves, trypan blue& LDH assays, 3H-leucine uptake and electron microscopy.
Cultures of Hep-G2 (human hepatoma), LoVo (human hepatic colorectal
cancer), SW620 (htnnan metastatic colorectal cancer) cell lines were studied.
Control non-malignant cell lines were used in the form ofhuman hepatocytes,
HUVEC (human umbilical vein endothelial cells) and U937 (histiocytic
iymphoma) cell lines. The ytotoxic effects of Lipiodol were compared with
that of its constituent fatty acids (Linoleic, Oleic, Palmitic and Stearic acids).
Other fatty acids used were iodinated Linoleic, Docosahexanoic and
Eicosapentanoic acids. The cultures were exposed to different concentrations
(1%, 2% and4% v/v) for a variable duration (3, 6, 12, 24, 48& 72 hours). All
the cell lines (malignant and non-malignant) have shown intra-cymplasmic
incorporation of membrane-bound lipid vesicles when. exposed to Lipiodol or
other fatty acids. There was a linear increase in the uptake in relation to
prolonged period of exposure to the fatty acids. The non-malignant cells
managed to void their contents of Lipiodol or other fatty acids as shown by
image analysis, but the malignant cell lines did not. This may explain why
liver cancers selectively retain Lipiodol in-vivo.
Lipiodol had no effect on the cell growth and viability, LDH release or protein
synthesis. Similar effects were seen with Oleic and Palmitic acids. However,
Linoleic and Stearic acids were very toxic to all the malignant cell lines but
not to the non-malignant controls. Iodinated Linoleic, Docosahexanoic and
Eicosapentanoic acids were cytotoxic to all the cell lines (malignant and
non-malignant). This study revealed that there was uptake and retention of
Lipiodol and all other fatty acids. Some fatty acids were only toxic to cancer
cells while others were toxic to all types of cells. The use of Linoleic acid or
Stearic acid in targeting liver cancers should be investigated in animal models.
This may prove to have great therapeutic benefits in targeting therapy for liver
cancers.
RADICALSURGERYFOR LIVERHYDATID DISEASE
S.Aifieri, GB Doglietto, C.Carfiero, F.Pacelli, G.Costamagna, M. Liberatori, F.Crucitti
Department ofSurgery, Catholic University, Rome, Italy.
BACKGROUND. Surgical treatment of hydatid liver disease remains controversial.
METHODS The outcome of90 consecutive patients who underwent surgical treatment in
the period 1983-1995 for hepatic hydatid disease was reviewed. It has been also analysed
the therapeutic approach in the management of biliary fistula. Total "closed"
cystopericystectomy was performed as the first choice procedure. Hepatic resection was
performed in where single large multiple cysts had destroyed segment
entire lobe ofthe liver. The residual cavity was left opened and drained with extemal
tube. Endoscopic retrograde cholangiography (ERC) has been adopted to detect and treat
biliary tract involvement.
RESULTS A total of 122 cysts in 90 patients surgically treated. Total
cystopericystectomy was adopted in 62 patients (70%); in 4 additional patients with
deep intreparenchymal cysts adherent to large vessels (inferior cava 3) to
hilar (n. 1), small portion of poorly vascularized pericyst was left in place
(subtotal pericystectomy). Total "closed" cystopericystectomy performed in 58
patients; treated with open cystopericystectomy.The remaining 23 patients
(25.8%) underwent hepatic resection. We observed 15 of cystobiliary
communication: discovered by ERC in symptomatic patients and treated
preoperatively by endoscopic sphincterotomy and 7 were discovered and treated during
operation. The (s.d.) operating time 214.6+_76 (range 70-450) minutes:
209.2+_61 (range 70-350) minutes for cystopericystectomy (n.66) and 227+_103
(range120-450) minutes for liver resection (n.23-p=0.42). "fhirty-six patients (40%)
required intraoperative blood transfusion: 1520+_1125cc (min250-max3000) and
1141+_669cc during liver resection (n.12) and cystopericystectomy (n.24) respectively
(p.2). The overall incidence of postoperative complications 19%: 19% and 17%
after cystopericystectomy and liver resection respectively (p =0.32). In of
external post-operative biliary fistula, cure achieved through endoscopic
sphincterotomy and introduction of temporary nose-biliary stent.Post-operative stay
was 14+_10 (rangeT-65) days with differences between cystopericystectomy and liver
resection:14+_11 (rangeT-65) and 14+_8 (rangeT-35) days respectively (p=0.9). Overall
postoperative mortality was 1%. Among the 72 patients available for follow-up, only
(1%) had local ofthe disease. Sixteen patients (18%) lost at follow-up.
CONCLU,ION Results suggest the safety and efficacy of radical procedures in surgical
management of liver hydatid disease. Total cystopericystectomy is the treatment of
choice. Liver resection is justified in selected cases. ERC is valuable tool for diagnosis
and treatment ofbiliary complications.
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OMENTALLY ADMINISTERED .PROSTAGLANDIN
EFFECTIVELY INCREASES PORTAL VENOUS BLOOD
FLOW IN PARTIALLY HEPATECTOMIZED RATS
T. Aono, K. Tsukada, T. Sakaguchi,
M. Ohtake, D. Ishiduka, N. Fujita,
K. Hatakeyama
Departments of Surgery and Physiology,
Niigata University School of Medicine,
Niigata, Japan
Portal venous blood flow (PVF) and
systemic arterial blood pressure (SAP)
were recorded after prostaglandin El (PGE)
administration to the greater omentum and
femoral vein in 66 percent hepatectomized
rats. Twenty-four male rats were used.
The PVF increased when PGE was given to
the omentum and femoral vein at 7.5 g/
kg/minfor 2 min. The magnitude of PVF
response after both administrations was
dose dependent, but the duration of PVF
response in the omental application was
longer than in the femoral administration.
The femoral injection reduced SAP
synchronistically with an increase in PVF,
while omental application caused no
change in SAP. These findings suggest
that the omentum is a better site for PGE
administration in the hepatectomized
condition, and that omental PGE delivery
is efficacious in increasing PVF without
systemic circulatory change.
V. At%JR0, It Kosti,K Stojlovi,B Davidovi,
V.vi;
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PERCUTANEOUS ASPIRATION OF THE
HEPATIC HYDATID CYSTS
E.Aygtin, A.Kartal, O.Karahan, K.0dev, S.Yol, C.Er
Department of Surgery, University of Selfuk, Konya, Turkey
Forty hepatic hydatid cysts of 30 patients were treated
by percutaneuos aspiration method between May 1992
and November 1995. Ultrasonography (US),
computerized tomography (CT), Latex agglutination and
Elisa tests were used either for diagnosis or post
drainage follow-up. Seventeen patients were female, and
13 were male, the ages ranged between 7 and 68 years
(mean, 42 years). Twentyseven cases had only one cyst
and 3 cases had more than one. Half volume of the cysts
we’re aspirated under the guidance of US or CT and 0.5
% silver nitrate solution was injected into the cyst as
well as. aspirated fluid. Five minutes later, cyst cavity
was aspirated totally and the catheter was withdrawn.
Three patients had allergic reactions (mild cyanosis in
two and bronchospasm in one patient) due to silver
nitrate injection, not necessarily to quit the procedure.
The patients were administered Albendazole (10
mg/kg/day) orally, for 13 days, 3 days before the
application and 10 days following the aspiration. Totally
5 secondary aspiration was necessary in three patients in
the early post drainage period because of insufficient
evacuation of the cysts. The mean follow-up period was
27 months. Recurrence was seen only in one patient with
abdominal cyst which was also treated percutaneously.
We concluded that, percutaneous aspiration of the
hepatic hydatid cysts was an effective and an alternative
method to the surgery in convenierit cases.
THE SPLIT LIVER IN LIVER TANSPLANTATION:A RECENT
EXPERIENCE
D, Azoulay, I.Astarcioglu, M. Johann, R. Adam, D. Castaing, H.
Bismuth
Hepato-Biliary Surgery and Liver Transplant Center, Paul Brousse
Hospital, Villejuif, France
The good results of liver transplantation (LT) have allowed its larger
use. However this increased use of LT has uncovered a relative
organ shortage. The split liver is one of the means to increase the
number of available grafts. We report here our recent experience
with this technique. From January to December 1995, a systematic
proposal to perform a split was made to the French organ sharing
network as often as possible. Ninety LT were performed using 61
whole grafts, 27 split liver grafts, 2 reduced size grafts. Twenty
livers were splitted at our center generating 40 split liver grafts: 23
transplanted at our center in 23 patients and 17 shipped to other
centers. We received 4 split liver grafts from 4 livers splitted in
other centers. Our 27 patients were transplanted for cirrhosis in 19
cases, amyloid polyneuropathy in 6 cases and fulminant hepatitis in
2 cases. Operative mortality (< day 60 post-LT) occured in one case
of fulminant hepatitis and long term mortality (> day 60 post LT)
occured in case of cirrhosis. One patientwas retransplanted at day
6 for primary non function due to a too small graft (the lowest liver
to recipientweight ratio 0.87).Patient and graft actuarial survival
are respectively91.4 + 5.8% and 87.5 + 6.8%. Twelve technical
complications occured in 10 patients: 3 arterial complications (2
thrombosis and dissection)of which 2 were successfully treated
by urgent desobstruction; biliary fistula" 4 cases, biliary stenosis: 2
cases; hemopedtoneum: 2 cases, segment4 necrosis: case. Eight
of these complications needed surgery to be controlled.
Conclusion 111 LT were performed with 87 livers realising an
economy of 24/111 grafts (22%). During the same period, 16
proposals of splitwere refused in France. The graft economy would
have been of 28%.. When used for elective transplantation ,the split
LT gives good results comparable to those of whole LT. Our results
promote the use of split LT every time it is possible.
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VALUE OF TRANSJUGULAR INTRAHEPATIC
PORTOSYSTEMIC SHUNT IN CIRRHOTIC PATIENTS
AWAITING LIVER TRANSPLANTATION.
D, Azoulay, J. Raccuia, D. Castaing, H. Bismuth
Hepato-Biliary Surgery and Liver Transplant Center, Paul Brousse
Hospital, Villejuif, France
From November 1991 to January 1995, 34 transjugular intrahepatic
portosystemic shunt (TIPS) were attempted in 34 cirrhotic patients
(mean 46.4 +_ 2.4; 22 66) candidates for liver transplantation (LT).
Patients were classified Child class A in 5 cases, B in 11 cases, C in
18 cases. Indication for TIPS was sclerotherapy failure in 23 cases
and intractable ascites in 11 cases.Two patients were excluded
because of technical failures which were treated by OLT in one case
and open calibrated porta-caval shunt in one case. The follow-up
with LT as end point was to 34 months (7.6+1.6 M).
Results: Early thrombosis (< 3 months) occurred in 8 cases: 6 were
desobstructed via the internal jugular vein and 2 were desobstructed
surgically together with calibrated porta-caval shunt. Late
thrombosis occurred in case with portal vein thrombosis and was
treated by mesenterico-caval shunt followed by LT 6 months later.
Recurrence of hemorrhage occurred in 2/22 patients who underwent
TIPS for sclerotherapy failure (one rupture of varices, one duodenal
ulcus).Ascites disappeared in 7/10 patients who underwent TIPS for
intractable ascites and was controlled together with diuretics in 2
patients. Ascites remained unchanged in patient.
21 patients were transplanted following TIPS with a mean delay 6.4
+ 1.6 (range: 1- 26) months. During the same period, 7 patients with
cirrhosis and surgical open porta-caval shunt were transplanted.
Comparison of patients with TIPS to patients with surgical open
shunt showed a shorter duration of operation for patients with TIPS
(332 + 351 vs 467 + 480 rain, P>0.05), less blood transfusion (3.5
+ 2.1 vs 7.3 + 2.6 L, P<0.05). Graft and patient survival at 3
months were comparable.
We conclude that TIPS controles the complications of portal
hypertension in patients awaiting transplantation. TIPS diminishes
blood requirement during liver transplantation procedure.
PORTAL VEIN EMBOLISATION IN THE STRATEGY OF MAJOR LIVER
RESECTION
D. Azoulay, J. Raccuia, D. Castaing, H. Bismuth.
Hepatobiliary Surgery and Liver Transplant Center, Paul Brousse
Hospital, Villejuif, France
Portal vein embolization (PVE) is useful with liver tumors when extended
hepatic resection is technically feasible, but, the potential for
postoperative liver failure prohibits primary surgical treatment. Achieving a
"functional hepatectomy" percutaneously, while inducing controlateral
hypertrophy, in anticipation of major hepatic resection is the goal of this
modality. This technique was applied in 20 patients who were already
enrolled in different protocols with neoadjuvant chemotherapy including
arterial chemoembolization for primary tumor, and chronomodulated
and/or hepatic artery infusion chemotherapy for hepatic metastatic
cancer. Although most patients had either primary or metastatic hepatic
tumor, one patient had cholangiocarcinoma and another had a
neuroendocrine tumor. Liver cirrhosis was associated with tumor in 5
(23%) patients. Final decision to perform hepatic resection was based
upon the degree of liver hypertrophy of the future remaining liver by
clinical, biologic, volumetric computed tomographic (CT) scan and tumor
response to chemotherapy. There were no deaths and one
complication. Exploration was performed after PVE in 18 (90%) patients,
while 2 (10%) are still awaiting decision to operate. At exploration 5/18
(28%) had disseminated disease and were considered incurable, while
the remaining 13 (72%) had hepatic resection with curative intent.
Specimens at the time of resection revealed tumor necrosis in 8 (62%)
patients (3 with 100% necrosis) and in 5 (38%) patients the resection was
less extensive than anticipated. Tumor margins were negative in all
patients resected (68%), while the remainder were either inoperable
(23%) or are still awaiting surgery (9%). There was a significant increase in
serum bilirubin after PVE (p<0.02) and a decrease in lactate
dehydrogenase (p=0.05) prior to surgery. There was no significant
change in other biochemical liver function tests or with indocyanine gree
(ICGR15). When primary resection of liver malignancy is not feasible for
various reasons, in both cirrhotic and non cirrhotic livers, neoadjuvant
PVE which was performed in conjunction with chemotherapy, permitted
resection with intent to cure, when otherwise was prohibitive.F013 F014
LIVER TRANSPLANTATION IN CIRRHOTIC PATIENTS WITH
RESECTED HEPATOCELLULAR CARCINOMA
Balsells J, Charco R, Murio E, L&zaro JL, Bilbao I,
Hidalgo E, Fdez-Cuadrado T, Margarit C.
Liver Transplant Unit. Hospital Vall d’Hebron.
Barcelona. Spain
The main causes of death following liver resection
(LR} for hepatocellular carcinoma (HCC) in cirrhotic
patients are tumour recurrence and liver failure. The
aim of this study was to analyze patientc who
underwent liver transplantation (LTX) after LR of
their HCC between Jul-87 and Feb-95.
LR was performed in 57 cirrhotic patients with HCC.
Recurrence of HCC was detected in 28 of 50 patients
who survived surgery (56%). Seven patients underwent
LTX, the indications being tumour recurrence in 4 and
liver failure in 3. Those patients transplanted for
tumour recurrence, only one patient is alive 9 months
later with no evidence of tumour recurrence; one died
from carcinomatosis 5 months post-LTX and the other
two died from cryptococcal meningitis and from upper
digestive bleeding with dyseminated aspergillosis
respectively and with severe recurrence of viral
hepatitis C in both. Liver failure was the indication
for LTX in one patient during the early postoperative
LR period and is still alive 38 months post-LTX. Other
two patients underwent LTX 47 and 5 months after LR,
but both died from septicaemia in early and late
postoperative periods, respectively. The actuarial
survival rates at 1 and 4 years for patients who
underwent LR and afterwards a LTX were 86% and 43%
respectively. (Actuarial survival of patients with LR
alone were 60% and 32%, respectively).
Conclusion: LTX may offer a second opportunity in
selected cirrhotic patients after LR for HCC. LR plus
LTX has an actuarial survival at 4 years of 43%.
PARTIAL PORTA-CAVAL SHUNT AND LIVER FUNCTION
G.Batignani, M. Zuckermann, R.Valanzano, F.Tonelli.
Dipartimento di Fisiopatologia C]inica-Unit& di Chirurgia
Universit& de]i Studi di .Firenze
From Apri.1 1993 to October 1995 19 patients mean age 63.5
years; range 54-75)-underwent partial portocava] shunt with
ringed Polytetrafluoroethylene (P.T.F.E.) prosthesis or t0
mm.). The mean follow up was of 10.3 months range 6-30 ).
17 of them were cirrhotics were Child A, Child B and
Chi]d C) while pts. had chronic active hepatitis. Viral sta-
tus was positive in pts., C pos. in 18 pts. while pts.
were alcoholics. 17 out of 19 pts. had documented previous vari-
real hemorrhages and pts. had concomitant portal hypertensive
gastropathy (P.H.G.). In pts.the indication was refractory
ascites. We used an graft in ten patients and 10 in
patients. patients were operated in emergency and in this
situation we used 10 mm. prosthesis in order to obtain bet-
ter decompression of the portal system.
Postoperative complications were: neuropathy prob]ably related
to criog]obulinemia, bleeding fron erosive gastritis, blee-
ding duodenal u|cers and duodenal perforation. In pt. (5.3%)
an HCC was showed year after shunt procedure.
pts. died after surgery so the overall operative mortality has
been 21% of these pts. underwent shunt procedure in emer-
gency setting and they were Child C (50%) and Child (20%).
Cumulative shunt patency in survived pts. was 100% and have
not observed neither episodes of reb]eeding from oesophageal
varices nor graft thrombosis during follow up. out 15
(26.6%) survived pts. had an episode of acute encepha]opathy
while only patient (6.6%) developped chronic encephalopathy.
Our results show that partial portacaval shunt with small dia-
meter P.T.F.E. prosthesis (8 or 10 mm.) is an effective procedu-
for the treatment of varicea] rebleeding with low rate of
chronic encephalopathy. We conclude that this technique, which
does not compromise liver transplantation, should be used in
Child Apts. when sc]erotherapy has failed, in presence of
P.H.G., when the pt. does not comply with sclerotherapy or when
he or she lives in non-urban area. Pts. with poor liver fun-
ction showed high morbidity and mortality so they are probably
better served with T.I.P.S. procedure. A clinical trial compa-
ring costs, complications and results of variceal injection-]i-
gation and partial portacaval shunt in Child Apts. might be
indicated.
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RISK FACTORS FOR MORTALITY AFTER HEPATIC RESECTION
W.O.Beehstein, N.Kling, O.Cmckelberger, S.Jonas, P.Neuhaus
Dept. of Surgery, Virchow Clinic, Humboldt University, Berlin, Germany
In order to identify risk factors for mortality at’mr elective hepatic resection a
retrospective tmivariate analysis of risk factors was performed. Between
1988 and 1995 315 hepatic resections were performed in 161 males and 154
females (median age 58 yrs., range 14-90 yrs.). 187 Resections were per-
formed for metastases, 64 for primary liver tumors, and 64 for benign lesions
such as hemangioma or FNH. Resection methods included 121 anatomical
lobeetomies, 56 extended lobectomies and 138 so-called minor resections
with removal of solitary ofmultiple segments or atypical subseg-
menteetomies.Tbe 30-day mortality in the whole series was 3.8% (12/315).
The following risk factors were significantly different between patients who-
died within 30 d and those that survived >30 days: bilirubin (Bilir),AST,
alkaline phosphatase (AP), albumin (Alb), pseudo-eholinesterase (pCHE),
prothrombin ace. to Quick, and duration ofsurgery (OP-time).Results are
shown in table 1, all values expressed as median, statistical analysis was
carried out with Mann-Whitney U-test.
Survival Bilir. AST AP Alb pCHE Quick OP time
mg/dl u/L u/L g/dl toq_, % (min)
< 30 d 1.3 24 298 3.6 1.8 91 240
> 30 d .6 13 141 4.2 4.8 100 200
.p-value <.05 <.001 <.001 <.001 <.01 <.05 <0.05
Age (62,5 vs. 58 yrs), median number of lesions (1 in each group), median
tumor size (68 vs. 50 ram), duration ofhilar occlusion (25 vs.26 rain), and
median number ofunits red packed cells (1 vs. 0) did not differ significantly
between both groups. There were significantly more early deaths in patients
with cirrhosis (5/42) compared to those without cirrhosis (7/273) and in
those with primary liver tumors (6/64) compared to those with metastases
(6/187) or those with benign lesions (0/64) (p <.05, Chi-square). Patients
sex, extend ofthe resection, and lobar involvement had no influence on early
outcome. The significantly different preoperative biochemistry values in
patients who died within 30 days following elective hepatic resection
underline the importance ofpreoperative patient selection for avoiding early
mortality.
AUXILIARY LIVER TRANSPLANTATION FOR FULMINANT
LIVER FAILURE LIMITS OF AN ATTRACTIVE CONCEPT.
J. Belghiti, F. Zinzindohoue, F. Durand*, R. Noun, A. Sauvanet,
J. Bernuau*.
Departments of Digestive Surgery & *Hepatology, Hospital
Beaujon, University Paris VII, Clichy, France.
Auxiliary liver transplantation (ALT) theoretically, bridges the
period of acute liver failure until the native liver (NL) rccovcrs
and immunosuppression can be discontinued. However, this
attractive concept is burdened by technical problems and by the
selection of candidates. We report our experience of ALT wilh
special references to early and long term graft function in
prospective study including all patients who undcrwent
emergency liver transplantation for acute liver failure from April
1.993 to October 1995.
Patients: Thirty patients aged from 16 to 62 years with acute liver
failure wcrc candidates for emergency liver transplantation
according to Clichy criteria. Causal disease was drug toxicity
(n=10) including paracetamol in 3; hepatitis B (n=6); hepatitis A
(n=2) and other (n=12). We decided to perform OLT in 18
because of age>60 years (n=3), pre-existing chronic liver discasc
(n=4), hacmodynamic instability (n=4), poor liver graft (n=2)
and poor neurological status with immediate risk .of cerebral
herniation (n=5). Seven patients died postoperatively including 5
after ALT; in the latter group mortality was due to vascular
thrombosis (n=3) graft compression (n=l) and sepsis (n=l). With
a follow up ranging from 3 to 31 months among the 7 surviving
patients, graft was removed in 2 respectively after and 7 months,
immunosuppression was stoped in 2 respectively after 9 and 27
months. Liver biopsy demonstrated the presence of mild fibrosis
in 3 respectively after 6 and 9 months.
Conclusion: After auxiliary liver transplantation for fulminant
hepatitis, there is no predictive value of the extent nor the delay of
sufficient regeneration of the native liver. The higher operative
risk associated with ALT suggests that this procedure should: (a)
not be indicated earlier than standard OLT; (b) be restricted to
patients < 50 years without haemodynamic instability and (c) be
performed using good quality ABO compatible graft.F017 F018
PREDICTIVE FAIDRS OF ACUTE RENhL FAILURE (ARF) IN LIVER TRANSPLANT (LT),
Bilbao I, Hidalgo E, Charco R, Balsells J, Lzaro JL, Murio E, F.Cuadrado T,
KRGARIT C.
Liver Transplantation Unit. Hospital Universitario Vall d’Hebr6n. Paseo Vall
d’Hebr6n s/n 08035 Barcelona. SPAIN.
ISE To Analyse the risk factors for ARF requiring renal depuration in
early postoperative LT.
MATERIAL Between 0ct-88 and Dec-94, 172 liver transplants were performed in
158 patients with end-stage liver disease. The median age was 51 years (r:16-
66). Child’s-classification prior to LT was: A(IO%); B(37%); and C(53%).
Ninety percent were UNOS and II status. Renal insufficiency prior to LT
attained to 18% of patients.
Donor and recipient factors studied in relationship to ARF were: preoperative
parameters (age, sex, indication to LT, Child-Pugh score, UNOS status,
laboratory data, renal function prior to LT), intraoperative parameters
(le6gth of surgery, type and length of anhepatic phase, preservation time,
periods of hypotension, blood product requirements, diuretic doses, balance,
etc), and postoperative parameters (prymary liver disfunction, blood products
transfused.ere).
IULTS More than 50% (88 patients) developed ARF while Jn ICU: 27% mild
(SCr 1,5-3); 7% moderate (SCr >3); and 17% severe requiring renal depuration
(30 patients). Renal depuration was required: immediatepestoperative days
in 19 between 5-14 days in and late postoperative 15 days in Type
of deputation employed was hemodyalisis in patients; ultrafiltration in
19; and eontinous arterio-venous ultrafiltration in 2. Overall postoperative
mortality in depuration group was 50% in contrast to 13,4% in the rest of
patients.
Univariate analysis of donor and recipient factors showed that: urgent
retransplantation, advanced Child-Pugh score, renal function prior to LT,
preservation time, blood product requirements, and primary liver disfunction,
were the variables observed statistically significant in relationship to ARF.
However, multivariate analysis revealed that among 38 variables investigated
in our serie, only two had independent prognostic value preoperative SCr
1.5 mg/dl and graft dysfunction grades III and IV.
CONCI,USIOIi Early ARF is common and severe complication in LT, with high
morbi-mortality, that can be predicted particularly in relation to some well-
known factors, mentioned aboved.
RISK FACTORS FOR SEVERE ISCHEMIC LESION (IL) AFTER
LIVER TRANSPLANT (LT).
.,Bilbao, E.Hidalgo, JL.Lzaro, R.Charco, J.Balsells,
E.Murio, A.Edo C.MARGARIT.
Unidad de Trasplante Heptico. Hospital Vall d’Hebr6n.
Barcelona, Spain.
To meet the demand for grafts to transplant patients
with end-stage liver diseases acute liver failure, it
is necessary to accept the called non-optimal donors,
which in adittion to other negative factors lead to
important graft dysfunction primary non-
function. The aim of this study is to analyse the risk
factors that could influence in the appearence of IL,
originated either in the donor (prepreservation injury),
during hypothermic storage (preservation injury),
during reperfusion/reimplantation period.
MATERIAL AND METHODS From October 1988 to December
1994 172 OLT performed in 158 patients. The mean
age was 51 years. Sex distribution 65% males and 35%
females.
Ischemic hepatic lesion classified regarding liver
function test during the first days Mild (GPT <
I000, and prothrombin time (PT) 60%); Moderate (GPT
1000-5000 and PT 30%-60%; and Severe (GPT > 5000 and PT
< 30%). All the events ocurring during the immediate
postoperative period during their stay in ICU
stored in database
RESULTS Out of 172 transplants 109 (63%) had mild
IL 45 (26%) had moderate IL and 18 (11%) had
IL. In the IL presented PNF and
retransplanted died.
Univariate and multivariate analysis revealed that:
advanced Child-C hepatopathy and older recipient age,
ICU donor stay longer than days, and positive
crossmatch associated with appearence of
graft dysfunction. Postoperative mortality and 1-year
graft survival for severe IL 50% and 33%
respectively, with differences statistically significant
compared to the rest of transplants.
Patients with ischemic lesion showed higher
morbidity in terms of greater need of dialysis, rate of
severe infections, need of respirator, and ICU stay.
CONCLUSION Incidence of severe ischemic injury was
10.4% with 2.3% of PNF. Risk factors for severe ischemic
lesion recipient age, Child-C, and donor ICU stay
longer than 5 days. As increased morbidity and decreased
graft survival found in this group of patients,
association of several risk factors should be thoroughly
outweight in order to perform LT.
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ENDOSCOPIC SCLEROTHERAPY (ES) OF GASTRIC VARICES
(GV)
OUR EXPERIENCE.
Bisello M.,Gerunda GE, Zangrandi F.; Neri D.; Merenda R.’ Meduri F.’
Barbazza F.;Da Giau G.;Bruttocao A., Ciardo L.; Scopece A., Girardi
R., Renon L., Maffei Faccioli A.
First Department ofGeneral Surgery University Padua.
GV bleeding presents high risck of mortality. Emergency surgery has
high mortality. ES og GV using Bucrylate (B) material, may be a valid
alternative particularly in emergency. The aim of this paper is to presents
our experience in Polidocanol Vs Bucrylate ES of GV bleeding.
MATERIALS: 52 Pts mean age 48+/-16 range 43-68 were trataed
in our Istitution. 50% had alcoholic cirrhosis, Ace.to Child pug risk 6%
were A,61% B, 33% C. Ace.to NIEC Criteria 61% were of type I, 35%
of Type II,4% of type III (type I+II 17% ). 88% and 12% were
respectively emergency and electively trated. 16pts were treated with
Polydocanol + Saline ES respectively 30+/-6 range 38-465 and 40+/-7
ml range 36-48 36 Pts were treated with B -ES (with or without


































Conclusion: B-ES represents a real efficacious method to resolve the
mergency ofGV bleeding. The complessity ofthe etechnic and the risks
for instruments and operators, needs a very experinced team.
LIVER TRANSPLANTATION FOR HEPATOCELLULAR
CARCINOMA ON CIRRHOSIS PROGNOSTIC IMPACT OFAN
ADAPTED PATIENT SELECTION
H Bismuth. R Adam.
Hepato-Biliary Surgery and Liver Transplant Research Center, Paul
Brousse Hospital, Villejuif, France.
Hepatocellular carcinoma (HCC) is an established but still debated
indication of liver transplantation (LT). The high risk of recurrence
and five year- suival.rates significantly lower (0-5.0% in different
series) than those of benign diseases have questionned the place of
LT for HCC in the current period of organ shortage. We report in this
study the consequences of a new selection of patients adapted from
prognostic indicators established in the first phase of a same series.
From November 1985 to March 1994, 109 patients with cirrhosis
were transplanted for HCC. Of these 109 patients, only 95 patients
with HCC diagnosed betbre LT were included in the study. The
presence of extrahepatic deposits on pretransplant staging or
peroperative exploration was considered as a contraindication to LT.
In the first period of our experience (November 85-December 91), the
selection criteria only included the absence of any extrahepatic tumour
(60 patients). After assessment of prognostic factors in this first
period (mainly tumor size > 30 mm, number of nodules > 3 and
presence of a portal thrombosis), we proceeded to a more restrictive
selection of those patients at very high risk of recurrence. Results in
terms of patient selection and 3 year-survival were as. follows
1st period (85-91) n=60 2sd period (92-94) n=35 p
No nodules >3 24 (40%) 6 (17%) 0.03
Size> 30 mm 29 (48%) 12 (34%) 0.01
Portal thrombosis 6 (10%) (3%) NS
No and Size<30 mm<3nod 21 (35%) 22 (63%) 0.04
>30 mm >3 nod. 14 (23%) (14%)
Recurrence 20 (33%) 4 (11%) 0.01
3 yr-Surv.(Overall- Disease free) 55%-49% 76.5%-70% NS-0.07
Conclusion: An adapted selection of patients with HCC for LT allows
a significant decrease of the recurrence rate and a trend to improved
survival. This warrants the indication of LT for HCC even in the
current period of organ shortage.F021 F022
AUXILIARY PARTIAL ORTHOTOPIC LIVER TRANSPLANTATION
(APOLT) IN FULMINANT HEPATITIS (FH).
H. Bismuth, D. Azoulay. D. Samuel, Ph. Ichai, F. Saliba, R. Adam, D.Castaing
Hepatobiliary Surgery and Liver Transplant Center, Paul Brousse Hospital.
Villejuif, France
APOLT has been proposed in the treatment of FH to provide temporary hepatic
support until the native liver regeneration. We report herein our experience with
APOLT for FH in 5 patients during the past 12 months. During the same period X
patients were treated at our center for FH needing liver transplantation.
Conventional orthotopic liver transplantation (OLT) was chosen in X most severe
cases to shorten as mudh as possible the waiting time for a liver graft. APOLT
was chosen as a potential bridge in 2 cases because the graft was ABe
incompatible, in case because of a too small graft from a living related donor,
and in 3 cases because the potential for native liver regeneration was judged
reasonnable in stable patients. The main caracteristics of the 5 patients are
sumarized in table 1.
In conclusion, Our experience with APOLT confirms the technical feasibility
of this approach in FH. ABe incompatible graft may be a good indication of
APOLT in FH. If, due to rejection or biliary complications, the graft should be
removed, there is a chance of regeneration of the native liver allowing to avoid
retransplantation.
patient cause of liver native survival Comments
n/sex/age FH graft* liver* after
APOLT
l/M/19 HBV 2-4 4-8 A,19M native liver regeneration, liver
graft removed at 10M
2/M13 unknown 5-8 1-4 A,13M native liver atrophy, chronic
rejection both removed and
reOLT at4M
3/F/58 drug 2-4 4-8 D,3M, Autopsy: no native liver
induced sepsis regeneration and normal graft
4/M/15 Reye 2-3 4-8 D, 10 autopsy dll, native liver
LRLT brain regeneration, mild graft
death rejection
5/F/40 HAV 5-8 1-4 A, 1M biopsy d15, partial native liver
regeneration, acute graft
rejection
according to Couinaud A alive, D, dead, d= day, m= month, M=male,
f=female, OLT= conventiaonal orthotopic liver transplantation
SECONDARY ALTERATIONS TO ISCHEMIA REPERFUSION INJURIES
AFTERPARTIAL HEPATIC ISCHEMIA IN WlSTARRATS USING
WEB2086
I.F.S.F. Boin, O. Castro e Silva Jr., L.S. Leonardi
Unit ofLiver Transplantation UNICAMP
Hepatic Studies Laboratory FMURP SP
The objective ofthis work was to verify and analyse, in Wistar rats, the
alterations caused by 90-minutes partial hepatic ischemia, followed by
immediate, 15 and 60 minutes reperfusion, using a PAF-antagonist
(WEB2086). A total of48 male Wistar rats were used, with mean weight of
310g, previously submitted to a 6-hour fast with water ad libitum. Twelve rats
were separated for hemodynamic and electrolytes analysis of: MAP, CVP, pH,
pCO2, PO2, BE, HCO3, Na, K, Ca++, GLY, Hb, htc. Thirty-six rats were
separated for analysis of mitochondrial function, RCR, liver function tests
(AST, ALT, LDH, LDHs) and GLY. In the first part ofthe study the twelve rats
were divided in two sub-groups of6 rats each. The first sub-group was
submitted to partial hepatic ischemia ofthe median and left lobes; the second
sub-group received a specific PAF-antagonist (WEB2086) minutes before the
ischemia. In the second part ofthe study the rats were also divided in two
sub-groups, one sub-group submitted to partial hepatic ischemia, the other
receiving WEB 2086 5 minutes before (20mg kg). The rats were submitted to
partial hepatic ischemia for 90 minutes and studied in reperfusion times of zero,
15 and 60 minutes (R0, R15, R60).The results ofthe several groups were
analysed with ANOVA and Friedman test. We observed statistically significant
difference in the time R0 ofthe following MAP, CVP, Na, Hb, htc, ADPO and
OPR. In the time R15: E III, MAP, HCO3, BE. In the time R60: CVP, BE,
HCO3,GLY, E IV and LDH. Although, the use ofWEB 2086 (PAF-antagonist)
had inhibited the hypotension proprierties ofPAF that occurred during the
reperfusion, we did not observed improvement in that liver function and the
mitochondrial function was maintained.
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EFFICACY OFTRANSARTERIALCHEMOEMBOLIZATION (TACE)
ASSOCIATED TO PERCUTANEOUS ETHANOL INJECTION (PEI)
IN THE TREATMENT OF SMALL HEPATOCELLULAR
CARCINOMA (HCC).
L. B010ndi, S. Sofia, N. Venturoli, A. Casali, S. Siringo, T. Livraghi,
E. Caturelli, G.L. Rapaccini, C. Bartolozzi, L. Gandolfi and the
multicentric study group of the Italian Association for the Study of Liver
Disease (AISF)
Non controlled studies have reported better results for the association of
TACE with PEI than for PEI alone in the treatment unifocal HCC.
Patients and methods. We report here the preliminary results of a
prospective multicentric controlled study comparing these two treatment
strategies in 150 cases of small (<5 cm) unifocal HCC in liver cirrhosis
in Child Pugh class A (n=89) and B (n=61) in whom liver resection was
not feasible (age >65 years; Child B class; esophageal varices at risk;
location of HCC in central segments). Patients were enrolled in 12
different italian centers since February 1992 to May 1994 and 84 of them
were randomly assigned to PEI and 66 to TACE + PEI. The two groups
were matched for sex, age, Child-Pugh class, size of HCC and AFP
level at entry. Diagnosis ofHCC was established by echo-guided liver
biopsy and unifocality at US examination was confirmed in all cases by
contrast-enhanced CT. In the group TACE + PEI, TACE was performed
prior to PEI. All patients were followed at four months intervals by US
and AFP. PEI was repeated in case of recurrence. The mean follow up
was 18 months in the group TACE + PEI and 19 months in the group
PEI. The treatment outcome was evaluated as follows: 1) successful
when the lesion remained stable or decreased over time; 2) local
progression; 3) diffuse progression. Survival curves in the two groups
were then assessed by the Kaplan-Meier method and compared by the
Mantel-Cox method.
Results. A decrease of the AFP levels was observed in both groups of
treatment at 12 months interval, but any significant difference was not
found between the two groups.A non significant (p<0.1>0.05) trend
towards a better outcome (80% stable disease vs 59%) at 16 months was
found in the group TACE + PEI. The analysis of survival curves showed
a non significant trend for an improved survival in the group TACE +
PEI in comparison with PEI alone (estimated survival at 24 months
65% vs 45%). The severity of liver cirrhosis was not worsened over time
in the group TACE + PEI in comparison with the group PEI.
Conclusions. A follow up longer than 2 years is needed to demonstrate a
possible better efficacy ofTACE + PEI in comparison to PEI alone in the
treatment of small unifocal HCC.
PARTIAL VS. TOTAL PORTACAVAL SHUNT: A
PROSPECTIVE RANDOMIZED TRIAL.
Capuss0tti L., V. Vergara, R. Polastri, H. Bouzafi, M.M. Marui.
Department of Surgery, Ospedale Mauriziano, Largo Turati 62 Torino,
Italy.
From January 1990 to December 1994, forty-six patients were considered
for inclusion in a prospective randomized trial. 23 patients underwent to
10 mm portacaval H-graR (Group 1) without collateral ligation, 23
underwent to side-to-side portacaval shunt (Group 2) in order to evaluate:
operative and long-term mortality and survival, hepatio score and hepatic
encephalopathy (HE). Inclusion criteria consisted of: age< 70, documented
hepatic cirrhosis, Child-Pugh’s classA or B (only patients with score 7),
maintained hepatic portal flow, no ascites, bleeding from oesophageal
and/or gastric vafices requiring two or more blood Units. Group 1:17/6
M/F, mean age 58 years (range: 27-67). 12 patients had alcohofic
cirrhosis. MeanY.SD ofhaemorrhagic episodes was 2.6+1.3. According to
Child-Pugh’s classification: 11 patients were class A, 12 class B. Group 2:
15/8 M/F, mean age 60 years (range:34-68). 13 patients had alcoholic
cirrhosis. Mean of haemorragic episodes was 2.3-0.7. Ten patients were
Child-Pugh A and 13 were B. Long term survival was calculated by
Kaplan-Meier method. Differences between the groups with respect to
preoperative parameters were examined usign the2 test and Student’s T-
test where appropriate. No operative mortality (at 60 days) occurred in
both groups. One patient of each group had an early postoperative
variceal haemorrage episode. No patient of group and 2 patients of
group 2 had one haemorrage episodes at 12 and 17 months after operation
(p=NS). Long-termHE was significantly lower (p < .05) in group (13%)
vs group 2 (39%). No patient of group and 2 patients of group 2 had
severe chronic HE. Long-term evaluation of hepatic score was 0.59’-0.11
in group and 0.67:L-0.11 in group 2 (p < .02). Actuarial survival rate at
1,3 and 5 years was 100%0, 77% and 67% in group and 86%, 63% and
52% in group 2 respectively (p .04 Gehan’s Wilcoxon Test). In
conclusion: partial shunt, mantaining a good hepatic flow, significantly
improves long-term survival and reduces postoperative encephalopathy
and postoperative hepatic deterioration vs. total shunt.F025 F026
Advantages and disadvantages ofinferior venacava preservation in ortothopie liver trans-
plantation
D. Casanova, M G Fleitas, E Martino, L Herrera, F Hemanz, JM Rabanal, G Solares
DepartmentofSurgery, University HospitalValdecilla, University ofCantabria, Santander,
Spain
Inferior vana cava preservation (IVCP) has been proposed an alternative procedure in
ortothopic liver transplantation (OLT). This techniques provides continuous caval flow
to the heart, minimizing the hemodynamic alterations and increasing the renal perfusion.
Aim: The objective is prospective study of ortothopic liver transplantation using IVCP.
Patients and methods: Between November 1990 and November 1995, 130 OLT were
performed in 118 adult patients (12 were retransplants). Donors and recipients were
matched for size (weight and height) andABO blood groups. During the surgery, in all
cases, the liver was removed preserving the inferior cava vena. Cross clamping the IVC,
was placed laterally preserving blood flow throughout the anhepatic phase. Results: We
have performed the hepatectomy with IVCP during the consecutives 130 OLT. Postop-
erative vascular complications (thrombosis of suprahepatic veins) related to the tech-
nique occurred in three patients (2, 3%), and need retransplantation to solve the compli-
cations. The advantages of this technique include the absence of retrocaval disection,
preservation ofcaval flow during the anhepatic phase, and allow to avoid the anastomosis
of inferior eava vein. Intraoperative hemadynamic data suggests the stability during all
the procedure:
Before lateral clamping During lateral clamping After revascularitation
Mean arterial pressure 88+/-14 89+/-13 82+/-14
Inferior pressure 19+/-4 20+/-6 19+/-6
Renal perfusion pressure 68+15 71+/-17 67+/-15
Cardiac Index 4, 7+/-1, 4, 4+1, 6, 4+/-2,4
Systematic vascular resistance 525+348 512+/-280 319+/-211
Conclusions: OLT with IVCP, appears to be feasible in all liver transplants without im-
portant surgical complications, and permit hemodynamic stability during the anhepatic
phase.
IMPROVED DONOR LIVERS FOR TRANSPLANTATION: ASSESSMENT
BY MAGNETIC RESONANCE SPECTROSCOPY.
K. Changani, B.Fuller, ). Bryant, *J. Bell, #S. Taylor-Robinson, tlVl. Ala-
Korpela, D. Moore, B. Davidson.
Dept of Surgery, Royal Free Hospital & School of Medicine; NMR Unit,
Hammersmith Hospital, London, UK.
Regeneration of hepatic ATP is one of the single most important pre-requisites
for liver function following transplantation This study has used clinical liver
harvesting and storage techniques in the pig to evaluate the benefits of a
prostacyclin derivative and adenosine following a period of hypothermic
reperfusion (HtR). The non-invasive technique of 3p magnetic resonance
spectroscopy (MRS) was employed to monitor ATP regeneration in real time
without the need of biopsy. Land Race Large White pigs (n=5, 30kg) were
anaethetised and intubated. Midline and lateral abdominal incisions were made
to expose the 4 anatomical lobes of the liver. Following hepatic artery
occlusion, the hepatic portal vein was cannulated and the liver perfused with
litre of ice-cold citrate .plus litre of ice-cold modified University of Wisconsin
solution (UW): Two other groups of pigs (n=5 per group) had either
adenosine (1.34g/1) or a prostacyclin derivative [ZK 36374] at 10SM added to
both solutions. The liver was positioned in the bore of a 1.5 Tesla Picker
Prototype MRS machine and phosphorus spectra collected at 26 MHz. The liver
was reperfused with the respective oxygenated buffer solution and the
regeneration ofATP monitored following the acquisition of2 min time resolved
spectra. Concurrently, changes in inorganic phosphate, phosphomonoesters and
phosphodiesters could also be resolved in real time. Spectra analysed
using dedicated program designed specifically from the biochemical
composition profiles of resonant peaks. Initial rates ofATP regeneration in the
UW group was 9.7 x 103s whereas groups with added adenosine (Ad) or the
prostacylin derivative (PD) had rates of 9.5 x 103s and 14.2 x 10"3s,
respectively. The maximal attained amounts of ATP with respect to total
phosphate in these same groups were 4.49 + 0.52% (UW), 5.82 :k 0.27% (UW
+ Ad) and 6.79 + 0.40% (UW + PD). These changes represent an increase
from the UW solution of 30% with added adenosine (p< 0.05)and 51% with
added prostacyclin (p<0.02). This study suggests that improvements can be
made in ATP regeneration using prostacyclin derivatives and adenosine to
buffer the adenylate pool.
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MAJOR LIVER RESECTIONS WITHOUT PREOPERATIVE BILIARY
DRAINAGE IN PATIENTS WITH OBSTRUCTIVE JAUNDICE
D. Cherqui, V. Rodriguez, R. Alon, N. Rotman, M. Julien, P.L. Fagniez.
Department of Surgery, H6pital Henri Mondor Crteil France
It has been suggested that obstructive jaundice increases the risk of liver
resections because of reduced regeneration capacities, increased operative
bleeding and general effects associated with jaundice. Therefore,
preoperative percutaneous biliary drainage is often recommended.
However, the risks of sepsis and tumor seeding along drain tracts led us
to avoid preoperative biliary drainage in these patients.
From 1989 to 1995, 85 major liver resections (> 3 segments) were
performed. 13 patients (15%) had obstructive jaundice and underwent
resection without preoperative bliary drainage. Mean serum bilirubin
was 215+108 Ixmol/L (60-439). They included 4 hilar cholangiocarcinomas,
4 gallbladd(r carcinomas, 3 intrahepatic cholangiocarcinomas extended to
the hilus and 2 tumors with thrombus extension in the biliary tract. These
cases were compared with 72 resections in patients without iaundice.
mean values jaundice + (13) jaundice- (72)
extended resection 13 (100%) 11 (15%) < 0.01
vascular exclusion 7 (54%) 16 (22%) < 0.05
clamping time 39 min 38 min
transfusions 5 units 2.6 units 0.08
operative time 5.9 h 3.6 h < 0.01
AST peak/minimal PT 543 / 54% 311 / 53% NS
biliary fistula 38 % 6% < 0,01
mortality 2 (15%) (2%) NS
hospital stay 28 days 15 days < 0,01
The two deaths were due sepsis and myocardal infarct and occurred in
one patient with the highest serum bilirubin concentration and
hypoalbuminemia and in one patient with renal failure.
These results suggest that most patients with obstructive jaundice can
undergo major liver resection without preoperative biliary drainage. A
long and complex procedure is necessary and the incidence biliary fistula
is high. Increased operative bleeding was observed but tolerance to
ischemia and regeneration were not affected by jaundice in this series.
Preoperative drainage may be indicated in selected cases (bilirubin > 300,
prolonged jaundice, hypoalbuminemia, renal failure).
EFFECT OF INOTROPES AND STEATOSIS ON
TISSUE PERFUSION OF HUMAN LIVER GRAFTS.
V. Chidambaram A.M. Seifalian; A. Giudiceandrea,
N.S.Sreekumar, M. Farouk, K. Rolles, B.R. Davidson.
University Department of Surgery, Royal Free Hospital
& School of Medicine, London U.K.
We studied the hepatic surface perfusion during organ
retrieval in humans donors using Laser Doppler flowmeter
(LDF) to assess the microcirculatory alteration caused by
inotropes used for cardiovascular support of donors and
fatty infilteration (steatosis) of the liver. Method: Using a
Multimoor LDF, we measured the surface perfusion as flux
units in 17 liver donors. Nine donors were on inotropic
support (dobutamine, high dose dopamine, epinephrine or
norepinephrine for a minimum period of 2 hours) and 5
livers were macroscopically fatty. The surface perfusion
was recorded continuously from 2 sites on each lobe at the
beginning of organ retrieval (Pre) and after mobilisation
isolation of its vessels (Post). The data, discussed as mean
+ SD was analysed using unpaired students test. Results:
Mobilisation of the liver caused no alteration to surface
perfusion (p> 0.05). The donors receiving inotropes (n=9)
had lower surface perfusion 150 + 49 flux units than those
(n=8) not receiving it 302 92 flux .units (p=0.002).
Macroscopically steatotic livers (n=5) had a diminished
perfusion 138 + 103 flux units compared with normal
(n=12)- 256 + 51 flux units (p=0.007). Conclusion:
Inotropes and steatosis diminish hepatic tissuegraft
perfusionLDF is an useful tool for assessment of
microcirculation during organ retrieval.F029 F030
PROGNOSTIC SIGNIFICANCE OF p53 PROTEIN IN
HEPATOCELLULAR CARCINOMA PATIENTS
Dong-Wook Choi. M.D,, Gui-Tark Hong, M.D., ]ong-lnn Lee, M.D.,
Nan-Mo Moon, M.D., Sang-Min Lee, M.D., Seung-Sook Lee, M.D.*
Department of Surgery and Pathology’, Korea Cancer Center. Hospital,
Seoul, Korea
Hepatocllular carcinoma(HCC) is the one of most frequent cancers in
Korea, and the mortality rate from HCC is highest in this country all
over the world, probably due to high hepatitis B virus infection rate
and extremely poor prognosis. Established prognostic factors in HCC
are presence of venous invasion, multiplicity, curative resection, but
we do nok know all about prognosis in curatively resected cases. So,
we studied i53 protein expression in Korea HCC patients, which is
independent prognostic factor in breast cancer and lung cancer. We
performed immunohistochemistry using Pab 1801, which is monoclonal
antibody for protein in 39 HCC patients, who underwent curative
liver resection in Korea Cancer Center Hospital. Positive expression
rate of ix53 protein was 2.6%. p53 protein expression seemed to be
higher in HCC patients with poor prognostic factors such as venous
invasion, encapsulation, and multiplicity, but they did not reach the
stastistical significance. And slightly better survival rates were
shown in p53 negative protein group, but no significant difference
was detected(p=0.593). In the other hand, presence of veflous
invasion, multiplicity and no capsule formation were related with bad
prognosis statistically(p<0.05) In conclusion, we could not detect the
prognostic significance of p53 protein expression in curatively resected
HCC patients, but we think that more extensive study will be needed
in more patierrts using diverse antibodies to mutant p53 protein.
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LIVER TRANSPLANTATION MEDIATED TRANSFER OF
IMMUNITY: ACCELERATED REJECTION OF A SKIN GRAFT
AFTER LIVER TRANSPLANTATION FROM A SENSITIZED
DONOR
Dahmen U, Tanigawa T, Rogiers X, *Lindkaer-Jensen S, Broelsch CE
Dept. of General Surgery, University Hospital Hamburg, Hamburg,
Germany, *Dept. of Surgery L, University Hospital Aarhus, Aarhus,
Dennmrk
Microchimerism after organ transplantation has been demonstrated
repeatedly in clinical and experimental transplantation. Little is known
about the functional relevance of the transferred immune cells. This
study analyses the immunological activity of the chimeric donor cells
in the recipient.
Male Lewis rats were either transplanted with a liver from a
previously ACI-skin-sensitized BN-donor or a nontreated BN-rat and
tested 2 weeks after liver transplantation with an ACI-test-skin graft
for the transfer ofthis. sensitization. Recipient sensitization before liver
transplantation was included as a control.
Transplantation of a liver graft from previously skin sensitized BN-
liver donors to Lew-recipients led to accelerated rejection of ACI-test
skin grafts (median of 10 days (n=11) compared to median of 13 days
in the control group (n=6); p-value (Mann-Whitney U test)
0.004729); indicating a transfer of donor sensitization to the recipient.
Similar results were achieved after recipient sensitization (median
rejection time of test skin graft 9.5 days, (n=2)). BN-skin grafts used
as marker for the tolerogenicity of the BN-liver graft were prolonged
to the same extent, including permanent acceptance, in all three
groups. Preliminary experiments using ACI-hearts as test grafts are
pointing in the same direction.
This is the first systematic approach to demonstrate donor specific
immune functions in a liver graft recipient, most likely explained by
transfer of donor derived lymphocytes. In addition the recipient
specific development of liver graft induced tolerance was not impaired;
leading to observation of both, donor and recipient specific immune
properties in the liver graft recipient, thus pointing towards merging of
donor and recipients immune system.
SYSTEMIC CHEMOTHERAPY IN METASTATIC COLORECTAL CANCER
ifcrri E,, Municinb O., Gazzaniga G.M.
1st Surgery Dept. S. Martino Hosp. Genoa Italy
On the basis of recent demonstrations in vitro of two possible
mechanisms of action and of induced resistance depending on the
dosage and schedule of FUra administration, we submitted, in
collaboration with the 1st Dept. of Medical Oncology IST of Genoa,
14 patients with metastatic colorectal cancer liver disease, considered
unresectable, without other sign ofrecurrence, to chemotherapy, from
August 1993 to Oct. 1995. According to this rationale we began a
phase II thai of schedule-oriented biochemical modulation of FUra
bolus by MTX and I Interferon, and FUra continous infusion by
Leucovorin. In particular, the treatment schedule provided a hybrid
regimen of two biweekly administrations of 600 mg/sqm of FUra
bolus, which had to be preceded the day before by 200 mg/sqm of
methotrexate, and had to be followed, the same day and the next day,
by two administrations of 3 x 106 l-Interferon i.m.; after an interval
of two weeks, the cycle arried on with three weeks of continuous
infusion of 200 mg/sqm per day of FUra, which was preceded every
first day of the week by an administration of20mg/sqm ofLeucovorin
bolus. The entire cycle was repeated after a week of rest, having first
evaluated the lesions through US/CT scans and plotted the percent
change of total measured tumour mass and dosed tumor markers. All
the 14 patients, with no prechemotherapy, had the primary colorectal
tumor mass resected for necessity and their livers were considered
unresectable for the characteristics of the hepatic metastases: their
number, dimensions, contiguity/continuity with important vascular
structures didn’t allow a radical operation. 13patients (average age
63) have completed at least one cycle of the treatment and have been
reevaluated, while one patient has just been included in the study; we
have obtained two complete responses, after six months of
chemotherapy, and, at the moment, also nine partial responses (75%
of all); two patients died after 8 months because of the advancement of
their illness. We have had one death due to toxicity after the first
administration of FUra, MTX and Interferon in the first cycle, and
two cases of III grade toxicity (diarrhoea and mucositis). The two
patients that had a complete response to the chemotherapy were
operated, two hepatic metastasis, in each one, that had reached
dimensions of 2 cm in diameter, were resected, after a previous US
controll.
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ANTI-FERRITIN MONOCLONAL ANTIBODIES FOR
DIAGNOSIS OF HEPATOCELLULAR CARCINOMA IN
CIRRHOTIC PATIENTS
P. De Nardi, *P. Magnani, *C. Songini, G. Ferrari, V. Di Carlo
Chirurgia Generale e *Medicina Nucleare IRCCS H S. Raffaele
Universit& degli Studi di Milano
Antibodies directed against hepatocellular carcinoma
(HCC) antigens have been used in animal models as well
as in humans. However lack of specific antibodies and the
high background level when radiolabelled antibodies are
administered, have hampered a wide use of
immunoscintigraphy. Recently a new method, employing
biotinilated monoclonal antibodie (MoAb), not directly
radiolabelled, and avidin has been used, for diagnosis of
CEA producing tumours, with good results. Aim of this work
is to evaluate the sensitivity of anti-Ferritin MoAb
immunoscintigraphy with the avidin biotin system, in
identifying HCC in cirrhotic patients.
Between Jenuary and December 1995, 9 patients with
proved HCC were studied. After performing abdominal
ultrasound, NMR(6 pts), Lipiodol Tc (6 pts) and biopsy, the
patients were injected with mg anti-Ferritin MoAb; 24-36
hours later 10 mg of avidin were administered and after
further 24 hours In-111 labelled biotin was injected. Two
hours after the radioactivity administration planar and
tomographic imaging were obtained. Eight patients
subsequently underwent surgery during which 10 lesions
were diagnosed. The lesions ranged in size between 1.5
and 13 cm. Seven patients underwent surgical resection.
Ultrasound, NMR and TC correctly diagnosed HCC in
8/9,6/8 and 6/6 cases respectively. Immunoscintigraphy
identified 6/9 HCC; no false positive radioactivity
localization was observed. The lower resolutive power of
immunoscintigraphy was 1.5 cm.
Our results suggest that anti-Ferritin immunoscintigraphy is
effective in localizing HCC nodes in cirrhotic patients.F033 F034
LIVER TRANSPLANTATION IN ANTI-HCV POSITIVE PATIENTS:
DYNAMICS OF HCV-VIREMIA AND CLINICAL EVOLUTION
I:D..e Raffele, R.Bellusci, A.Manzin, R.Miniero*, B.Santoni, E.Lucci, M.Clementi#,
L.Solforosi, F.Fruet^, G.Sprovied*, A.Mazziotti, A.Cavallad. Clinica Chirurgica II,
Universit& di Bologna; lstituto di Microbiologia, Universit& di Ancona; *Laboratodo
Centralizzato, Policlinico S. Orsola, Bologna; # Dipartimento di Scienze Biomediche,
Universit& di Tdeste; ^Sevizio Trasfusionale, Policlinico S. Orsola, Bologna. ITALY.
INTRODUCTION. The hepatitis C virus (HCV) is one of the major etiological agents of
end-stage liver diseases requiring liver transplantation (OLT). However, recent studies
demonstrate the high rate of reinfection after transplantation in HCV carriers. The
purpose of the study was to evaluate: 1) the evolution of post-transplant viraemia in
patients anti-HCV positive pre-OLT; 2) the clinical behavior of transplanted patients
reinfected with the HCV; 3) the relation between HCV viraemia and ALT levels.
PATIENTS AND METHODS. Sixty-one patients transplanted between 1987 and 1994,
who were anti-HCV positive after OLT, with a post-OLT follow-up >3 mos. entered the
study. Twelve (19,7%) became anti-HCV positive after OLT and 49 (80,3%) were anti-
HCV positive pre-OLT. Their follow-up is 50,4+30,7 mos. Fifteen (24,6%) were also
HBsAg positive pre-OLT. Antibodies against HCV were assayed using an ELISA assay
and a RIBA assay of 2nd and/or 3rd generation. For HCV-RNA detection, a PCR was
employed. RESULTS. Ten patients were HBsAg positive after OLT. Among 51 HBsAg
negative patients, persistent or intermittent elevations of ALT levels were >2xN in 37 and
<2xN in 7; five patients always showed normal ALT levels (two other patients were
excluded). Seriated post-OLT determiantions of the HCV-RNA were available in 51
patients out of 61 (6+4 determinations per patient): 5 (9,8%) were HCV-RNA negative (3
were HBsAg positive after OLT and 2 had a follow-up <5 mos.), while 46 (90,2%)
resulted HCV-RNA positive at least once. In this group of patients, a total of 307 post-
OLT determinations were avail.dole: 103 (33,7%) resulted HCV-RNA negative. In 16
patients, one or more determinations of the HCV-RNA resulted negative after
demonstration of viremia. No correlation was evident between viraemia and ALT levels:
the HCV genome was usually found also in patients with persistingly normal ALT values,
while HCV-RNA fluctuations were observed in patients with persistent ALT alterations.
CONCLUSIONS. In our experience, patients carrying the hepatitis C virus were at high
risk of reinfection after OLT. The HCV-RNA reappearead eady in the serum in most
cases, although without any apparent correlation with ALT levels. Signs of hepatitis of
the transplanted liver, although usually mild and subjectively asymptomatic, were
frequent. In these patients, repeated PCR assays may be useful for confirmation of HCV
active replication, especially in case of abnormal liver function tests and histology, when
a differential diagnosis with rejection is required.
TOWARDS GENE THERAPY FOR LIVER MALIGNANCIES: ISOLATED
LIVER PERFUSION FOR LIVER-SPECIFIC DELIVERY OF SUICIDE
GENES WITH RECOMBINANT ADENOVIRAL VECTORS
W.K. de Roos, F.J. Fallaux, A.W.K.S. Marinelli, Magi der Eb, I.Hal. Borel
Rinkes, C.J.H. der Velden, O.T. Terpstra, R.C. Hoeben. Dept. ofSurgery and
Medical Biochemistry, University Hospital Leiden, State University ofLeiden. The
Netherlands.
Introduction. Hepatic suicide gene therapy may provide approach to treat
irreseetable hepatic malignancies, either primary metastatic. This strategy
involves the infection of tumor and liver cells with replication-defective adenoviral
vectors carrying suicide genes. Subsequently, systemically administered cytotoxie
substrates selectively destruct replicating tumorcells, infected with suicide genes,
whereas infected liver parenehymal cells unaffected because of their minimal
proliferative activity. Systems have been developed to deliver genes in-vivo with
replication-defective adenoviral vectors. A major in this approach is that
suicide genes could theoretically enter non-target organs with high mitotic activity
and, in this way, cause their destruction. The present study has focused the
development of strategies to achieve targeted and efficient adenovirus-
mediated gene delivery to the liver.
Methods. For this purpose, analysed the efficiency and liver-specificity of gene
transfer with recombinant adenoviruses administered via isolated liver-perfusion
(ILP). ILP involves the complete vascular isolation of the liver. The E-coli LacZ
gene and the f’n’efly lueiferase gene, carried in adenoviral vectors (Ad.RSV.f3-gal and
Ad.CMV-Luc, respectively), used reporter genes. In Wistar rats, the
recombinant adenoviral vectors were administered to the liver via either intraportal
infusion (IPI) ILP. Ex-vivo perfusion experiments with the Ad.RSV.13-gal were,
initially, performed to .optimize conditions for hepatic gene transfer.
Results. Ex-vivo perfusion of rat livers with 2x109 plaque forming units (pfu) for 10
minutes was sufficient to infect at least 40% of the liver cells. Similar effieiencies
were obtained in liverlobes of Rhesus monkeys, illustrating the feasibility of this
approach in primates. In-vivo gene transfer via IPI ILP performed with 2x 109
PFU of Ad.CMV-Lue. A significantly efficient gene transfer (p=0,028)
found in the ILP group when compared to the IPI group (mean 5,2x106 1,1xl06
lights units/mg protein, respectively). Also, gene transfer via ILP proved
reproducible. Although detectable in both groups, extrahepatie luciferase activity
considerably reduced in the ILP group.
Conclusions. Our data demonstrate that perfusion of vaseularly-isolated liver with
adenoviral vectors be used modality for efficient, reproducible and highly
specific delivery of suicide genes to the liver.
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SIMULTANEOUS LIVERAND COLORECTAL CARCINOMA SURGERY
E. de Santibafies, A. Alder, F. Bonadeo, M. Benati, G. Ojea Quintana, M.
Ciardullo, J. Pekolj, J. Matera, P. Argibay, and C. Vaccaro.
HPB Surgery Section, General Surgery Service, Hospital Italiano,
Buenos Aires, ARGENTINA
Between May 1982 and September 1995, 311 liver resections were
performed as a results of colorectal metastasis. In 55 patients
(17,6%) liver surgery was performed simultaneous with colorectal
resection. The purpose of this report is the retrospective study of
morbi-mortality risk in simultaneous liver and colorectal surgery as
well as long-term and free of disease survival. The average age of
the group was 61,3 years (38-82); 36 were male and 19 female. 11 of
the initial tumors were found in the right colon (20%), 22 in the left
colon (40%) and 22 in the rectum (40%). was classified as Duke’s
A (1.8%), 15 Duke’s B (27,2%), 26 Duke’s Cl (47.2), 13 Duke’s C2
(23,6).Hepatic resections consisted of: right Iobectomy 4 cases
(7,1%); left Iobectomy 2 (3,6%), central Iobectomy (1,8%); left
lateral segments 7 (12,7%); 20 segmentectomy (36,3); multiple
segments 10 (18,1%); right tdsegmentectomy (1,8%); wedge
resections 10 (18,1%). Colonic procedures consisted of: right
colectomy 13 (23.6%); left colectomy 4 (7,2%); total colectomy 3 (5,4
%) subtotal .colectomy (1,8%); Anterior rectal resection procedures
19 (34,5%); low anterior resection 10 (18,1%); low anterior resection
and hysterectomy 2 (3,6%); Miles .procedures 3 (5,4%). Average
surgical time was 4,3hs (2-6hs). Average ventilatory support time was
12.8hs (3-48); average intensive care stay was 49.4 (12-96hs). Mean
hospital stay was 9 days (6-24). Postoperative complications were:
intralxIominal abscesses 7 cases (12,7%); hepatic failure 3 (5,4%);
sepsis 3 (5,4%); atelectasis 2 (3,6%); bile leakage (1.85); pleural
effusion (1.8%) and anastomotic leakage (1.8%); 34 patients
received post-operative systemic chemotherapy; operative mortality
rate was 0%. The follow up was possible in 80% of patients, with an
average time of 25,6 (3-108). Free of disease survival was 53,5% at
year; 17% at 3 yr. and 7% at 5 yr. Actuarial survival rate was 87% at
yr.; 37 % at 3 yr. and 30% at 5 yr. Conclusion: Simultaneous
surgery can be performed with similar mortality and morbility rate
than sucesive colorectal and hepatic surgeries.
LIVER TRANSPLANTATION FROM LIVING RELATED DONORS:
IMPACT ON MORTALITY RATE IN WAITING LIST PATIENTS.
E. de Santibafies, M. Ciardullo, F. Mattera, J. Grondona, J. Pekolj, D.
D’Agostino, J. Sivori.
HPB Surgery Section, General Surgery Service, Hospital Italiano,
Buenos Aires, ARGENTINA
Scarcity of cadavedc donors, especially pediatric donors, has
prompted the implementation of the living related donors liver
transplantation program around the world.Despite the use of the
reduced-size liver technique, mortality rate of patients On waiting list
was 39.2%, in 1992 and above 50% in recipients with weight less than
10 kg. Since then, the living related donors technique has been an
option for patients with low weight and end-stage liver disease. 24
donors whose mean age was 30 years (13 fathers, 9 mothers,
uncle, grandfather) were studied. Preoperative evaluation included
liver volume via CT scan, hepatic vasculature and a complete
medical and psychiatric evaluation. 54% of potential living related
donors were refused due to liver conditions 6, psychological reasons
4, asthma 1, hepatitis c. and pregnancy 1. Mean age of the 11
donors was 29.3 years (22-37) and weight was 65.5 Kg (47-76).
Postoperative complications included case of duodenal ulcer and
case of wound infection. Hospital mean stay was 5.6 days. All donors
are currently well and alive. Recipients included 10 children with
biliary atresia and child with ATT deficiency. The group’s mean age
was 2.2 years (0.9-10) and weight was 0.7Kg (7.4-26). Recipients
urgency status was elective in 10 cases and of high urgency in case
(primary non-function of cadavedc liver). The technique employed
was similar to the described by Broelsch and others. Postoperative
complications in pediatric transplants were: Biliary (1 biliary leakage
and 2 strictures) 3 cases (27%); infectious (2 peritonitis and
intrabdominai abscess) 3 cases (27%); portal thrombosis, case
(9%); pulmonary haematoma, case (9%) and atelectasia case
(9%). The patient in high urgency status died of a stroke while in the
other group patient received a retransplant due to portal thrombosis
and patient died due to multiorganic failure.Currently, mortality rate
of children on waiting fist has decreased by 16.4%. Conclusion: The
living related donor technique has allowed a decrease of mortality
rate of children in waiting list.F037 F038
CELL PROLIFERATION-RELATED MARKERS
PROGNOSIS OF RESECTED HEPATIC METASTASES.
R. Doci., A. Costa, P. Bignami, L. Mochen, L. Gennari.
Istituto Nazionale Tumori, Milano, Italy
Neoplastic tissue of 104 patients who had undergone curative
hepatic resection for metastatic colorectal cancer was processed
for determination of 3H-dT Labeling Index (LI); p53 and bcl-2
expression; and DNA ploidy. Clinical and pathological features
were recorded: stage of primary, percentage of hepatic
replacement (PHR), and site and number of metastases. The
prognostic impact of different variables was evaluated by uni-
and multivariate analysis.
At the first analysis the disease-free survival at 4 years was
significantly rdated to LI, PHR and Dukes’ stage of primary. At
multivariate analysis only LI of metastases and Dukes’ stage of
primary retained their statistical significance. The disease-free
survival of two groups of patients, one combining favorable (LI
< 11%; Dukes A+B) and the other unfavorable factors (Dukes
A+B, LI > 11%; Dukes C), was significantly different (30 vs
5%; p=0.002). LI and Dukes’ stage can help in selecting patients
with different prognoses.
DIURESIS VERSUS THERAPEUTICABDOMINAL
PARACENTESIS EFFECTS ON ASCITIC FLUID INTER-
LEUKIN-1, OPSONIC ACTIVITYAND COMPLEMENT
El-Said Hassaa, MyriamAbou SeifHelmy
Hepatobiliary Unit, Faculty ofMedicine, Alexandria University,
Alexandria, Egypt.
In this randomized controlled study, the effects of diuretics on
ascitie fluid interleukin-1 (IL-11), opsonie activity (OA)and
complement C3 concentrations were compared with those of
therapeutic paracentesis in patients with mixed cirrhosis (i.e. mixed
schistosomal hepatic fibrosis and cirrhosis) and tense ascites.
Twenty four patients were randomly allocated to two groups:
groupA included twelve patients treated with spironolactone (200-
400 rag/day) and group B included twelve patients treated with
twice weekly 3-4 liters paracentesis for two weeks. Ascitic fluid
samples from all patients were analyzed for total protein and
albumin concentrations, C3 and lJ_,-l13 levels and OA at the
beginning and 2 weeks after treatment. IL-1[, an immuno-
regulatory cytokine that stimulates a variety of cells that function
as effector ofimmune response towards antigens, was significantly
decreased following, paracentesis while it remained almost stable
among the diuretic treated patients. The ascitic fluid OA and C3
concentrationsincreased significantly in diuretic treated patients
(P<0.05) while patients treated with paracentesis had significantly
decreased C3 concentration, andtheir ascitic fluid OA remained
stable. It can be concluded that diuretics, may have the potential
advantage over therapeutic paracentesis of providing better
protection from spontaneous bacterial peritonitis.
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SYSTEMIC, PORTALAND RENAL HEMODYNAMICS
INPATIENTS WITH SCHISTOSOMAL HEPATIC FIBROSIS
AND ASCITES: ROLE OF GLUCAGON
El-Said Hassan. MyriamAbou SeifHelmy,
Sanaa Ashour Mohamed
Hepatobiliary Unit, Faculty ofMedicine, Alexandria University,
Alexandria, Egypt.
In the present study, systemic, portal and renalhemodynamics were
assessed using Doppler flowmetry in 24 patients with schistosomal
hepatic fibrosis (SHF); 12 of them had ascites due to portal
hypertension and 12 were non ascitic and in 12 healthy subjects.
Also, renal function tests, fractional sodium excretion (FENa) and
plasma level of glucagon, an endogenous vasodilator were
determined in all patients and healthy subjects. Hemodynamic
assessment ofsystemic and portal circulations showed a significant
decrease in systemic vascular resistance and significant increases in
cardiac index, and portal vein blood flow volume and congestion
index in patients with SHF regardless ofthe presence of ascites as
compared with healthy subjects. These circulatory changes were
associated with significant increases in plasma glucagon levels in
the ascitic and non-ascitic patients but without" significant
correlations between these parameters. Moreover, these hemo-
dynamic alterations become more marked with development of
ascites. Renalhemodynamics showed a significant decrease in hilar
renalblood flow and significant increases in renovascular resistance
indices in ascitic and non-ascitic patients as compared with healthy
subjects. It can be concluded that peripheral arterial vasodilatation
particularly in the splanchnic area is the trigerring signal for sodium
retention and ascites formation in patients with SHF. Hyper-
glucagonemia might contribute to the occurrence of these
hemodynamic abnormalities. Considering these hemodynamic
changes, the use ofvasoactive drugs in the management of ascites
should be carefully studied in the future.
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PREOPERATIVE SELECTIVE PORTAL VEIN EMBOLIZATIONS (PPVE)
ARE AN EFFECTIVE MEANS OF EXTENDING THE INDICATIONS OF
MAJORHEPATECTOMY INNORMAL AND INJURED LIVER
D. Elias, T. Deba6re, A. Roche, S. Bonvalot, Ph. Lasser
Department of Surgical Oneology, Instistut Gustave-Roussy, Comprehensive
Cancer Center, Villejuif, France
The objective was to determine retrospectively the efciency of selective pre-
operative portal vein embolization (PPVE) in inducing hypertrophy of the
future remaining liver before major hepatectomy resecting a substantial portion
of functional liver parenchyma. Twenty eight patients with initially
unresectable liver tumors had PPVE between sept 87 and sept’95. Twenty-three
of them were curatively hepatectomized after PPVE. They represent 6% of the
371 patients hepatectomized for malignant lesions in the same period. PPVE
was done under sonographic guidance, using a simple 5-F catheter, by the
transparenchymatous approach of a branch of the portal vein, controlateral to
the embolized liver. Different types ofPPVE were performed, according to the
site of the tumors: right liver, right liver and segment IV, right liver and left
lobe, left liver and bisegment V-VIII, and central liver (segment IV-V-VIII). In
23 cases, isobutyl-2-cyancrylate glue was injected for free flow distal and
proximal embolization, to block the portal tree definitively. 3-D volumetric
assessments of the liver were done before PPVE and one month later, before
hepatectomy.
Remits Induced hypeophy of the non-embolized liver was successful in
25 cases (89%). The mean percent increase in volume was 70% (SD:50) for the
28 patients. The mean ratio between the remaining liver and the whole
functional liver was 21.5% before PPVE, and 33.9% after PPVE. Three
patients were not hetectomized because liver hypertrophy could not be
induced and two patients for cancer-related reasons. Two patients died during
the postoperative course with no symptoms of liver failure during the three first
weeks following hepatectmy.
Conclusion PPVE was an efficient means of inducing hyperthrophy of the
future remaining liver in 89% of the cases and permitted a 12.4% mean
enhancement in the ratio between this remaining liver and the whole liver.
These very good results were due to the distal and proximal free flow
embolization technique with a non absorbable material, and an interval of one
month between PPVE and hepatectomy. Indications in normal liver
parenchyma are for patiehts with a very small left lobe or necessitating a right
hepatectomy with wedge resections in the left liver. Indications for damagedF041 F042
EVALUATION OF THE LIVER FUNCTION WITH THE
LIDOCAINE (MEGX) TEST
G Ercolani. A Mazziotti, GL Grazi, E Jovine, R Calliv, A Gallucci,
E Scalzi, G Varotti, A Gardini, A Principe, A Cavallari
2 Dept Surgery, University ofBologna, S.Orsola Hospital, Italy
The lidocaine (MEGX) test, which has been recently proposed as a
sensible index ofthe hepatic function in organ donors, has been employed
in the evaluation of patients carrying chronic liver diseases or hepatic
tumors. MATERIAL AND METItODS The study was carried out in
200 patients admitted from 2/93 to 2/95. There were 120 males and 80
females; their mean age was 52.6 +/- 13.4 (ranging from 21 to 80 years).
Admission diagnosis were hepatocellular carcinoma in 90 cases, hepatic
metastases in 34, decompensated cirrhosis in 41 and different focal liver
lesions in 35. Overall, cirrhosis was present in 112 (56%): according to
the Child-Pugh classification there were 74 A’s, 34 B’s and 4 C’s. The
MEGX test was performed together with the laboratory tests studying the
liver function. Values of the MEGX test (normal level > 50 g/ml) were
statistically compared with results of conventional laboratory tests to
assess its efficacy in revealing liver failure. RESULTS There were no
major complications with the MEGX test: 38 (19%) patients experienced
minor side effects as dizziness and headache. Linear regression analysis
carried out with the MEGX values and the index of hepatic function
revealed a significant correlation with total bilirubin, prothrombin activity,
ammoniemia, albuminemia, phosphatase alkaline, AST and ALT (P<.05
for each index), but multiple regression revealed a significant correlation
only with cholinesterase, ammonemia and total bilirubin. 125 (62.5%)
patients had a reducedMEGX values: ofthese 107 (95.5%) were cirrhotic
and 18 (20.5%)were not cirrhotic (P<.05). The sensibility, specificity and
diagnostic accuracy of the MEGX test in revealing cirrhosis were 95.5%,
79.5% and 88.5% respectively. CONCLUSIONS The MEGX tests
appears to be a reliable index in the study of the hepatic function. It is
easy to be performed and it promptly gives useful informations on the
state of the residual liver function. The test is very sensible for revealing
the presence of cirrhosis.
LIVERTRANSPLANTATION FORBUDD CHIARI SYNDROME
M. Farouk S.W. Ahmet, T.R. Kurzawinski, B.R. Davidson, K. Rolles.
University Dept. of Surgery, Royal Free Hospital, London, UK.
Portocaval shunt surgery for end-stage Budd Chiari Syndrome (BCS) is
often unsucessful. We report the long term results in 8 BCS patients who
were treated by hepatic transplantation over a period of 5 years (age
range: 27- 58 years). The indication for transplantation in 6 patients was
chronic end stage decompensated liver disease and 2 patients was
fulminant liver failure secondary to acute BCS. All patients had hepatic
outflow obstruction confirmed by venography which also revealed
significant caval obstruction in three patients (retrohepatic
gradient>12mm Hg). Standard orthotopic transplantation was performed
with veno-venous bypass being used in 5 patients (mean ascitic volume
6 litres). Recipient hepatectomy was noted to be difficult in all patients
with chronic disease because of severe peri-caval fibrosis. Coagulation
profiles were continually monitored and the underlying hypercoagulable
state treated appropriately by full early postoperative anticoagulation.
Using this method, no arterial or portal thrombotic episodes have been
encountered. Both patients from the fulminant group died. The first
patient with acute BCS died of cardiac arrythmia after unclamping ofthe
graft at the time of surgery. The second patient with acute BCS
presented very acutely and initially underwent portocaval shunt surgery-
but because of gross ascitic fluid production and secondary dilutional
coagulopathy required urgent transplantation. Subsequent to this she
developed multiorgan failure secondary to sepsis and died month after
transplantation. All patients in whom OLT was performed for chronic
disease (6) are alive and well with a mean follow up of 52 months (range:
16 130 months). In conclusion we have found that OLT is associated
with a good long-term outcome in patients with BCS who present with
established hepatic fibrosis. Our limited experience of OLT for acute
BCS has not been favourable.
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BACTERIAL TRANSLOCATION DURING PORTAL
CLAMPING FOR LIVER RESECTION. A CLINICAL STUDY.
M. Ferri, A. Gavelli, S. Gabriel, Ph. Franconeri, C. Huguet
Department of Surgery, Anesthesiology and Microbiology,
Princess Grace Hospital, Principality ofMonaco
The migration of viable enteric bacteria across the intestinal barrier
(Bacterial Translocation) has been experimentally demonstrated
after liver resection. A prospective study was carded out to assess
the incidence and the clinical significance ofbacterial transloeation
in 14 patients undergoing elective liver resection (10 major
hepatectomy) under normothermic ischemia (mean duration 40
13 minutes). A systemic and portal blood sample and a mesenterie
lymph node (MLN) were simultaneously obtained before and after
resection, and cultured for a qualitative analysis. All specimens
taken before resection were sterile. After resection, blood cultures
were sterile in all eases, and the systemic blood remained sterile up
to 24 hours; the MLNs were culture positive in 6 of i4 patients
(43%). Patients with positive MLN showed no postoperative
septic complications. The only septic complication occurred in a
patient with a negative MLN. in conclusion, bacterial transloeation
in the MLNs significantly occurs during portal triad clamping and
liver resection, athough it does not predispose to postoperative
infectious complications.
A GALACTOSE BASED CONTRAST AGENT TO IMPROVE PORTO-
HEPATIC DOPPLERSONOGRAPHY
G. Fischer, G. Paumgartner, R. Rak* and M. Sackmann
Dept. ofMedicine I1, University ofMunich, Klinikum Grosshadern,
81377 Munich, ScheringAG 13342 Berlin; Germany
Background. Microbubbles of air packed in galactose (SHU 508 A, Schering)
constitutes a doppler-ultrasound contrast agent [DUSCA], which doubles doppler
signal intensity from the vessel of interest. DUSCA has the size of erythrocytes and
circulates through both the pulmonary and systemic circulation with a half-life-
time of about minutes. Aim ofthis study was to investigate effects and
tolerability ofDUSCA in patients with portal hypertension and insufficient doppler
signal intensity, because portal and hepatic veins can not be visualised sufficient
enough for conventional dopplersonography [DS] in up to 15% of such patients
(J Ultrasound Med; 1990: 9:705).
Material and methods. A Hitachi-Picker ultrasound unit with a 3,5 MHz convex
array was used for DS. 146 patients with liver diseases ofvarious origin were
investigated prospectively (male n=93, female n=53; age 14-83 years, mean 50+13
years). 210 examinations were performed, in 39 patients repeatedly (mean 1.9+1.0
examinations). The patients were referred to DS to determine the presence of
portal hypertension (n=49), to exclude portal (n=64), splenic (n=7), or hepatic
(n=l5)vein thrombosis or to evaluate TIPS function (n=75).
Patients were included in the study when no diagnosis could be made by means of
DS. Due to the characteristic effects ofDUSCA the study could not be blinded to
the investigator. In 194 examinations (92.3%) a diagnosis could be made without
DUSCA. The remaining 16 patients (7.7%) received DUSCA to assess portal
(n=10) or hepatic (n=4) vein patency or to evaluate TIPS function, (n=2). 8 ml of
DUSCA (400 mg/ml) were quickly injected i.v.. Angiography, CT, or MRT,
respectively was performed as a control in every patient after receiving DUSCA.
Results. Portal and hepatic vein could be unequivocally assessed in 12 patients
(portal vein thrombosis n=3, hepatic vein thrombosis n=l, in the remaining 8
patients the vessels were patent), whereas in 2 patients portal vein thrombosis
could only be suggested, but not confirmed. TIPS function could be assessed
correctly in the 2 patients after receiving DUSCA.
No serious side effects were encountered. 11 patients did not feel anything after
injection ofDUSCA, patients had short (dtlration less then halfan hour), self
limiting episodes of discoinfort (bad taste (n=2), temperature sensations at the
injection site, dizziness, and palpitations, n=l each)possibly related to DUSCA.
Summary and Conclusion. The galactose based DUSCA SH U 508 A is well
tolerated and appears to be of great value in the assessment ofportohepatic vessels
not amenable to conventional dopplersonography.F045 F046
IMPACT OF TIPS ON THE LIVER TRANSPLANT (LT) OPERATION
M. Fraimln, S. Pan, A. Hoffman,C. Cosenza,L. Sher, L. Makowka, R. Lopez
Liver Transplant Service, St. Vincent Medical Center, California, USA
TIPS is being used with increased frequency to treat the complications of
portal hypertension in transplant candidates. However, its impact on the
transplant operation is unknown. Methods: We reviewed our experience
with LT in recipients with and without TIPS. The incidence of portal vein
thrombosis (PVT), operative blood use, operative time, the use ofvenovenous
bypass (VVB), and survival were compared using t-test and Fisher’s exact
test. Results: Seventy-eight adults had LT for chronic disease from 1/1/94 to
11/30/95 at Cedars-Sinal & St. Vincent Medical Centers. Twelve patients
(15.4%) had TIPS placed prior to LT: 23.3% of recipients in 1995 & 10.4% in
1994. Five patients had TIPS in place for > lyr. There was no difference in
the age, disease indication, or operative time between the two groups.
operative partial or use of 30 days year
PRBC’s complete VVB survival survival
(units/pt) PVT% (n) % (n) (%) (%)
TIPS 5.1 + 4.7 41.7 (5) 25.0 (3) 91.7 75.0
(n=12)
no-TIPS 8.2 + 8.9 6.1 (4) 60.6 (40) 97.0 93.9
(n=66)
p-value 0.248 0.003* 0.029* 0.400 0.069
*p<0.05
Five patients (41.7%) with TIPS had partial or complete PVT at the time of
LT (4 with TIPS in place for > yr.). Four of these needed thrombectomy
prior to porto-portal anastomosis and required an interposition vein graft to
the superior mesenteric vein. In 2 patients (one with PVT), the TIPS extended
to the confluence of the superior mesenteric and splenic veins necessitating
extraction prior to portal anastomosis
Conclusions: TIPS effectively controls portal hypertension prior to LT and
may decrease the need for VVB. However, it predisposes patients to PVT,
particularly if placed > yr prior to LT, and may impact the transplant
operation. In the transplant candidate, TIPS should be performed by an
experienced radiologist and considered a temporary bridge to liver
replacement. The transplant surgeon should be prepared for portal venous
reconstruction in patients with TIPS.
F047
AN IMMUNOLOGICAL COMPONENT TO SUICIDE GENE THERAPY
S. Gagandeep, I. Pope. B. Green, S. Christmas, 2D. Klatzmarm,
A.R.Kinsella and G.J. Poston.
Department of Surgery, University ofLiverpool, Liverpool, U.K.
2L’ Hopital de la Pitie Salpetriere, Paris, France.
The integration and over expression of the herpes simplex virus type
thymidine kinase (HSV1-TK) gene in localised tumours, results in turnout
regression following the administration of the specific nucleoside analogue
ganciclovir (GCV). Although only 10-20 per cent ofthe tumour cells take up
the HSV1-TK the neighbouring cells die as a consequence of what has been
termed the "bystander effect". Subcutaneous tumours were created
following the injection of x 106 cells of the mouse colon adenocarcinoma
cell line MC26. All control mice were co-injected with x 106 cells of the
NB16 packaging cell line expressing the nls-lacZ gene and all test mice
were co-injected with x 106 cells of the PLJ-TK packaging cell line
expressing the HSV1-TK gene. The mice were divided into four groups:
nude Balb/C mice into a control and a test group (Groups and 2
respectively) and normal Balb/C mice into a control and test group (Groups
and 4 respectively). Seven days were allowed for retroviral gene
transduction and tumour growth prior to treatment with GCV twice daily for
five days. At the end of this time the animals were sacrificed and the tumour
volume in each group was assessed. A significant tumour regression was
observed in the test groups versus the control groups. The mean tumour
volume was 42.1mm in the control groups (Groups and 3) compared with
3.3nun in the test group 4 (p<0.01). The test group for nude mice did not
respond with the same efficacy only reaching a reduced tumour volume of
20.5ram (p<0.05) These data demonstrate a near. complete regression of
established subcutaneous tumour in normal Balb/C mice following the
successful transduction of the HSV1-TK suicide gene followed by treatment
with GCV. The same was not true for the Balb/C nude mice suggesting a
strong cell mediated immune component to the ’bystander effect’. It is
therefore possible that suicide gene therapy may trigger a more general anti-
neoplastic action by facilitating a specific anti-tumour immune response.
Further experiments to determine if there is a generalised systemic anti-
tumour immune response are in progress. We have also developed an
animal model for the treatment of multiple hepatic metastases in the rat,
with the packaging cell line delivered by hepatic artery cannulation. In this
way it may be possible to treat patients with otherwise inoperable hepatic
metastases by suicide gene therapy.
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HIGHLY-SENSITIVE IDENTIFICATION OF a-FETO
IN CIRCULATING PERIPHERAL BLOOD OF HEPATOCELLULAR
CARCINO PATIEBTS
Fume,’, Juni Tamlm, Shin-iehi Seto, Takayuki
First Oent of Surgery, Kyoto University,
Kyoto, Japan
In order to capture hepatocellular carcinoma (HCC) cells in
circulating peripheral blood, we ade analysis to see if
a-fetoprotein {AFP) mPaNA exists in the peripheral blood
obtained from patients with HCC and also, as a control, from
hepatitis-viral-aarker-pasitive patients without HCC and a
healthy volunteer. As the number of HCC cells in lcc of
peripheral whole blood and the quantity of AFP alLNA are
expected to be very stall, the analysis was performed by the
reverse transcription followed by an original three-step
polymerase chain reaction. By this highly-sensitive method,
5 of 7 HCC patients were positive for AFP mRNA. These 5
positive patients consisted of 3 with clinically apparent
recurrence, one preoperative patient with tumor thrombus
in the portal vein and one recurrence-free patient who
developed clinically detectable recurrence 3 months after
this analysis. On the other hand, one follow-up patient
without any clinical recurrence and negative for AFP eflNA
showed no recurrence even after 3 months. One preoperative
patient, whose serum AFP protein level was as high as
67213 ng/ml was negative for AFP mRNA Neither 4 patients
with positive viral markers nor a healthy volunteer was
positive. The results suggest that detection of AFP mRNA
from HCC patients’ peripheral blood by our highly-sensitive
RT-PCR may be a practical and powerful tool to diagnose the
preoperative spreading of ItCC and to monitor its recurrence.
F048
AGEING ENHANCES ANOXIA/REOXYGENATION INJURY IN ISOLATEE)
RAT HEPATOCYTES.
A. Gtsbarrini, S. De Notariis, M. Simoneini, P. Caraceni, G.R. Angelini, G. Sica, A.
Colantoni, E. Trevisani, A. Mazziotti, A. Cavallari, P. Pola, M. Bemardi.
Angiology and Internal Medicine, Catholic Universty of Rorna; Medical Pathology,
University ofBologna, Italy.
The reoxygenation phase that follows period of prolonged anoxia i,
characterized by the massive formation ofoxygen free radicals (OFR), highly reaetiw,
substances responsible of damage to cell membranes. Ageing is associated with
reduction of antioxidant status. Aim of this study was to determine the effects o:f
ageing on the sensitivity of liver cells to a period of anoxia/reoxygenation. OFIt
formation and cell injury were evaluated in hepatoeytes isolated from rats of different
ages.
METHODS: Sprague ,Dawley male fed rats of 2 or 8 months of age were utilized.
After isolation, liver cells were cast in agarose gel threads and perfused with
oxygenated Krebs Henseleit bicarbonate buffer (KHB). A 2 h period of anoxia wa.,
obtained shifting the gas phase of the perfusate to 95%N2-5%CO2. Successively, tht
cells were reperfused for h with oxygenated KHB. OFR were evaluated by
enhanced chemiluminescence: anion superoxide (02-) by adding mM lueigenin to
the solution, hydrogen peroxide (H202) by adding 10 mM luminol. Cell damage
was assessed by measuringLDH release in the effluent.
RESULTS: in basal conditions, no differences were observed in the levels o:f
lucigenin or luminol-enlumced chemiluminescence between the two groups (13:t:1 vs
144-4 nA and 234-3 vs 244-5 rtA, respectively). During anoxia, lucigenin ox
luminol-enhanced chemiluminescence, expression of 02- and H202 formation,
respectively, decrease to background values, while LDH release was signifieamtly
greater in cells isolated by older animals (750% vs 490% after 2 h of anoxia; p<0.05).
During reoxigenation, OFR formation increased in both groups; such a rise, however,
was markedly greater in cells obtained from older rats: 02- reached a peak after 15
rnin (1404-10 vs 1004-11 hA; p<0.05), while H202 increased progressively during the
hour of reoxygenation (1214-9 vs 834-12 rib.; p<0.05). LDH release rise markedly
during reoxygenation in both groups; newly, however, higher values were observed
cell obtained from older rats (1300% 750%; p<0.05). The peak of lueigenin.-
enhanced chemiluminescence, expression of 02- production, was observed 10-15
min before the peak release ofLDH.
CONCLUSIONS: our results show that: 1) liver cells produce high level of anion
superoxide and hydrogen peroxide during the reoxygenation phase that follows
period of prolonged anoxia; 2) the age of the rats influences the sensitivity of liver
cells to anoxia/reoxygenation injury.F049 FOO
SPLIT LIVER TRANSPLANTATION IS THE RIGHT
GRAFT RECIPIENT AT RISK ?
K.A: Gawad X. Rogiers, M. Malag6 and C.E. Broelsch
Department of Surgery, University of Hamburg, Germany
Introduction: The increasing shortage of donor organs has led
to an increased application of split liver transplantation. Three
different techniques for the partition of the liver were applied:
The classical technique and the new techniques of ex-situ and
in-situ (in the heart beating cadaveric organ donor) splitting
that have been introduced by our group.
Patients and methods: Between 1.1.94 and 31.12.95 thirtyone
split liver transplantations have been performed at our
department. During the same time 115 whole organ
transplantations were performed. 15 patients with a mean age
of 33 (5-64) years, a mean weight of 62.5 (28-89) kg and a
mean donor/recipient ratio of 1.1 (0.7-1.9) received right liver
grafts. 5 (31%) transplantations were performed high urgent.
Results: Classical technique: patient survival 3/5, graft
survival 2/5. Median cold ischemic time 850 (550-1005)
minutes. Median postoperative GOT-peak 617 (120-1100) U/I.
Ex-situ technique: patient and graft survival 3/5. Median cold
ischemic time 715 (510-960). Median postoperative GOT-peak
534 (168-4389). In-situ technique: patient and graft survival
6/6. Median cold ischemic time 690 (285-875). Median GOT-
peak 196 (122-1232) U/I.
Conclusion: Partition of the liver in the heart beating
cadaveric organ donor results in a right graft with superior
initial function and a better survival compared to the "ex-situ"
techniques. Should these results be confirmed with increasing
numbers a systematic approach to liver splitting with the in-
situ technique should be aimed at.
DISTAL SPLENO-RENAL SHUNT (DSRS):LONG TERM PORTAL
PERFUSION (PP) MAINTENANCE.
Gerunda G.E.; Zangrandi F.;Neri D.; Bisello M.; Merenda R.; Barbazza F.;
Meduri F.; Da Giau G., Ciardo L.; Bruttocao A.; Maffei Faccioli A.
First Department ofGeneral Surgery- University Padua.
Maintenance of high portal perfusion is the most important feature of
DSRS. When spleno-pancreatic disconnection (SPD) is added survival and
quality of living are increased. 91 Patients that previously bleeded from
oesophageal varices underwent DSRS in the first 26 a traditional, limited,
porto-splenic disconnection was performed in the other 65 a spleno-
pancreatic, spleno-colic and gastro-colic disconnection (SPD) was added.
Peri-operative mortality was 14%, related to Child’s risk (Child A-B 4%).
No mortality due to rebleeding from esophageal or gastric varices was
reported; loss of long-term PP was observed in 23%. Persistence of disease
and incomplete SPD were the two prognostic factors related to survival
(38% vs 11%-p<0.001 and 43% vs 14%-p<0.05 respectively).
DSRS:TYPE OF DSRS AND ELECTIVE EVS
SURVIVAL
Porto-systemic encephalopathy (PSE) was found in 24% (evident in 4%)
and was influenced by worsening of PP (57% vs 23% -p<0.01), by
persintence of disease (48% vs 17% -p<0.02) and incomplete SPD (48% vs
14% -p<0.05).
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LOSS OF HETEROZYGOSITY ON CHROMOSOME 16q IN
SMALL (<4 cm) HEPATOCELLULAR CARCINOMA.
.L..Gramantier..i, B.Stecca*, S.Gaiani, A.Mazziotti**, P.Chieco*,
A.Casali, L. Masi, A.Cavallari**, L.Bolondi. Dipartimento di
Clinica Medica e Gastroenterologia; *Istituto Oncologico F. Addarii,
Ospedale S.Orsola, Bologna; **Clinica Chirurgica II Universitt di
Bologna, Italy.
Introduction: The genesis of human cancers, including HCC, is
thought to be due to multiple genetic alterations. Loss of
heterozygosity (LOH) has been frequently found at multiple loci in
HCC: lp, 4q, 5q, 8p, 8q, 10q, llp, 13q, 16q, 17p, 22q. Loss of
some putative tumor suppressor genes within these chromosomal
regions might be involved in transformation of hepatocytes to
malignant tumor cells.
Aim of this study was to analyze small HCC without signs of local
or systemic spread, to define a minimal region of loss on
chromosome 16q, where other previous reports made on unselected
cases ofHCC found large areas of LOH.
Materials and Methods: twenty-eight cases of small (less than 4 cm
in diameter) HCC were selected. Extracted DNA was screened for
LOH by means of PCR-SSCP. Blood lymphocytes, liver cirrhosis
and HCC were available for 6 cases, being available in the remaining
cases either blood lymphocytes or liver cirrosis.
Results: analysis of 10 polymorphic microsatellite markers on
chromosome 16q identified 3 out of 28 cases of small HCC
exhibiting LOH of 16q in at least one locus. One tumor had
monosomy of 16q, displaying allelic loss for all informative markers
tested, and 2 out of 19 informative cases revealed a minimal area of
loss at 16q24 (D16S413 locus). None of the cases of liver cirrhosis
presented LOH in the loci analyzed.
Conclusions: our data confirm in some small HCC, the LOH on
chromosome 16q that was frequently found in advanced HCC. The
deletion of this area was associated to large, metastasized HCC in a
previous report, where only 6 early lesions were examined. In our
study the minimal area of loss was restricted at 16q24 (D16S413
locus).
COMBINED, ARTERIAL AND PORTAL, OILY
CHEMOEMBOLIZATION (OCE) OF LIVER
NEOPLASMS
A.M.Granov, D.A.Granov. P.G.Tarazov
Dept Surgery & Div Angio/Interventional, St.Petersburg
Research Institute ofRoentgenology and Radiation
Therapy, St.Petersburg, Russia
The purpose of this study was to assess the effecacy of
combined, arterial and portal, OCE vs arterial OCE alone
in patients with unresectable liver malignancies.
Between 1986 and 1994, 109 patients with advanced
hepatocellular carcinoma HCC, 27 cases and liver
metastases Mts, 82 cases underwent 179 courses of
OCE. We used a new liposoluble cytostatic Dioxadet (l 5-
20 mg) or Doxorubicin (30-100 mg) in iodized oil for
arterial procedure. In 45 patients, the same solution was
injected into the portal vein 15-20 days later.
The 1-2-3yr survival for arterial OCE was 20%, 10%, 0%
for HCC, 51%, 6%, 0% for colorectal and 43%, 22%,
14% for other liver Mts. The same rates for combined
treatment were 83%, 42%, 25% for HCC, 81%, 23%, 9%
for colorectal and 91%, 36%, 9% for other Mts.
These data show that portal OCE may be useful addition to
arterial OCE in patients with unresectable liver
malignancies.F053 F054
HBV INFECTION DOES NOT AFFECT SURVIVAL AFTER
LIVER TRANSPLANTATION.
GL Grazi, A Mazziotti, C Sama, E Jovine, FG Stefanini, A Gallucci,
V Pilotti, G Varotti, A Cavallari
2 Dept. Surgery, University of Bologna, S.Orsola Hospital, Italy
Liver transplantation (LT) has became the elective treatment for end-stage
liver diseases: questions still arise on its efficacy in HBsAg positive
cirrhotics. MATERIAL AND METHODS Of the 123 cirrhotics grafted
over the past 9 years, 39 (31.7%) were HBsAg positive. Four (10.3%)
were HBeAg positive, (2.6%) was HBV-DNA positive and 17 (43.6%)
were anti-Delta positive. An HBV specific intramuscular prophylaxis (to
keep anti-I-IBs titer over 100 mU/ml) was carried out in the latter 28
cases. RESULTS Three HBsAg patients (7.7%) died within 30 days for
HBV unrelated diseases (2 M.O.F. and primary graft non function).
Survival ofthe entire group of 123 cirrhotics was 75.7% and 69.9% after
mad 3 years respectively. Twelve (33.3%) patients retumed HBsAg
positive after a mean time of 10.3 + 15.5 months (range 43 days-55.8
months): recurrence appeared in 3 (75%) I-IBeAg positive patients and in
5 (29.4%)out of the 17 anti-Delta positive. The I-IBV-DNA positive
died 80 days after LT because of stroke. The recurrence rate was 72.7%
in the group of patients without prophylaxis and 16% in the group with
prophylaxis (p=0.0008). Survival was 77.8% and 73.3% for HBsAg
negatives and 71.7% and 63.1% for HBsAg positives after and 3 years
respectively (p=NS). The hazard of I-IBsAg recurrence in treated patients
was reduced to 24.9% as compared to untreated patients. There were 3
deaths due to HBV relapse, 2 in the untreated group and in patients
treated with immuno globulins. Of the 8 surviving patients with I-IBsAg
recurrence, 3 (37.5%) did not present signs of the disease, while in 5
(62.5%) cases recurrence developed into a mild chronic hepatitis.
CONCLUSIONS Recurrent disease can occur after LT for HBV related
cirrhosis with evidence of viral replication. Prophylaxis protocols seem
effective in the prevention of I-IBsAg reappearance after LT and they
represent a further tool in the postoperative treatment of HBsAg positive
cirrhotics. LT can be successfully performed in these patients only with
the adoption of such protocols.
PORTAL VEIN THROMBOSIS AFTER SPLENECTOMY AND
DEVASCULARIZATION FOR BLEEDING ESOPHAGEAL
VARICES: APOTENTIALLY LETHAL SYNDROME
I. Hamdi, A. Khamag, J. Faitori
Department of Surgery, Arab Medical University, Benghazi, Libya
Although portal vein thrombosis is a well-recognised phenomenon in
patients with liver cirrhosis, its incidence after splenectomy and
esophago-gastric devascularization is underappreciated.
We present nine cases of thrombosis of the portal vein after
splenectomy and devascularization (Hassab operation) performed on
46 patient (19.6%) for bleeding esophageal varices. There were 7
men and 2 women. The mean age was 42 years (range, 32-64 years).
Six patients were classified as Child grade C and three patients were
Child grade B. Seven patients survived the event and two patients
died, representing mortality rate of 22.2%. We currently employ the
flow Doppler ultrasonography for both diagnosis and follow-up.
Resolution of the thrombus was observed in one patient and
cavernous transformation of the portal vein occurred in 6 patients.
Mesenteric venous infarction of the small bowel was not encountered
in any patient in this series.
Portal vein thrombosis should be suspected in patients who develop
fever, abdomi’nal pain, and with or without intestinal complains after
Hassab operation, even if the operation is remote. Prompt treatment
is lifesaving.
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A LOW CENTRAL VENOUS PRESSURE REDUCES BLOOD LOSS
DURING LIVER SURGERY
S.S. Hanna, J. Proctor, T.P. Hanna
Division of General Surgery, Sunnybrook Health Science
Centre, University of Toronto, Toronto, Canada
A retrospective study was carried out using our liver
resection data base to determine the relationship
between Central Venous Pressure (CVP) and blood loss
during liver resection. The data base contained ii0
patients who underwent liver resection between 1980 and
1995 and who had their CVP recorded. Since January I,
1991 an attempt was made to keep the CVP as low as
possible especially during the liver transection phase.
Prior to January i, 1991 no attempt was made to maintain
a low CVP. Patients were divided into 2 groups: major
liver resections (n=66) and minor liver resections
(n=44). A liver resection of 1-2 Couinaud segments was
considered a minor liver resection and a resection of 3
or more segments was considered a major liver resection.
Mean CVP, Estimated Blood Loss (EBL), and Number of
Units of. Blood transfused (NUB) were compared in major
and minor liver resections before (n=49) and after
(n=71) January I, 1991. There were 31 major and 18
minor liver resections before January i, 1991 and 35
major and 26 minor liver resections after that date.
Analysis of variance confirmed that after the
introduction of our low CVP policy there was a decrease
in both EBL and NUB; and as expected the reduction was
greater in patients undergoing major liver surgery
(P=O.OI). A low CVP is associated with less blood loss
during liver resection. It is recommended that liver
surgeons communicate this information to the
anaesthetists involved in the care of their patients in
order to achieve the goal of keeping the CVP at or below
5 cm H20 to minimiz blood loss during liver surgery.
SEGMENTAL VOLUME IN LIVING RELATED TRANSPLANTATION
(LRT): CLINICAL CORRELATION AND DONOR: RECIPIENT RATIO
TG Heffron. AN Langnas, IJ Fox, AJ Matamoros, JC Anderson, DR
Mack,TM McCashland,A Dhawan,S Kaufman, RK Zetterman, TJ Pillen,
D Sudan, J Jerius, JA Vanderhoof, BW Shaw Jr.
Reduced sized cadavedc and LRT were developed in response to
pediatric donor shortage. The pediatric donor pool may be enhanced by
using the largest donor/recipient ratio possible. However, large disparity
between donor and recipient graft size may lead to significant problems
resulting in graft and/or recipient loss. Preoperative estimation of
segmental volume is necessary to avoid donor/recipient size
disparity.Accuracy of preoperativesegmentalvolumemeasurement and
effect of donor recipient size disparity were retrospectively reviewed in
26 LRT’s and one cadaveric donor. Matedal and Methods: Over 3 years
LRT recipients(median age.8 years and wt 8kg) accounted for 29%
(26/91) ofpediatric liver transplants. Left lateral segmental (LLS) volumes
were measured preoperatively via CT volumetry in living related donors
and compared with surgical weight and displaced volume. A 6 kg
recipient in acute fulminant hepatic failure emergently utilized acadaveric
LLS from a 130 donor requiring further resection of the left lateral
segment. Results: Donor/recipient weight ratio ranged from 2.9 21.5
(average 11.1). Unear Reoression Correlation Coefficient: Surgical
measured volume/surgical measured weight (N=12) .9: Preoperative
estimated volume/surgical measured wt(.N=26) .6: Donor
weight/surgical measured weight (n=26) .2. Preoperative volume
(n=26) average 229 ml (157-363ml), Surgical segmental volume (n=12)
average 292 ml (200-300ml), Surgical measured weight (n=26) average
298.5 g avg (190-440 g). Patient and graft2 year actuarial survival in the
LRT group was 87% and 80% respectively. No grafts were lost
secondary to donor recipient size disparity. Conclusion: Preoperative
segmental volume estimation via linear CT scanning is an accurate
method to determine segmental livervolume before donor hepatectomy.
Left lateral segmental volume could not be accurately predicted from
donor weight. Segments from donors greater than 20 times the recipient
weight may be successfully utilized for transplantation. In emergent
conditions, LLS grafts may be further reduced.
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DISTAL SPLENORENAL SHUNT IN 1990’S: PATIENT
SELECTION AND OUTCOME.
J. M. Henderson, C. Agnor.
The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
This study prospectively evaluated 42 patients having distal
splenorenal shunt (DSRS) from 10/92 to 10/95. Selection for
DSRS was based on: variceal bleeding refractory to endoscopic
and pharmacologic therapy; adequate liver function (Childs A-31,
B-10, C- 1); etiologies were alcoholic-14, cryptogenic-9, PBC-6,
post hepatic-6, portal vein thrombosis-3, others-4. Five patients
were shunted emergently, and 37 had elective DSRS, with standard
DSRS in 37 patients and modified selective shunts in 5. There was
no hospital mortality. The median hospital stay was 9 days, with
median hospital charges of $23,000. There was one shunt
thrombosis in a patient with a myeloproliferative disorder who
required splenectomy/devascularization. Early rebleeding occurred
in 3 patients (7%): all had patent shunts, and bleeding resolved
with nonoperative management. Late rebleeding occurred in one
patient (2%) in the presence ofa patent shunt. Mild/moderate
encephalopathy was found in 4 patients (10%) at median follow-up
of 18 months. There have been 2 late mortalities, one from liver
failure and one with a progressive myeloproliferative disorder.
Two patients have required liver transplant to date, one with
sclerosing cholangitis, and one with a cryptogenic cirrhosis 16
months after emergent DSRS. We conclude that DSRS plays a
role in managing patients with variceal bleeding in the 1990’s:
good risk patients can have variceal bleeding controlled by DSRS
with low morbidity.




Liver Transplant Unit. Hospital. Gral. Universitari
Vall d’Hebron. Barcelona. SPAIN.
The Portal Vein Thrombosis (PVT) is a common
complication observed in patients with end-stage
liver diseases,and it has been considered as
relative contraindication. We have studied a
total of 195 LTx in 177 patients, made from
December 1988 to August 1995, with 18
retransplantations. The median age of the group
was 51 years old, 19 male and 5 female. The maln
end-stage liver diseases which required LTx
were:Postnecrotic cirrhosis (111/195), Malignant
hepatic tumors (36/195), Cholestatic diseases
(13/195) and Acute hepatic failure (8/195). The
preoperative diagnosls was done by Doppler
ultrasonography and detected 4.6% thrombosis
(9/195). The real incidence of PVT found at time
of surgery was 12.3% (24/195). Nine out of 24
PVT were complete (total occlusion of portal
trunk) and 15 were partial. A higher incidence of
PVT was observed in patients affected by CHV
(15/86 vs. 9/109, X2=3.75, p=0..05). Upper GI
bleeding and sclerotherapy sesslons were more
frequent, in patients with PVT (p<0.05). During
surgical procedure, resection and end-to-end
anastomosis was performed in 15 cases,
thrombectomy and anastomosis in 7 cases,
anastomosis at confluence of mesenteric superior
vein and splenic vein was performed in one case,
and anatomic venous iliac graft in another. When
we compared operative mortality and postoperative
mortality there were no significant differences.
Only one patient who had had PVT before LTx
presented thrombosis after LTx, while 2 patients
without previous PVTdeveloped further thrombosis
(1/24 vs 2/171 ,NS). There was a-higher incidence
of hepatic artery thrombosis developed after LTx
in. those, patients with previous PVT:3/24vs
43/171, X=6.27, p= 0,013 and OR= 5.9. In summary
we believe that PVT can not be considered as a
contraindication to LTx.
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TREATMENT OF IRRESECTABLE HEPATOCELLULAR
CARCOMAWITH REPEATED TRANSIENT
DEARTERIALIZATION. (ARANDOMIZED STUDY)
1J.F. Huang, 1W-S. Wang, 1L-j. Liang, 1M-D. Lu, 2B. Jeppsson, 2B.
Persson, 2S. Bengmark
1Department of Surgery, First Affiliated Hospital Sun Yat-Sen University
ofMedical sciences, Guangzhou, China, 2Department of Surgery, Lund
University, Lund, Sweden
40 patients with the irresectable hepatocellular carcinoma (HCC) admitted
to the department ofHPB surgery in the first affiliated, hospital ofSUMS
were randomized into two groups: 20 (each) from February 1994 to April
1995. Patient’s inclusion criteria are non-resectable primary hepatocellular
carcinoma. Preoperative diagnosis was confirmed by ultrasonography or
computed tomography with biopsy.
40 patients were treated with hepatic artery ligation (HAL) and repeated
transient dearterialization (RTD) respectively. Postoperative response to
treatment, liver function change (ALT), AFP, imaging examination ofthe
tumour, patient’s survival were evaluated in two groups.
It has been shown thatRTD is superior toHAL in terms ofthe objective
response to therapy, reduction oftumour size, patient’s symptom relief,
liver function and AFP changes and patient’s survival. (In RTD group,
operative mortality was 0, morbidity was 10%, the effective rate was 70%,
the mean survival time was 8.2 months, 6 month survival was 79.7%; in
HAL group, operative mortality was 35%, morbidity was 35%, the
effective rate was only 5%, mean survival time was 5.1 months, 6 month
survival was 35.8 %).
It seemed to us thatRTD would be a promising palliative option for HCC
and it has its own significance ofthe armamentarium for the management
ofHCC.
PERCUTANEOUS NEEDLE ASPIRATION AND
DRAINAGE OF SOLITARY HYDATID CYSTS
OF THE LIVER.
R.Ikramo..v, V.Vishnevsky, A.Gavrilin.
A.V.Vishnevsky Institute of Surgery,Moscow,Russia.
We present a method of percutaneous treatment of
hydatid cysts of the liver which reliably prevents
dissemination of scoleces of the parasite within the
abdominal cavity and development of anaphilactic
shock. The method involves percutaneous puncture of
the cyst with CHIBA needle, aspiration of cyst
content, injection of antiparasitic solution/30% NaCI/
for 10 15 min. with subsequent puncture of the cyst
with troacar- catheter and aspiration of cyst content
with chitinous membraine/.The cysts where drained
for 2 weeks with irrigation of cyst with 30% NaCI
solution. Futher removal of remnants of the chitinous
membrane was performed under the gidence of
fistuloscopy and fistulography.Eight patients were
treated by this method with no mortality and
morbidity. Follow-up of 7 pts. for 3-10 years showed
no recurrences.
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TITLE: Effect of Total Hepatic Vascular Exclusion During
Liver Resection on Hepatic Ultrastructure
Authors: A.M. Isla, M.E. Moussa, C.E. Sarraf, H. Sawada,
N.A. Habib
ABSTRACT:
Total vascular exclusion (TVE) during liver resection is
achieved by clamping the hepatic artery, portal vein,
infrahepatic and suprahepatic vena cava. It aids the surgeon
in resecting lesions close to major blood vessels and diminish
blood transfusion. A major drawback of TVE is liver
ischaemia.
Eleven non cirrhotic patients that underwent major resectional
liver surgery under TVE were studied. The duration of TVE
(warm liver ischaemia) ranged between 16 and 48 minutes.
Biopsies were taken at three stages: pre-ischaemia, before the
application of vascular clamps; ischaemic, just at the end of
TVE; and post-ischaemia, 12 to 120 minutes following
reperfusion. Light-electron microscopy study was performed
to study the hepatic architecture, hepatocyte morphology, bile
canaliculi and sinusoids. All specimens were coded and
assessed blindly for tissue (light microscope level) and cellular
(electron microscope level) changes. Prior to TVE hepatocytes
and hepatic architecture were as normal as could be expected.
During ischaemia the hepatic architecture was distorted due
to widespread collapse of sinusoidal spaces. Hepatocytes
showed focal chromatin condensation at the nuclear margins,
distented nuclear envelope and swelling of both mitochondria
and endoplastic reticulum. After reperfusion these changes
reversed.
It can be concluded thatTVE over a period of 48 minutes has
no irreversable deleterious effects on the ultrastructure of the
non-cirrhotic liver.
HIGH PREOPERATIVE SERUM ALANINE TRANSAMINASE
LEVEL INCREASES THE RISK OF LIVER RESECTION FOR
HEPATOCELLULAR CARCINOMA (HCC) IN CHILDS’ GRADE A
CIRRHOTIC PATIENTS
P. Jagot, O. Farges, R. Noun, J. Belghiti.
Department of Digestive Surgery; Hospital Beaujon, University Paris VII,
Clichy, France
Liver resection in patients with liver cirrhosis (even in the absence of
overt liver insufficiency) is associated with greater risk than in patients
without underlying liver disease. Because the incidence of HCV-cirrhosis
related HCC is anticipated to increase rapidly in the near future we have
assessed, by multivariate analysis, parameters associated with in-hospital
mortality and morbidity in a consecutive series (1984-1994) of 108
Childs’ grade A cirrhotic patients undergoing liver resection of an HCC (1
or less liver segment, 2 segments or or more segments in 42, 23 and 43
patients respectively).
Parameters entered for analysis included age, aetiology of cirrhosis,
preoperative serum bilirubin, AST, ALT, GGT, albumin, creatinine
levels as well as prothrombin time, presence or absence of pathological
features of superimposed active hepatitis, extent of resection, type and
duration of vascular clamping and amount of intraoperative blood loss.
Overall incidence of in-hospital death and major postoperative
complications were 8.3% and 48.1% respectively. By univ,’uiate analysis,
preoperative serum ALT levels (p=0.001) and intraoperative transfusions
(p=0.01) were the only parameters significantly associated with in-
hospital death. However, only serum ALT concentrations was an
independent risk factor. In-hospital mortality in patients whose
preoperative serum ALT was below 2N (n 77), comprised between 2 and
4N (n 23) and greater than 4N (n 8) was 3.9 %, 13.0 % and 37.5 %
respectively. Increased ALT levels (> 2N) was also associated with an
increased incidence of postoperative ascites (58 vs. 32 %, p=0.01), kidney
failure (16 vs. 0 %, p=0.0003) and UGI bleeding (6.4 vs 0 %, p 0.02).
Conclusion: In contrast to previous studies, we have shown that
preoperative serum ALT level is an independant and reliable predictor of
in-hospital mortality and morbidity following liver resection in Child A
cirrhotic patients. Our results suggest that cirrhotic patients with ALT >
2N should undergo only a subsegmentectomy or, if a larger resection is
considered, be considered as liver transplant candidates. Alternatively, anti-
viral therapy may prove usefull in patients with an HCV-related cirrhosis.
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PIGGY BACK VS CONVENTIONAL TECHNIQUE IN LIVER
TRASPLANTATION: PRELIMINARY REPORT OF A RANDOMIZED TRIAL.
E Jovine, A Mazziotti, GL Grazi, M Morganti, B Nardo, M Masetti, F Pierangeli,
B Begliomini, P Gaito-Mazzet’d, R Paladini G Martinelli, A Cavalliri
2 Department of Surgery, University of Bologna.
The Piggy-back technique of liver trasplantation preservs the full length of the
recipient inferior vena cava and avoids the utilization of veno-venous by-pass.
We are performing a randomized trial to asses if there are any significative
advantages of the piggy back versus the conventional technique in adult
trasplant recipients. MATERIALS AND METHODS: From January 1995 and
December 1995, 54 liver transplantations in adults were performed in our
Institution, 30 of whom were included and randomized in our study. All the
patients considered were cirrhotics and patients with previous abdominal
surgery, acute hepatic failure, renal insufficiency or retransplantations were
excluded. In the Piggy back technique a temporary porto-caval shunt has never
been used. All conventional operations have been performed utilizing a Griffith
veno-venous by-pass. Hemodynamic parameters (CO, CVP, MAP, AMP, pH,
pO2, pCO2, BE) registred at different time of operation, blood loss, cold and
warm ischemic time, surgical time, intraoperative and postoperative
complications, graft function, ICU and hospital stay, were evaluated in both
techniques. RESULTS: Two patients randomized as Piggy back were switched
to conventional technique for a presence of a caudate lobe embracing
posteriorly .the retrohepatic vena cava and for a caval lesion respectively. No
patients developed vascular complications or postoperative hemorrhage. There
were no intraoperative deaths. The following table shows main evaluated
parameters:
:I:P 0.05
Blood loss Operating Warm PGNF Renal Failure
time ischemia
(I) (min.) (min.) (#) (#)
Piggy Back (13) 1.9+1.2 476.8+82.8 48.5+14.5:1:3 (20%) 0:1:
Conventional (15) 2.7+2.9 500.8+95.0 60.6+12.6 3 (23%) 4 (30.8%)
There were no significant differences in the intraoperative hamodynamic
parameters. We observed a trend toward the reduction of ICU (7.3+7.1 vs
4.3+1.3) and total hospital stay (27.5+17.6 vs 17.0+3.0) with the use of the
piggy back technique. CONCLUSIONS: These preliminary results don’t show
any statistical differences except for the renal insufficiency and the warm
ischemic time. The Piggy back technique is feasible in the majority of the cases
and can be used safely in patients who undergo liver transplantation saving
costs (veno-venous by-pass, intraoperative blood requirement, hospital stay).
Further evaluations are necessary to establish the real supremacy of this
technique.
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SIGNIFICANCE OF MEMBRANE FLUIDITY OF ItEPATOCELLULAR CARCINOMA IN
POSTOPFATIVE RECgRRENCE
T.Kasmateu, J.Tanaka.=, N. Ftmaki, T.Kaldou, S.Seto, M. Imamura
aFirst Department of Surgery, Kyoto University,
=Dent of Sttvgery, Shig Mical Center for Adult Dies,
loto, dapan
Membrane fluidity of tumor cells has been suggested to influence
tumor invasion or metastases. The present study was conducted to
clarify whether or not membrane fluidity (MF-value) of hepato-
cellular carcinoma (HCC) is related to postoperative recurrence.
Membranes of reseCted HCC tumors and non-tumorou liver tissues
from the same patients were prepared by gradient ultracentrifugation
and fluidity was determined by ’pectrofluorophotometer equipped
with polarizer using 1,6-diphenyl-1, -hexatriene as a probe dye.
MF-values of both tumor and non-tumor_ tissues (0.232 and 0.231,
n=55, individually) were significantly higher than that of normal
liver controls (0.190, n=12, p<0.001). However, no significant
difTerence was observed between tumor and non-tumor, as a whole.
Although MF-values of HCC’s did not concern tumor size, number,
capsular invasion or intrahepatic metastasis, they significantly
related to tumor invasion into the portal vein (p<0.05) and serum
a-fetoprotein value (p<0.05}. Recurrence group (0.212, n=23) had
a significantly lower F-value than that of recurrence-free group
(0.242, n=32, p<0.01). From the comparison of MF-value between
tumor and non-tumorous liver tissue in individual case, HCC
patients were classified into three groups.
Group MF-value of tumor is kigher than that of non-tumor
and the difference is more than 0.01. (n=28)
Group 11: MF-value of tumor is lower than that of non-tumor
and the difference is more than 0.01. (n=19)
Group I: Difference in MF-value between tumor and non-tumor
is less than 0.01. (n=9)
Three-year disease-free survival rates were 54 in group and 8
in groupH and p=O.021 by og-rank analysis.
In conclusion, membrane fluidity intimately concerns postoperative
recurrence of HCC after hepatic resection.F065 F066
FACTORSAFFECTINGRECURRENCEINHYDATIDDISEASE
S. Khcturav, C trgil, Y.Ozen, C.Ac, H.Bilgel
Department of Surgery, Uluda University School ofMedicine, Bursa/Tiirkiye
A follow-up programme was carried out for 240 patients that were operated
in our center due to hydatid disease, but only 131 patients could be contacted
and clinically evaluated. A complete physical examination, routine chest x-ray,
abdominal ultrasound (US), abdominopelvic CT and indirect hemaglutination for
hydatid disease (IHA) were performed on all patients. In this study, the data of45
patients who were either found to be recurrent after this investigation or were
operated in our center initially with the diagnosis of secondary hydatidozis, were
analized. The effects of misdiagnosis, mistreatment and inappropriate follow up
methods on the reccurrence rate have been evaluated.
Ofthe 45 cases, 6 had recurred twice, 2 had recurred three times. Altogether
there were 55 recurrences. 30% dextrose solution was used as a scolosidal agent at
the first operation in 51.6% of the case. While in 71.1% of the 45 cases multipl
hydatid cysts (HC) were found, 48.8% of these had recurred in the liver as unilo-
culer cysts. 24.4% ofthe first recurrences were free intraabdominal cysts (FIAC).
4 ofthese "were FIAC only and 7 ofthem were accompaind by liver hydatitozis.
Only of these 11 FIAC were diagnosed as FIAC in the first operation. Totally,
13 of the 55 recurrences (23.6%) had an extrahepatic intraabdominal localization.
When 13iHD cases were considered, the reccurrence rate in solitary cysts was
18.2% and the recurrence rate in multipl cysts was 31.6%. In FIAC this
recurrence rate was even higher, being 56.25 %.
9 cases (16.4) were diagnosed in the early 2-6 months period following the
first operation. Those were probably not real recurrences and should be accepted
as preoperative or intraoperative insuffient evaluation. It was found that US was
20% less efficient than CT in determining the recurrences. In four cases who were
not included in these 45, CT and/or US suggested recurrence but diagnostic
aspiration excluded this possibility. In tiffs study IHA was also used as a parameter
to define recurrence: When titrations which were higher or equal to previous
titrations were considered as an index of recurrence, IHA had a 92.3% sensitivity
and 46.8% specitity.
In this series, total cystectomy was performed in a very limited number of
cases and there was not a cese in which pericystectomy was performed. Therefore,
the effects ofthe application of radical procedure on recurrence could not be
evaluated.
In conclusion, careful preoperative and intraoperative evaluation and
meticulous surgery will decrease recurrences in hydatid diseases.
COMPLIANCE of EXTENDED LIVER RESECTIONS
Kupcsulik P.K.,Pinkola K.Antony P.,Harsanyi L,Flautner L.
1st Dept of Surgery,Semmelweis Univ.of Medicine,Budapest
Between 1989 and 1995 443 patients underwent surgery for
liver tumor. 244 interventions were performed for liver
malignancy. Preoperative chemoembolisation was applied in
47 cases of liver carcinoma. No direct intraoperative advantage
of arterial embolisation was detected comPared to the
nonembolised patients. In contrast to this 2 year survival of
chemoembolised patients is superior to the controls ,however.
Intraoperative portal clamping was used in 26 cases.
Noninvasive circulatory monitoring by impedance cardiography
showed transient, but significant diminution of CO and
decrease of PVR. 3 minutes reperfusion after 30 minutes liver
ischaemia resulted significant elevation of CO, but complete
restitution occured only in the early postoperative phase.
Intraoperative blood loss interferes significantly with CO
recovery. In 1/26 pts with portal clamping splenic rupture
occured. No long lasting splanchnic stasis or any other form of
circulatory consequences after portal clamping was observed.
Despite to the risk of transient portal devascularization, its
combination with ultrasonic dissector significantly diminishes
blood requirements during extended liver resections.186
surgical interventions resulted in removal of tumorous mass.
Lethality of this group was 3.1. percent respectively.
The use of ultrasonic dissector, its combination with partial
vascular liver exclusion diminishes intraoperative blood loss,
and promotes extended resection of the liver.
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RANDOMIZEDTRIALOF END TO END VS SIDE TO SIDE BILE DUCT
ANASTOMOSIS AIrI’ERORTHOTOPIC LIVERTRANSPLANTATION
TR Kurzawinski, L Selves, M Farouk, Dooley, A Burroughs, KR Rolles,
B R Davidson.
Liver Transplantation Unit, Royal Free Hospital and School of Medicine,
London UK.
The best method of biliary reconstruction is controversial and much debated
technical aspect of orthotopic liver transplantation (OLT). The aim of this study
to compare end to end (E-E) and side (S-S) duct to duct biliary
anastomosis after OLT.
Patients undergoing OLT were randomized to receive E-E (n=50) or S-S
(n=50) duct to duct biliary anastomosis without T tube. Patients age, sex, graft
preservatior time and indication for transplantation were similar in both groups.
Within 30 days of OLT all patients were scheduled to have endoscopic
retrograde cholangiography (ERC). Cholangiographic findings were classified
normal, leak or stricture. Biliary complications were defined as leak or
stricture which required endoscopic or surgical treatment. Data were analyzed
according to intention to treat.
60 patients received E-E and 40 S-S anastomosis. 10 patients randomized to
have S-S had E-E anastomosis done due to shortness of recipient or donor duct.
Number of biliary abnormalities on ERC were similar in both groups (E-E 32%
vs S-S 30%, NS), leaks (18% vs 16%) and biliary strictures (14% vs 14%).
There was difference in .number of biliary complications (E-E 22% vs S-S
22 %). Patients and anastomosis survival was similar (median months E-E 11 vs
S-S 13.5,NS, E-E 7.5vs S-S 8.5,NS).
This is the first randomized study of E-E versus S-S biliary reconstruction
following OLT and it showed no short term benefit of either technique. We
would like to conclude that either of anastomoses could be used according to
surgeon preference.
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M ROLE OF WHOLE-BODY POSITRON EMISSION TOMOGRAPHY
WITH 18 FLUORODEOXYGLUCOSE IN IDENTIFYING OPERABLE
COLORECTAL LIVER METASTASES
D.T.M. Lai, M. Fulham, M.S. Stephen, K.M. Chu, D.M.
Sheldon, D.W. Storey, T. Sachinwalla, M.J. Solomon,
J.F. Thompson.
Departments of Upper, Gastrointestinal Surgery & PET,
Royal Prince Alfred Hospital, Sydney.
The accuracy of whole-body positron emission
tomography (PET) with [18] fluorodeoxyglucose was
compared with conventional radiology in the selection
of patients with operable colorectal liver
metastases.
Between May 1993 and October 1994, 34 patients with
suspected colorectal liver metastases were evaluated.
There were 18 males and 16 females with an average
age of 62 years, 5 month. Staging by conventional
radiology consisted of abdominal CT (n=34), chest
Xrays (n=15), and chest CT scans (n=19) to evaluate
extrahepatic disease i:t all patients, and magnetic
resonance imaging (n=24) and CTantiography (n=3) of
the liver to determine anatomical resectability in 27
patients. PET scan was performed in all patients
within 8 weeks of conventional radiology.
PET identified unsuspected extrahepatic malignancy in
II patients (32%) that was missed by conventional
radiology, and these included paraaortic nodal
metastases (n=6), pulmonary metastases (n=3) and
loco-regional recurrence (n=2). PET consequently
affected the clinical management in i0 patients
(29%). However, PET did not provide any additional
information compared to conventional radiology in the
assessment of hepatic metastases per se.
In conclusion, PET improves the preoperative
evaluation and selection of patients with isolated
colorectal liver metastases for hepatic resection.F069 F070
LONG-TERM RESULTS OF LIVER RESECTION OF
HEPATOCELLULAR CARCINOMA IN CIRRHOSIS
P. Lamoureux. H. Bouzari, C. Vons, L. Capussotti, G.
Borgonovo, C. Smadja, D. Franco.
Services de Chirurgie, H6pital Antoine Bcl&e, Clamart, Universit6
Paris XI, France, et Ospedale Mauriziano, Turin, Italie.
Liver resection still remains the best treatment for the majority of
hepatocellular carcinomas (HCC) in cirrhotic patients. The purpose
of this work was to analyze the results of resection in a series of 200
consecutive patients with HCC and cirrhosis operated on from 1992
to 1994. Mean age was 61 years (range 62 to 78 years). Cirrhosis
was of alcoholic origin in 40% of patients. HBV and HCV markers
were positive in respectively 23% and 59% of patients. Liver
function was good in 79% of patients and most of them (74%) had a
single HCC nodule. Nineteen p.cent had major (right or left) and
81% had limited liver resection. Operative mortality was 7.5%.
Cumulative 5-year survival was 30% and cumulative 5-year
recurrence rate was 69%. The survival rate was significantly higher
in Pugh’s A (34%) than Pugh’s B-C patients (12%n p<0.001) and
in patients with preoperative serum oFP concentration less than 500
ng/ml (36%) than in those with higher levels of aFP (10%, p<0.01).
The survival rate was significantly higher in patients without
pathological predictive markers of recurrence. Significant
pathological markers of recurrence were fhe absence of free margin
of non tumorous parenchyma (p<0.01), a tumor above 5 cm
(p<0.02), the absence of a capsule around the tumor (p<0.01) and
the presence of satellite nodules and distal portal invasion
(p<0.001). Postoperative adjuvant arterial chemotherapy slightly
decreased the recurrence rate but did not increase survival. This
study confirms that liver resection is a good treatment of HCC in
cirrhotic patients with a good liver function and a small unique
nodule with no biological nor pathological signs of invasiveness.
PERGUTANEOUS HEPATIC INTRA-ARTERIAL YTTRIUM-90
MICROSPHERES FOR INOPERABLE HEPATOCELLULAR CARCINOMA
W.Y. Lau, T.W.T. Leung, S. Ho, M. Chan, P. Johnson, A.K.C. Li
The Joint Liver Cancer Study Group, Prince of Wales Hospital, Shatin, New
Territories, Hong Kong.
Our previous studies have shown that radioactive yttrium-90 microspheres,
when given in the hepatic artery, concentrated preferentially in liver tumours,
giving an average tumour normal internal radiation dose ratio of 4:1. The
need for intraoperative dosimetry by laparotomy has been replaced by the use
of simulation technetium-99m macroaggregated albumin scan which have been
shown to accurately predict the distribution of the therapeutic yttrium-90
microspheres.
Over a period of 3 years, 89 patients with inoperable hepatocellular carcinoma
were treated with hepatic intra-arterial yttrium-90 microspheres given through
an angiographic catheter placed percutaneously using the Seldinger technique.
The dosage given was calculated using a partition model taking into account of
extrahepatic shunting, the tumour normal ratio and the liver tumour non
tumour volumes measured on computed tomography. There were 76 males
and 13 females. The median age was 54 years (range 24- 85). Sixty-eight
patients had primary inoperable tumours, 20 had post-operative recurrences,
and had recurrence after lipiodol-ITM therapy. The turnout dose given was >
12,000 rads.
All patients had a drop in alpha-fetoprotein of over 80% of the pre-treatment
level. Patients with pre-treatment normal alpha-fetoprotein were monitored with
ferritin levels which showed a similar drop after therapy. The median survival
was 8 months (median survival for systemic chemotherapy in previous studies
was 10 weeks). The patient with the longest survival was 25.9 months after
treatment. He is still alive.
This study suggests that radioactive yttrium-90 microspheres may be of use in
patients with inoperable hepatocellular carcinoma. A randomised study to
further evaluate this treatment is indicated.
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HEPATOCELLULAR CARCINOMA PRESENTING AS OBSTRUCTIVE
JAUNDICE
W.Y. Lau, K.L. Leung, T.W.T. Leung, M. Chan, S.C.H. Yu, A.K.C. Li
The Joint Liver Cancer Study Group, Prince of Wales Hospital, Shatin,
New Territories, Hong Kong.
Obstructive jaundice as the main presenting feature of hepatocellular
carcinoma is uncommon.
In a period of 111/4 years, 48 of 2,037 patients with hepatocellular
carcinoma seen in our hospital presented with obstructive jaundice (2.4%).
There were 39 men and 9 women. The mean age was 54 years (s.d.
12.9). Obstructive jaundice was diagnosed by blood tests, ultrasound and
cholangiography (ERCP or PTC). Hepatocellular carcinoma was diagnosed
by either histological proof or in patients with space occupying lesions in
the liver with serum alpha fetoprotein of over 500 ng/ml.
Ultrasound showed dilated intrahepatic biliary system in all 48 patients.
The pathologies causing obstructive jaundice included tumour casts (n
10), free tumour fragments in the extrahepatic biliary systems (n 7),
diffuse tumour involvement of intrahepatic ducts (n 28), extrahepatic
bile duct obstruction by enlarged porta hepatis lymph nodes (n 3) and
haemobilia (n 8). Some patients had more than one pathology.
Patients with potentially operable liver tumours were further evaluated
with computed tomography and hepatic angiography. Preoperative
investigations revealed 37 patients to have inoperable tumours and they
were treated with endoscopic stent (n 24), percutaneous stent (n 6),
stent put in by combined endoscopic percutaneous approach (n 2) or
supportive treatment only (n 5). Eleven patients underwent laparotomy
and "curative resection" was possible in 9, while the other 2 had surgical
intubation only. With proper management the survival of patients with
hepatocellular carcinoma with obstructive jaundice was similar to those
without jaundice. Four patients who had "curative" liver resection were
still alive, had no evidence of disease at 11.6, 13.7 and 99.2 months
after operation and one had recurrence and is still alive 20.5 months after
surgery.
Patients with hepatocellular carcinoma with obstructive jaundice should
be treated actively. Good palliation, and occasional cure, are possible.
LIVER RESECTIONS A SINGLE INSTITUTIONAL
EXPERIENCE OF 612 PATIENTS
B. Launois, M.A.C. Machado, C. Stasik, G. Spiliopoulos, B. Chareton, JP.
Campion
Department of Surgery, University ofRennes France.
Between 1972 and 1995, 612 patients underwent laparotomy in view of
liver resection. There were 400 males and 212 females with a mean age of
56.4 +/- 14.3 years. Indication for surgery included hepatocellular
carcinoma (n=207), other primary liver tumors (n=47), liver metastases
(n=221), benign liver tumors (n=77), liver trauma (n=21). and others
(n=39). Variables were compared using X test or Fisher’s exact test.
Survival was calculated according to the Kaplan-Meier method and
survival curves were compared using the Logrank test.
RESULTS 205 patients underwent major liver resections comprising at
least segments. 128 patients underwent right hepatectomy, 63 patients
underwent left hepatectomy and 14 patients had or 4 non-contiguous
segments removed. 199 patients had or 2 segments resected and 68 had
non-anatomical resections. 131 exploratory laparotomies were performed
for unresectable tumors. Overall resectability rate was 78.6 %. Operative
mortality and morbidity was 6% and 21% respectively. 5-year survival
following resection of colorectal metastases, hepatocellular carcinoma
developed on cirrhotic and non-cirrhotic livers was 24.6%, 21.7% and
28.6% respectively (p= NS) When results of our early experience were
compared to those obtained after 1990 there was a significant decrease in
operative mortality and morbidity. Five year survival was also improved.
(p < 0.05).
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IS LIVER TRANSPLANTATION (OLT) A RATIONAL APPROACH
FOR NEUROENDOCRINE METASTASES (NEM) REPORT OF A
FRENCH MULTICENTRIC STUDY OF 31 CASES.
Y.P. Le Treut*, J.R. Delpero*, D. Houssin, D. Cherqui, P. Segol, G.
Mantion, L. Hannoun, G. Benhamou, B. Launois, O. Boillot, J.
Domergue, H. Bismuth, (*) H6pital la Conception, 147 Bd Baille,
13005 Marseille and ACHBT.
Indications of OLT for NEM are still a matter of controversy, as far
as only limited data are available. This retrospective study involves
31 cases of OLT collected among 11 centers from 1989 to 1994. There
were 17 males and 14 females, age 45 + 9 years (M + SD). Primary
tumor site was pancreatic in 17 cases, ileal (7), bronchial (3), gastric
(2) colonic, rectal or lymphatic (1 each). Tumor varieties were
carcinoid (15 cases), gastrinoma (7), glucagonoma (1), nonfunctioning
(8). Hormonal-related symptoms were present in 17 patients.
Seventeen patients (54 %) underwent excision of the primary tumor
and 23 (74 %) received chemotherapy before OLT. There was a 30 + 32
months interval (median 19, range 2-120) between the diagnosis of
NEM and OLT it was 31 + 34 months for carcinoid and 29 + 30 months
for others-NEM. Fourteen patients had not undergone resection of
primary tumor at the time of OLT simultaneous removal of the
primary tumor and NEM was performed in 11, one by ileal resection, 3
by Whipple resection and 7 by upper abdominal exenteration (with
synchronous pancreatic transplant in 3 cases). In the 3 remaining
cases, the site of the primary tumor was discovered only after OLT.
Six patients (19 %) died post-operatively 4 out of 7 after "cluster
’esection" and all 3 after composite liver and pancreatic graft. Major
surgical complications occured in half of the patients. Among the 25
survivors, 4 died from late complications of the procedure, without
evidence of recurrent disease (4, 5, 8 and 10 months after OLT), and 8
patients died of recurence (2 to 41 months after OLT). Thirteen
patients are still alive. Overall actuarial survival rates were 58 %
at one year and 36 % at 5 years (5 patients). Theses rates were 80 %,
80 % and 69 % at 1, 3 and 5 years respectively for the 15 patients with
carcinoid tumors, versus 38 %, 15 % and 0 % respectively for the 16
patients with others NEM. Theses results suggest that OLT can
achieve benefit in patients with carcinoid metastases, but not in
patients with other type of NEM.
Authors: LIEDKE, M; ROGIERS, X; BRUNKEN, C; MALAGO;
FRILLING, A; BROELSCH, CE.
The efficacy of hepatic resection for more than 4 liver
metastases from colorectal carcinoma?
During the last decade, surgeons have taken a more aggressive
attitude in the treatment of primary or secondary liver tumors,
partieulary those from colorectal primaries. Several authors have
demodstrated, that resection ofa single metastastie lesion is benifieial
for the patient.
From jan. 1986 til dee. 1993, we underwent by 142 patients
liverreseetions for hepatic metastases of colorectal cancer. The
patients devided in three groups
(group 1: one metastase n 61, group 2:2-4 metastases n=48,
group3: more than 4 metastases n=23), which were analysed
retrospectivly.
The overall hospital mortality was 3,52%. The results are illustrated
in table 1.
Tab.l:
’i" 161 14*ao t.6" t6"/. t-% r./. tt.t" t.t’
12 14
|/3/17 2.0% :)2.9’% 8.3% 47.9% |.3%’ 4.i%
1!42 .z.. I’
Our results represent, that the most benifit have patients with RO
resection. The number of metastases in the liver is a deeeiding factor
for the prognoses and the survival benifit patients will have from the
resection. The group 3 had the highest hospital mortality and only
Ro reseeted patients will have a benifit from the liverresection.
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DEARTERIALIZATION THERAPY OF LIVER CANCER-
INSTITUTIONAL EXPERIENCE
G. Lindell, B. Ohlsson, B. Jeppsson, B. Persson, S. Bengmark, K-G.
Tranberg
Department of Surgery, Lund University, Lund, Sweden
Normal hepatic parenchyma is supplied by portal and arterial blood.
In contrast, overt liver tumours have a predominant arterial supply,
which is the basis for treating hepatic tumour with arterial ischemia.
This report reviews our total experience for hepatic non-endocrine
tumours during 1971-1995. The material consists of 80 patients
(aged 59 (37-77) years) with primary liver cancer (n=15), colorectal
liver metastases (n=61) or other hepatic malignancies (n=4) and in-
eludes all consecutive developments: complete (permanent) dearte-
rialization (n=12), intermittent (16 h) dearterialization (n=26) and
repeat transient dearterialization (1-2 h once or twice daily using an
implantable occluder) (n=42). The liver tumours were bilateral in 90
% of the patients and occupied 25-75 % of the liver in 2/3 of the
patients. Extrahepatic tumour was present in 29 % of the patients. 51
patients received chemotherapy, mainly 5-fluorouracil and leuco-
vorine. Patients with primary liver cancer had a median survival
(after start of treatment) of 9 months and a 5-year survival rate of 7
%; corresponding figures for patients with colorectal liver cancer
were 11 months and 2 %. There were no obvious differences in sur-
vival between permanent (n=8), intermittent (n=24) and repeat tran-
sient (n=29) dearterialization for colorectal liver cancer (median
survivals were 10, 11 and 13 months, respectively). Liver tumour
volume and a history of weight loss varied negatively with survival
in patients with colorectal liver cancer. Three patients (4 %) died in
the postoperative phase, and 5 patients (6 %) suffered from hepatic
or intraabdominal abscess formation. It is concluded that hepatic
dearterialization is of doubtful benefit but may be considered in
carefully selected cases with tumour growth confined to the liver.
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BILIARY COMPLICATIONS AFTER HEPATIC RESECTION
C.M. Lo, S.T. Fan, E.C.S. Lai, C.L. Liu, J. Wong
Department of Surgery, The University of Hong Kong, Queen Mary
Hospital, Hong Kong.
A retrospective study was conducted to determine the incidence, risk
factors and consequence of biliary complications after hepatic resection
and to evaluate the management. Between January 1989 and October
1995, 347 hepatic resections were performed at the Department of
Surgery, The University of Hong Kong at Queen Mary Hospital. There
were 251 male and 96 female patients with a mean age of 53.2 years
(range 2-86). Major hepatic resection (defined as resection of or more
segments according to Couinaud’s description) was performed in 229
(66%) cases"and the liver was not cirrhotic in 169 (49%) patients.
Twenty-eight (8.1%) patients developed biliary complications. The
biliary complication rate was 6.5% from 1993 to 1995 and 9.5% from
1989 to 1992 (p=0.31). The hospital mortality rates for the 2 periods
were 4.8% and 12.3% respectively (p=0.01). The clinical presentation
included biliocutaneous fistula (n 18), peritonitis (n 3), intraabdominal
abscess (n=6) or intraoperative bile duct injury (n=l). The site of
leakage was from the raw surface (n=2), right/left hepatic duct stump
(n=6), common hepatic duct (n=3), bilioenteric anastomosis (n=4), T-
tube insertion site (n=l) or unidentified (n= 12). Logistic regression
analysis revealed that the risk of biliary complication was increased by
older age, higher preoperative white cell count, longer operation time
and a higher serum total bilirubin days after operation. Ten of 28
(35.7%) patients with biliary complications died in hospital, most often
due to intraabdominal sepsis. Initial treatment consisted of surgery (n 9;
6 died), percutaneous drainage (n=9; died), endoscopic papillotomy 4-
stent (n=4; died) and conservative (n=6; nil died). The development
of biliary complication was associated with a higher incidence of liver
failure and prolonged hospital stay. We conclude that biliary complication
is a frequent cause of morbidity and mortality after hepatic resection and
may be avoided by shortening of operation time. A high bilirubin level
days after hepatic resection should arouse suspicion and facilitate early
detection. Reoperation carries a high mortality and non-operative
management is effective in selected patients.F077 F078
"PIGGY-BACK" IMPLANTATION WITH TEMPORARY
PORTACAVAL SHUNT- A SUPERIOR TECHNIQUE FOR
LIVERTRANSPLANTATION
J.A. Lowell. S. Shenoy, S. Dolan, T.K. Howard. Section of
Transplantation, Washington University School of Medicine, St.
Louis, MO, USA
Liver transplantation (OLTx) is most commonly performed with
vena caval replacement.Veno-venous bypass (VVB) during the
anhepatic phase is used routinely, selectively, or not at all. Without
VVB, significant volume loading is required; there maybe
hemodynamic instability, and bowel edema maybe problematic. By
preserving the vena cava, and anastomosing the donor vena cava to
the recipient’s hepatic veins ("piggy-back"), the complications
associated with vena caval clamping and replacement are obviated.
Portal vein (PV) decompression is accomplished by creating a
temporary portacaval shunt (PCS) during the native hepatectomy,
which is then ligated and taken down during the graft implantation.
Results: We have used this technique in 58 consecutive adult
OLTx recipients. The etiology for liver disease included: Hepatitis
C (n=14), ETOH (n=ll), Cryptogenic (n=6), PBC (n=7), PSC
(n=6), and other (n=14). 2 patients had previously been
transplanted. 10 patients had previous TIPSS procedures. 2
patients required PV extension grafts because the TIPSS was
extrahepatic. patient had a large spontaneous porta-systemic shunt
and did not require a PCS. All patients .(including patient
transplanted for fulminant hepatic failure) demonstrated stable
hemodynamics during hepatectomy and implantation. Median
operative PRBC replacement was 2.0 units (range 0-19). 18
patients (31%) received no PRBC transfusions, and 34 patients
(58%) received 2 units or less. No complications attributable to this
technique were noted. 55/58 patients are currently alive and well.
VVB costs of approximately $4,000 per patients were saved using
this technique. Conclusions: This technique of OLTx is safe, and
offers all of the benefits of VVB without incurring its risks and
costs. Early creation of the temporary PCS may be especially useful
in the difficult hepatectomy.
LIVER TRANSPLANTATION AFTER JEJUNO-ILEAL BYPASS
J.A. Lowell*, S. Shenoy*, S. Dolan*, M. Peters#, T.K. Howard*
Departments of Surgery* and Medicine#, Washington University
School of Medicine, St. Louis, MO, USA
Jejuno-ileal (JI) bypass was developed as a therapy for morbid
obesity in the late 1960’ s, but has since been abandoned because of
a high rate of complications, including cirrhosis (incidence 7-10%).
The need for liver transplantation (OLTx) after JI bypass has been
infrequent, with only 4 previous patients reported in the literature.
However, as the time to the development of symptomatic end-stage
liver disease (ESLD) after JI bypass maybe quite long (25 years or
more), the incidence of patients who will require OLTx may now
only be increasing. We retrospectively reviewed our experience with
JI bypass and OLTx in 280 adult patients since 1985] Results: 3
patients (2 females) have undergone OLTx for decompensated
ESLD due to steatohepatitis after JI bypass, all within the last 48
months. One patient had concomitant alcoholic liver disease. The
mean age of this group was 51 years (range 46-60). The mean
duration from time to JI bypass to OLTx was 24 years (range 23-
35). Two of three patients had other complications related to the JI
bypass (renal and biliary stones). One patient had the JI bypass
taken-down prior to OLTx, which precipitated acute liver and renal
failure, necessitating urgent OLTx. One patient had the JI bypass
taken-down at the time of OLTx. The third patient continues to have
the JI bypass and is followed closely with monthly liver function
studies and yearly liver biopsies,.and to date (2 years post-OLTx)
has not demonstrated any complications attributable to the JI bypass.
The patient who underwent concomitant OLTx and JI bypass take-
down, has developed recurrent obesity, while the other two patients
have not..Conclusions: The incidence of patients who require
OLTx after JI bypass maybe on theincrease. Takedown of the JI
bypass may precipitate acute liver failure in the cirrhotic patient, and
lead to the need for urgent OLTx. JI bypass reversal should be
accomplished either at the time of OLTx, or if signs of liver
dysfunction occur after OLTx. OLTx recipients maybe at risk for
recurrent obesity after takedown of the JI bypass.
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CHANGES OF LIVER PERFUSION IN PRESENCE OF COLORECTAL
CANCER METASTASES
L. Lupo, GL OiGiulio*, A. Panebianco, G. Angelel#*, V. Memeo
Ist. di Clinica Chirugica and *Radiologia, University of Bad, Italy
Changes in liver blood flow were observed in presence of overt
metastasesby invasive and non invasive methods.
Doppler Ultrasound is a non invasive method to quantify liver
blood flow by measuring the mean velocity Vm and the cross-
section area A of the hepatic artery and the portal vein.
To assess the relationship between blood liver perfusion and the
presence and extent of liver metastases, the Hepatic Perfusion
Index (HPI), defined as the Arterial/Total blood flow ratio, was
evaluated by Colour Doppler US in 20 patients with US detected
hepatic colorectal cancer metastasis (MET), in 33 patients with
confined colorectal cancer (CA) and in 24 control subjects (CON)
matched for ageand weight.
Results HPI resulted significantly higher in MET than in CA and
CON: 0.2.5 SE 0.04 v.s O.17 0.02 v_s 0.10 0.025 ),
p<O.O001 Wilcoxon test) by increase of arterial flow + :32
%, p< O.O0 I) and reduction of portal flow 18 %, p<O.05 ). By
uni- and multi-variate analysis HPI resulted correlated to the.
number of lesions: >3 metastasesv__s < :3:0.:30 v_s 0.21, p< 0.05
andR2= 0.29, p<O.O01.
In conclusion, H PI correlated with the presence and number of
liver metastases in patients with cdo-rectal cancer, as effect of
increased arterial blood supply and reduced portal flow.
HPI could be proposed as a test for liver metastasis screening.
PREDICTIVE FACTORS OF SURVIVAL FOLLOWING SURGERY
FOR COLORECTAL LIVER METASTASES
M.A.C. Machado C. Stasik, G. Spiliopoulos, B. Chareton, JP. Campion,
B. Launois
Department of Surgery, University ofRennes France.
Nearly 40% of patients with colorectal malignancies will develop liver
metastases in the course of their illness. The aim of this retrospective study
was to determine predictive factors of long-term survival in patients
treated surgically.
Between 1976 and.1995, 166 patients underwent surgery for colorectal
liver metastases. There were 98 males and 68 females with a mean age of
59.8 years (range: 31-80). 123 metastases were metachronous and 43 were
synchronous of the primary tumor. Prognostic variables were analyzed
using the 2 test and Fisher’s exact test. Survival was calculated according
to the Kaplan-Meier method and survival curves were compared using the
Logrank test.
100 patients underwent major liver resections comprising at .least 2
liver segments: right hepatectomy (n=48), left hepatectomy (n=17),
resection of 2,3 or 4 non-contiguous segments (n=35). Minor resections
and non-anatomical resections were performed in 22 patients. The
resectability rate was 86.5%. Operative mortality and morbidity was 6.2%
and 28% respectively. Mean hospital stay for survivors was 16 days. 1,3
and year survival rate was 75%, 32.3% and 24.6% respectively.
Predictive factors of long term survival included size of metastases,
number of metastases, staging of the primary tumor and resective margins.
CONCLUSION: Exploratory laparotomy is indicated in most patientswith
colorectal liver metastases. Resectability is best assessed using
intraoperative ultrasound. Resection should only be undertaken when
complete eradication ofthe disease is possible.
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PROGNOSTIC VARIABLES INFLUENCING LONG TERM
RESULTS OF RESECTIVE SURGERY FOR HEPATOCELLULAR
CARCINOMA
M.A.C. Mac.ha..do, C. Stasik, G. Spiliopoulos, B. Chareton, JP. Campion,
B. Launois
Department of Surgery, University ofRennes France.
Worldwide hepatocellular carcinoma is among the most common
malignancies. The aim of the present study was-to identify prognostic
variables having an influence on long-term survival.
Between 1974 and 1995, 207 patients underwent surgery for
hepatocellular carcinoma. There were 185 males and 22 females with a
mean age of 60.1 +/- 11.7 years. The liver was cirrhotic in 149 patients and
non-cirrhotic in 58 patients. Prognostic variables were analyzed using the
Z test and Fisher’s exact test. Survival was calculated according to the
Kaplan-Meier method and survival curves were compared using the
Logrank test. 37 patients (18%) underwent major liver resection
comprising or more segments. There were 25 right hepatectomies, 12 left
hepatectomies, 25 left lobectomies, 6 right lateral segmentectomies, 57 of
or 2 segments and 11 non anatomical resections. 71 patients had
exploratory laparotomy only. The resectability rate was 65.7% Operative
mortality for patients resected was 8.4%, 9.5% for those with cirrhosis
versus 4.8% for patients with non-cirrhotic livers (p= NS.). Morbidity was
34.7%. 1, and year survival for cirrhotic patients was 70%, 43.1% and
21.7% respectively. 1, and 5 year survival for non-cirrhotic patients was
81%, 50% and 28.6% respectively (p= NS). Prognostic variables included
tumor size, number of tumor nodules, serum affafetoprotein levels’ and
resective margins.
CONCLUSIONS Because of the high rates of early recurrence associated
with liver transplantation and the palliative nature of intraarterial/systemic
chemotherapy, resection remains the mainstay of therapy for resectable
hepatocellular carcinoma.
LIVER RESECTION" THEEASTERN EXPERIENCE
SPECIALCOMPARISON WITHALCOHOL INJECTION
M. Makuuchi
Second Department of Surgery, University of Tokyo, Tokyo, Japan
Since October 1979, we have laparotomized 1391 patients for
hepatectomy. Hepatic resection was undergone 1274 (91.6%).
among them, 829 had hepatocellular carcinoma and hepatectomy was
carried out 777 (93.7%). Five hundred ninety five patients had the
largest tumor no more than 5 cm in diameter. Hepatic resection was
camed out in 572 (96.1%).
Resection area of the liver was decided depending on the indocyanine
green retention rate at 15 min. After laparotomy, intraoperative
ultrasonography was performed for .evaluation of extent of HCC in
the liver and indication of hepatic resection and operative procedure
were finally decided. Vascular occlusion techniques such as
selective vascular occlusion or Pringle maneuver were routinely
applied. Division of the liver was proceeded under the guide of
ultrasound.
Survival rate of all the series at five years was 40 %. Survival rate
in patients received systematic subsegmentectomy was significantly
better than that in limited resection. The most significant prognostic
factor was year trends. After 1985, 5-year survival reached to.65 %.
Repeated resections were one of the important factor to improve long
term survival.
Since 1990, percutaneous ethanol injection therapy (PELT) has been
generally performed. However our recent group study clearly
suggested that first choice of treatment in small HCC was surgery,
not PELT. Even in early HCC, hepatic resection showed much
better survival than PELT when pathological diagnosis was made by 6
pathologists specialized in liver tumors. Therefore, indication of
PElT in Japan may be limited in near future.
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HOW IS POSSIBLE A CERTAIN PREOPERATIVE DIAGNOSIS IN THE
MANAGEMENT OF BENIGN TUMORS OF THE LIVER?
G. Mangiante*, N. Nicoli*, F. Nifos*, GC. Mansueto, P.P. Aurola*, L.
Bortolasi*, C. lacono*, A. Ace.rbi*, G. Serio*
Departments of Surgery and Radiology , University of Verona, Verona, Italy
A certain preoperative diagnosis is mandatory in the management of benign
tumors of the liver as hemangioma (HMG), focal nodular hyperplasia (FNH)
and hepatocellular adenoma (HCA); periodic follow-up is the best therapeutic
choice. In order to evaluate diagnostic and therapeutic work-up we review
retrospectively the results of biochemical data and diagnostic imaging
procedures as US, CT, abdominal angiography (ANG), magnetic resonance
(MRI), tecnetium colloid scintigraphy (TCS), DISIDA scintigraphy (DISIDAS) of
90 pts with HMG, 50 pts with FNH and 12 pts with HCA observed from 1975
to 1995. Sensitivity and specificity of each test for benign lesions were
determined through the ratio of the true .and false positive rate and the true
and false negative rate at radiologic findings of the total number of hepatic
neoplasms, considering not only benign tumors but also malignant lesions as
hepatocellular carcinoma, colangiocellular carcinoma and metastases. All the
results were confirmed by hystologic diagnosis. In the pts with HMG, MRI and
ANG reached the best sensitivity and specificity (respectively 96% and 100%),
while specificity of US and CT were respectively 66% and 99.3%. In the pts
with FNH US had a low sensitivity (66%) but a very high specificity (98%),
while CT scan showed sensitivity 88% and specificity 99%; in this group of pts
the best results were reached by TCS (sensitivity 94% and specificity 100%)
and DISIDAS (sensitivity 91%, specificity 100%). In the pts with HCA the best
results were achieved with ANG (sensitivity 75%, specificity 98%), while US
showed the worst sensitivity (only 7%); in this case the most common
differential diagnosis was with malignant form. The contribution of imaging
techniques is able to obtain a quite sure diagnosis of HMG and FNH: only
symptomatic cases have to be resected. The diagnostic doubt in HCA is still
too high and these lesions have always to be resected.
CLINICAL UTITILITY OF INTEGRATION OF IMAGING METHODS IN
THE DIAGNOSIS OF FOCAL LIVER LESIONS
G. Maresc, A. De Franco, R. Manfredi, A.R Cotroneo, G.B. Doglietto*, P.
Marano, F. Crucitti*
Department of Radiology and Surgery*, Universith Cattolica del Sacro Cuore,
Policlinico "A. Gemelli", Rome, Italy.
PURPOSE: to evaluate if the imaging methods integration, echo-color-Doppler
(ECD), computed tomography (CT) and magnetic resonance imaging (MRI)
enhances the results of the single method in detecting and characterizing focal
liver lesions
MATERIALS AND METHODS: 35 patients with focal liver lesions underwent
ECD, CT and MRI. Semeiologic criteria were determined for each method, and a
first diagnostic evaluation is expressed. Subsequently all three diagnostic
methods are evaluated together, and a final, integrated evaluation is expressed


























CONCLUSION: The imaging integration is very helpful in the preoperative
staging in oncologic patients (number, and site of the lesions), and enables a
better tissue characterization for a variety of signs.
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The present study was done to assess the efficacy ofvmious therapeutic
modslities in the management of gastric vmiceal bleeding. Dining the last
I0 yesrs, 60 patients presented with bleeding from astric vsrices (GV).
The cause ofportsl hertemion was cirrhosis in 23, extrshepatic portal
venous obstnon (EHPVO) in 22, non cirrhotic portal fibrosis in 13
and/solsted splenic vein thrombosis in 2 patients. SRe ofbleeding was
lessereue GV (LCGV)in 16 und fundnl GV(FG in 44 patients
(isolated FO-’V-13 sndFGV + esophageal varices in 31). Endoscopic
sdrotherapy (EST) was initially successful in controlling bleeding from
LCGV in all 16 patients, 15 continued on chronic EST and one required
ekctive mrgety. Of44 patients with bleed fromF, itj/tiai control
could be achieved with balloon tamponade in 12 of25 (48%) patients,
with EST in 2 of 15 patients (13/6) and with injection ofglue in 3 of4
patients (75%). Fwe ofthese 17 responders were continued on chronic
EST, 2 patients wre lost to follow up and 10 patients were subjected to
elective modified Sugiura’s mrgety. Emergency urgety was performed
in 27 patients (modified Sugiura’s operation-25 and porto-caval shunt -2)
alter other therapies had failed or in those who had rebled a/ter initial
control Remits’. Operative mortality was nt for the elective group, 360/6
for emergency devmculaation and 50% for shunt surgety.Mortty
ws 63% for crrhotics (all Childs score C), 25% forVO and 25%
for NCPF. There were 2 late deaths due to liver cell failure in the
cirrhotic patients. Twenty five patients are alive and free from rebleed.
In conclmion, while LCGV can be successfully managed with EST,
Fundal varices respond poorly to conservative therapy. Surgery in the
form ofgastroesophageal devacularbation with stpling i highly
successful in controBing active bleeding as well as for long term
prevention ofrebleed from fundal variees and should be the therapy of
choice for these patients.
USEFULNESS OF ANGIO CT FOR DIAGNOSIS OF HEPATOCELLULAR
CARCINOMA
S.Mikami, H.Kinoshita, K.Hirohashi, S.Kubo, H.Tanaka,
T.Tsukamoto, ToShUtO, C.Sakata,
Second Department of Surgery, Osaka City University
Medical School, Osaka, Japan
In the last seven years, 67 new nodules of
hepatocelluer carcinoma (HCC) were detected in non-
tumor specimens which had been resected from in 43 of
213 patient of HCC at our institution. Despite
improvement of several imaging modalities, many
hepatic nodules not detected preoperatively are
thought to exist in resected specimens. This study was
performed to evaluate the detectability of hepatic
nodules on computed tomography during angiography
(angio CT) compared other modalities including digital
subtraction angiography (DSA), computed tomography
with other methods (conventional CT), magnetic
resonance imaging (MRI) and ultrasonography (US).
Forty-seven patients with HCC underwent hepatic
resection or liver biopsy after angio CT. In these 47
patients, seventy-three nodules were detected in
resected specimens or in needle biopsy specimens.
These nodules included 54 nodules of HCC, 3 of early
hepatocellular carcinoma (eHCC), 5 of adenomatous
hyperplasia (AH), 5 of hemangioma, and 6 of other
benign lesions. The rate of detection of all hepatic
nodules was 91.8% (67 nodllles out of 73; 67/73} with
angio CT, 58.9% (43/73) with DSA, 74% (54/73) ith
conventional CT, 72.5% (37/51) with MRI and 80.8%
(59/73) with US. The rate of detection of eHCC and AH
was 50% (4/8) with angio CT, 12.5% (i/8) with DSA and
conventional CT, and 25% (2/8) with MRI and US. In
conclusion, in this study angio CT could detect
hepatic nodules more frequently than other imaging
modalities. However, thirteen nodules in 9 cases
detected preoperatively with anglo CT were not
detected with intraoperative US. This suggests that it
is important to follow these nodules carefully.
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ARE HILLAR HYDATID CYSTS A TREATH TO INTRAHEPATIC BILE DUCT
INTEGRITY
Milicevic MN, Jeki IM, Bulajic PD, Zuvela M, Radovic Z, Djukic V, Kova.evi6 N.
The First Surgical Clinic, Clinical Center of Serbia, Belgrade, Yugoslavia
INTRODUCTIOll Intrahepatic bile duct (IHBD) hydatid cyst HC
communication is a common complication of liver hydatidosis. Aim of the
study was to analyze effects of sRe, size and number of cysts on the incidence
of IHBD-HC communication.
MATERIAL AND METHODS There were 132 22,3% patients with IHBD
HC communication out of a total of 593 operated for hydatid disease. Male
female ratio was approx. 1:1 51,5 48,5% ), age ranging from 18 to 79, mean
age 40,4 yrs. Only 22 pts. 16,66 % out, of 132 presented with symptoms
and signs of bile duct obstruction. Intraoperative diagnostics consisted of IO
cholangiography and IO US when necessary. Out of 84 pts. with hillar
localization of the cyst 28 pts.(33.3%) had IHBD-HC communication while only
104 pts.(20,4%) of 509 pts. with non-hillar HC communication had
communications. Solitary cysts were bigger in the group with hillar
localization, in average 13,9 cm compared to 10,3 cm. Management of IHBD
HC communication depends on the site of the communication, which can be
accurately verified by IO cholangiography. It was possible to suture the
communication in 72 pts. (70,5%). Communication with major ducts
demands more sophisticated procedures.
DISCUSSION Features of the cyst depend of it’s size, site, viability and
infection status. It has been demonstrated that the probability of IHBD-HC
communication increases with hillar location, size and multiplicity of cysts.
The communication is not always apparent during operation and should be
carefully searched for especially in bile stained cysts. IO cholangiography and
IO US are useful tools in.determining operative strategy.
CONCLUSION Hillar hydatid cysts frequently communicate with bile ducts.
Due to the proximity of major bile ducts visualization of the communication
site is useful in planing surgical strategy.
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RECURRENCE PATTERN OF HEPATOCELLULAR CARCINOMA
AFTER CURATIVE RESECTION
K. Nagahori, M. Matsuda, J. Okuda, M.Yamamoto,Y. Matsumoto
FhstmlofSurgery, Ya-na,mhi Medcl Univsity, Ynmshi,Jpm
One cause of high incidence of intrahepatic recurrence after curative operation
for hepatocellular carcinoma (HCC) might be the multicentric occurrence (MC)
ofHCC different from the primary tumor. In this study we tried to clarify the
characteristics of MC determined by histopathological and molecular biological
analysis. <Patients and methods> We analyzed the recurrence pattern of 106
patients who underwent curative primary resection between October, 1983 and
December, 1994 in our hospital. While the cumulative survival rates 2 and 5
years after the operation were 82 and 64%, respectively, the corresponding
cumulative disease-free surviVal rates after the operation were 56 and 31%,
respectively. <Results> Recurrence was seen in 45 patients. Clinicopathologic
variables in the recurrence group were cx}mpared with those in the disease-ee
group. The sex of the patients, HBs Ag, HCV-Ab, tumor staging, tumor size,
extent of hepatic resection did not affect the incidence of recurrence, but
recurrence occurred less frequently in the patients with noncirrhotic liver
(p=0.004) and in the patients with multiple HCC (p=0.0008). Among 41
patients with intrahepatic recurrence, one to three nodules in the same lobe as
the primary tumor were seen in 9, those in different lobe in 12, multiple
nodules in 18 and marginal recurrences in 2. In 29 patients whose recurrent
HCC were analyzed for donality, 14 showed MC of HCC and 10 metastatic
HCC. Repeat resection was performed in 10 patients with the form of one to
three nodular recurrence and in 8 the recurrences were MC. The survival rate
after the re-operation was the same as that after the first resection.
<Conclusion> It seems important to detect MC, especially in cirrhotic liver,
in the early stage after the first operation and perform radi"cal treatments in order
to prolong the survival.F089 F090
ROUXLOOPRECONSTRUCTION(RLR) ASPRIMARYTREATMENTFOR
BILIARY COMPLICATIONS FOLLOWING ORTHOTOPIC LIVER
TRANSPLANTATION(OLT)
A Nandy, N Doctor, L Horgan, A Burroughs, B Davidson, K Rolles
Hepatobiliary and Liver Transplantation Unit, Royal Free Hospital School of
Medicine, London, UK
RLR is one method of treating biliary complications after OLT. This study
looks at the morbidity and outcome of 24 consecutive "RLR’s performed
between 23rd of July 93 and 26th of October 95 as primary procedure for
biliary complications fillowing OLT. There were 17 males and 7 females with
mean of 42.9 years. All had duct to duct anastomoses at OLT. Nine patients
presented with biliary leak, 13 with stricture, with biliary cast and with
biliary sludge. All were associated with sepsis. 5 patients had associated hepatic
artery thrombosis. Patients who hadbiliary leak had RLR at mean peroid of
2.7 weeks after OLT. Patients presenting with strictures had mean peroid of
13.5months between RLR and OLT. Preoperatively 11 patients had nasobiliary
and 2 had percutaneous transhepatic drainage for a mean period of 5 days. The
post-operative hospital stay ranged from 5 days to weeks (mean .10.5 days).
Early complications were pneumonias, renal impairment, haematemesis
and colitis all which resolved with treatment. Ofthese, only the pneumonias
were directly related to the procedure. The mean period of follow up was 9.2
months. There were no early or late anastomotic complications. patient
developed hilar tricture and another left hepatic duct stricture which
required RLR revision. There were 4 unrelated deaths. RLR is a safe and
effective procedure when performed primary procedure for biliary
complications following OLT.
REDUCTION OF RAT HEPATIC ISCHEMIA/REPERFUSION INJURY BY INTERMITTENT ANOXLA
B. Nardo’, A. Gasbarrini^, M. Simoncini^, S. Cuccomarino’, S. De Notariis^, A. Recordare*, P. Caraceni^, F. Trevisani^, A. Mazziotti’, M. Bernardi^, A. Cavallari"
Clinica Chirurgica If* and Patologia Medica, University of Bologna, Italy
INTRODUCTION. The most used technique to control intraoperatory bleeding
during hepatoresection is the "Pringle manouvre" (temporary clamping of the
hepatic pedicle). In spite of advantages, reperfusion injury represents an
important problem in case of prolonged clamping. Intermittent clamping has
been recently proposed as a method to reduce organ injury. In this study, we
compared survival, hepatic adenosine triphosphate (ATP) level and lipid
peroxidation (LP) in rats exposed to intermittent vs continuous ischemia of the
liver. MATERIALS AND METHODS. Liver ischemia was induced in male
Wistar rats (weight range 200-250 g), by clam-ping the appropriate branches of
the portal vein and hepatic artery of the left lateral and medial lobes of the liver
with noncrushing microvascular clamps. The times of ischemia were 60, 90 and
120 min intermittently (periods of 30 min of ischemia followed by 10 min of
reperfusion) or continuously. Partial ischemia was performed to avoid
splanchnic congestion. At the end of the ischemia, the right lateral and caudate
lobes of the liver were removed. Survival of the animals was assessed at days. ATP and LP lev.els were evaluated at the end of the ischemic time and hour
after reperfusion by bioluminescence analysis and malondialdehyde (MDA)
tissue concentration. RESULTS. Intermittent clamping markedly improved the
animal survival at all the ischemic time considered when compared to the
continuous group (60 min: 100% vs 25%; 90 min: 75% vs 0%; 120 min: 50% vs
0%). ATP and MDA concentrations were significantly reduced after 2 hours of
intermittent or continuous ischemia; however, the decrease was markedly
greater in liver exposed to continuous ischemia (0.66:-0.05 vs 0.910.07
pmol/mg; p<0.01). After reperfusion, ATP and MDA levels increased in both
groups; however after hour of reperfusion, MDA concentration was
significantly lower in liver exposed to intermittent ischemia (2.1:-0.6 vs
4.6:0.7; 13<0.05). CONCLUSIONS. Intermittent oxigen deprivation of the
liver is followed by an higher rat survival, if compared to continuous ischemia. Moreover, it reduces liver energy depletion caused by anoxia and decreases
tissue lipid peroxidation that occurs during reoxygenation. These results suggest
that intermittent rather than continuous "Pringle manouvre" may reduces liver
injury during resections.
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ORTHOTOPIC LIVER TRANSPLANTATION (OLT) WITH
PRESERVATION OF THE INFERIOR VENA CAVA (IVC) AND A
TEMPORARY PORTO-CAVAL SHUNT (PCS).
D. Neri, G.E. Gerunda, R. Merenda, F. Barbazza, A. Bruttocao, G. Da
G-iau, A. Maffei Faccioli
Istituto di Chirurgia Generale I, Padua University
OLT is a codified surgical procedure since many years. The use of the
veno-venous by-pass (VV) during epatectomy and the resection of the
IVC with the recipient liver are steps of the usual technique. Recently
some AA. described the preservation of the recipient IVC and the
implant of the graft performing an end-to-side anastomosis between the
donor IVC and a cuff obtained or by the confluence of the recipient
suprahepatic veins (Piggy-back technique, PBT) or by a longitudinal
enlargement of the recipient left suprahepaic vein (Belghiti technique,
BT). Moreover the recipient IVC preservation make possible to perform
an end-to-side PCS during the anhepatic fase to avoid the use ofthe W.
From July 1991 to December 1995 we perform 77 OLT in 67 patients.
The standard technique was used in 7 cases, all with the VV. The PBT
and the BT were used both in 35 cases; VV was restrict to only 6 cases
ofPBT; PCS was used in 16 and 24 cases ofPBT and BT, while in 13
and 11 cases respectively we were able to perform nor a VV nor a PCS,
because portal vein clamping was well tollerated. All the new techniques
have pros and cons and the surgeons working in this field have to know
all the possibility, even ifthe standard technique is the right choice,when
the dissection of the IVC appear too difficult. Moreover performing a
PBT it is possible to cross-clamp the IVC when the surgeon have to
prepare a cuffusing both the recipient suprahepatic veins; the BT, with a
longitudinal clamping ofthe IVC,. avoid this problem. In any case the use
ofthe techniques ofIVC preservation have these advantages: 1) avoid of
the VV, with the associed risks, cost and time consume, 2) easier control
of the bare area, 3) easier mobilization of the liver performing
hemostasis, 4) eventually, an easier retransplantation.
THE EFFECTS OF THROMBOXANE A2 SYNTHETASE
INHIBITOR (OKY-046) ON HEPATIC ISCHEMIA-REPERFUSION
INJURY IN RATS WITH OBSTRUCTIVEJAUNDICE
S. N0shima, N. Morita, Y. Kobayashi, D. Hayashi, K. Okamura, T.
Inokuchi, M. Orita, H. Shinagawa, T.Takahashi, K. Esato
First Deprtment of Surgery, Yamaguchi Univ, Ube., Japan
The effects of OKY-046, a thromboxane A2 synthetase inhibitor, on
complete hepatic ischemia with obstructive jaundice were studied in
male Wistar rats in vivo. This objective was to investigate the
influence of OKY-046 on the hepatic microcirculation as measured by
tissue partial oxygen pressure (tPO2) and on release of interleukin-8
(IL-8) in hepatic tissue after reperfusion. Fourteen days after bile duct
clamping rats were subjected to 30 minutes of warm complete liver
ischemia and then reperfusion 30 minutes. Rats were divided into
three groups; the first without treatment (group C), the second
administered OKY-046 from .15 minutes before hepatic ischemia to
the end of the experiment (group OKY), and the third Gadolinium
chloride (group Gd) was injected intravenously to evaluate the
contribution of the Kupffer cell to IL-8 production. Group OKY
maintained significantly higher levels of tPO2 at 5, 10, 15 min after
declamping compared with group C (/7<0.05). The level of IL-8 in
liver tissue in group OKY tended to be lower compared with group C.
Group Gd demonstrated the lowest level of IL-8 among the three
groups (/7<0.05). Results demonstrated that OKY-046 improved the
hepatic microcirculation during the reperfusion period, influenced the
Kupffer cells, and depressed the concentration of IL-8 in liver tissue.
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SSESSNIgT OF STENOSIS IB TRANSJUCULAR INTRAHLVPATIC
PORTUSYSTENIC SHUNTS: A PROSPECTIVE DOUBLE-BLIBDED
STUDY CONPARINC ULTRASOUND kITH DIRECT PRESSURE
NEASURENET
C. Oens, D. garner, CoBartolone, R.Eisenstein,
J.Hiblen, T.giley, T.Layden
Department of Radi(logy and Internal Medicine,
University of Illinois Medical Center, Chicago,
Illinois, USA
A Prospective, double-blinded study was undertaken
to assess the sensitivity of ultrasound in determin-
ing patency, stenosls or occlusion of transjugular
intrahepatic portosystemic shunts on routine follow-
up examination. Thirty-six evaluations were preform-
ed on twenty-seven patients over a four month period.
The ultrasonographer and the interventional radiolog-
ist were blinded to each others findings. The data
was collected and analyzed by the gastroenterologist.
Of the-thirty-six examinations preformed, ultrasound
was inaccurate in assessing.the status of the shunt
42% of the time.
Our study contraindicates the current openion that
ultrasound is highly sensitive in detecting early
stenosis of intrahepatic portosystemic shunts. With
the high restenosis rate seen with transjugular
intrahepatic portosystemic shunts and the high
morbidity associated with recurrent variceal bleed,
accurate assessment of shunt patency and early
detection and correction of shunt stenosis is
paramount in the management of patients with
portal hypertension and intrahepatic shunts.
THE USE OF PROSTAGLANDIN E1 IN LIVER TRANSPLANT (LT)
RECIPIENTS WITH SEVERE GRAFT DYSFUNCTION (SGDF)
SPan, R. Lopez, A. Hoffman, L. Sher, M. Fraiman, L. Makowka
Liver Transplant Service, St. Vincent Medical Center, California, USA
Severe hepatic allograR dysfunction is associated with graR loss and may
predispose to infectious eomplidations. Prostaglandin E1 (PGE1) has
cytoproteetive and vasodilatory properties which improve endothelial cell
integrity and increase hepatic blood flow. We evaluated the use of PGE1 in
recipients with SGDF following ABO compatible LT. METHODS: SGDF
was defined as poor bile production & one or more of the following: 1) initial
prothrombin time (PT) > 19see., 2) initial AST > 2000u/l, 3) elevation of PT
for 24hrs, 4) elevation ofAST for 24hrs. Thirty-nine recipients had SGDF &
22 were treated with PGE1 at 0.009 + 0.003meg/kg/min for 68.9 + 32.6 hrs
(mean + SD). The change in PT & AST at 24 & 48hrs, the use ofFFP within
48hrs, ICU stay & graft loss within 3mos due to re-LT for nonfunction or
death due to infection were compared using t-test& Fisher’s exact test.
RESULTS: Control (n=17) PGE1 (n-22) p value
(mean+SD) (* P<0.05)
Baseline PT 19.14 + 3.07 20.87 + 4.06 0.152
APT at 24hrs 1.05 + 3.32 1.18 + 3.66 0.057
A PT at 48hrs 1.48 + 3.14 4.39 + 3.58 0.013"
Baseline AST 2404 + 1037 3437 + 1754 0.038*
A AST at 24hrs 311 +_ 1614 1151 +_2282 0.031"
A AST at 48hrs 962 _+ 1529 2622 _+ 1791 0.004*
Graft loss in 3mos 6 (35.3%) (4.5%) 0.030*
Four patients had re-LT (3 in control, in PGE 1). Three control patients died
due to infection & SGDF. The use of blood products & ICU stay were not
statistically different. The cost of PGE1 therapy was $972 + 645/pt. PGE1
was well tolerated.
CONCLUSIONS: PGE1 improves allograft function as measured by PT &
AST and reduces allograft loss due to re-LT & death from infection.
However, it does not diminish the need for blood products or shorten ICU
stay. The cost of this therapy should be weighed against the cost ofre-LT, the
morbidity & mortality of serious infection, and limited donor availability.
Our data support the need for a controlled trial.
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PROPHYLACTIC SCLEROTHERAPY (PES) IN HIGH’RISK CIRRHO-
TICS SELECTED BY ENDOSCOPIC AND HEMODYNAMIC CRITERIA
A SECOND PROSPECTIVE CONTROLLED RANDOMIZED TRIAL
K-J. Paquet, J-F. Kalk, C-P Klein
Dept. of Surgery and Medicine, HEINZ-KALK-HospitaI,
D-97688 Bad Kissingen, Germany
Aithough the first variceai bieeding in patients with
iiver cirrhosis has an extremeiy high mortaiity rate,
prophyiaxis is a matter of controversy. Thirteen
controiied triais of.scierotherapy (ST) for the preven-
tion of the first variceai hemorrhage in cirrhotics ha-
ve given confiicted resuits. Main reasons were
different patients" popuiations and different seiection
criteria. Therefore, we designed a new study in which
89 from 396 investigated patients after endoscopic and
hemodynamic seiection were randomised either to ST (44
patients) or controi (45 patients). Admission criteria
were no history of variceai bieeding, the presence of
high risk varices, i.e. varices degree III and IV with
minivarices on their top and a portai pressure over
16mmHg. ST sessions were performed at time O, 7, 14,
21, 28 .days, untii the varices were reduced at Ieast
for two degrees in size and compieteiy covered by fi-
brous tissue. Foiiow-up endoscopy was performed at four
and thereafter at six month intervais. Controi.patients
underwent repeated ciinicai investigation and endoscopy
at six months intervais. Bieeding episodes were treated
by emergency scierotherapy (EES) in both groups, whene-
ver possibie. Mean foiiow-up was 33 months. Anaiysis of
the resuits were performed by Students T- and Longrank
test. Variceai bieeding occured in 12 ST-patients
(27.3%) and 33 controIs (73.3%) (p < 0.01). Overaii-
motaiity was 31.8% in ST-pat. and 68.9% in controis (p
< 0.01). PES was abie to proiong survivai in CHILD
ciass A and B but not in C. It is conciuded, that PES
does reduce the incidence of first variceai bieeding in
cirrhotics and is abIe to proiong survivai in pat. with
good iiver function if oniy high risk patients are se-
iected and PES is performed by endoscopic expets.
24
PROGNOSIS OF DISTAL SPLENORENAL SHUNT IN CIRRHOTICS
WITH SCLEROTHERAPY FAILURES AFTER STRICT SELECTION BY
FUNCTIONAL AND HEMODYNAMIC CRITERIA
K.-J.Paquet, A.Lazar, F.Janocha, R.A.O.Sonak, R. Kuhn
Dept of Surgery, Medicine, HEINZ KALK-Hospitai (HKH),
D-97688 Bad Kissingen, Germany
Endoscopic scierothezapy (ES) and recentiy Iigation
(EL) has been estabiished as therapy of first choice in
cirrhotics with bIeeding esophageai varices. However,
eariy or.iater scIerotherapy faiiures (SF} occur in a
frequency between 20 to 50%. In concurrence to ES and
in spite of TIPS shunt procedures are stiii the best
prophyiaxis for recurrent variceai hemorrhage. Shouid
this modaiitiy not offered to SF with good iiver reser-
ve? From Jan. I, 1983 untx Jan. I, 1995 922 pat.
with bieeding esophageaI varices were admitted to HKH;
507 (55%) beIonged to the CHILD-PUGH (CP) ciassifica-
tion A and B. 162 (32%) were SF; 72 of them were seiec-
ted for distai spienorenai shunt (DSRS) on the basis of
the foiiowing criteria: iiver voIume between 1000 and
2500mi, portai perfusion index over 30%, exciusion’of
activity and progression of iiver cirrhosis (LC) by
biopsy. LC was mainiy of aicohoiic origin (51/75%). 48
were maIe and 24 femaie with a median age of 52.3
(16-71) years. 38 were CP A and 34 B. In ten cases DSRS
was technicaiiy to risky; a narrow-iumen mesocavai in-
terposition shunt was performed. Thus, 62 pat. (6.7%,
12.2%) received DSRS. -Hospitai mortaiity was 4.8%. In
two cases (3.2%) recurrence of variceai hemorrhage oc-
cured because of shunt thrombosis (I) and a shunt iumen
of 7mm (I). VariceaI hemorrhage couid be stopped by
emergency or eiective ES. AII pat. couid be foiiowed up
to Juiy I, 1995; there was no case of. shunt encephaio-
pathy and 8 further deaths. Cumuiative survivai time
according to KAPLAN-MEIER is 80% after five and 70% af-
ter ten years. Thus, eiective DSRS in a highiy seiected
patients popuiation offers the current best decompres-
sive method for recurrent variceai hemorrhage after SF.F097 F098
INDUCTION OF PLASMINOGEN ACTIVATOR INHIBITOR (PAI-I)
mRNA BY SHORT-TIME WARM ISCHEMIA IN HUMAN LIVER.
R,Pellicei*, F.Dondero*, A.Antonueci*, M.Barabino*,
M:Bertoeehi*, C.Bottino*, G.Dardano*, F.Ermili*,
R.Mondello*, N.Morelli*, A.Pozzo*, U.Valente*,
L.Sampietro#, D.Storaee#, D.Boeri#, M.Maiello#
*Transplantation Center of Genoa #Department of Internal
Medicine University of Genoa, Italy.
Histologic finding of the primary failure suggest that at
least the final pathway of the process leads to ischemic-type
injury and many observations document altered coagulation
and fibrinolysis during the postoperative period of OLT.
PAI-1 is the main modulator of fibrinolysis, is a component
of the acute phase response to injury and is synthesized by
endothelial cells and hepatocytes. Aim of this work is to
study .the effect of ischemia-riperfusion injury on PAI-1
mRNA synthesis in human liver. In 10 subjects undergoing
partial hepatectomy for localized lesions the unaffected
portion of the liver was biopsed before the clamp of the
hepatic-vessels and at the end of the surgical procedure,
after an average period of recovery from ischemia of 76+/-3 9
rain. Total RNA was isolated by the guanidine isothiocyanate
method. The amount of transcripts encoding for PAI-1 and
T-actin mRNAs was determined by the Norhtern technique,
with 32p-labeled eDNA probes. After an average 30 min. of
ischemia a four fold increase of PAl-1 mRNA (2p<0.01).is
detectable in the hepatic tissue. The increase of PAl-1 mRNA
is evident even after a very short time of ischemia (7 min.)
and does not seem to be time dependent. The mRNA de novo
synthesis seems also very rapidly induced, since its increase
is detectable already after 20 rain. of recovery from the
vascular occlusion. It seems also relevant the great
individual variability of PAI-I synthesis both in basal (1 to 5
in an arbitrary scale) and in the post ischemia-riperfusion
state (4 to 20). A decrease of fibrinolytic activity due to the
ischemia-riperfusion induced PAl-1 overproduction may
play a key role in the pathogenesis of both the primary
failure and thrombotic complications.
COMPARISON OF DIFFERENT METHODS FOR THE TREATMENT OF
NONPARASITIC LIVER CYSTS
A. Petri, 1. Makula*, S. Karesonyi
Department of Surgery, Institute of Radiology, Albert Sz(C)nt-Gyfrgyi Medical
University, Szeged, Hungary
Nonparasitic liver cysts (NC) belong to the most common benign focal
diseases. Usually they are accidentally detected by different radiological
imagine methods when examining patients with atypical complaints. Only a
small part of them cause characteristic complaints to the patients.
Between I982 and 1995 eightytwo patients underwent operations because of
NC of the liver, 18 of them were operated on by laparoseopie way. The
were 16 male (mean age: 51.9 years) and 66 female (mean age: 54,6 years)
patients.
The most typical complaint was pain in the right hypoehondrial region (n
80).
The mean size of the cysts were 57.4 mm in diameter (20 140 ram).
Seventyfour were solitary and eight were multiple.
In thirtyone eases we performed an enueleation, in sixty eases a fenestration
and in one ease a punction of the cysts. A liver resection had to be carded out
in two eases. The gall-bladder was removed simultaneously at eleven patients.
Except for the laparoseopie way the operations have been carried out in
temporary occlusion of the hepatoduodenal ligament according to Pringle.
Postoperative morbidity rate was low in both groups. Fever could be observed
in eight eases, leueoeytosis in one ease, jaundice in three eases, pleuritis and
hydrothorax in one ease, suppuration of the wound in one ease and a sterile
abdominal wall disruption also in one case. There was no mortality.
Another twentysix patients with NC have been treated with ultrasound guided
puntion of the liver cysts. There were four male and twentytwo female
patients (mean age: 58.27 years). The cysts were solitary in twentythree cases
and multiple in three other cases. The number of the cysts were thirtytwo.
The cysts have been sclerotized with aetoxysclerol in three cases and by
means of absolut alcohole in four cases. In one case an ultrasound guided
drainage of the liver cyst was carded out. One case had to be operated on
besause of recurrence of the cyst. Mortality could not be observed.
In the laparotomised group the everage time of the hospitalisation was 14.3
days, and among the patients who were operated on by laparoscopic way 7.0
days. In the third group the patients did not require any hospitalisation.
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INTERMITTENT OR CONTINUOUS HEPATIC PEDICLE CLAMPING. A
RANDOMIZED STUDY
F. Pierangeli, P. Jagot, O. Farges, A. Sauvanet, S. Jany, J. Belghiti.
Department of Digestive Surgery, Hospital Beaujon, University Paris VII,
Clichy, France.
Pedicle clamping reduces blood loss during hepatic resection. In an effort to
increase the tolerance of the liver to ischemia, intermittent pedicle clamping
(IC) has been used, especially in cirhhotic patients by many authors. The aim
of this study is to assess the results obtained by IC and continuous clamping
(CG) by means of controlled study.
Patients and.methods Sixty three consecutive patients who underwent hepatic
resection without total vascular exclusion were included from April 1995 to
December 1995. Patients were stratified according to the presence of an
underlying cirrhosis. Patients randomly assigned to IC (15 min) included 20
non cirrhotic and 10 cirrhotic whereas 23 non cirrhotic and 10 cirrhotic were
assigned to CG. Both groups were well matched with respect to operative ri’sk
factors as age, extent of resection and preoperative hepatic function. Clamping
duration, total operative bleeding volume with special reference to bleeding
volume during the hepatic clamping phase and [xstoperative liver tolerance
including prothrombin time (PT), bilirubin serum level(B) and
aminotranslrases (ALT,AST) were compared and summarized as follow
Results l) In the non cirrhotic group
Clamping ]’otal operativelClamping operative Mortality Hepatic
[Duration(mn) bleeding (ml)/bleeding (ml) ()
failure(n
C 40-_13 1494+ 1100/ 503+242 0
CG 39+13 1271+ 1050| 242+221
NS NS [ p<0,01 NS NS
Postoperative AST serum level was higher in the CG group than in the IC
group with significant difference at day 2 (322 + 180 and 148 + 108
respectively)(p<0,05). Postoperative PT and Bilirubin were not different.
2) In the cirrhotic group
Clamping ]Total operative Clamping operative Mortality Hepatic
IDuration(mn) bleeding (ml) bleeding (ml) (n) failure(n)
IC 47+12 1347+267 531+317 O 0
CG 32+9,5 11228+761 413+302 2
p<0,01 NS NS NS P<0,1
Postoperative Bilirubin was significantly higher in the CG group than in the.
IC group at day 2, day and day5. PT, AST and ALT were not different in
the two groups.
In conclusions although operative bleeding during the clamping phase is
increased, intermittent pedicle clamping is better tolerated than continuous
clamping and should be used especially in cirrhotic patients.
HGF/SF ENHANCES TUMOUR-MATRIX INTERACTION
BY STIMULATION OF THE PHOSPHORYLATION OF
FOCAL ADHESION KINASE AND PAXILLIN
MCA Puntis andWG Jiang. University Department of Surgery,
University ofWales College ofMedicine, Cardiff, UK
Cell-matrix interaction is an essential parameter in the process of
liver metastasis formation. This interaction is via the binding of
extracellular matrix and cellular integrin and activation ofdown-
stream signals including the focal adhesion kinase (FAK) and
paxillin. This study examined the role ofhepatocyte growth
factor/scatter factor (HGF/SF), a tumour invasion promoter, in
tumour-matrix interaction.
Human colon cancer cell HT115 was used. The basement
mmbrane (matrigel) was used to determine cell-matrix interaction.
Cell numbers after adhesion were determined by Hoescht 33258
assay. Tyrosine phosphorylation offocal adhesion kinase and
paxillin was detected by immunoprecipitation and Western blotting.
The presence ofHGF/SF in the assay system significantly increased
cell-matrix binding and this was seen in a concentration dependent
manner. Pretreatment of cell with HGF/SF and subsequently
depletion ofHGF/SF also increased the binding, suggesting an
activated adhesion mechanism. HGF/SF increased the tyrosine
phosphorylation ofboth focal adhesion kinase and paxillin shortly
after treatment. This was seen together with the activation of
HGF/SF receptor (cMET proto-oncogene).
We conclude that HGF/SF enhances tumour-matrix interaction by
stimulation ofthe phosphorylation offocal adhesion kinase and
paxillin.
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INTRAOPERATIVE ASSESSMENT OF THE GRAFT BLOOD FLOW
PERFUSION IN LIVER TRANSPLANTATION BY LASER DOPPLER
FLOWMETER: FIRST CLINICAL EXPERIENCE
A. Seifalian, S. MaileR*, K. Rolles, B. Davidson
University Department of Surgery and Liver Transplantation and *Department
ofAnaesthesia, Royal Free Hospital and School ofMedicine, London, U.K.
Satisfactory graft re-perfusion is fundamental to successful liver
transplantation. Laser Doppler flowmetry is a technique which can measure
hepatic blood flow ’continuously without altering the floff in the
microcireulation. Here we report its first application to clinical liver
transplantation.
Hepatic tissue microcirculation was measured intraoperatively in 22 liver
grafts. Data was examined with respect to (a) effects ofportal vein (PV) inflow,
and (b) effect of hepatic artery (HA) inflow, both up to 30 min after
revascularisation. Laser Doppler flowmeter (LDF) readings from the surface of
the left lobe were validated against total liver .blood flow using an
electromagnetic flowmeter (EMF) on PV after revascular.isation ofPV flow.
There was a significant correlation (r 0.96; p < 0.001, n=8) between surface
left lobe liver perfusion using the LDF and total liver blood flow measured by
EMF. The LDF was reliable and robust under clinical conditions and provided
reproducible measurements of perfusion with a coefficient of variation of
approximately 4%. Re-perfusion of the transplanted liver with venous blood
was accompanied by an immediate increase in liver blood flow perfusion. Over
the subsequent 10-30 minutes there was no significant increase in flow and re-
perfusion of the graft with arterial blood did not increase liver blood flow
peffusion. Hepatic tissue blood flow showed a negative correlation with cold
isehaemic time (r -0.48, p < 0.025, n=22) on graft perfusion at the early phase
of revascularisation of portal vein blood, but this correlation disappeared by the
end ofthe operation (r -0.11, p 0.611).
We conclude that LDF provides a reliable non-invasive method of monitoring
liver graft blood flow perfusion during transplantation.
SINGLE CENTRE EXPERIENCE IN HEPATIC MALIGNANCY AND
TRANSPLANTATION
SreekumarNS EI-WashM, DavidsonBR, RollesK, BurroughsAK.
University Dept of Surgery, Royal Free Hospital, London, UK.
Past decade has brought major changes in treating Hepatic Malignancies with
OLT. This study looks at outcome of Transplantation for tumors.
283 patients underwent 316 OLT from 22-10-1988 to 22-10-1995.42 had
tumors(l4.8 %), classified into following three categories.
1. 7/42 had OLT (1988-1990)for large irresectable tumors without other liver
diseases; HCC(4/7), CCA(1/7), Epitheloid Haemangioendothelioma (1/7),
Recurrdnt Cystadenocarcinoma(1/7). 5/7 died of metastasis(4/12 to 2 yrs). 2/7
disease free at 5 years(HCC & ReccystadenoCa).
2. 21/42 patients had eirrhosis(HBV-7, HCV-6, ALD-1, PSC- 4, Glycogen
Storage Disease-2, and Budd Chiari Syndrome-l), and rnalignancy-
HCC(17/21), 4/21 cholangiocarcinoma (CCA). Pre-operative
staging(l, II, "Transplantable") was upgraded in pathological staging (Stage-III-5,
IVa-4, IVb-1).Adjuvant therapy (15/17, HCC only) preop were Lipiodol
Epirubicin(9), TACE+Epi(1), Targeted alcohol(2),Targeted Ale+IV Epi(2).
Post op Chemotherapy in 7 patients so far, IV Epirubicin(6), 5FU+ Cisplatin(1).
One CCA patient(NED 4yrs) is alive. Two died of reccurence; 8/12 and 2 yrs,
confirming poor prognosis ofOLT in CCA reported by others. 2/17 HCC have
reccurenee, 9/17 have died- metastasis(l), reccurent Hepatitis B with no tumor-
4(5/12 to 17/12 post OLT), other causes (4/17). 7/17 are alive NED (4/12 to
5yrs).
3. 14/42 had incidental HCC diagnosed postoperatively(7/14) or suspected
preoperatively(7/14) in OLT for ESLD. Lesions were < 1.Ocm(1), lto eros(6),
> 3.0cms(5);unifocal(8), and multifocal(4). 5/14 died with NED, and 9/14 are
alive (5/12 to 6.4 yrs) with recurrence in 1.
OLT has a role in the treatment of HCC. Careful preoperative staging is
required,including exploratory laparotomy, backup recipient, and improved
imaging techniques for tumors in cirrhoties. Study protocols are required to
evaluate adjuvant therapy in HCC. Incidental tumors have better prognosis but
pathological staging determines the outcome.
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POST-TRANSPLANTATION GROWTH IN PEDIATRIC LIVER RECIPIENTS
Renz, de Roos, Rosenthal, J.Po Roberts, N.L. Ascher,
and J.C. Emond
Liver Transplant Program, University of California San
Francisco, San Francisco, CA
Growth failure is major complication in children with end-
stage liver disease. While transplantation liver
failure, post-transplantation growth patterns have been
well characterized. We examined growth patterns in pediatric
liver recipients determine the incidence of growth
restoration after transplantation and identify risk factors
associated with poor growth. Between 1988 and January 1995, 38
recipients (male:22, female:16) with follow-up of
22.4+/-14.5months included according to the following
criteria: age 15years younger, greater than year post-
transplantation, liver only recipient, extensive post-
transplant follow-up, and have not required retransplantation.
Children classified by age and indication for
transplantation: cholestasis (50%), metabolic (28%), fulminant
hepatic failure (12%), hepatitis (5%), and miscellaneous(5%).
Immunosuppression CSA/prednisone primary therapy with
cell induction. Tacrolimus reserved for treatment failures.
Post-transplant growth assessed year by comparison
of individual recipient weight for height growth to age
and sex-matched National Center for Health Statistic (NCHS)
growth percentiles and classified as:below NCHS predicted, 0-
15% above NCHS predicted, 16-40% above NCHS predicted, and
greater than 40% above NCHS predicted.
GROUP (years): 0-I (n=ll) 1-2 (n=9) 2-7 (n=8) 7-15(n=I0)
age. (mo) 5.6+/-2.0 17.2+/-3. 656.2+/-16.0 146.7+/-15.0
<NCHS (%) I0 22 12 30
0-15% abv NCHS (%) 45 12 12 20
16-40% abv NCHS (%) 8 33 50 50
>40% abv NCHS (%) 27 33 25
Rapid growth (>15% above NCHS predicted) observed in 61% of
recipients below years of age. In recipients with
cholestatic disease (n=20), there inverse relationship
between NCHS percentile transplantation and year post-
transplant growth. Age related year growth below
the age of however, recipients above the age of
demonstrated overall poor growth. relationship found
between growth and incidence of rejection. These data
demonstrate that despite pre-existing growth failure, most
recipients grow well. Catch-up" growth occurred in each
recipient group with rapid growth in 61% of recipients below
years of age. Below years, there inverse
relationship between year post-transplant growth and NCHS
percentile transplant. While the role of immunosuppression
could be clearly defined, data in close agreement
with growth data obtained from pediatric renal recipients.
SCID MOUSE AS MODEL FOR TRANSPLANTATION STUDIES
J.F. ReD,z, M. de Roos, Z. Lin, Dalal, and N.L. Ascher
Liver Transplant Program, University of California
Francisco, San Francisco, CA
Mice expressing the Severe-Combined-Immunodeficiency trait
(SCID) lack functional and lymphocytes and have been
widely used for the study of B-cell development, cancer, and HIV
research. The purpose of this investigation to determine the
immune response of reconstituted SCID mice and the
validity of the SCID model for transplantation studies.
C3H SCID mice screened by fluorescence activated cell sorting
(FACS) and radial-immunodiffusion assay (RID) defined
SCID if CD3-, CD22- and [IgG] <5mg/L. SCID mice pre-
treated with 250R g-radiation reconstituted (recon) with 3-
5x107 donor bone cells (syngeneic[syn]: male C3H,
allogeneic[allo]: male BALB/c) by injection. Four weeks post-
transplant, engraftment determined by i) FACS, 2)
repopulation of blood (WBC), thymus, and spleen, 3) and 4)
histologic evaluation. Greater than 90% of syn and allo
reconstitutions expressed CD3+,CD4 +, CD8 +, and CD22 cells of
donor origin in peripheral blood and spleen. Cell subpopulations
significantly different between SCID mice and C3H
BALB/c SCID- controls with engraftment stable for >4 months.
WBC, total thymocyte, and total splenocyte counts
significantly elevated (p< 0.05: ANOVA, students’ t) following
to levels found in wild-type controls. Serum [IgG] for
SCID mice >150mg/L (n=10) 32226mg/L for wild-type
controls with histologic lymphocyte engraftment of spleen,
duodenum, and thymus. Immune function against donor, recipient,
and third party antigen assayed in vitro by mixed lymphocyte
response (MLR) and cell-mediated cytotoxicity. AIIo-SCID
splenocyte response against third party antigen
significantly elevated (p<0.01: ANOVA, students’ t) compared
SCID with stimulation index (SI) equal donor and
recipient wild-type controls. In vivo immune function
determined by full-thickness skin grafting and pancreatic islet
cell transplantation. AIIo-SCID mice demonstrated rejection of
third party skin grafts between post-operative days 9-14
(controls: postoperative day 7-11). islet transplantation
experiments, alIo-SCID mice accepted both donor and recipient
background islets (euglycemic 100days) while rejecting third
party donor islets between post-transplant day and 9.
Chimerism within the alIo-SCID further assayed by FACS
analysis of the liver nonparenchymal (NPC) cell fraction. The
NPC fraction express MHC Class II and central in antigen
presentation. With engraftment, the alIo-SCID NPC fraction is
principally of donor background. The immunologic role of these
cells is under study. The SCID model demonstrates
stable chimera with and T-cell immune function comparable
wild-type mice. Thus, it useful model for the
induction of chimerism, thymic education, and cellular and
tissue transplantation studies.
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SMALL-FOR-SIZE GRAFT UTILIZATION IN LIVING RELATED LIVER
TRANSPLANTATION
J.F. Renz, N.L. Ascher, J.P. Roberts, R.C. Lim, and J.C. Emond
Liver Transplant Program, University of California San
Francisco, San Francisco, CA
Living related liver transplantation (LRLT) is effective
modality for children with end-stage liver disease. Optimal
results have been realized in small children using adult
donors since the minimal graft volume necessary to support
homeostasis is unknown. While formulae exist to predict
donor liver volume based upon body surface (BSA), ideal
body weight, and volumetric computed tomography, to date,
study has analyzed small-for-size graft function the lower
threshold of graft size is approached. From July 1992
through November 1995, 20 LRLT have been performed 18
children and two small adults. Recipients divided into
"small-forlsize" ([SFS], male:3, female:3, median age:160mo)
and "appropriate-for-size" ([AFS], male:9, female:5, median
age:14mo) groups based upon the actual volume of the
transplanted graft. Small-for-size" is defined actual
graft volume less than 60% of predicted recipient liver
calculated by BSA (SFS mean=0.38+/-0.1%, AFS mean=l.20z0.2%).
Retrospective analysis of intra-operative, clinical and
laboratory data indicate SFS grafts exhibit specific
patern of dysfunction the lower threshold of functional
volume is approached. Early function significantly
decreased in the SFS group with PT=18.2+/-2.2sec 14.8+/-1.6sec
post-operative day(POD) #3 (p=0.034) and remained
significantly different through POD #12 (p<0.05). All SFS
recipients developed cholestasis with significantly increased
bilirubin by POD #7 and remained significantly
cholestatic through POD #60 (p<0:05). Histologic review of
protocol biopsies in the SFS group revealed diffuse
ischemic pattern characterized by preservation injury" with
cellular ballooning POD #7 which progressed to
cholestasis; however, early ischemic injury, evaluated by
aspartate-aminotransferase, not significantly
different between SFS (294+/-134) and AFS (183+/-55) at 24 hrs.
Regression analysis indicated significant correlation
between graft volume and impaired function (p<0.001) with
exponential decrease in graft function below 50% of expected
liver An independent correlation also identified
between graft function and both donor and recipient blood
loss indication of surgical injury. The recipient of
the smallest graft (23% of expected liver volume) required
retransplantation for primary nonfunction. This study
represents early attempt to define the lower limits of
small liver graft in LRLT which is imperative for the
ultimate expansion of LRLT include larger children and
adults.
INCIDENCE OF BACTEREMIA AFTERBAND LIGATION
AND SCLEROTHERAPY OF ESOPHAGEAL VARICES: A
COMPARATIVE STUDY IN SCHISTOSOMOTIC
PATIENTS.
MRS Rohr, ES Siqueira, RR Castro, E Della Libera Jr., ___
Ferrari Jr.
Division of Gastroenterology, Universidade Federal de Sio
Paulo, Sio Paulo, Brazil.
The incidence of transient bacteremia after Endoscopic
Sclerotherapy (ES) of esophageal varices (EV) reaches 50% in
some studies. This number is thought to be reduced with
Endoscopic Band Ligation (EVL). We compared the incidence
of transient bacteremia after both procedures in patients with
hepatosplenic form of Schistosomiasis and EV. Five and 30
minutes after each treatment session, blood samples were
inoculated in soy broth medium (BACTEC(R)). Aerobic and
anaerobic cultures were performed. A total of 87 procedures
were included: 50 in the ES group and 37 in the EVL.
Bacteremia diagnosed by positive cultures occurred after 5
sessions: 2/50 (4%) of ES (one culture was positive in the 5
rain. sample: Peptostreptococcus sp. and another in the 30 min.
culture: and Streptococcus sp.). In EVL group, 3/37 (7,6%)
procedures were accompanied with bacteremia
(Staphylococus aureus at 5 minutes, Staphylococcus aureus at
5 and 30 minutes, and St.phyl.ocoeeus epidermidis at 5
minutes). No patient developed clinical evidence of infection.
In conclusion, incidence of bacteremia after ES or EVL, in
patients with hepatosplenie schistosomiasis was not statistically
significant (p > 0,05) when procedures were performed in
hepatosplenie schistosomiasis. Imunologieal differences
between sehistosomotie and cirrhotic patients could explain the
low incidence ofbaeteremia in this study.
F107 F108
HEPATIC HEMANGIOMA: US, CT and MRI FEATURES.
6-48 MONTHS IMAGING FOLLOW UP.
A. ROLLE, C. BONINI, et al.
Sanatorio Parque. Fundaci6n Dr. R.J.Villavicencio
Rosario. Argentina.
The hepatic hemangioma is the most frequent benign tumor of
the liver. It is generally an ordinary and incidental finding in
imaging routine examinations being mainly a problem for
oncologic patients. They are more frequently found in women in
the dght lobe of the liver. Many authors have pointed out the
differences among the imaging methods in order to establish
the diagnoses of this lesion. The purpose of this paper is to
introduce the US, CT, and MRI features of the hepatic
hemangioma in a great number of patients (791) and to make a
6-48 monthsUS follow up so as to determine possible changes
in size and signal. Between December 1989 to December 1994
we examined 791 patients with hepatic hemangioma over a
total of 30566 individuals. These 791 patients have undergone
1192 studies. All of them are under clinical, laboratory and
imaging follow up. Hepatic hemangioma showed an
hyperechoeic US feature en 93.2%, with no wall, and posterior
enhancement (Bismuth criteria); in CT 100% of the lesion were
hypodense without enhancement and hyperdense in 96.7%
after contrast administration. The eady angioscan technique
presented peripheral enhancement being opacified all the
lesion in late section (303 (Freeny’s tdad). The succes of the
CT examinations depended on tumor size, intravenous contrast
administration, patient cooperation, and angioscan technique.
In MRI 92.5% of the tumors were hypointense in T1 and 91.3%
hypedntense in T2. The hemangiomas do not present changes
as regards size and US features dudng two years, for wich,
in an appropriate clinical context US follow up is not
essential.
PROTECTIVE EFFECTS OF TRIIODOTHYRONINE ON ISCHEMIA
REPERFUSION INJURY OF THE LIVER.
A. Sa_alam, (3. akrak, H. Paaollu, F. Ozt0rk, A. Tutus}, Y. Arlta
Departments of Surgery, Biochemistry and Pathology, Erciyes
University School of Medicine, Kayseri, Turkey.
We investigated the protective effect of triiodothyronine (T3) on a liver
ischemia reperfusion model on rats. Portal and left lateral lobes of the
liver clamped and 70% liver ischemia was made. Following the
ischemia clamp was opened and reperfusion was established.
Study was carried out on T3 treatment and control groups. L
triiodothyronine in a dose of 300 mcg/kg/day per os for 10 days was
given to the treatment group and hyperthyroidism constituted. Each
treatment and control groups has 7 subgroups: sham operation,
ischemia only, 15 minutes, 2 hours, 24 hours, 48 hours and 7 days
following ischemia reperfusion injury. Animals are sacrificed after
obtaining blood and tissue samples, repeated reoperation is avoided.
Serum AST ALT LDH values and tissue lipid peroxidation were
studied, and histopathologic examinations of the ischemic liver were
done.
AST, ALT, LDH and lipid peroxidation of the ischemic tissue were
significantly lower in the treatment group when compared controls.
Histopathologic damage was also less severe in the treatment
groups.
These findings suggests that L triiodothyronine pretreatment has
protective effects on ischemia reperfusion injury of the liver.
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HOW TO IMPROVE NATIVE LIVER REGENERATION IN AUXILIARY
LIVER TRANSPLANTATION
A. Sauvanet, S. Yang*, D. Bernuau, P. Beyne*, MH. Denninger*, D.
Lebrec*, S. Erlinger*, J. Belghiti. Department of Digestive Surgery and
*Hepatology, H6pital Beaujon, Clichy, France Inserm U-327, Facult6
Bichat, 75018 Paris, France.
In case of fulminant hepatitis, auxiliary liver transplantion (ALT) is proposed
to supply for the naiive liver (NL) until it regenerates. Technical factors of the
NL regeneration are not yet known. The aim of this experimental study was to
assess the NL regeneration according to the graft (G) weight and the location of
portal anastomosis in ALT.
Material and Methods: 24 syngenic ALT using an arterialized G were performed
in a rat model after a 80% reduction of the NL and were allocated into 4 groups
A 50% reduced-sized G anastomosed to the superior mesenteric vein (SMV)
and NL vascularized by the pancreas, the spleen and the stomach (n=6), B
full-sized G on SMV (n=6), C 50% reduced-sizexl G anastomosed to the portal
vein (PV) and NL vascularized by the stomach (n=5), et D full-sized G on PV
(n7). NL and G regeneration were assessed at day 2 or day 4 by in vivo
incorporation of tritiated thymidine, then by weighting at day 30 after sacrifice.
Weight variation of the NL (AW (W30-W0)/W0) was calculated as well as
the ratio NL/W NL weight/rat weight and L/W NL weight + G weight/rat
weight at ALT and at sacrifice (respectively NL/W0, NL/W30, L/W0, et
L/W30).
Resllts: At day 0, the ratio L/W0 was 2.88+0.25% (group A), 4.58+0.28%
(group B), 2.68+0.15% (group C), and 4.73+0.16% (group D) respectively
(normal value 3.88+0.24%). At day 2 and day 4, tritiated thymidine
incorporation in NL was more important when G was anastomosed to PV but
did not change according to the G size. At day 30, AW of the NL was more
important in case of a full-sized G (groups B+D vs A+C) and G anastomosis to
the PV (groups A+B vs C+D). The AP of NL was + 212+123% in group B
and + 96+81% in group C (p=0.07, Mann-Whitney’s U-test). The ratio
NL/W30 was 2.32+0.68% in group B and 1.21+0.63% in group C (p=0.02).
The ratio L/W30 was normalized in groups A (3.87+0.37%) and C
(3.82+0.41%), and was still increased in groups B (4.65+0.60%) and D
(4.56+0.63%).
Conclusions: In this model of ALT 1) A better NL regeneration at day 30
was observed using a full-sized G anastomosed to the SMV; 2) This result is
not fully determined by the regeneration occuring until day 4 3) Excess of
overall liver weight persists at day 30.
HEPATIC HYDATIDOSIS. A MULTICENTRIC STUDY OF SURGICAL







Ne retrospectively reviewed 971 surgical cases of hydatid
cyst of the liver of patients treated over the period
1970-1995, in order to evaluated indications and results
of the surgical procedures.lETHODS:patients were divided
into 3 groups:Group 1:n-238 Radical Treatment:total per
cystectomy or segmentectomy in emergent cyst, when the
risk is low. Group 2:n=524 Conservative Treatment:paid
pericystectomy,marsupilization, omentoplasty or external
drainage,In multiple hepatic cyst,very large or complic
te cyst or when the operative risk is high. Group 3:n-
209 Combined treatment, including biliary tract surgery.
RESULTS:, orbility Nortality Recurrence
Group 1: (n=238) 19 3.7 0.8
Group 2: (n-524) 29 1.3 1.5
Group 3: (n-209) 4.7 0.5 2.4
Total serie(n-971) 21.3 1.8 1.5
DISCUSION: Surgery remains today the only definite treat
ment. Radical procedures were the first choice (in sele
ted cases) in the last ten years, because the progress
in hepatic surgery attain to the obetives of shortening
the duration of treatment and decreasing the postopera-
tive recurrence rate. Ne concluded that in our experie
ce the best clinical reaults were obtained with surgical
treatment selected oreach patient.
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SURGICAL TREATMENT OF HYDATIDE DISEASE OF LIVERAND
POSTOPERATIVE ULTRASONOGRAPHIC EVALUATIONS
13. Shukriu, A. Siqeca
Department of surgery, Medioal Centre, Prizren, Kosove
There were 43 cases ofliv hydatide disease treated surgically, which are
evaluated, all performed during the period ofJune 1986 to O_ktober 1995.
Offthe cases mentioned, 31 (or 72.1%) were females while the rest 12 or 27.9%)
being male. Concerning the professional back?ung, all were housewifes
respectively farmers. Localisacion ofthe hydatide cysts on the right lobe of
liver was present on 30 (or 69.77%) ofcases, on the left on (or20.93%)
while in both lobes on4 (or 9.3%) ofall cases. Number ofthe cysts in the liver
was in scale from to 3, in average size of 11.7 cm. In 16 cases (or 37.21%)
there were complications ofthe hydatide liver disease present: in 7 cases
(or 16.28% there was a rupture ofcyst in biliary tract with cystobilliary fistula,
in cases (or 18.61%) the secondary cysts in peritoneal cavity and in one case
(or 2.32%) a recidive ofhydatid cyst of liver. In 39 cases (or 90.7%) the partial
pericysteetomia was performed, removal ofthe cyst with omentoplication of
the cavity remained while in 4 cases (or 9.3%) there was no omentoplication_
performed. In cases with rupture ofthe cyst in billim7 tract the explbration ot-
the billiary tractwas performed, with the remora ofthe twin cyst and closing
ofcystobiliary fistula with omentum. The secondary cysts in the peritoneal
cavity were completely removed. There were no intra or postoperative complica-
tions in any ofthe cases mentioned.
Postoperatily all the eases were examined by ultrasound after 3fi and 12 months.
There was no complication evident in controls performed by ultrasound
examination in the cases, whatsoever.
We have specifically examined the remaining cavity.in the liver at..er the rein.oval
ofthe cysts and came to a conslusion that in cases where omentoplicasion
the cavity within three months while on cases without the omentoplication it took
over six months. As an outcome ofour researchwe consider that the partial
pericystectomia with omentoplication gives satisfactory results with a low
postoperative morbidity. We sugest ultrasound controls in evaluation ofthe
remaining cavity in the liver and appearance ofeventual complications.
BAND LIGATION OR SCLEROTHERAPY IDF ESOPHAGEAL
VARICES IN PATIENTS WITH HEPATOSPLENIC
SCHISTOSOMIASIS
ES Siqueira, MRS Rohr, CQ Brant, M Morais, AP Ferrari Jr.
Division of Gastroenterology, Universidade Federal de Sao Paulo,
Sao Paulo, Brazil
Hepatosplenic Schistosomiasis (HS) is the leading cause of Portal
Hypertension (PH) in Brazil. Variceal bleeding is the major
complication of the disease and carries high mortality. Although the
studies comparing efficacy of Endoscopic Sclerotherapy (ES) and
Variceal Ligation (EVL) in the trealanent of esophageal varices in
cirrhotic patients showed similar efficacy and lower incidence of
complication with EVL, there are no studies using only patients with
pre sinusoidal PH. We performed a prospective, double blind,
randomized study to compare efficacy, complications and recurrence
of esophageal varices treated by ES or EVL in patients with HS and
Esophageal Varices (EV). Thirty six patients were included (18 in
each group). They were treated with repeated endoscopy sessions
until eradication ofEV. Six months after eradication, endoscopy was
performed to look for recurrence and local complications. Less,
sessions were necessary to eradicate VE in EVL group (2,9 vs. 3,9,
p=0,04). Efficacy was similar in both groups (100% in EVL and
88,8% in ES). Treatment failure occurred in 2 (12,2%) patients in
the ES group, who developed uncontrollable gastric variceal bleeding
and were referred to surgery. There were not significant differences
in the incidence of complications. However, 50% of the patients in
the ES group needed additional sedation during or inunediately after
the procedures and it did not happen in any patient ofthe other group.
There was only one case of recurrence in ES group: We concluded
that both endoscopic methods of treatment of EV are efficient, with
similar incidence of complications and recurrence in this study with
schistosomotic patients. Eradication occurred faster and with less
pain in EVL group.
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META ANALYSYS OF EFFICACY OF ENDOSCOPIC SCLEROTHERAPY (ES) ON THE
FIRST VARICEAL BLEEDING (FVB) AND MORTAUTY RATE IN CIRRHOTICS WITH
HIGH RISK VARICES (HRV) IN LONG TERM (24 too) RCTS
S. SIRINGO. R. COGMANDRO, G. vITrURINI, C. CARBONE, B. MISITANO, L. BOLONDI,
R. CORINALDESI.
ISTITUTO DI CBNICA MEDICA E GASTROENTEROLOGIA-BOLOGNA. ITALY
In unselected clrrhotlcs the 2 yr. FVB rate is 25/, and 40"1, of the episodes occur within the
first 6 mo (Hepatology 1994;20:66). Pts with HRV should have at least a 10"/. higher FVB rate
respect the baseline risk. To minimise heterogeneity we grouped RCTs with similar: a)FVB rate
in the placebo groups; b)length of f-u. RCTs whose placebo groups had a 24 mo FVB rate
>35% were defined as RC,Ts of HRV. We Included RCTs: a)with an average f-u of 24 mo;
b)with a yr. FVB rate >35% in the placebo group; c)whose results were published in life lables
or data communicated by the Authors when requested. Eight of 9 RCTs met these criteria. A
total number of 749 pts was included :347 treated and 372 controls (CTR). The FVB rate in the
pooled control groups was 48.4% (range 34%-80*/.), 42*/0 of the episodes occurred within 6
mo. The sample size of 749 pts was required to significantly decrease by >10"/, the risk of a
FVB (a=5%; 1-1]=80%). The Messod’s method for censored data was used (CompuL
Progr.Meth.Biom.1993;40:261). The table show the results: among treated pts them was a
trend toward a reduction of the FVB rate dudng the first 6 mo, then the FVB rate significantly
decreased within and after the first six months.
CUM. BLEED. FREE RATE CUM .SURVIVAL RATE
K. Paquet et al. (1986)
T. Sauerbruch et al. (1988)
G. Piai et al. (1988)
R. P0tzi et al (1989)
E. Kobe et al. (1990)
D. Trigger et aL (1991)
R. De Franchis et al. (1991)
K. Paquet et al. (1994)




6 rno 6 mo mo mo
ES CTR ES CRT ES CRT ES CRT
94 72 91 10 97 83 82 10
79 82 51 57 86 77 59 47
90 84 80 38 93 87 66 43
80 86 64 60 85 86 72 46
87 82 69 33 94 88 67 61
88 80 66 52 88 86 66 56
69 77 58 52 76 85 42 47
81 67 75 31 93 85 75 30
5.2 17. 5.8 16.6
0.75 0.45 0.68 0.47
(0.52-1.10) (0.35-0.60) (0.45-1.04) (0.36-0.62)
0.07 <0.001 0.04 <0.001
CONCLUSIONS. ES should be recommended as long term therapy to prevent the FVB in
selected pts with HRV.
SURGICAL VS NON-SURGICAL FOCAL LIVER
LESIONS: PRE-OPERATIVE EVALUATION WITH SPIO-
ENHANCED MR IMAGING
C. Stoupis. H-U Baer, p. Vock, M.W. B0chler.
Clinic for Visceral and Transplantation Surgery and Dept.
of Radiology, University Hospital of Berne, Switzerland
Purpose: To assess SPIO-(superparamagnetic iron
oxide, a reticuloendothelial system-RES-contrast agent)
MR imaging (MRI) in detecting and characterizing liver
lesions before surgery.
Methods: 50 patients with known or suspected liver
lesions were examined with SPIO-enhanced MRI.
Qualitative and quantitative analyses and correlation with
surgical and pathological findings were performed.
Results: SPIO enhanced T2-weighted MRI images
demonstrated marked decrease in signal intensity of liver
(96%). This sequence provided improved liver lesion
detection and diagnostic confidence compared to plain
MR (81% and 86% resp.). Cases of FNH (n=16) were all
depicted and characterized in SPIO-enhanced MRI and
the central scar was better seen in post contrast images.
Hemangiomas (n=12) revealed different signal behavior
than FNH and all were correct identified in enhanced
MRI. Adenomas (n=4) were found to have different RES
activity. Hypervascular metastases (n=18), because of
lack of RES cells were all depicted in SPIO-MRI.
Conclusion: SPIO-enhanced MRI has the potential to
be the non-invasive method of choice in the preoperative
evaluation of focal liver lesions due to its efficacy to
detect and potentially characterize surgical from non-
surgical liver lesions.
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HEPATIC ARTERIOVENOUS FISTULAS AND ANEURYSMS
P.G.Tarazov, A.A.Polykarpov
Division of Angio/lnterventional, St.Petersburg Research
Institute of Roentgenology & Radiation Therapy,
St.Petersburg, Russia
A retrospective study was carried out on 39 patients with
vascular diseases of the liver, Of them, 37 pts had intrahepatic
arterioportal fistulas (APFs) mostly due to hepatocellular
carcinoma (HCC, 21) or iatrogenic trauma (11); the 5
remaining cases included APF in cirrhotic (2),
herrmngiomatous (2), and normal liver (1). One patient with
hepatic hemangioma had hepatic artery-to hepatic vein fistula
(AVE) and the other one with cirrhosis had an aneurysm of
the common hepatic artery (CHAP,). Treatment included liver
surgery (4 resoctable HCCs), transcatheter embolization 20
7 HCC+6 large iatrogenic APFs+5 benign
APFs+IAVF+ICHAA ), and observation 15 10 HCC+5
small iatrogenic APFs ).
Surgie treatment was uncomplicated in all 4 pts.. Of them,
two are alive in 2 and 3 yrs and two died of HCC 1.5 and 2.5
yrs later.
Arterial embolization successfully controlled portal
hypertension in all 18 pts with APF and normalized systemic
hypertension in a patient with AVF. Unfortunately,
recanalization of CHAA developed after embolization. The
survival of these 20 pts depended on the main liver disease and
varied from 6 me (HCC) to 10 yrs in benign cases.
All 10 pts with untreated HCC-related APFs died of massive
van’ceal bleeding within 2 me. All 5 srnall iatrogenic APFs
showed spontaneous thrombosis during follow-up.
It is concluded that large long-standing APFs cause severe
poazl hypertension with consequent variceal bleeding, so
arterial embolization is indicated in mo ltients. Hepatic
AVS is also successfully treated bymn, while surgery
may be indicated in CHAA.
RESECTION OF COLORECTAL LIVER METASTASES-
A 25-YEAR EXPERIENCE
K.-G. Tranberg, B. Ohlsson, U. Stenram
Departments of Surgery and Pathology, Lund University, Lund, Sweden
This is a review of 107 consecutive patients with colorectal liver
cancer resected with curative intent during 1970-1995. The hepatic
tumours were single in 60 patients (56 %), unilateral in 81 (76 %)
and associated with extrahepatic disease in 12 (11%). Types of first
resection were: right hepatectomy 48, extended right hepatectomy 9,
left hepatectomy 10, extended left hepatectomy 1, left sectorectomy
8, mono- or polysegmentectomy 7, major atypical resection 6 and
minor atypical resection 18. In addition, reresections were performed
in 12 patients. Overall median survival was 27 months, and 5-year
survival rate was 25 %. Median survival was 21 months in patients
operated before 1985 and 53 months in patients operated later; cor-
responding 5-year survival rates were 18 and 46 %, respectively.
Recurrence in the liver alone occurred in 18 patients (17 %), at
hepatic and extrahepatic sites in 43 (40 %) and at extrahepatic sites
alone in 19 (18 %). Prognosis was significantly improved by a low
number of liver tumours, a free resection margin and no extrahepatic
tumour (Cox’s proportional hazards model), corroborating the find-
ings in our 1985 review. Three patients died perioperatively (major
bleeding 2, liver failure 1) (operative mortality 3 %), but no patient
died from complications after 1985. Major postoperative complica-
tions (bleeding 3, liver insufficiency 1, intraabdominal abscess 6,
respiratory insufficiency 1) were seen in another 8 patients (7 %). It
is concluded that survival after curative resection for liver colorectal
secondaries is favoured by a low number of hepatic tumours, no
extrahepatic disease and a free resection margin. These selection
criteria have been more strictly adhered to during the last ten years,
which coincides with the observed improvement in survival.
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FOLLOW-UP AFTER CURATIVE SURGERY FOR COLO-
RECTAL CARCINOMA: RANDOMIZED COMPARISON WITH
NO FOLLOW-UP
K.-G. Tranberg, B. Ohlsson, U. Breland, H. Ekberg, H. Graffner
Departments of Surgery, Lund University, Lund, Sweden and
Helsingborg Hospital, Helsingborg, Sweden
This study investigated the value of intense follow-up after curative
surgery of cancer in the colon or rectum. 107 patients were random-
ized to no follow-up (control group, n=54) or intense follow-up
(follow-up group, n=53) after surgery and early postoperative
colonoscopy. Patients in the follow-up group were followed at fre-
quent intervals with clinical examination, rigid proctosigmoido-
scopy, colonoscopy, computed tomography of the pelvis (in patients
operated with abdominoperineal resection), pulmonary x-ray, liver
function tests, and determinations of carcinoembryonic antigen
(CEA) and faecal hemoglobin. Follow-up ranged from 5.5 to 8.8
years after primary surgery. Tumour recurred in 18 patients (33 %)
in the control group and in 17 patients (32 %) in the follow-ul
group. Reresection with curative intent was performed in three
patients in the control group and in five patients (four ofwhom were
asymptomatic) in the follow-up group. In the follow-up group two
asymptomatic patients with elevated CEA levels were disease-free
three and five and a half years after reresection and were the only
patients apparently cured by reresection. No patient underwent
surgery for metastatic disease in the liver or lungs. Symptomatic
metachronous carcinoma was detected in one patient (control group)
after three years. Five-year survival rate was 67 % in the control
group and 75 % in the follow-up group (p> 0.05); the corresponding
cancer-specific survival rates were 71% and 78 %, respectively. It is
concluded that intense follow-up after resection of colorectal cancer
did not prolong survival in this study.
PERCUTANEOUS FINE NEEDLE BIOPSY OF LIVER
TUMOURS- IMPACT ON PATIENT MANAGEMENT AND
OUTCOME
K.-G. Tranberg, B. Ohlsson, J. Nilsson, M. Akerman, U. Stenram
Departments of Surgery and Pathology, Lund University, Lund, Sweden
Percutaneous fine needle aspiration biopsy followed by .histo-
pathological examination was carried out in 208 patients with liver
tumours. Indications for aspiration biopsy were: suspect recurrence
of previously resected primary (n=63), tumour of unclear origin or
type (n=144) or ascites (n=1). The final diagnosis was primary liver
cancer (n=103), colorectal liver cancer (n=47), non-colorectal liver
metastases (n=49), benign tumour (n=5) and no tumour (n=4). Com-
pared to the final histopathological diagnosis, cytological examina-
tion resulted in: correct diagnosis in 85 patients (41%), correct
classification as benign or malignant in another 72 patients (35 %),
suspect malignancy in 10 patients (5 %) with malignant tumour,
erroneous classification of a malignant lesion as benign or a benign
lesion as malignant in 24 (12 %) and 4 (2 %) patients, respectively.
Cytology was inconclusive in 13 patients (6 %). Considering the
information available when aspiration biopsy was carried out, cytol-
ogy provided new and correct information in 75 patients (36 %),
confirmed a previous suspicion in 81 patients (39 %), gave no con-
elusive information 28 patients (13 %) and incorrect information in
24 patients (12 %). Cytological diagnosis was. valuable for planning
further investigation and treatment in 58 patients (28 %) but was of
no or doubtful importance in 139 patients (67 %). In 11 patients
(5 %) it led to repeat aspiration biopies without definite diagnosis,
delay of treatment or unnecessary investigations or operations. Im-
plantation metastasis was recorded in 7 patients (3 %). It is con-
eluded that fine needle biopsy is of limited value in the management
of liver tumours and that the benefits and risks involved do not jus-
tify its use in candidates for curative resection.
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CHEMOEMBOLIZATION AND ALCOHOLIZATION FOR HEPATO-
CELLULAR CARCINOMA IN CIRRHOSIS BEFORE LIVER TRANS-
PLANTATION: ASSESSMENT OF EFFICACY.ON SPECIMENS AND
CLINICALOUTCOME.
R. Troisi; U.J.Hesse; P. Pattyn; M. Praet*; L. Defreyne $ and B. de Hemptin-
ne. Departments of: Surgery and Liver Transplantation, Pathology, $ Radio-
logy, University Hospital Ghent, Belgium.
Liver transplantation LT has been widely accepted in of irreseetable
HCC because of the severity of the underlying cirrhosis, the location of the
tumour within the liver hilus, or the extent of the liver involvement, but the
benefit of pretransplantation tumor treatment with ehemoembolization (TAE
and/or percutaneous alcohol injection PEI is still under investigation. We
report our results after preoperative treatment with TAE and PEI, regarding the
clinical outcome and the recurrence rate after LT for HCC. Material and
methods: 17 patients underwent total hepatectomy and orthotopic liver trans-
plantation for irresectable HCC on cirrhosis. There were 15 males and 2 fema-
les, whose ages ranged from 39 to 63 years (median age +/- sd 54 +/- 5.7 ).
All the patients were eirrhotics, with prevalence of HCV infection in all but
two, one affected by alcoholic cirrhosis and the other by cholestatic liver disea-
se. The tumour nodules were solitary in 9 cases, multiple in 8, with mean size
of 28 +/- 15 mm, ranging from 10 to 70 mm. TAE and PEI were performed in
all but two patients, and repeated every 2-3 months (TAE until time and
every 2-3 weeks PEI until 6 time ). Results: the serum a-fetoprotein level was
useful for evaluating the therapeutic effect, showing important decrease in
patients with level higher than 100 ng/ml. Mild to severe local pain occurred
immediately after PEI and high fever >38 *C developed after TAE in halfof
the patients without any complications. Extensive tumour necrosis 90%
was seen in 9 patients, but tumour could not be found in despite positive
preoperative liver biopsy (in two) and most suggestive preoperative radiog-
raphic imaging in the other one. We lost four patients: two because of tumour
recurrence at 8 and 37 months after LT, one because fulminant recurrence of
HBV infection after retransplantation and the other one because of cerebral
bleeding, respectively at 16 and months after LT. The median follow-up is 20
+/- 15 months range 6-48 ), with total recurrence rate of 11%. The overall
actuarial survival and tumour free survival is 76% at four years.
Coneluion: in our opinion in selected patients treated with combined adju-
vant therapeutic options now available such as TAE and PEI, long-term survi-
val could improve even further if extensive tumor necrosis can be obtained.
Efforts should be made to treat the patients before transplantation to reduce
tumour volume and hopefully reduce micrometastasis.
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INTRAARTERIAL SYSTEMATIC CHEMOTHERAPY FOR
NON OPERABLE HEPATOCELLULAR CARCINOMA
E.Tzoracoleftherakis, D.Kyriakopoulou, S. Kakkos, A.
Dimakopoulos, C. Mitsoulas
Department of Surgery, University of Patras, Patras, Greece
The efficacy of intraarterial infusion of adriamycin in
inoperable hepatocellular Carcinoma remains controversial.
A series of 68 patients with inoperable hepatocellular
carcinoma (mean age 63 years, range 49-75) were studied
prospectively. The atients randomised to receive
adriamycin 50 mg /m, either bolus infusion via
implantable intrarterial catheter and port inserted in the
hepatic artery (31 patients) systemic chemotherapy
with bolus injection (37 patients), every 21-28 days. The
Karnofsky scale of the patients at diagnosis at least
70 %. Complication resulted in the arterial infusion group
were: infection of the port pouch 2, catheter migration I,
hepatic artery aneurysm, myelosupression 1. Five patients
died without receiving chemotherapy. Of the remaining 26
patients, 17 (65.4 %) had subjective improvement, while
the 15 (57.7 %) presented objective improvement. The
Karnofsky scale showed improvement in patients (30.8 %)
while I0 (38.5 %) remained stable. The survival 69.2
(18 patients) in months and 11.5 (3 patients) in 12
months. The survival was 7.1 months (2-16 months).
In the systemic chemotherapy group major complications
included 3 cases of myelosuppresion. Three patients
discontinued chemotherapy. Of the remaining 34 patients, 15
(44.1%) had subjective improvement while the 15 (44.1%)
presented objective improvement. The Karnofsky scale
improved in patients (20.6 %) while Ii (32.4 %) remained
stable. The survival 55.9 (19 patients) in months
and 5.9 (2 patients) in 12 patients. The mean survival
6.5 months (1-13 months). There was difference in the
survival of the groups. There was equal decreased
survival of the cirrhotic patients in both groups. The
quality of life remained at acceptable level during the
treatment and until the death.
In conclusion, slight superiority of intraarterial
chemotherapy against the systematic is anticipated.F121 F122
LIVER RESECTION FOR HEPATOCELLULAR CARCINOMA ON
CIRRHOSIS.
A.Uzzau, F.Bresadola M.Sistu, N.Cautero, M.G.Ventroni, G.Anania,
S.Intini, P.Soro
Department of Surgery, University of Udine, Udine, Italy
A retrospective study was carried out on 53 liver resection for HCC
performed over a six years pedod (June 1989-June 1995). Seventy-two
consecutive patients were enrolled as possible candidate to resection 12 of
which (16.6%) were escluded from a surgical therapy as a consequence of
the following cdteda: multifocality, portal thrombosis, and metastases. Out
of 60 patients suitable for surgical treatment 53 underwent liver (resection
index of 88.3%). Only one patient with haemoperitoneum underwent
emergency exploration and resection. Istologically proven cirrhosis were
present in 95.8% of the patients and Child-Pough’s class was A in 63%, B
in 28.2% and C in 8.8% respectively. In the last four years thirtyfive
patients (66%) were prospectively evalueted for surgical risk by mean of
the Okamoto index and all resulted under the cdtical value of 50% (mean
29,9%, SE 6.8). Intraoperative US exploration was always employed and
all resections were done under transparenchymal approach by Kelly-
fracture. Pringle clamping was used in 62.2% (with mean clamping time of
29.5 min., SE 2.85, range 8-74).
Histological studies showed HCC in 45 patients, cholangiocaroinoma in 6
and fibrolamellar vadant in 2. In 62.2% cases HCC was single nodular
whereas in 37.8% was multinodular. The mean diameter of the lesions was
6.4 cm (range 1-17, SE 0,4). In 23% of the cases the tumor was
encapsuled and a free margin of resection was present in 73%.
In this series morbidity was 37.7% and two patients died within 30 days,
with an overall mortality rate of 3.7%. Excluding deaths within one month,
long term survival rates were investigated in relation to vadous prognostic
factors using Kaplan-Meier method.
The overall survival at 1, 2, 3 and 5 years was 67%, 54%, 43% and 21%.
Seventheen patients (35.4%) had recurrences dudng the first two years
and were treated by TACE or peroutaneous alcooi injection. Statistical
analysis of prognostic factors showed that a free resection margin and a
single lesion was associated with a better survival (53% survival at 5 years
for single lesion and 36.8% for free margin resection vs 22.5% for multiple
lesions and 0% for patients without free margin resection)..
WARM (20C) FLUSH OF COLD STORED LIVERS PRIOR TO
REPERFUSION ATTENUATES PRESERVATION INJURY.
B.A. van Wa.qensveld, M.E. Reinders, T.M. van Gulik, W.M. Frederiks1,
R.J.A. Wanders and H. Obertop. Depts of Surgery, 1Cellbiol. and Histol.
and 2Biochem. Academical Medical Center, Amsterdam, the Netherlands.
In a previous study, we have shown a beneficial effect of intermittent warm
(20C) rinsing on microcirculatory injury in cold stored rat livers. Aim of this
study was to evaluate the temperature effect (4C vs 20C) of a single flush
preceding reperfusion in a rat liver preservation model. Preservation injury
was assessed by measuring AST, LDH, hyaluronic acid (HA) and purine
nucleoside phosphorylase (PNP). HA is metabolized by the sinusoidal endo-
thelial cells (SEC) of the liver; uptake or release therefore reflects SEC func-
tion or death, resp. Release of PNP is associated with SEC death. Methods.
.Rat livers were washed out in situ via the portal vein with UW solution (4C)
and after hepatectomy, were stored at 4C. Immediately after hepatectomy
(tO, control livers) and after 8hr, 16hr and 24 hr cold ischemic time (CIT),
resp, the livers were reperfused for 90 mins via the portal vein with oxygena-
ted Krebs Henseleit buffer (37C, without albumin) containing HA (34-55
pgr/L). At the end of CIT, prior to reperfusion, the livers were flushed with 10
ml UW solution, either at4C or 20C. During reperfusion, bile production
was monitored and HA (radiometric assay), PNP (fluorescence spectro-
scopy), LDH and AST were measured in the reperfusion medium. Results.
Mean bile production was highest in control livers (1.88 + 0.31 IJI/gr/min).
After 8hr CIT, significantly more bile was produced by livers preflushed with
20C UW, as compared to those preflushed with 4C UW (1.61 + 0.13
IJI/gr/min vs. 0.84 + 0.15 pl/gr/min, p=0.006). After 16hr and 24hr CIT, more
bile was produced in livers preflushed at 20C, however not significantly
different (1.03 vs. 0.99 pl/gr/min at 16h/20C and 16h/4C, resp., and 1.30
vs. 0.94 pl/gr/min at 24h/20C and 24h/4C, resp.). HA uptake after 90 min
reperfusion in the contol group (tO) was 49%. After cold storage, progressive
leakage of HA was seen in all groups, except for the 8h/20C livers in which
HA was taken up. PNP and AST release increased progressively in all
groups with prolonged CIT, without showing differences between the 4C
and 20C flush groups. LDH release increased with CIT in all groups, and
was not significantly different except for the 8h/20C and 8h/4C groups
(38.0 + 9.2 U/I and 80.6 + 16.8 U/I, resp.; p=0.004). Conclusion. Warm
(20C), single flush of cold stored livers prior to reperfusion attenuates
preservation injury. This effect was most evident after 8h storage, compared
to 16h and 24h storage, suggesting that the beneficial effect of warm,
pretransplant flush solutions decreases with prolonged preservation times.
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TRANSPLANTATION FOR ALPHA ANTITRYPSIN (A1AT)
DEFICIENCY.
G Vennarecc.i, T Ismail, BK Gunson, *D Kelly, AD Mayer, JAC
Buckels, E Elias, P McMaster.
The Liver Unit, Queen Elizabeth Hospital and *The Children’s
Hospital, Birmingham, UK.
End-stage A1AT deficiency related-liver disease is the most
common genetic cause for orthotopic liver transplantation
(OLT) in children, although a rare indication in adults. The
pathophysiology of the disease is poorly understood and the
natural history, disease progression and outcome is
unpredictable. OLT is the only therapeutic option for end stage
liver disease. Of 1000 OLT performed between 1982-1994, 39
transplants (35 patients; 13 children, 22 adults) were for A1AT
deficiency. Eleven children presented with features of neonatal
hepatitis and intrahepatic cholestasis and two with
hepatosplenomegaly. Jaundice failed to relapse in five and
portal hypertension was present in all cases. Liver disease in
adults presented with sudden onset and a progressive course
leading to liver failure. Eight (2 children) patients had
obstructive respiratory disease at time of OLT. All children were
homozygous (PiZZ) with a median serum AIAT level of 0.45 g/I
(range: 0.4-0.95 g/I). Two adult patients were PiZZ, 3 were
PiMM with the remaining being heterozygous. The median
serum A1AT level for adults was 1.10 g/I (range: 0.2-2.27 g/I).
Fifteen OLT (13 patients, 10 male, 4 reduced grafts) and 24
OLT (22 patients, 19 male) were performed in children and
adults respectively. Two children were retransplanted for
chronic rejection and two adults for hepatic artery thrombosis
and ischaemic graft failure. Current year post transplant
survival figures are 73% for adults and 87.5% for children.
Replacement of the cirrhotic liver results in acquisition of donor
phenotipe, a rise in serum levels of AIAT and apparent
prevention of associated disease. All survivors have normal
liver function, good quality of life with no liver disease
recurrence or lung disease progression.
LIVER TRANSPLANTATION FOR PRIMARY HEPATIC MALIGNANT
DISEASE
Emilio Vicente M.D. Victor S. Turri6n M.D.. Javier Nuito M.D. Fernando
Pereira M.D. Nicol P. Mora M.D. Julian Ardaiz M.D. Valentin Cuervas-
Mons M.D. Antonio L. Sanrom=ln M.D. Angel Candela M.D.
Liver Transplantation Unit. Hospital Ramdn y Caal. Clfnica Puerta de Hierro.
Madrid. Spain
Liver transplantation is now widely accepted as a worthwhile treatment for
selected patients with primary liver cancer. At Hospital Ramtn y Cajal and Clfnica
Puerta de Hierro, we performed 340 liver transplantation between March 1986 and
December 1995. 31 patients underwent transplantation for primary malignant
disease. 23 patients had hepatocellular carcinoma, including of the fibrolamellar
type, 7 were diagnosed of cholangiocarcinoma and of hepatoblastoma. Of the 31
patients, 6 were female and 25 were males. The ages of the patients ranged from 12
to 63 years. 4 ofwhom were less than 20 years old.
patients (9%) died in the first 3 months from complication of
transplantation. Of the remaining patients who survived more than months, 4
(14%) developed recurrent disease, diagnosed 7 months to 9 months after liver
replacement. The only patient treated for fibrolamellar hepatoma is alive without
tumor at more than 8 years after transplantation.
CARCINOMA HEPATOCELLULAR
20 of 22 patients with carcinoma hepatocellular had associated underlying
liver disease. These patients were stratified according to the TNM classification:
Stage I: 3 patients, Stage II: 10 patients, Stage III: 6 patients and Stage IVa: 3
patients. Actuarial survivals for all 22 patients with carcinoma hepatocellular at
year, 2 years and 3 years were 57%, 50% and 41%, respectively. Stage and II (5
years actuarial survival: 56%) and incidental hepatoma (4 years actuarial survival:
77%) have a good prognosis after transplantation..
CHOLANGIOCARCINOMA
of the 7 patients who underwent liver transplantation for
cholangiocarcinoma had nodal involvement and/or perineural and vascular invasion
with infiltration of tissue around biliary tract. The 7 year actuarial survival was
66%. 2 patients survived tumor free for more than seven years. In patient,
recurrence occurred in the trasplanted liver, seven months after transplantation.
We conclude that liver replacement for malignant hepatic neoplasms should
be considered for a selected group of patients with unresectable lessions and without
evidence of extrahepatic disease.
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RESULTS OF 118 LIVER RESECTIONS FOR METASTASES OF
COLORECTAL CARCINOMA
I.Vogel, D. Henne-Bruns, B.Kremer
Department of Surgery, University of Kiel, Kiel, Germany
Between 1985-1994 118 liver resections in 113 patients with liver
metastases of colorectal carcinoma were performed by our group at the
University hospitals of Hamburg and Kiel.
The data of 106 cases were analysed in a retrospective study regarding
the following prognostic factors:
age, sex, Iocalisation and stage of primary tumor, size, number and
Iocalisation of metastases and extent and radicality of the liver
resection.
The results showed, that a significant influence regarding the long term
survival rate could only be archieved in patients, in which a R0-resection
with a histollogically proven tumor free margin of more than cm was
performed (p= 0,0087).
For patients in this group (n=46) a 5-year-survival rate of40% was
observed: In patients with tumor free resection margins less than cm
(n=38) the 5-year-survival rate was only 10% and comparible to,patients
with Rl-resections (n=7). None of the patients with R2-resections
(n=15) survived 5 years.
Other significant prognostic factors were the number of metastases and
their size. Patients with more than 3 metastases or metastases > 10 cm
had a significant shorter survival (p= 0,0467/p= 0,0472) than patients
with 1-3 metastases or metastases < 10 cm.
Our data support the importance of a sufficient safty margin in liver
resections for colorectal metastases.
TRANSPLANTATION OF AUTOLOGOUS CULTURED
HEPATOCYTES IN PRIMATE: A MODEL FOR GENE
THERAPY OF CONGENITAL HYPERCHOLESTEROLEMIA.
C. Vons, D. Mahieu, M. Andr6oletti, F. Bargy, A. Weber, F.
Capron, D. Franco.
Services de Chirurgie, H6pital Antoine B6cl&e et H6pital St Vincent
de Paul, ICGM H6pital Cochin, Paris, et Service
d’Anatomopathologie, H6pital Antoine B6cl6re, Clamart, France.
A possible treatment of autosomal hypercholesterolemia is the
transplantation of autologous hepatocytes transfected with the gene
coding for the LDL receptor. The purpose of this work was to
assess the feasibility of preparing a large amount of hepatocytes
from primate liver and to transplant them within the portal system.
Nine Macacus Cynomolgus females weighing 3 to 6 kgs were used.
The left posterior liver lobe was carefully removed under general
anesthesia. This lobe represents about 30% of the total liver mass.
During the same operation the catheter of an intravenous infusion
chamber was inserted in the inferior mesenteric vein with its tip
positioned at the confluence with the splenic vein. The chamber was
inserted subcutaneously on the chest. Postoperative (5 days)
portography through the catheter demonstrated the patency of the
portal system in all cases. Hepatocytes were prepared from the
resected liver lobe by perfusion of collagenase. Palmate hepatocytes
were cultured during 5 days in DMEM. They were then slowly
infused into the portal system (108 cells in 20 ml of saline) through
the catheter inserted into the inferior mesenteric vein. There were no
postoperative death and infusion of cultured hepatocytes was well
tolerated. Liver biopsies were taken from each remaining liver lobe
under general anesthesia 7 and 14 days after hepatocytes
transplantation. Histological examination of specimens showed
hepatocytes in the sinusoids lumen of the liver. Our model
represents a good model for transplantation of autologous
hepatocytes in primates.
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PROLONGED INTERMITTENT ISCHEMIA FOR HEPATIC
RESECTION OF THE CIRRHOTIC LIVERS EFFECTS AND
LIMITS
..Cheng-Chung Wu. Chih-Jen Huang, Dah-Cherng Yeh, Tse-Jia Liu, and
Fang-Ku P eng, "lsichung Veterans General Hospital, Taichung, Taiwan
Clamping of hepatic pedicle (Pringle’s maneuver) is uscfid tcchnique
for reducing operative bleeding in hepatic resection. Although normal liver
can tolerate conlin=ous varm ischemia for more than 60 rain, the upper lime
limit for cirrhotic:: liver is still undefined. On the other hand, intermittent
clamping of liver Iedicle is reported to be better than continuous clamping.
To determine the cffects and limits of prolonged intermiltent liver ischemia
on cirrhotic liver, we retrospectively reviewed our results of hepatic resection
on cirrhotic patienls using this technique. During operation, liver
parcnchymal disse.::tion was performed under repeat chmping of liver
pedicle for 15 min and dcclamping for rain. Based on the total ischcmic
time, these paticnl::. vcrc divided into thrcc groups: group A, 40rain (39
patients), group B 10-80 rain (28 patients) and group C > 80rain (16
patients). The non ,tumorous liver parcnchyma was prescrvcd as much as
possible. Longer tc, tal ischcmic time was required in the resection of larger
lumor(p=0.0()2). :.d was associalcd with longer operating time, grealer
amount of operati, blood loss and blood transfision (p<0.001). It also
resulted in higher clevalion of posloperative levels of serum transaminases
and lactic dchydro.’.cnase (p<0.001). Two patients in group A died of
operation. The opctativc morbidily, morlalilv and late hepalic failure ralc is
nol diffcrcnl amon..:, Ihe Ihrcc groups. The longcsl Iotal ischcmic lime in Ihis
series is 204 rain. Iowcver. the tippcrmost time limits for warm ischcmia on
cirrhotic liver requires fi=rther investigation.
THREE DACADES EVOLUTION IN SURGERY FOR PRIMARY
LIVER CANCER
X.D. Zhou Z.Y. Tang, Y.Q. YU, Z.C. Ma
Liver cancer Institute, shanghai Medical University,
Shanghai 200032, China
During 1958-1994, 2018 patients with pathologically
proven primary liver cancer(PLC) were explored and
80 patients(68.4%) underwent liver resection.
Comparison with PLC data of 1958-1970(n=125), 1971-
1982(n=359), and 1983-1994(n=154), encouraging changes
in the prognostic pattern were observed, overall 5-year
survival being 6.9%, 18.(%, and 46.%, respectively,
and 10-year survival being 6.(%, 11.8%, and 5.4%,
respectively. The major factors .hat related to these
encouraging results may be as follows: (I) A remarkable
increasing proportion o1" small PLC (<bcm), . (4/)
18.4%(66/59), and 35.%(519/154), respectively. (2)
A remarkable increasing proportion o curative
resection, 40.6%(26/64), 69.5%(121/174), and 88.6%
(1012/1142), respectively, (5) A remarkable increasing
proportion of limited resection, 6.%(4/64), 43.7%
(76/174), and 74.@%(854/1142), respectively, which has
resulted in decreasing operative mortality, 25.4%
15/64), 4.6%(8/174), and I.%(17/1142), respectively.
4) The increase number of re-operation for recurrent
PLC(O, 27, and 114 patients) and cytoreduction and
sequence resection for initially unresectable PLC(O,
5, and 67 patients) have added weight to improving
survival urther. These results indicate that early
detection and curative resection are the principal
factors influencing long-term survival; limited
resection instead of lobectomy is the key to decrease
operative mortality; re-operation for subclinical
recurrence remains an important approach towards
urther survival ]rolongation ater curative resection
of PLC; cytoreduction and sequence resection may
provide a hope for survival prolongation in some
patients with unresectable PLC.
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CHANGES OF SPLANCHNIC ARTERIAL
RESISTANCES SIX MONTHS AFTER LIVER
TRANSPLANTATION.
G.Zironi, F.Piscaglia, *GL.Grazi, *E.Jovine, *M.Morganti,
N.Venturoli, C.Serra, M.Valgimigli, G.Donati, *A.Mazziotti,
*A.Cavallari, L.Bolondi. Istituto di Clinica Medica e
Gastroenterologia, * Clinica Chirurgica II, Univ Bologna, ITALY
Introdoction: liver cirrhosis is characterized by increased intestinal
blood flow with reduced arterial resistances. On the contrary hepatic,
splenic and renal artery resistances are reported to be increased. Aim:
to assess the effect of orthotopic liver transplantation (OLT) on
splanchnic hemodynamic changes induced by liver cirrhosis. Materials
nd methods: 20 patients submitted to OLT for end stage liver
cirrhosis (m=14; with ascites=12; 14 HCV+ and/or HBV, 3 alcohol,
PSC, PBC, Byler’s disease), when first in the waiting list,
underwent .an abdominal Doppler US exam to assess resistance
indexes (RI) (an indirect measurement of resistance) in the superior
mesenteric, intrahepatic, intrasplenic and renal interlobular arteries and
portal blood flow velocity in the right portal branch. The same
measurements were repeated at six months in 17 patients (none with
ascites, two suffering from rejection, two retransplantated). The 3
other patients had died. Student t-test for paired data was used for
statistical analysis. Results: at six months portal blood flow velocity
increased from 14.4 to 28.6 crn/sec (p<0.01) and splenic artery RI
decreased from 0.601 to 0.525 (p<0.025). RI changed from 0.678 to
0.644 in the intrahepatic artery, from 0.651 to 0.618 in the renal artery
and from 0.810 to 0.841 in the superior mesenteric artery: these
changes didn’t reach, however statistical significance. C0nclu.si0ns:
OLT reverts the splenic artery RI increase. Persistance of a mild
overflow in the splanchnic vascular bed after OLT is suggested by the
marked increase of portal flow velocity and the incomplete reversal of
superior mesenteric artery dilation (normal RI values in our
experience=0.88). The contribution of the persistance of collateral
pathways to this event should be investigated. Morevoer the high
portal flow, probably stimulating the arterial buffer response with
arterial costriction, could hide significant reduction of hepatic artery
RI. Renal artery RI tends to decrease after OLT, probably not reaching
statistical significance, only because in this series of patients the
preOLT levels were already in the normal range (<0.70).ORAL PRESENTATIONS
Topic: PANCREASF130 F131
PANCREATITIS-INDUCED ACUTE LUNG INJURY AND THE
COMPLEMENT SYSTEM
J. Acioli, M. Isobe**, S.Kawasaki*
*First Department of Surgery and **First Department of Medicine
Shinshu University School of Medicine, Japan
Objective: We analyze, using a cerulein-induced acute pancreatitis model,
the role of the activated complement system (ACS) in PMNs priming
and lung sequestration, event related to the acute lung injury and ARDS
occurring in this disease. Participation of the ACS at an early stage is
evaluated using a specific receptor of the complement system activated
components. Material and metlods: Supramaximal doses of the secreta-
gogue cerulein were infused for 4h to produce a mild edematous pancre-
atitis in Lewis rats. Soluble complement receptor, sCR! (BRL55730-
Smithklein Beecham Pharmaceuticals), was used to block the comple-
ment cascade. Rat lungs were resected at the end of the experiment for
measurement of myeloperoxidase (MPO), a marker ofPMN accumula-
tion. Mac-1 expression on surface of leukocytes ("in vitro" and "in vivo’
flowcytometric studies) was used to access activation status. Broncho-
alveolar lavage (BAL) and wet:dry weight ratio indicated the degree of
lung injury, Histological studies were performed in HE-stained speci-
mens. R..sults: High MPO levels were found in rat lungs 4h after induc-
tion of pancreatitis, indicating a high concentration of PMNs at this
time (OD460=1.54+/-0.13, n=8). This data was confirmed by histologi-
cal examination. Treatment with sCRI before pancreatitis induction sig-
nificantly reduced the pulmonary concentrations of PMN
(OD460=1.00+/-0.16, n=8). Also Mac- upregulation (activated pattern)
was observed in circulating PMNs of rats with pancreatitis and in neu-
trophils incubated with serum of pancreatitis group rats as early as 2h af-
ter induction. This could be reversed by addition of sCR- 1. During the
time observed it could be seen no evidence of lung injury as shown by
no change in wet:dry weight ratio and BAL fluid microscopy..Conclu
sion: l)Cornplement system is responsible for neutrophils priming and
consequent lung sequestratio erly in the course of pancreatitis in this
model, and this could be effici,zntly reversed by the use of sCR-1.2)No
lung injury could be demnstrated in the period observed, suggesting
thai the function enhancement of the primed neutrophils occurs at a later
stage probably under int.uence of another inflammatory mediator.
PANCREATIC ENDOTHELIAL BARRIER ALTERATIONS IN
EXPERIMENTAL ORGAN DYSFUNCTION
R. Andersson, X.M. Deng, Z.W.Sun, X.D. Wang
Department of Surgery, Lund University, Lund, Sweden
Alterations in pancreatic endothelial barrier integrity results in leakage el
blood components, tissue edema, hemorrhage and necrosis. Over-activation
ofmacrophages might be one ofthe responsible factors initiating pancreatic
endothelial barrier compromise. In the first experiment, three kinds of
macrophage stimulators (zymosan, concanavalin A (CCV) and thiogly-
colate medium (TM)), were chosen to evaluate the influence on pancreatic
endothelial barrier integrity 24 hours after intraperitoneal challenge with
0.25 and 0.50 mg of the various substances per g bodyweight (BW).
Zymosan induced a significant increase in pancreatic tissue water content,
interstitial fluid volume and extravascular protein volume and a decrease in
intravascular plasma volume as compared to controls. The administration
ofTM and CCV had none or minor effects on the endothelial barrier and
induced an increase in reticuloendothelial system (RES) function, while
zymosan resulted in a compromise ofRES. In the second experiment, the
dynamics ofpancreatic endothelial alterations induced by various doses of
zymosan by determining endothelial permeability to 24 hours after
challenge. Pancreatic endothelial injury was evident from one hour
increasing by time. In the third experiment, possible mechanisms by which
zymosan induced endothelial injury was investigated. Pretreatment with
dimethyl sulphoxide (a scavenger), indomethacin (a cyclooxygenase
inhibitor), and verapamil (a calcium channel blocker) partly prevented the
increase in endothelial barrier permeability. Pretreatment with N-acetyl-L-
cysteine, a scavenger ofmultiple oxygen free radicals completely protected
from endothelial injury. Pretreatment with allopurinol (xanthine oxidase
inhibitor), L-NNA and L-NAME (nitric oxide inhibitors), and pargyline
(monoamine oxidase inhibitor) had no significant effects.
Thus, zymosan resulted in a compromised pancreatic endothelial barrier.
Over-activation of macrophages might play an important role in the
etiology of pancreatic dysfunction. Multiple factors including a variety of
oxygen free radicals are probably involved.
F132 F133
OPEN MANAGEMENT OF THE ABDOMEN FOR NECROTIZING PANCREATITIS
K. Bosscha P.F. Hulstaert, A. Hennipman, H.G. Gooszen, Th.J.M.V.
van Vroonhoven and Chr. v.d. Werken
Department of Surgery, University Hospital Utrecht, The Netherlands
Purpose of study. A prospective study was performed to evaluate ’open
management of the abdomen’ as the treatment for acute necrotizing pancre-
atitis, a disease with high morbidity and mortality to even 70 per cent.
Systemic effects of infected necrosis are the main causes of death. Necro-
sectomy and drainage are the main elements of surgical treatment. ’Open
management of the abdomen’ with scheduled relaparotomies in the SICU
was adopted as our standard treatment in ease of extensive areas of
infected necrosis.
Patients. From June 1988 through January 1995, 28 patients were treated
along these lines. The mean age was52 years, range 29-76 years. The
cause was gallstone diseas in 11 patients; 8 patients had "alcohol-induced
pancreatitis. In 9 patients the underlying .cause could not be determined.
The Ranson-seore before the start of the ’open management of the abdo-
men’ was 4.9 + 0.3 (mean + SEM), whereas the Imrie-seore was 4.0:1: 0.2.
The APACHE II-seore was 18.4 + 1.3 and the SAP-score was 14.4 + 0.6.
Preoperatively computed tomography eonf’lrmed clinical diagnosis in 20
patients; in 8 patients extensive areas of necrosis were detected at explora-
tive laparotomy who needed exploration anyway.
Results. The mean number of relaparotomies performed in the SICU was
17, range 3 to 70. Colonic perforation led to subtotal eoleetomy with end-
ileostomy in 5 patients. Nine abscesses were drained pereutaneuosly. Seven
fistulas developed in 7 patients: 6 closed spontaneously, one needed a
diversion ileostomy. In 14 patients severe bleeding occurred without
mortality. Eighteen patients developed MOF; in total 11 patients died (39
per cent). Probably, in two patients MOF was directly related to progressi-
ve necrosis of the bowel. Seven patients needed dialysis. The mean
duration of stay in the SICU was 27 days, range 5 to 101 days; the mean
duration of hospital stay was 69 days, range 5 to 171 days.
Conclusion. Despite neeroseetomy and drainage by means of prolonged
’open management of the abdomen’, mortality of acute neerotizing panere-
atitis with extensive areas of necrosis remains high. The treatment strategy
as described has considerable additional morbidity of the gastrointestinal
tract.
PROGNOSTIC INDICATORS FOR SURVIVAL AFTER
RESECTION OF PANCREATICADENOCARCINOMA
R. Polastri, F. Bertolino, G. Mmsa, L. Capusso.
Department of Surgery, Ospedale Mauriziano, Largo Turati 62 Torino,
Italy.
We have rewieved our experience with pancreatic resection for cxocrinc
pancreatic cancer in order to evaluate short- and Ions-term survival. A
number of variables were evaluated to identify factors predictive of long-
term survival. From January 1982 tober 1994 we performed 92
pancreatic resections for adenocarcinoma of cxocrine pancreas. Sixty-one
were males and 31 females, mean age was 62+11 years (range:34-82).
The operative procedures consisted of 66 pancreaticodumics
(PD), 7 distal pancreatectomies and 19 total pancreatcctomies. Forty-
three of the PD included a distal 8astrectomy and 23 were pylorus
preserving; patients had a pancrcatogastrostomy. Twenty-two patients
(23.9%) had associated vascular resoctions. Survival was analyzed by the
method of Kaplan-Meier. Differences in survival among variables were compare with the log-rank test. Operative mortality rate (60 days) was
6.5% (6 patients). Major morbidity related to operative procedure was
seen in 18.4% of patients(17 patients). Actuarial survival rate at 1, 5 and
10 years was 51.7%, 10.5% and 5.6% respectively. The factor
significantly influencing a poor prognosis were: neoplastic invasionof
preaortic lamina (j0.006) and metastatic lymph node involvemm
(pffi0.002). Vascular invasion, age >70 years and perioperative blood
transfusions were not associated with a worse prognosis.
In conclusion: according to many data in literature, prcaortic lamina
invasion and lymph nodes metastases are the main prognostic factors
influencing survival.
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STAGING LAPAROSCOPY WITH LAPAROSCOPIC
ULTRASONOGRAPHY: OPTIMIZING RESECTABILITY IN
HEPATOBILIARY AND PANCREATIC (HBP) MALIGNANCY.
MP Callery, GM Doherty, JA Norton, NJ Soper, and SM Strasberg,
Department of Surgery, Washington University School of Medicine,
St. Louis, Missouri, U.S.A.
Open laparotomy has traditionally been required to stage
hepatobiliary and pancreatic (HBP) cancers accurately. For
unresectable patients, costs and morbidity have been high. Today,
laparoscopy alone or combined with laparoscopic ultrasonography
(LUS) is being examined for its value in defining the extent of
malignancy. We have analyzed our routine implementation of this
new staging technique in our HBP Center. METHODS: Staging
laparoscopy (SL) with LUS was performed in 50 consecutive patients
with HBP malignancies. All patients were considered to have
resectable tumors as determined by traditional preoperative staging
modalities. Primary tumors were located in the liver (n=7), biliary
tract (n=ll), or pancreas (n=32). Preoperative staging studies
included computed tomography (96%) alone or combined with
antegrade/ retrograde cholangiography (72%), arterioportography
(22%) and magnetic resonance imaging (14%). An average of 2.7
preoperative studies per patient were required to initially determine
resectability. SL-LUS was performed to detect occult hepatic,
lymphatic or peritoneal metastases, and to detect local tumor invasion
rendering the tumor unresectable. SL-LUS was performed under the
same anesthetic as the subsequent laparotomy (70%) or as a separate
staging procedure (30%). RESULTS: SL-LUS predicted a resectable
tumor in 28 patients (56%). At laparotomy, 26 of 28 were actually
resectable indicating a false-negative rate of 4%. SL-LUS indicated
unresectability in 22 patients (44%). SL alone demonstrated
previously unrecognized occult metastases in 11 patients (22%). For
an additional 11 patients (22%) in whom SL alone was negative, LUS
determined unresectability as a result of vascular invasion (n=5),
lymph node metastases (n=5), or intraparenchymal hepatic tumor
(n=l). All cases of unresectability due to vascular invasion were
validated by laparotomy. 5 of 6 lymph node or hepatic metastases
were proven histologically by LUS-guided needle biopsy rather than
laparotomy. CONCLUSIONS: SL with LUS optimizes patient
selection for curative resection of HBP malignancies. Unnecessary
laparotomy can be safely avoided in unresectable patients reducing
costs and morbidity.
IS THE PREOPERATIVE DIAGNOSIS OF A BENIGN AMPULLOMA
SAFE?
O. Chapuis,A. SauvaneL Ph.Ponsot, P.Hammel, P.Bernades, J. Belghiti.
F6d6ration d’H6patogastroent6rologie M6dico-Chirurgicale, H6pital Beaujon,
Universit6 Paris VII, Clichy, France.
Malignant ampullomas can be curatively treated by pancreaticoduodenectomy
(PD). A local excision can be proposed in case of benign ampulloma. The aim
of this study was to evaluate the value of side-viewing duodenoscopy (SVD)
with biopsies, endoscopic sphincterotomy (ES), and endoscopic
ultrasonography (EUS) for preoperative diagnosis of benign and malignant
ampullomas.
M..aterial et methods From October 1989 to September 1995, 26 patients with
ampulloma were explored preoperatively by SVD including ES in 9 cases
and EUS. The papilla of Vater was always explored at SVD and tbrceps
biopsies were performed in all patients except one with a typical malignant
tumour. EUS evaluated the T stage of the TNM classification in all patients
except six because of a previous ES (n=5) and difficulty to localize the papilla
(n=l). The N stage of the TNM classification was evaluated by EUS in all
cases. A curative resection was always performed 2 local excisions of the
ampulla (one adenoma with low-grade dysplasia and one xanthoma), and 24 PD
for 20 carcinomas (including 9 (45%) N1) and 4 benign lesions.
Results At SVD, papilla was. both ulcerated and protruding into the duodenal
lumen in 10 cases, prominent and smooth in 15 cases, and normal in one case.
Histologic examination of the 25 biopsies revealed malignancy in 1.0 cases
(always confirmed by pathological examination of the resected specimen) and a
benign lesion in 15 cases (resected specimen 6 benign lesions and 9
carcinomas); among the 9 biopsies performed after ES, two only revealed
carcinoma (resected specimen 4 benign lesions and carcinomas), with an
accuracy rate of 64% globally and 66% after ES. At EUS, 13 lesions were
presumed limited to ampulla (benign lesion or stages T in situ and T1) but 4
out of these 13 were classified T2 or more histologically; among the 7 tumours
classified T2 or more by EUS, one was histologically limited to ampulla. The
accuracy rate of EUS for the T stage was 75%. At EUS, lymph nodes were
presumed benign (NO) in 21 cases (histology NO in 15 cases and NI in 6
cases) and metastatic (N1) in cases (histology NO in 2 cases and N1 in
cases), with an accuracy rate of 69%. All endoscopic explorations were
compatible with benign lesion in 11 patients histologically, 6 patient out
of these 11 had a carcinoma including one with a T1N1 and two with a T2N0
tumour.
Conclusions In patients with ampulloma tumour, SVD with biopsies even
after ES, and EUS are not accurate enough to make sure preoperatively that the
tumour is benign. Therefore a local resection cannot be safely indicated.
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PANCREATICODUODENECTOMYFOR
PEERIAMPULLARY TUMOR TAIWAN EXPERIENCE
MF Chen, YY Jan
Department of Surgery, Chang Gung Memorial Hospital
In a 11-year period between 1981 and 1991,297 patients with
periampullary tumor were refered to our surgical department and
131 pancreaticoduodenectomy were performed, including 79 for
ampullary carcinoma, 22 for pancreatic head tumor, 18 for distal
common bile duct carcinoma and 12 for duodenal tumor.
Those patients who received pancreaticoduodenectomy
consisted of 78 female and 53 male and their mean age was 55.8
years with a range from 21 to 82 years.
The overall mortality ofthe 131 pancreaticoduodenectomy was
7.63% and it was 4.76% in the last 5 years. The complication
rate was as high as 38.9%. The anastomatic leakage (15.3%)
was the leading cause of hospital mortality. Several factors
were analyzed and revealed that old age, abdominal pain,
duration of symptoms, serum bilirubin, albumin and serum AIk-P
levels and operative blood loss all did not influence the survival
rate. However, female patients, no lymph node metastasis, and
well-differentiated tumor had better survival. Excluding the
papillary cystoadenocarcinoma ofpancreatic head, leiomyo-
sarcoma ofduodenum and benign disease, the actual 5-year
survival of ampullary, pancreatic head, distal common bile duct
and duodenal carcinoma were 47.4%, 20%, 30.8% and 33%
respectively.
Female patients, patients with out lymph node metastasis and
with well-differentiated carcinoma had better prognosis.
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OVEREXPRESSION OF TISSUE FACTOR INCREASES
PANCREATIC CANCER CELL INVASION
V. Chinswangwatanakui, A.K. Kakkar, N.R. Lemoine*, S. Tebbutt,
R.C.N. Williamson
Department of Surgery, Royal Postgraduate Medical School’,
London, U.K.
Imperial Cancer Research Fund, London, U.K.
Tissue factor (TF), the transmembrane cellular receptor which is the
physiological initiator .of blood coagulation is not expressed in
normal pancreatic tissue, but in the adenocarcinoma of the pancreas
its expression increases with progressive dedifferentiation. We have
studied the effect of TF expression on in vitro invasion by the
human pancreatic carcinoma, cell line MIA PaCa-2. The full length
TF gene (1360 base pairs) was cloned into the plasmid DNA vector
pcDNA3 in sense and antisense orientations. Diagnostic DNA
digests confirmed the correct orientation of the cloned genes. These
vectors were used to transfect the MIA PaCa-2 cell line in vitro
using the lipofectin method. Expression of TF sense gene resulted
in a five fold increase in cell surface procoagulant activity frooa 7.8
thromboplastin units per 10 cells for wild type to 40 units
(p=0.001). There was a small reduction in procoagulant activity for
the TF/antisense clones to 7.6 units per 10 cells. The total
antigenic content ofTF gene product (sense or antisense) markedly
increased from 160 pg/mg for wild type to 7733 pg/mg for sense
and 856 pg/mg for antisense, h vitro invasion was assessed in a
standard matrigel assay by counting the number of cells per high
powered field, after haematoxylin staining. The mean + s.d. number
of cells successfully invading through matrigel was 60.75+13.04 for
the wild type and 210.2+57.62 for the TF/sense clone (p=0.02,
95% CI:-276.45 to -55.02) and 42.2+6.43 for the TF/antisense
clone (p=0.09; 95% CI: -8.11 to 51.98). This study is the first to
demonstrate that cellular expression of TF may influence the




S.A. Dadvani, A.N. Lotov, V.J. Zavodnov, L.V. Chistov,
G.Ch. Musaev, V.N. Avakian.
Surgical Clinic No 1, Moscow Medical Academy, MOSCOW,
RUSSIA
Pseudocysts and abscesses of pancreas in abdominal surgery, par-
ticularly at the peak of the acute inflammation, are one of the most
often and serious complications ofpancreatitis.
From 1986 to 1995 years 128 patients with pancreatic pseudocysts
were hospitalised in oar clinic. Traditional surgical treatment was per-
formed in 17 patients with calculous pancreariris complicated by for-
marion ofpancreatic pseudocysts and in 3 patients with cystadenoma.
The other patients were treated with ultrasound-guided percutaneous
punction and drainage ofpancrearic pseudocysts, including 13 cases of
internal percutaneous cystogastro- and cystoduodenostomy. Simulta-
neously a complex set of conservative therapy including high doses of
sandostatin (600-800 mg/day) was carried out for preventative pur-
poses (3 days) or treatment of pancreatiris. Percutaneous fulfdling of
cystogastroanastomosis was performed in 10 patients with pseudocysts
of pancreas body and tail by means of the Hancke percutaneous pan-
creatic cyst drainage set/"COOK", Denmark/. Obtained material was
sent for cytological, biochemical and bacteriologic investigations.
For the fwst time in our clinic we performed ultrasound- and endo-
scope.guided percutaneous formation of internal cystoduodenoanas-
tomosis using, catheter of our own modification in patients with pseu-
docysts of pancreatic head. Both patients had pancreonecrosis and
acute destructive pancreariris complicated by obstructivejaundice. On
the 3-rd 4-th day after cystoduodenostomy the level of direct biliru-
bin decreased to normal and on the 7-th 8-th day the patients were
discharged.
In one prient during the earliest stage of our work the at,en to
form cystogastroanastomosis was failed, which demanded sursical
treatment. Long-term results (14-46 months) didn’t show disease recur-
rence. Therefore, we think that percutaneous cystogastro- and
cystoduodenostomy is less traumatic and highly effective and should
be the method of choice in treatment of such patients.
ENDOSCOPIC DRAINAGE OF PANCREATIC SEUDOCYSTS. E Della Libera Jr, ES Siqueira, CQ Brant, M Morais, AP Ferrad Jr,
DL Carr-Locke.
Division of Gastroenterology, Universidade de Sio Paulo, $io
Paulo Brazil
Pancreatic pseudocysts have been successfully treated by
endoscopic drainage (cystogastrostomy or duodenostomy, and
transpapillary drainage). We report our experience with
endoscopic therapy ofpancreatic pseudocysts.’From July/94 to
August/95, 16 patients with pancreatic pseudocysts were
referred to ERCP because ofpersistent pain and/or jaundice. In
4/16 (25%) endoscopic therapy was not performed because we
were not able to place a guide wire beyond a pancreatic
stenosis and there was no indentation of gastric or duodenal
wall. In the remaining 12 patients (9/3 mal,e/fernale ratio), mean
age 38.2 years (range 24 64 years), 15 pseudocysts were
treated with cystogastrost0my (5), cystoduodenostomy (2) and
transpapillary drainage (8). Etiology was: alcoholic chronic
pancreatitis (8), blunt abdominal trauma (2), surgical trauma
(2). Pseudocysts mean size was 7.83 cm (range 3,5 18 cm)
and were located in the head (4), body (8) and tail (3).
Complications were present in 7/16 patients: 2 early stent
occlusion, fever, pneumoperitoneum, bleeding,
proximal migration and perforation. Except for the
perforation that required surgery, all complications were minor
and medically and/or endoscopically managed. There were no
deaths. Mean follow up was 150 days (range 15 360 days)
and mean stent period was 134 days (range 30 210 days).
Clinical improvement was noted in 11/12 (91%): all but one
pseudocyst resolved, 8 patients are asymptomatic and 3 are
taking small doses of analgesics. In the only patient that
persisted, with pain, stent was removed and she was sent to
surgery because ofchronic pancreatitis.
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The expression of growth associated protein 43 and clinical
symptoms correlated in patients with chronic pancreatitis. P. Di
Sebastiano. T. Fink, E. Weihe, H. Friess, H.G. Beger, P. Innocenti and
M.W. Buechler.
Surgical Unit, D’Anmmzio University, Pierangeli Clinic Pescara (Italy);
Institute of Visceral and Transpantation Surgery, University of Beme
(CH); Department of General Surgery, University ofUlm (FRG)
Background/aims. Changes in innervation pattem and neuropeptide
content have been demonstrated in chronic pancreatitis. Growth
associated protein-43 (GAP-43) is expressed at high levels in the
developing nervous system. Recent studies demonstrated re-expression of
GAP-43 after experimental lesions of peripheral nerves. We used GAP-
43 as a marker of. neuronal plasticity in chronic pancreatitis and
correlated histological findings with clinical data. Methods. The
innervation ofthe normal pancreas from 14 organ donors was determined
immunohistochemically with the panneuronal marker protein-gene
product 9.5 (PGP 9.5) and the expression of GAP-43 was also
characterized. The findings were compared with results obtained from 29
patients with chronic pancreatitis. The density of PGP 9.5 and GAP-43
was quantified by image analysis. In addition, patients responded .to a
symptom questionnaire for the evaluation of clinical findings. Results. In
chronic pancreatitis a marked increase of PGP 9.5 and GAP-43
immunostaining was observed: digitized morphometry revealed that 70%
of PGP-9.5-immunoreactive nerves were also GAP-43-immunoreactive
whereas in the controls the relative area of GAP-43 was less than 3%
(p<0.01). GAP-43-immunoreactivity significantly correlated with the
intensity ofpain (p<0.01) and duration of disease (p<0.05). Conclusions.
GAP-43 re-expression at high levels both in nerves and intrinsic neurons
indicates an axonal sprouting mechanism in chronic panereatitis; the
correlation between clinical symptoms and GAP-43-immunostaining
suggest a link between plasticity of peripheral nervous system and pain
generation in chronic pancreatitis.
ROLE OF ADJUVANT RADIOTHERAPY IN TREATMENT
OF RESECTABLE PANCREATIC HEAD CARCINOMA.
G. Doglietto, D. Frontera, G. Viola, G. Alfonsi, M.
Buononato, A.G. Morganti *, N. Cellini *, F. Crucitti.
DEPARTMENT OF SURGERY; * DEPARTMENT OF
RADIOTHERAPY- CATHOLIC UNIVERSITY SCHOOL OF
MEDICINE, ROME, ITALY.
From March 1990 we adopted a combined multirnodal treatment of
resectable pancreatic head carcinomas including subtotal (or total, when
needed) pancreatectomy, intraoperative irradiation (IORT)and external
beam radiation therapy (EBRT). Twenty-two patients were treated
following the above mentiorted protocol: 20 subtotal and 2 total
panereatectornies were performed. IORT was delivered to the tumor bed
(including celiac axis, portal vein and origin of superior mesenteric
vessels) with a dose of 10 G-y. Mean time spent to cma3’ out IORT
(patient’s transfer to the bunker, irradiation and return to the operating
room) was 54 minutes. Postoperative major complications were observed
in 5 patients (23 %) and mortality was 9 % (2 cases). Postoperative EBRT
of the tumoral and lymphatic bed (3 beams or box technique 50 Cry) was
performed in 16 patients. In 6 cases (27 %) postoperative EBRT was not
started because of postoperative death (2 cases) or unsuitable clinical
status. In the more recent period of our experience, 12 patients underwent
preoperative "flash" radiotherapy of the liver and the pancreas (opposite
beam technique 5 Gy) to treat possible liver micrometastases and to
reduce tumor spread during surgery.
Median survival was 11.8 months. Statistical analysis showed a
significantly better survival in women (19.9 months vs. 9 months: p<0.04)
and in patients undergoing preoperative "flash" EBRT (25.6 months vs.
9.5 months: p<0.03).
Our experience suggests that combination of EBRT and IORT with
surgical resection of pancreatic cancer is safe, tolerable and offers a good
local control. High frequency of liver metastases suggests the need to test
new therapeutic combinations: in this respect, neoadjuvant radio-
chemotherapy seems to be the most promising.
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ACUTE NECROTIZING PANCREATITIS (ANP): ANALYSIS OF 108 CONSECUTIVE CASES
G.B. Doglietto,E Pacelli, G. De Vivo, s. Alfieri, C. Carriero, M. Malerba,E Crucitti
Department of Surgery, Catholic University ofRome Rome, Italy
AIM. To review our experience in the management ofANP.
MATERIALS AND METHODS. Hospital charts of 108 patients with ANT consecutively
admitted at our Unit between 1981 and 1995 were retrospectively reviewed. Demographic
data, etiologic factors, diagnostic procedures, treatment modalities, mortality and evolution
of the disease noted. Apache lI was calculated in all patients. ANT
diagnosed the bases of standard clinical criteria, ultrasonographie and computed
tomographie The presence of secondary infection detected by clinical t’mdings
(persistently febrile course associated with leukoeytosis despite heavy antibiotic treatment)
and eonfLrmed in all eases by both intraoperative and bacteriological findings.
Conservative treatment based fluids and electrolytes replacement, cardiac and
emodynamie monitoring, wide spectrum antibiotics (in ease of proven sepsis) and total
parenteral nutrition; when necessary patients were traaferred in ICU for supportive
treatment of renal and respiratory failure. The indications for surgical treatment were: the
development of secondary infection, acute abdomen, MOF syndrome and
eardioeireolatory shock. The surgical procedure consisted of abdominal entrance by
bilateral subcostal incision, exposure ofthe pancreas by dividing the gastroeolie omentum,
debridment and neerosectomy; in the presence of pancreatic abscess, the purulent
collection entirely drained externally. At the end of operation the abdomen closed
after the placement of large-bore sump drains and passive Penrose drains. In of
infection, since 1987, open treatment with marsupialization of the lesser peritoneal
routinely adopted.
RESULTS. 55 patients female and 53 male. The age 55.5 (range 17-93).
Gallstones were the most frequent etiologic factor (55 patients). Apache II score was
13.75. In 63 patients the necrosis sterile: 13 underwent emergency operation for shock
(n.6), acute abdomen (n.2) MOF (n.5), in 50 conservative treatment adopted with
completely resolution in 23 and development of pseudocyst in 27. In 45 patients (46.6%
transferred from other hospitals) documented secondary infection: infected necrosis
in 31 and pancreatic abscess in 14; all these patients surgically managed. Overall
mortality rate 17.5 %: 8% (n.5) for sterile necrosis and 31.1% (n.14) for secondary
infections (38.7% for infected necrosis and 14% for pancreatic abscess).
DISCUSSION. Controversy still surrounds the optimal management of ANP particularly
regarding the indications, the timing and the methods of surgical intervention. For sterile
necrosis in the absence of severe systemic eomplieatious conservative treatment seems to
be justified beth for the natural history of the illness (high incidence of resolution) and the
poor results of early surgery. In presence of secondary infection surgical treatment is
mandatory.
LONG-TERM RESULTS IN DERIVATIVE vs RESECTIVE
PROCEDURES FOR CHRONIC PANCREATITIS.
M. Faleoni, C. Bassi, N. Sartori, G. Talamin t, L. De Santis, A. Bonora,
R. Salvia, E. Caldiron,. G. CavalliniX and P. Pederzoli.
Surgical and Medical Departments. University of Verona, Italy.
Indications and evaluations of surgical results in duetal derivations
compared to pancreatic resections are sill matter of debate, owing to not
yet clear natural history of chronic pancreatitis and changes in the course
of the disease after surgery.
From 1971 to March 1995, out of 753 patients suffering from chronic
pancreatitis 484 (56.7%) of them (421 males, 63 females; mean age 41.6
years, range 17-76 ys) were submitted to pancreatic surgery; severe not
responding pain (73%) and pancreatic pseudocysts (10.6%) were the most
frequent indications to surgery.
In 398 patients (82.2%) we performed derivative procedures (267
pancreaticojejunostomy, 68 cysto-pancreaticojejunostomy, 50 cysto-
jejunostomy, 9 Du Val procedure, 4 double sphincteroplasties); 86 pts
(17.8%) underwent pancreatic resections (28 Whipple procedure, 33
Puestow procedure, 20 distal pancreatectomy without anastomosis, 5 total
pancreatectomy).
In two series were found no significant differences as regards sex, age,
etiology, calcifications, time of appearance and severity of symptoms;
main pancreatic duct was significantly more enlarged in derivated than
resected patients (p<0.0001).
Length of operation, units of transfused blood, postoperative mortality (2
versus 5) and morbidity, hospital staying time were significantly lesser in
derivated group (p<0.0001).
A similar number of patients in two series (77.2% vs. 71.9%) were pain-
free after a 6.1 years median follow-up.
Given comparable results in reducing pain, we suggest that derivative
surgery has however to be preferred owing to the less biological load;
pancreatic resection instead has to be performed when pancreatic duct is
not enlarged and in case of complications related to pseudocysts and
suspect of pancreatic cancer.
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LIVER CHEMOEMBOLIZATION IN SYNCHRONOUS METASTASES
FROM ENDOCRINE TUblORS OF THE PANCREAS.
M. Falconi, C. Bassi, A. Bonora, G.C. Mansueto G. Butturini, E. Caldiron,
17,. Salvia, N. Sartori, G. Talamini and P. Pederzoli. Surgical and Radiological
Departments, Gastroenterology Service. University of Verona, Italy.
The biological behaviour and slow evolution of endocrine pancreatic tumors, even
in presence of liver metastases, have prompted to most radical surgical approach
and to research of any effective adjuvant treatment. Since 1991, hepatic arterial
chemoembolization (TACE) has been proposed in the treatment of malignant
endocrine pancreatic tumors, on the experience of primary hepatic malignancy.
From 1985 to June 1995, we observed 63 patients (25 males, 38 females; mean
age 53.8 years, range 17-78 ys) suffering from histologically proven endocrine
turuour of the pancreas, in 28 cases (44.5%) of functioning type, non functioning
in 35 (55.5%). In 23 patients (36.5%) the turnouts were malignant with presence
at diagnosis. (17 pts) or onset during follow-up (6 pts) of liver metastases.
Of 17 patients (74%) presenting synchronous metastases, one patient underwent
radical resection with the removal of the only metastasis detected; 8 patients were
not submitted to radical surgery because of either locally advanced disease or not
available TACE.
Eight patients (3 ruales, 5 females; mean age 43.8 years, range 49-67) underwent
one or more treatment of TACE prior and/or after the palliative resection of
pancreatic malignancy. After cannulation of proper hepatic artery, according to
Seldinger technique, whole liver parenchyma was microembolized with solution
of Lipioidol FU (10 ml) and dacarbazine (Deticene) 500 mg; afferent artery was
then embolized with fragments of Spongostan or contour ruicrospheres. The
response to the treatment was assessed by CT-scan within 30 days. TACE was
repeated, if possible, within 90 days and in case of relapsing disease and the
patients were followed up by CT-scans every 3 months.
Of the 8 patients undergoing TACE, 2 died respectively after 11 and 18 months
from surgery, while 6 patients are still alive after mean follow-up of 26.3
months (range 12-55), 2 with stable and 4 with progressive disease. The response
to the first course of TACE was positive in 5 of these cases, with 14 months
mean time of stabilization. In one recently treated patient the response cannot yet
be assessed. The median actuarial survival of these 8 patients is more than 55
months.
These results suggest that TACE, combined with surgical resection of pancreatic
turuor, seems to be able of stabilizing the disease for certain time and increasing
patient survival. Further studies are necessary to settle the choice of better chemo-
terapeutic, dosage and time intervals between treatments.
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FACTORS CONTRIBUTING TO SUCCESSFUL TREATMENT
OF INFECTED PANCREATIC ffECROSIS G. Farkas, J. Mton, Y. M,Sndi E. Szederk6nyi
Department of Surgery and Institute of Microbiology", A. Szent-
Gy6rgyi Medical University, Szeged, Hungary
Infected pancreatic necrosis and sepsis are the leading causes of
mortality in necrotizing pancreatitis. Sine 1986, 136 patients
with infected pancreatic necrosis have been treated. The mean
number of APACHE II score was 17.5 (range 11-31). In all
cases, the infected necrosis was combined with retroperitoneal
abscesses. 93 were situated in the right or left retrocolic area, 13
in the subphrenic region, and 30 in the retroduodenal or
subhepatic area. The surgical treatmcr’ was performed on average
18.5 days (range 8-25 days) after the ,,,set of aerate pancreatitis.
The operative management consisted of wide-ranging
necrosectomy in the total affected area, combined with
widespread lavage and suction drainage. In 62 of the 136 cases
(45.5%), some other surgical intervention (distal pancreatic
resection, splenectomy, cholecystectomy, sphincteroplasty or
colon resection) was also performed. Continuous lavage and
suction drainage was applied for an average of 39.5 days (range
21-90 days), with an average of 8.5 (range 5-15) litres of saline
per day. The bacteriologic findings revealed mainly enteral
bacteria, but Candida infection was detected frequently. The
incidence of fungal infection was 21%. Twenty-three patients
(17%) had to undergo reoperation. The cytokine production
capacity (TNF, IL-1 and IL-6) was shown to correlate with the
prognosis. The overall hospital mortality was 6.6% (9 patients
died). In our experience, infected pancreatic necrosis responds
well to aggressive surgical treatment, continuous, long-standing
lavage and suction drainage, together with supportive therapy
consisting of immunonutrition and blockade of cytokine
production, combined with adequate antibiotic and antifungal
medication.F146 F147
TGF-[31 AND IL-6: NEW ASPECTS IN PANCREAS REGENERATION
Gy. Farkas Jr., T. Talcs, *Y. Mfmdi and J. Lonovics
First Department of Medicine and *Department of Microbiology,
Albert Szent-Gytrgyi Medical University, Szeged, Hungary
Some reports suggest that a low dose of eholeeystokinin oetapeptide (CCK-8)
may induce regeneration of the pancreas. This regeneration can be detected in
ever increasing degree up to the end of the first month; it then becomes stable.
We wanted to investigate whether changes occur in the serum TGF-[31 and IL-6
levels during regeneration, and whether there is a eormeetion between their
levels and the rate of regeneration in rats.
Distal pancreas resection (75%) was performed. CCK-8 was administered
subcutaneously in a 300 ng/kg dose 3 times per day to the investigated group,
while the control animals received the same amount of saline. The rats were
examined 3, 7, 14 and 28 days after the first injection. Serum TGF-[31 levels
were determined by ELISA, IL-6 levels by bioassay, DNA content by Giles &
Meyers method.
The weights of the residual pancreas.were increased in both groups on day 3. At
subsequent times the weights decreased in the controls but increased
continuously in the CCK-8-treated group. There was significant difference on
day 14, andon day 28 the pancreas weight almost doubled in the CCK-8 group,
whereas it decreased to the normal level in the controls. The DNA content of
the pancreas was continuously higher in the treated than in the control group. It
reached the maximum level on day 28, with a significant different (1800 + 350
vs. 780 + 240 y/pancreas). The protein content reached its highest level on day
28 in the CCK-8-treated group (32.435 + 7.88 rag/pancreas). A significantly
higher level of IL-6 was measured on day 7 ,s. the control (250 + 70 vs. 50 +
30 pg/ml). It later decreased, but remained above the control level. Significantly
different TGF-[3 levels were measured on days 7 and 14 (290 + 40 vs. 155 +
70, and 275 + 10 vs. 180+ 65 ng/ml, respectively). There was no difference
between the TGF-[31 and IL-6 levels in the two groups by day 28. No significant
changes in the amylase levels were observed; they remained at a normal level
(4.8 + 0.8 U/ml). This indicates that the increase in the pancreas weight was
not caused by panereatitis.
Our results reveal that regular low dose of CCK’8 injections resulted in pancreas
regeneration following 75% distal resection. This was indicated by increases in
the pancreas weight, and in the DNA and protein contents of the pancreas.
Significantly elevated serum TGF-I and IL-6 levels were also detected up to
day 14. These data suggests that TGF-[31 and IL-6 might play a stimulatory
effect in the early stage of regeneration of the pancreas.
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TOTAL PANCREATECTOMY IN END-STAGE CHRONIC
PANCREATITIS
W.R. Fleming, R.C.N. Williamson
Department of Surgery, Royal Postgraduate Medical School,
Hammersmith Hospital, London, United Kingdom
Forty patients underwent total pancreato-duodenectomy for
end-stage chronic pancreatitis. There were 34 men and 6
women, with a median age of 39 years (range 21-66 years).
Alcoholism was the major aetiological agent (30 patients),
and five patients had had previous acute idiopathic
pancreatitis. The overwhelming indication for operation was
severe abdominal pain, complicated by failing exoefine and
endocrine function. Resection was performed in one (n=17)
or two stages (n=23), following previous proximal (7) or
distal (16) panereateetomy; progression from partial to total
pancreateetomy occurred over an interval of 8-96 months
(median 15 months). Another 6 patients had undergone
previous pseudoeyst or duet drainage procedures. The
pylorus was preserved in 28 patients and the spleen in 10.
Median operation time was 6 hours (range 2.5-8.5 hours) and
median blood loss 2000 ml (range 500-16000 ml). There
were two hospital deaths and three patients required
reoperation. Of 38 survivors, 30 obtained complete or
substantial relief of pain. There were 15 late deaths at 2.5-
120 months postoperatively, 13 in the alcohol group and 11
disease-related. Total panereateetomy can relieve the
intractable pain of chronic panereafifis at the cost of possible
premature death from continuing alcohol abuse.
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OPEN PANCREATIC DRAINAGE IN SEVERE
NECROTIZING PANCREATITIS
G. Ftlrrith M. Suteu, I. Mihut, D. Grecea, O. Chira
st Surgical Clinic, University of Medicine and Pharmacy,
Cluj-Napoca, Romania
The aiin of this study was to analyse comparatively results of controlled
open pancreatic drainage in noninfected and infected pancreatic necrosis.
Twenty four patients with necrotizing pancreatitis were treated surgically by
open lesser-omental-sac drainage (celiostomy) in the last five years. They
were classified into two groups according to date and indications of surgical
drainage: a group of 12 patients with early celiostomy (in the first week after
the onset ofpancreatitis) for noninfected necrosis, and the second group of
12 patients with late celiostomy (2 to 12 weeks after pancreatitis) for
infected necrosis and pancreatic abscess. Age, sex and etiology of
pancreatitis were similar between surgical groups. The diagnosis has been
based on clinical syndrome, laboratory tests including bacteriologic
cultures, ultrasound andCT scan findings. Drainage procedure consisted in
marsupialization of lesser-omental sac by suturing open gastrocolic
ligament to anterior peritoneum. Abdominal wall was left largely open in
this site and the drains were inserted via celiostomy. Only 6 patients with
early operation underwent necrosectomy at date oflaparotomy and repeated
necrosectomy was possible in 4 patients. The necrosectomy was carried out
during laparotomy in all patients of the second group and three to nine
reexploration via celiostomy were needed for removal large residual necrosis
and purulent material. In group with noninfected necrosis, eight patients
died postoperatively (66.6%) because of multiple-organ-system failure. In
the second group with pancreatic abscess, only one patient died early after
surgery (8.3%) of septic shock. Two patients developed postoperatively
distant submesocolie abscesses resolved by relaparotomy. Other
postoperative complications were pancreaticocutaneous fistulas resolved
spontaneously (2 patients) and external bleeding (1 patient) requiring
surgical hemostasis. In conclusion, controlled open pancreatic drainage is
more effective in patients with infected pancreatic necrosis and stable
biologic condition. It facilitates intermittent debridements of residual
necrosis and purulent loci. Early open drainage is not proved to be ofbenefit
to unstable patients with severe pancreatitis and noninfected necrosis.
ANALYSIS OF PURE PANCREATIC ,JUICE AND BILE FOR DIAGNOSIS OF
MALIGNANCY K-RAS POINT MUTATION, CEA AND CYTOLOGY
N.Futakawa W.Kimura, N.Sata, S.Yamagata, Y.Takei, I.Han, K.Morikane,
T.Inoue, H.Shinkai, T.Muto
First Department of Surgery, University ofTokyo, Tokyo, Japan
[Aim]To investigate the validity ofK-ras codon 12 pointmutation, values ofCEA,
CA19-9, and cytology of pure pancreatic juice and bile for a diagnosis of
pancreaticobiliary carcinoma.
[MaterialsandMethods] Sixty fourcases suspected ofpancreaticobiliary diseases,
were examined. Pure pancreaticjuice could be obtained andmeasured in33 cases--
malignant :14 cases (42%), neoplasitc :19 cases (58%), and benign 14 cases
(42%). Bile couldbemeasuredin33 cases--malignant: 20 cases (61%) andother 13
cases were benign non-neoplastic diseases. Pure pancreatic juice was taken from
ERP catheter for 5 min without stimulation of secretin. Bile was also taken without
stiulation. K-ras codon 12 point mutation, values of both CEA and CA19-9, and
cytology-were examined. K-ras mutation was detected by two-step PCR-RP
method. Serous CEA, CA19-9 were also examined.
[Results] 1. CEA values of pancreatic juice in cases with carcinoma were
significantly greater than those inbenigngroup (P<0.01). When cut-offline ofCEA
values was set up to 50 ng/ml, predictive values were described bellow. 2. K-ras
mutation of pure pancreaticjuice was more frequent in carcinoma group (P<0.02).
3. When discrimination analysis was applied (Formula 1), accuracy was 100%. 4.
CA19-9 in sera was most useful for diagnosis of bile duct carcinoma.
Pure Pancreatic Juice Serum
ras mutation CEA50 cytology CA19-9100 Discriminant
(nl/ml) (U/ml) Analysis
PPV 67 (1OO) 64 75 75 1OO
NPV 83 (78) 75 69 70 100
Accuracy 79 (83) 73 70 71 1OO
PPV Positive Predictive Value NPV Negative Predictive Value
discrimination between neoplastic and non-neoplastic diseases
<Formula 1>
0.145*(Age) + 0.0157*(P_CEA)+ 2.51*(P_ras + 0.00801"(S_CA19-9)
0.00000398*(P_CA19-9) 10.83> 0 P Pure Pancreatic Juice S Serous
(mutant), 0 (wild type)
[Conclusion] K-ras mutationand value ofCEA ofpure pancreaticjuice were useful
for discrimination between benign and malignant diseases of the pancreas. With
multivariate analysis (formula 1), much better discrimination was possible.
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SANDOSTATIN IN THE MANAGEMENT
OF ACUTE HEMORRHAGIC PANCREATITIS
E.Galperin, A.Chevokin, L.Platonova, N. Shono,
G.Aehaladze, K.Docuehaev.
Department of Liver surgery, Seehenov Moscow Medical
Academy, Russia
Two groups (each of 14 identical patients with acute
hemorrhagic panereatitis) were investigated. The diagnosis of
acute pancreatitis was made on the basis of clinical findings,
data of laparoseopy, US, and laboratory studies. All patients
had severe pancreatitis with three and more positive
Ranson’s prognostic signs. 10 patients had multiple organ
failure. Both groups received the routine administration of
antibiotics and dynamic laparoseopy with drainage of the
abdominal cavity. The first group was treated for 6 days with
3x200 ttg of Sandostatin s.c. The second group wasn’t
treated with Sandostatin and was arranged as the control
group. The results was follows: in 12 patients among 14,
treated with Sandostatin, brought to the break of the illness
in the first phase. In 2 eases developed septic complications.
These patients were operated on. In Sandostatin treated
patients the normalisation of the inflammatory and toxic
manifestation appears earlier then in the control group (5-7
days versus 11-12 days). Using of Sandostatin in the
beginning of pancreatitis prevents the development of septic
complications. These complications appeared in 2 patients
out of 14, that received Sandostatin from 4-5th day of
panereatitis. In the control group 5 of 14 patients were
operated on because of purulent complications. Application
of Sandostatin led to the normalisation of serum proteases
on 3-5 day. At the same time was noted an increase of
antiferments. Sandostatin plays a useful role in the treatment
of acute hemorrhagic panereatitis.
RAS PEPTIDE VACCINATION IN PATIENTS WITH
ADVANCED PANCREATIC CANCER: RESULTS OF A
PHASE I/II STUDY.
M. K. Gjertsen 1, A. Bakka2, J. Breivik1, I. Seterdal1, T.
Gedde-Dahl III1, K. T. Stokke B. G. Solheim4, T. S. Egge5, O.
Sreide2, E. Thorsby and G. Gaudernack
lInstitute of Transplantation Immunology, 2Department of
Surgery, 4Red Cross and National Blood Centre and
5Department ofRadiology, The National Hospital and University
of Oslo, Norway. 3Pronova a.s., Gaustadalleen 21, Oslo,
Norway.
In a pilot phase I/II study we have tested synthetic ras peptides used as
a cancer vaccine in five patients with advanced pancreatic carcinoma.
The treatment principle used was based on loading professional
antigen-presenting cells (APCs) from peripheral blood with a synthetic
ras peptide corresponding to the K-RAS mutation found in tumour
tissue from the patient. Peptide loading was performed ex vivo and the
next day APCs were re-injected into the patients after washing to
remove unbound peptide. The patients were vaccinated in the first and
second week and thereafter every 4-6 weeks. In 2 of the 5 patients
treated, an immune response against the immunising ras peptide could
be induced. None ofthe patients showed evidence of a T-cell response
against any of the ras peptides before vaccination. The treatment was
well tolerated, and could be repeated multiple times in the same
patient. Side effects were not observed even if an immunological
response against the ras peptide was evident. We conclude that ras
peptide vaccination according to the present protocol is safe and can
result in an immune response even in patients with advanced malignant
disease. In a clinical setting where tumour is surgically removed, such
T- cell responses may be of potential benefit.
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ACUTE PANCREATITIS IN CARDIAC AND RENAL ALLOGRAFT
RECIPIENTS-AGRAVECOMPLICATION
E. J. Hagopian, J. Finegold, J. A. Chabot, P. D. Stevens, J. A. Fayter, Y. H.
Hahn, A. I. Benvenisty, and M. A. Hardy.
Departments of Surgery, Medicine, and Radiology, Columbia University
College of Physicians and Surgeons, New York, NY, USA.
The purpose of this report is to define the outcome of acute pancreatitis and to
characterize and compare the disease and treatment patterns in cardiac and
renal allograft recipients. Medical records of cardiac and renal allograft
recipients from 1980 to 1994 whose ICD-9 codes included acute pancreatitis
reviewed. Pancreatitis defined abdominal pain associated with
either hyperamylasemia (E200) and/or classic radiographic findings.
Severity of pancreatitis classified mild (hospitalization ranging 1-7
days), moderate (>7 days), (ICU admission). During the study
period, 1432 transplantations performed including 726 cardiac and 706
renal allografts. Twenty-four patients developed acute pancreatitis following
transplantation yielding incidence of 1.7%. Of 706 renal allograft
recipients, 11 0.6%)developed acute pancreatitis whereas 13 of 726 cardiac
recipients (1.8%) developed the disease. Severity of disease likely
to be classified moderate in both groups (69% cardiac, 67% renal);
however, mild disease frequent in renal (18%) than in cardiac (7.7%)
whereas disease frequent in cardiac (23%) than in renal (18%)
allograft recipients. An unknown (including infectious) etiology
identified most commonly in both groups (69% cardiac, 73% renal). In 18%
of renal and 23% of cardiac recipients, cholelithasis determined to be the
initiating factor for pancreatitis whereas ERCP found to be causative in
7.7% and 8.3% of cardiac and renal patients respectively. Computed
tomography images available for review in 70%. A large proportion of
allograft recipients classified radiologically in the most by
the Balthazar criteria. Three of 13 (23%) cardiac allograft recipients and 0 of
11 (0%) renal allograft recipients required operative pancreatic debribement.
All patients requiring operative intervention had pancreatic candidiasis. Four
of 24 patients (17%) died. The mortality in the cardiac group 23% (3 of
13) compared to 9% (1 of 11) in the renal group. Operative intervention
resulted in 100% mortality (3 of 3). In conclusion, pancreatitis is relatively
common among cardiac and renal allograft recipients and most frequently is of
uncertain etiology. Cardiac allograft recipients present with severe
disease which frequently requires operative intervention and results in
higher mortality.
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DUODENAL COMPLICATIONS AFTER WHOLE ORGAN
PANCREAS (PA) TRANSPLANTATION (TX)
NS. Hakim, E. Benedetti, DER Sutherland, R. Gruessner
Department of Surgery University ofMinnesota
There is a broad spectrum of duodenal complications after bladder-drained PA
TX using the duodenal segment technique; little is known of the effect of
duodenal complications on the long-term prognosis of patients and PA grafts.
MATERIALS AND METHODS: We studied incidence and outcome of
duodenal complications after 373 bladder-drained (stapled duodenoscystostomy
in 95%) whole organ pancreatico-duodenal transplants (7/85 thru 1/95)-.
Complications were defined as early if they occurred within the first
postoperative month, and late otherwise. Mean follow-up was 5.5 months
(range, to 108 months). RESULTS: 1. There were 42 duodenal leaks
(11.3%); 12 early with a mean of 11.5 days (range, 1-28 days) and 30 late with
a mean of 6.9 months (range, 1-36 months). The site of the leak was at the
duodeno-cystostomy site (tne bladder anastomotic leaks) in 15 cases, at the
stapled proximal duodenal stump in 8, and at the stapled distal duodenal stump
in 4. In the other 15 cases it was impossible to identify the exact site of the
leakage because the patients were treated conservatively and the studies
(CystogranffCT Scan) were unable to identify the site. In 23 (55%) patients the
leakage xvas oversexvn; but 6 (14%). 4 patients had a recurrent leak requiring
enteric conversion 2 to 12 months after lhe first leak. 12 (28%) patients with
small leaks were treated conservatively with an indwelling catheter for to 2
months with resolntion of the leak. 2. Gross hematuria (defined as severe
enough to requi.re cystoscopy) occurred in 26 patients (7%), 10 early with a
mean of 14 days (range, 7-21 days) and 16 later with a mean of 11.5 months
(range, 1.5-60 months); 2 (8%) patients had an enteric conversion and 2 (8%)
had a graft pancreatectomy. 3. Two patients (0.5%) had recurrent bladder
stones requiring repeated cystoscopies and removal of stones encrusted at the
site of visible staples. There were no graft losses. 4. Nine patients (2.4%) with
recurrent UTI reqnired cystoscopy and removal of stitching and staple material
as the focus of iafection. There were no graft losses or conversions. 5. CMV
duodenal ulceration was identified in 6 (1.6%) patients; 2 patients had etateric
conversion. CONCLUSIONS: Duodenal complications are common, but are
not associated with high rate of PA graft loss (8%); mortality from duodenal
complications in our series xvas 0%. Early surgical intervention, including
enteric conversion is safe and can decrease morbidity and mortality in this
patient population.F154 F155
PARTIAL DUODENOPANCREATECTOMY WITH RADICAL
LYMPHADENECTOMY IN PATIENTS WITH PANCREATIC AND
PERIAMPULLARY CARCINOMA
D.Henne-Bruns, I.Vogel, B. Kremer
Department of Surgery, University of Kiel, Kiel, Germany
Between 1988 and 1995 76 patients with pancreatic and periampullary
carcinoma recieved a partial duodenopancreatectomy.
49 patients underwent partial duodenopancreatectomy with extended
radical retroperitoneal lymphadenectomy (Group A: cancer of the head
of the pancreas, n=27, periampullary cancer, n=22) and 27 patients
partial duodenopancreatectomy with only regional lymphadenectomy
(Group B: cancer of the head of the pancreas, n=16, periampullary
cancer, n=l 1).
Perioperative mortality was 6,5 % (n=5) respectively (Group A: n=3,
Group B: n=2). All three deaths in Group A where due to erosion and
bleeding of the hepatic artery, in Group B due to pancreatitis and
pneumonia. The last 56 operations where performed without
perioperative mortality.
The cumulative 1-,3-, 5- year-survival rates for patients with pancreatic
cancer were 62,1%, 34,5%, 34,5 % for Group A and 41,3%, 34,4%,
22,9% for Group B. In patients with periampullary carcinoma the 1-, 3-,
5-year-survival rates were 71,1%, 42,2%, 23,6% for Group A and
80,8%, 80,8/.o, 80,8% for Group B.
The analyses according to the tumor stage showed, that for patients
with smaller pancreatic carcinomas (stage and II) the 5-year-survival
rate could be improved by the extended lymphadenectomy (Group A:
58,3%, Group B: 38,9%)
Patients with stage Ill/IV tumors showed no improvement in survival
(3-year-survival rate Group A: 23,8%, Group B: 28,3%, 5-year-survival
Group A and B: 0 %).
In patients with periampullary carcinomas partial pancreaticoduodenec-
tomy with only regional lymphadenectomy seems to be superior to
partial pancreaticoduodenectomy with extended radical retroperitoneal
lymphadenectomy, but might be explained by selection of early stages
of Group B and small numbers of cases.
CARCINOMA OF AMPULLA OF VATER. RESULTS IN 60 PANCREATICO-
DUODENECTOMIES
C. lacono*, G. Zamboni*, A. Scarpa, E. Facci*, L. Bortolasi*, G. Prati*, G.
Bogina*, G. Serio*
Departments of Surgery* and Pathology University of Verona, Verona, Italy
Pancreatico-duodenectomy (PD) is the treatment of choice of Carcinoma of
Ampulla of Vater (CAV). The purpose of this paper is to report our results in
60 patients that underwent PD between 1970 and 1994 for CAV. Forty-three
patients were male and 17 were female. Mean age was 56.8 years (range 35-
73). Jaundice was present in 48 pts, 14 of these underwent percutaneous,
surgical or endoscopic biliary drainage before PD. Operative risk was
estimated with ASA score: 25 pts were ASA 30 ASA and 5 ASA II1. The
histology of the tumors were: 57 adenocarcinomas and 3 small-cell
neuroendocrine carcinomas. Five adenocarcinomas were Stage according
Talbot Classification, 20 were Stage II, 11 were Stage III and 21 were Stage
IV. The degree of differentiation was: well differentiated (Grade I) in 7 pts,
moderately differentiated (11)in 22 pts, poorly differentiated (111)in 24 pts. Four
cases were colloid carcinoma and the degree of differentiation was not
assessed. The 3 small cell neuroendocrine carcinoma presented with regional
lymph nodes metastases.
Global operative mortality was 6.6% (4 out of 60 pts). This rate was 16.6% (2
out of 12 pts) in the decade 1970-1980 and was 4% (2 out of 48 pts) in the
following period 1981-1994. Morbidity rate was 48% (surgical complication:
35%, medical complication: 30%).
The three pts with small-cell neuroendocrine carcinoma died at 6, 7 and 17
months because of disseminated metastases. The actuarial survival rate at 5
and 10 years was calculated in 51 pts with adenocarcinoma and was 48.8%
and 16.9% respectively (Kaplan-Meier method). The 5 years survival rate
calculated according to the Stage was: 50% for Stage 73.6% for Stage II,
27% for Stage III and O% for Stage IV. The 5 years survival rate of 35 pts
without lymph nodes metastases (Stage II, III) and of 16 pts with lymph
nodes metastases (Stage IV) was 57.5% and 0% respectively; the comparison
of these 2 groups was statistically significant (p-value< 0.001). The 5 years
survival rate calculated according to the grading was: 80% for Grade 54% for
Grade and 26% for Grade III.
The scoring system, based on the sum of Grade and Stage, allows to divide
the pts in 2 groups: group (score 2-4) and group 2 (score 5-7). The 5 and 10
years actuarial survival was 91.6% and 32.7% respectively for group and
23.9% and 11.9% for group 2 (p-value 0.0003). The scoring system
represents a useful way to evaluate the prognosis of pts with CAV.
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COMPARISON OF PANCREATOGASTROSTOMY AND
PANCREATOJEJUNOSTOMY AFTER PANCREATODUODENECTOMY PERFORMED BY A SINGLE
SURGEON
S.W. Kim, E.G. Youk, Y.H. Park
Department of Surgery, Seoul National University College of
Medicine, Seoul, Korea
The anastomosis between the remaining pancreas and the
intestinal tract after pancreatoduodenectomy(PD) has been the
site of complications responsible for considerable morbidity and
mortality. Pancreatogastrostomy(PG) has been recommened by
a few surgeons for some theoretical and practical advantages
over pancreatojejunostomy(PJ). The purpose of this study is to
determine whether PG can be a safe alternative to PJ.
Eighty-six PDs performed by a single surgeon for peri-
ampullary cancers during a 4.5-year period from Mar. 1991 to
Sep. 1995 were analyzed to compare early results of PJ(n=38)
and PG(n=48). PG was performed at the low body posterior
wall of the stomach by two-layer interruped suture. PJ was
done by the conventional end to side method with pancreatic
stump anastomosed to the antimesenteric border of proximal
jejunal end. The two groups were comparable for age, sex,
diagnosis, stage and operation time. In PJ group, anastomotic
leakage developed in 6 patients(15.8%) and 3 of them(7.9%)
died of complications related to leakage. In PG group patient
(2.1%) developed leakage and expired due to bleeding and
patient died of respiratory failure without any abdominal
complication. Pancreatic leakage rate was lower in PG group
than in PJ(P<0.05). Other major complications and incidence in
PJ/PG group were biliary fistula(3/1), bleeding(0/1), abdominal
abscess(2/2), delayed gastric emptying(0/2), choledocho-
jejunostomy stricture(0/1), afferent-loop obstruction(I/0) and
hepatic dysfuction(1/0), respectively and all these were
improved conservatively except one case of bleeding that was
not related to leakage. Overall morbidity/hospital mortality
were 34.2/7.9% and 18.8/4.2% in PJ and PG group,
respectively. No evidence of endo/exocrine insufficiency have
been found during the follow-up except two who developed
diabetes, one in PJ and the other in PG group. Suspicious
marginal ulcer was detected in one patient in PJ group. In PG
group, anastomotic patency could be confirmed by measuring
amylase activity of gastric aspirate during early postoperative
period. In conclusion, PG showed more favorable early outcome
than PJ. Besides, considering technical feasibility and easy




PANCREATICOJEJUNOSTOMY WITH REGARD TO GASTRIC
ACIDITY.
I, Kovacs.,P.Arkosy.,Mrs.Mahunka.,P.Sapy.
2nd.Department of Surgery and Laboratory Informatics University Medical
School ofDebrecen.
The indications of surgery and the operation of chronic pancreatitis with duct
abnormalities is a contentious subject. The main indication for operation is
the intractable pain. There are three main types of operation: partial or total
resection of the gland duct drainage and denervation. There are two main
drainage method in painful chronic pancreatitis: the longitudinal
pancreaticogastrostomy -which has not spread widely- and the conventional
pancreaticojejunostomy. The aim of our prospective study to measure
whether the pacreatic juice released into the stomach had any effect on
gastric acidity compared both form of surgery and evaluate the results of
surgical treatment.
Between 1992 and Oct. 95 43 patients with chronic pancreatitis were
selected to this study, investigated and operated in our Surgical Department.
22 patients underwent pancreaticogastrostomy, 7 cases had pancreatico-
cysto-gastrostomy and in 14 patients pancreaticojejunostomy was applied
when a two layer wide anastomosis was created between the pancreatic duct
and the antrum or the jejunum loop to relieve the symptoms. A 24 hours
gastric monitoring was taken on every patient before and 6 weeks after the
operation. The patients have received netiimicin prophylaxis before surgery.
Following a complete postoperative check up was found that both types of
operations are effective for pain relief (74%), the median pain scores reduced
from 12o (30-220) to 40 (10-190). 83 % of the patients had no digestive
problems due to pancreatic enzyme substitution. The average postoperative
weightgain was 3.8 kg. The number of diabetic patients increased from 9 to
12. There was not perioperative death. Three patients needed reoperations.
According to our statistical evaluation of24 hours gastric pH monitoring test
no alteration was detected in gastric pH level in both groups pre- and
postoperatively. It might be the lack of activation of the pancreatic enzymes
at the anastomotic site by the low gastric pH level and the decreased
pancreatic exocrin function. On the basis ofpH measuring and evaluated data
we can consider the pancreaticogastrostomy -which is a simple and quick
procedure- is also a good operation choice to releive intractable pain in
selected patients with chronic pancreatitis associated with duct dilatation.F158 F159
PREDICTIVE VALUE OF CT-SCAN FOR CLINICAL OUTCOME IN ACUTE
PANCREATITIS.
Ph.M. Kru1, A.R. van den Biezenbos2, K. Bosscha1, M.S. van Leeuwen2,
M.A.M. Feldberg2, H.G. Gooszen.
Departments of Surgery and Radiology, University Hopital Utrecht, Utrecht,
The Netherlands.
Purpose of the studle. Acute pancreatitis.cannot adequately be classified by
clinical or radiological cdteda, or even by a combination of both. Established
clinical scoring systems have major drawbacks. Evaluation is necessary within
48 hours after initiation of pancreatitis. Referred patients cannot be classified for
that reason. Therefore we conducted a study to asses the additional value of
established CT scores in comparison with the clinical Simplified Acute Physio-
logy (SAP) score in predicting outcome in patients with acute pancreatitis.
Paints. Forty five patients underwent dynamic contrast-enhanced CT, scored
according to Balthazar, the CT Severety Index (CTSI) and Schr6der. The SAP
score was calculated within 24 hours of the CT-scan. The predictive values of
these for mortality, intervention and hospital stay 20 days were compared.
Results.
Positive Mortality Intervenlion Hospital stay
predictive value 20 days
Balthazar D or E’ 41% 84 % 66%
CTSI 6 41%. 84 % 66 %
Schr6der > 6 50 % 85 % 55%
sAscore’ ’> 8 48 % ’83 % 65 %
Negative Mortality Intervention Hospital stay
predictive value _> 20 days
Balthazar A- C 92 % 69 % 69%
CTSI 5 92 % 44 % 66 %
Schr6der 5 84 % 69 % 44 %
sAPscore 7 42 % 45 % 55 %
conclusions. For identification of patien.ts with severe acute pancreatitis, by
prediction of clinical outcome, there is no clear additional benefit of CT scores
compared to SAP score. However, to exclude the possibility of severe
pancreatilJs, any type of CT scodng system is more useful than the SAP score.
The data show that eady CT-scan in acute pancrealflJs is of limited clinical
significance. CT-scanning should be limited to palents,concidered to be
operated upon, because of detoriated clinical condilon.
THEMANAGEMENT OF PANCREATIC NECROSIS INA
SPECIALIST REFERRAL CENTRE
Paul C Leeder, Iain G Martin, Michael J McMahon (MJM)
Department of Surgery, The General Infirmary at Leeds, UK.
A retrospective study of 144 patients with acute pancreatitis, treated
consecutively over a seven year period by one consultant (MJM). 70
were admitted from our local population and 74 were transferred
from other hospitals. The mean age was 53 years (17-91) and 90
patients were male. The aetiologyWas thought to be ethanol in 44
patients, gallstones in 51, idiopathic in 33 and due to other causes in
16 patients. Dynamic CT imaging was performed in 99 patients and
formed the basis of all subsequent management. Pancreatic necrosis
was diagnosed in 54 patients on CT. In 24 ofthese patients (44%),
infection was demonstrated within the necrosis either by fme needle
aspiration or subsequently at operation. One patient was found to
have infected pancreatic necrosis which was not diagnosed at CT. Of
the 144 patients, 74 were managed conservatively, 33 had
radiological intervention and 33 required operation, which consisted
ofdebridement ofnecrosis in 27 patients. Surgery was carried out a
mean of27 days after presentation with a mean delay of 11 hours
(range to 31) after a decision to operate was made. Forty.ofthe
144 patients required intensive care support and 79 needed
intravenous nutrition. Overall 26 ofthe 144 (18%) patients died. The
best predictor ofmortalitywas theAPACHE H score on admission
(p<0.001). 14 (56%) patients with infected pancreatic necrosis died
compared with only 6 (20%) ofthose with demonstrated sterile
pancreatic necrosis. 70% ofpatients undergoing pancreatic
debridement died, a mean of68 days from onset oftheir attack. The
mean length of stay ofpatients surviving their attack was 44 days
(range to 173). At an estimated cost ofup to 250,000 per patient,
this very sick group ofpatients pose a formidable challenge and
place a great demand upon therapeutic and support services.
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THE INFLUENCE OF ANTIOXIDANTS ON BACTERIAL
TRANSLOCATION IN ACUTE PANCREATITIS IN THE RAT
P. Leveau, X. Deng, V. Soltesz, Z. Sun, I. Ihse, R. Andersson
Departments of Surgery and Medical Microbiology,
Lund University, Lund, Sweden
Severe acute pancreatitis is associated with infectious complications
and multiple organ failure. The present study was carried out to
determine the incidence of bacterial translocation in severe experi-
mental pancreatitis in the rat and the influence of an antioxidant (N-
acetyl-L-cystein).
Acute pancreatitis was induced by the intraductal infusion oftauro-
deoxycholate in the rat. At induction of acute pancreatitis or sham
operation the animals received either sterile saline or N-acetyl-L-
cystein intravenously. Sampling for bacterial cultures from portal and
caval vein blood, mesentdric lymph nodes, spleen, pancreas, liver,
lungs, peritoneal fluid, distal small intestine and colon was performed
12 h after induction of acutepancreatitis.
The bacterial overgrowth in the distal small intestine noted 12 h after
induction of acute pancreatitis was prevented by treatment with N-
acetyl-L-cystein. The frequent bacterial translocation to especially
mesenteric lymph nodes, but also to peritoneal fluid, liver, pancreas,
spleen and lungs, was completely prevented by pretreatment with N-
acetyl-L-cystein.
Severe acute pancreatitits in the rat thus results in changes in the
bacterial ecology in the intestine with bacterial overgrowth and
bacterial translocation, both to mesenteric lymph nodes and also
systemic dissemination to blood and various organs. Treatment with
the antioxidant N-acetyl-L-cystein prevented bacterial translocatien,
maybe by affecting the previously described permeability changes in
the gut barrier.
PROGNOSTIC SIGNIFICANCE OF THE KI-67 ANTIGEN AND
P 53 GENE MUTATIONS IN PANCREATIC CARCINOMA.
S, Linder, C. Parrado4, U. Falkmer4, M. Blhsj62, P. Sundelin2,
A. yon Rosen3.
Departments of Surgeryland Pathology2, Stockholm S6der
Hospital; Departments of Surgery and Pathology4, Karolinska
Hospital, Stockholm, Sweden.
Survival time in patients with adenocarcinoma of the pancreas is
short, also when radical surgery is attempted. Various biological
properties may be responsible for the rapid tumor progression. In
the present study the expression of proliferation associated nuclear
antigen Ki-67 and p53 gene mutations were studied as prognostic
factors.
Metods. Fifty-three patients, 17 men 65 years (45-83) and 36
women 66 years (45-83) underwent attempted curative resection of
pancreatic carcinoma (50 Whipple resections, 3 pancreatectomies).
All original specimens were re-evaluated and paraffin embedded
material was used for immunohistochemical analyses. Monoelonal
antibodies were used with the ABC technique, M/B-1
(Immunotech) which detects Ki-67 antigen and DO-1 (Dako)
reacting with both wilde type and mutant p53. MIB-I positive
nuclei were detected with interactive image analysis.
Results. The median percentage of Ki-67 positive nuclei was 29,7
(0,5-82,1). Staining for p53 was negative in 22 tumors, positive in
26, and in 5 stainings were unsuccessful. Median survival time
was 12,5 months (2,5-125), 4 patients being alive. High
proliferation rate (> 45% MIB-1 positive nuclei,, n--- 14) correlated
with shorter survival time (p< 0,01) as did the presence of p53
mutations (p< 0,05).
Conclusions. High proliferation rate indicated by the Ki-67 antigen
and the presence of p53 mutations correlates with shorter survival
time in pancreatic carcinoma.
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CT CLASSWICATION OF PANCREATIC TRAUMA
F Loria, S CantoN*, G Loria, P Frosina, A Blandino, G Acen.ti, C
De Renzis, E Scribano, C Frola*.
Ist. Radiologia Univ. Messina-*IV Div. Radiologia Osp. 5. Manhao,
Genova
Our goal is to assess the usefulness of CT i.n the classification of
pancreatic trauma and tbr determining a prompt and correct
diagnosis.
6 patients with pancreatic trauma were examined with CT. Scans
were obtained after administration of both oral and intravenous
urographic contrast agents. In all cases we repeated sequences at 4
mm sfice thickness in the pancreatic region. Pancreatic trauma
classified in contusion, parenchymal lacerations with or without duct
distruption and complete rupture.
2/6 patients showed, at CT scamfing, a pancreatic contusion with
enlargement of the pancreas and peri pancreatic edema in the region
of the body of pancreas around the superior mcscntcfic artery. 2/6
patients exhibited parenchymal lacerations with peripancreatic fluid
collections, in one cases was associated distruption of the main
pancreatic duct. In 2/6 patients CT scans demonstrated complete
rupture of the pancreas as a clear separation(fracture line) across the
long axis of the pancreas. The fracture line was present across the
neck of the pancreas ventral to the lumbar spine, with retropefitoneal
fluid collections. Thickening of fle left anterior prirenal fascia was
seen in 2/6 cases. 3/6 patients had associated a traumatic injul?v."
invol,&ng the liver, the spleen and the duodenum.
Meticulous attention to the scarming technique is hnportant to avoid
false positive or false negative diagnosis or delay in the diagnosis
which commonly leads to complications as pscudocyst or abscess.
When diagnosis and smgew are prompt, as in our series, patients
have a benign postopertive course.
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COMBINED PANCREAS-KIDNEYTRANSPLANTATION (PKT) AFTER
PREVIOUS TRANSPLANTATION
J.A. Lowell, R.J. Stratta, R.J. Taylor, R. Sindhi, D. Sudan, P. Castaldo,
Department of Surgery, University of Nebraska Medical Center, Omaha
Nebraska,. USA
The purpose of this study was to report our experience with PKT in pa-
tients who have undergone previous transplant. From 4/89 through
11/95, a total of 133 PKTs were performed at our center. Eleven pa-
tients underwent PKT after previous kidney transplant, including one
patient who underwent simultaneous pancreas and double kidney
transplant. The mean recipient age was 40 years with a mean duration
of diabetes of 27 years. Six had previous kidney transplant alone
(KTA), 4 had 2 previous KTA, and had a previous PKT. The mean
interval between transplants was 6 years. Before retransplant, 4 pa-
tients had undergone previous transplant nephrectomy (TN; n=3) or
pancreatectomy (TP; n=l). At the time of retransplant, 8 patients had
concomitant procedures including bilateralTN (n=2), unilateralTN (n=4),
native nephrectomy (n=2), and splenectomy (n=l). Venous extension
grafts on the kidney and/or pancreas were needed in 3 patients. Mean
HLA-ABDr match was 2.3 with a mean kidney cold ischemic time of 16.7
hours. Mean operative blood replacement was 2.0 units, and the mean
operating time was 6.2hours. All but one of the patients received qua-
druple immunosuppression. The mean length of initial hospital stay was
20 days with a.mean of 1.5 readmissions. There were 4 acute rejection
episodes (1 pancreas, 3 kidney), all successfully treated with steroids.
Seven major infections occurred (3 CMV, 2 line sepsis, 2 peritonitis).
Patient survival is 100% with a mean follow-up of 37 months (range 2-
65). Kidney and pancreas allograft survival are 91% and 73%, re-
spectively. Three grafts (2 pancreas, kidney) were lost early from
thrombosis, with two (1 kidney, pancreas) successfully retransplanted.
No patient required dialysis after transplant, and all patients are currently
dialysis-independent with a mean serum creatinine of 1.9 mg/dl. Con-
clusion: PKT after previous transplant is a challenging but safe proce-
dure that often requires concomitant procedures, the use of vascular
extension grafts, and atypical placement of the allografts. However, the
excellent results justifies an aggressive policy of retransplantation in the
diabetic patient with a failed or failing allograft(s).
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CYSTIC NEOPLASMS OF THE PANCREAS STUDY OF 72
CASES
M.A.C. Machado*, G. Spiliopoulos*, P. Volpe**, A.L. Montagnini**, C.
Stasik*, T. Bacchella**, J.E.M. Cunha**, J.P. Campion*, M.C.C.
Machado**, B. Launois*.
Department of Surgery and Transplantation Unit.
*-University ofRennes, France. **- University of Sito Paulo, Brazil.
Cystic neoplasms are an uncommon group among pancreatic tumors.
These lesions are seen more frequently in recent surgical practice, probably
because of advances in diagnostic and surgical techniques. The aim of this
study is to describe the diagnostic features and therapeutical options in the
management of cystic tumor of the pancreas. We report here our
experience with 72 patients with pancreatic cystic tumors over a ten-year
period. Sixty-two four patients were women and ten were men. The .mean
age of patients was 55.2 years (range, 21 to 81 years).
Mild abdominal pain was the main symptom in 70 % of patients. The
lesion were incidental finding in 10% of patientsl CT scan provided the
diagnosis of cystic tumor in 94% of patients while ultrasonography
provided the same diagnosis in 78% of patients. All patients underwent
surgical treatment. The pathological diagnosis was: thirty patients with
mutinous cystadenoma (41.7%), thirty-two patients with serous
cystadenoma .(44.4%), ten patients with mutinous cystadenocarcinoma
(13.9%). There was no operative mortality. Seven of ten patients with
cystadenocarcinoma ultimately died of the disease. One patient with
extended resection is still alive years after surgery without recurrence of
the tumor. The survival rate was 20.5% at years. All patients gath
cystadenomas (mucinous or serous type) that underwent complete resection
are alive or died from other causes.
Only complete resection of the cystic tumors of the pancreas provides
certain pathological diagnosis, the best chance of cure and may remove the
risk of malign transformation of the cystadenomas, particularly of the
mucinous type, with minimum operative risk.
THE PATHOLOGICAL DIAGNOSIS OF PANCREATIC
CYSTADENOMAS IS POSSIBLE BEFORE SURGERY ?
CLINICAL AND RADIOLOGICAL STUDY OF 60 PATIENTS
M.A.C. Machado*, G. Spiliopoulos*, P. Volpe**, A.L. Montagnini**, C.
Stasik*, T. Bacchella**, J.E.M. Cunha**, J.P. Campion*, M.C.C.
Machado**, B. Launois*.
*-University of Rennes, France. **- University of SiIo Paulo, Brazil.
Cystic neoplasms represent up to 15% of cystic lesions of the pancreas.
The aim of this study is to analyze retrospectively 60 cases of cystic tumors
of the pancreas operated on between 1990 and 1995. There were 53
women and 7 men with mean age of 55.9 years. All patients were operated
on. 27 patients presented a mucinous cystadenoma (45%), 24 presented a
serous cystadenoma (40%) and 9 patients presenteda mucinous
cystadenocarcinoma. There were 12 pancreaticoduodenectomies, 2 total
pancreatectomies, 28 distal pancreatectomies, 8 enucleation and 8 biopsies.
There was no operative mortality. A preoperative diagnosis of serous
cystadenoma was made in 15 patients, confirmed in 12 of them (80%). A
preoperative diagnosis of mucinous cystadenoma was made in 19 patients,
confirmed in 12 ofthem (63.2%) while 2 presented a cystadenocarcinoma.
Undetermined cystic lesion was the diagnosis proposed for 16 patients.
The final diagnosis was serous cystadenoma (n=10), mucinous
cystadenoma (n=2) and cystadenocarcinoma (n=4). Ten patients received
preoperative diagnosis of pancreatic pseudocyst, but in eight of them the
peroperative diagnosis was correct. Unfortunately twocases were mistaken
by pseudocysts and a drainage into a viscous organ was performed. Both
patients were reoperated .on after diagnosis of cystic neoplasm. The final
diagnosis was mucinous cystadenoma (n=6) and cystadenocarcinoma
(n=4) (Table 1).
Table Presumed preoperative diagnosis compared to final pathological diagnosis.
Serous Mucinous Cystadenocarcinorna
cystadenoma cystadenoma
Undetermined cystic lesion 10 2
Serous cystedenorna 12 3 0
Mucinous cystadenoma 13
Pseudocyst 0 6 4
CONCLUSION The pathological diagnosis of cystic neoplasm is still not
possible before the surgery. Resection should be the treatment of choice.
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GASTRIC MOTILITY UNDER DELAYED GASTRIC EMPTYING
AFTER PYLORUS PRESERVINGPANCREATICODUODENECTOMY
IN DOGS
D. Maeda S. Takahashi, M. Kitajima, Y. Ogata*, M. Fujisaki**
Deptment of surgery Keio univ. school of medicine, Tokyo,
Tochigi cancer center, Utsunomiya, **Ashikaga red cross hospital,
Ashikaga, Japan
INTRODUCTION We have often experienced delayed gastric emptying after
pylorus preserving pancreaticoduodenectomy (PPPD), but the mechanism of
the delayed gastric emptying is still under. Therefore we have investigated
the cause of that by dogs. MATERIAL AND METHODS PPPD
performed on the nine mongrel dogs. Reconstruction was carried out by
modified Cattd’s procedure. The right gastric artery and the pyloric branch of
the vagus nerve were preserved. Straingage force transducers (S.G.T) were
placed the stomach body, antrum and the jejunum. On the 7th
postoperative day we gave five dogs barium and meal, and confirmed the
patency of the pyloms ring by X-ray. On the 7th, 14th and 28th postoperative
days we studied the contraction of the stomach and thejejunum for 24hrs and
measured plasma motilin concentration in four dogs. Five normal dogs were
implanted S.G.T. on the stomach body, antrum and the duodenum to obtain
control measurements of gastrointestinal motility and measured plasma
motilin concentration. RESULTS Pylorus ring patency In all dogs
given barium and meal could it passed through the pylorus ring and
confirmed the patency of that. Motor activity of the stomach On the 7th
postoperative days only irregular and short contractions were observed. The
interdigestive myoelectrical complex (IMC) of the stomach did not appea. On
the 14th postoperative day bands of strong contractions like the IMC
appeared. But the duration and the cycle were different from the IMC
significantly. Plasma motilin concentration Plasma motilin concentration
when the bands of strong contractions appeared did not differ from those of
other phases. CONCLUSION In the dogs undergone PPPD the pyloms was
open and the disorder of the gastric motility was the cause of the delayed
gtric emptying after PPPD. On the 14 postoperative day the bands of
strong contractions like the IMC appearext It was supposed that appearing
those contractions showed the process of recovering from the delayed gastric
emptying. It was speculated the low motilin concentration gave rise to the
disorder of the gastric motility.
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PANCREATIC PSEUDOCYSTS ASSOCIATED WITH CHRONIC
PANCREATITIS early and late results of 1367 operations.
A. MaQyar, L. Flautner, I. Pulay, T. Tihanyi, L. Harsnyi
First Department of Surgery, Semmelweis University Medical School,
Budapest, Hungary
The authors performed 1367 operations on 1155 patients for pancreatic
pseudocysts complicating chronic pancreatitis during 7 years between
1987 and 1993.
In 38% of the cases an acute exacerbation of the previously known
chronic pancreatitis have been detected, whereas in the remaining 62%
the pseudocysts constantly persisted without new onset of acute
inflammatory changes. The surgical procedures of choice were drainage
in 88%, resection in 12%.-The majority (73%) of drainage procedures
were internal, directed towards the gastrointestinal tract. Based on the
favourable results the authors preferred anastomoses performed between
the pseudocyst and stomach (posterior cystogastrostomy), as well as the
pseudocyst and duodenum (blunt forced cystoduodenostomy).
Additionally at the same time efforts have been made to resolve the
morphological alterations of the duct of Wirsung caused by chronic
pancreatitis. This has been achieved by pancreatic duct decompression
procedures such as cysto-Wirsungo-gastrostomy, and sphincteroplasty of
the papilla of Vater. (53% of the operations were such combined
interventions.)
The early postoperative morbidity was 12.9%, mortality was 1.46%.
The early mortality was significantly increased by complications
requiring reoperations, such as insufficiency of the anastomosis,
haemorrhage, and abscess formation. There were no statistically
significant differences regarding complications and early death rate
between the combined and non-combined procedures.
In the patient group (n=700) that have undergone operations in the first 5
years a long term follow up using standardised questionnaires was
completed. 87% of the answers were satisfactory for evaluation with an
average of 44 months follow up period. The late recovery results were
found to be excellent in 23%, good in 36%, satisfactory in 30% and poor
in 11%. The late mortality after 4 years follow up was found to be
15.5%.
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INDICATIONS OF FIBRIN SEALING IN PANCREATIC SUR-
GERY WITH SPECIAL REGARD TO OCCLUSION OF A NON
ANASTOMOSED PANCREATIC STUMP WITH FIBRIN SEA-
LANT
AP Marczell, Chirurgische Abteilung,
Hanusch-Krankenhaus, Heinrich Collin-Str. 30, A-1140 Vienna
Due to the specific properties of pancreatic tissue the comp-
lication rate is high. The bad results has prompted us to
apply fibrin sealant increasingly in pancreatic surgery in the
following indications: (1) wedge excision and enucleation;
(2) tail resection and left pancreatectomy; (3) resection of
head of pancreas, with or withdut pancreatojejunostomy;
(4) drainage operation: and (5) traumatic lesions.
1. Fibrin sealing allows seamless sealing of the tissue defect.
2. Following tail resection or left pancreatectomy, the re-
section surface is trimmed in the form of a fish mouth: the
gaping wound edges are approximated and sealed, and the
"lips" are covered with an additional coat of the fibrin sea-
lant.
3. Following Whipple’s operation for chronic, pancreatitis
both anastomoses hepatico- and pancreaticointestinal
are sealed with fibrin sealant. In cancer surgery the remai-
ning pancreas is occluded with fibrin sealant via the panc-
reatic duct. The pancreatic duct is ligated and the resection
surface sealed with an additional layer of fibrin sealant,
eventually in combination with collagen fleece. In 92 pa-
tients there was no lethal case. As to local complications,
there was one case of a clinically necrosing remaining
pancreatitis and 9 cases of postoperative pancreas fistulae.
4. In interventions to secure an internal drainage the ana-
stomosis can be sealed with a cuff of fibrin sealant.
5. Lesions of the tail, possibly perforating: combined head
and corpus lesions with intact main duct; and management
of all surfaces.
In 301 applications of fibrin sealant we have had only 20
failures. The high fibrinolytic activity of the pancreatic
tissue requires a aprotinin concentration of the sealant of
at least 10.000 KItJ/ml to avoid premature dissolutation of
the fibrin.
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CYSTIC TUMOURS OF THE PANCREAS: OUR EXPERIENCE WITH
40 CASES
Marrano D., Casadei R., Greco V.M.,TaffurelliM.,MirmiF.
ist Surgical Clinic, University of Bologna, Bologna,
Italy
Cystic pancreatic tumours are uncommon. In the ist Sur-
gical Clinic of the University of Bologna, from 1975 to
1995, 0 cases have been treated: they represent 7.5% of
all pancreatic neoplasms (532 cases) and 24.4% of all
cystic pathologies seen at our Institute dring this pe-
riod. Different histopathological types of cystic tun
mours were observed of which 19 (47.5%) were malignant
(19 mucinous cystadenocarcinomas), 16 (40.0%) benign
(7 serous cystadenomas, 6 mucinous cystadenomas, 2 lym-
phangiomas, cystic insulinoma) and 5 (12.5%) of unce
tain malignancy (3 intraductal papillary neoplasms, 2
solid and cystic tumours). Of the 40 cases, 35 (87.5%)
underwent surgical resection, of which 19 left pancrea-
tectomy, 8 pancreatico-duodenectomy (4 according Child,
4 Traverso-Longmire), 4 exeresis of neoplasia, 3 sub-
total pancreatectomy and, finally, 2 total pancreatecto-
my. Resection of benign and uncertain malignancy cystic
tumours was always possible (resecability index 100%);
in mucinous cystadenocarcinomas, instead, pancreatectomy
was performed in 14 out of 19 cases (resecability in-
dex 73.6%). In these patients two-year and five year
survival was respectively 46.2% and 36.9%. Of the 16 p
tients with benign cystic tumours, died of postopera-
tive complication and 15 were still alive and well at a
mean follow-up time of 45 months (range 4-132 months).
Three patients with intraductal papillary neoplasms and
two with solid and cystic tumours of the pancreas were
still alive and well at a mean follow-up time of 68months
(range 1-147 months). For all cases two-year and five-
.year actuarial survival was respectively 71.1% and 62.2%.
These results indicate that cystic tumours of the pan-
creas have a high Xndex of resecability (87.5%) and a
relatively good prognosis with respect to solid pancre
tic neoplasms. For these reasons careful differential
diagnosis is essential and, in the case of positivity
for cystic tumours, aggressivesurgicaltreatmentmust be done.F170 F171
ENDOCRINE PANCREATIC TUMOURS: OUR EXPERICEWITH59 CASES
Marrano D., Greco V.M., Casadei R. Taffurelli M.
ist Surgical Clinic, University of Bologna, BolognItaly
Endocrine pancreatic tumours are rare. In the ist Sur-
gical Clinic of the University of Bologna from 1975 to
1995, 59 cases were observed: they represent 11.1% of
all pancreatic neoplasms (532 cases). Two groups of en-
docrine tumours were recognized: functional and non func.
tional. Functional endocrine tumours were distinguished
in 21 insulinomas, 15 Zollinger-Ellison syndrome, 2 Vi-
pomas, glucagonoma, somatostatinoma and PPoma. In-
sulinoma were benign in 17 case, malignant in 2 cases
and, finally., in 2 cases on iperplasia of B cells was
shown. All were resected (14 left pancreatectomy with
splenectomy, 6 enucleation and left pancreatectomy
with hepatic resection of metastasis). Zollinger-Ellison
syndrome were supported by a gastrinomas in 9 (64.2%)c_a
ses; in 5 (35.8%) gastrinomas were occult; in case
iperplasia of G antral cells was shown. All identified
gastrinomas were resected. The other very rare functional
endocrine tumours were all resected; in case (somato-
statinoma) with hepatic resection of some small metasta-
sis and in another one (vipoma) with resection of retro-
peritoneal lymph nodes. Non functional endocrine tumours
were resected in 15 out of 18 cases (index of resecabili
ty=83.3%) (8 left pancreatectomy, 3 enucleation, 2 pancrea_
toduodenectomy and 2 intermediate pancreatectomy). Of the
59 endocrine pancreatic tumours 32 (54.2%) were benign,27
(45.8%) malignant. Resection of benign endocrine tumours
was always possible while a pancreatectomy was performed
in 24 out of 27 malignant tumours (index of resecability
88.8%). In 3 cases pancreatic resection was associated
to hepatic metastatic resection. In all cases postopera-
tive cours were uneventful with relief of the endocrine
symptoms. Five-year survival were 100% for benign tumours,
60.2% for malignant. These data indicate that endocrine
pancreatic tumours have an high index of resecability(95%).
Moreover it is important to resect alo hepate etasta
sis when it is possible because of relief of endocrine
symptoms and relatively good prognosis due to slow gro-
wing of these tumours.
EFFECT OF E,.ARLYJEJUNAL FEEDING ON THE SEPTIC
COMPLICATIONS IN ACUTE PANCREATITIS
A prospective, randomized study
Pardavi G., Varga Gy., R,-icz I.,
Dept. of Surgery, Petz AladAr County Hospital, Gy6r, Hungary.
Purpose of study: The necrotized tissue of the pancreas is colonized by
bacteria r,ainly from the colon which may lead to abscess or infectet
necrosis. Our purpose was to prove, that early jejunal feeding decreasing
the paralytic condition and distension of colonic wall, starting the passage
and preserving .the normal colonic bacterial flora can reduce the rate of
septic complicati.om.
Patients and method: The study included 38 patients with acute,
biliary panereatitis, randomizing into two groups. In group A (n=lS)jeju-
nal feeding was started in the fh’st 24 hours (second jejunal loop; Survimed
OPD, Freseaius). In group B (n=20) total parenteral nutrition was applied.
Between the two groups neither in the male:female ratio 13:5 and I8:2"1,
nor in the average age (48.2 and 44.7 years) nor in the etiolomy 13 and 16
alcoholic; 5 and 4 idiopathic) were significant differencefound.
Results: Necrosis developed altogether in 14 patients (36.8 %). In groupA
two infected and three sterile necrosis were detected. In group B four
infected, one sterile necrosis and four abscess were found. Septic compli-
cation due to bacterial contamination developed in cases in group A
(11%) and in 8 cases in group B (40 %). Statistical difference is signifi-
cant (p=0.047; Fisher-test). In group A four patients, in group B eight
patients underwent operating procedure. Mortality rate was 5.5 % in the
group ofjejunal feeding and 10 % in the control group.
Conclusion: Our results suggest that early jejunal feeding in the treat-
ment of acute panereatitis reduce the rate of bacterial contamination of
necrotized pancreatic tissue mainly in the later phase of disease, after the
first week.
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DIAGNOSTIC AND SURGICAL MANAGEMENT OF INSULINOMAS.
C. Pasquali, C. Sperti, G. Liessi, S. Pedrazzoli.
Semeiotica Chirurgica Univ. of Padua, Radiology-Castelfranco V.
Hosp., Italy.
From 1966 to 1995, 70 patients with organic hyperinsulinism (29 M, 41 F)were
observed in our Department. Sixty five patients underwent surgery. Seven/65
patients had 2 operations (3 of them referred after surgery from other centers).
Preoperative arteriography (AG) was performed in 61 cases; ultrasonography
(U.S.) was performed in 26, computed tomography (C.T.) in 37, and magnetic
resonance (M.R.) in 17 cases. T:anshepatic portal sampling (P.V.S.) was
performed in 28 patients. Four cases had an intra-arterial injection of calcium
(I.A.C.I.). Six patients underwent 11 l-In octreotide scintigraphy. Intraoperative US
was performed in 28 patients. Sensitivity ofAG was 35.4%; we had 7 false
positive tests (10.8%). The tumor was detectable with C.T. in 37.8% and in 46.2%
with U.S. scan; false positive results occurred 3/37 (8.1%) and 1126 (3.8%) cases
respectively. M.R. was positive in 10/17 patients (58.8%). Octreotide scintiscan
localized a single (1/6) 2 cm. tumor. P.V.S. gave positive results in 82.1% of
cases. I.A.C.I. was positive in 2 cases. In the last 12 years (1984-95; 29 patients)
AG, C.T. and U.$. showed a correct positivity rate of 41%, 45% and 52%
respectively, however, only 18/29 patients (62.0%) underwent surgery with a
correct pre-operative imaging information. Seventy-two laparotomies were
performed in 65 patients: 5 explorations (2 for metastases), 2 pancreatico-
duodenectomies, 23 tumor excisions, 36 left pancreatectomies (18 with spleen
preservation 4 atypical pancreatic resections and 2 near-total pancreatectomies.
Seven patients required reoperation. In 73.3% of the laparotomies a tumor was
felt or seen. In 3 cases, additional undetected adenomas were resected by
chance. Overall negative surgical exploration rate was 27.7% (20/72 cases) and
in 14/20 the preoperative imaging was wrong or negative. Operative U.S. correctly
localized the tumor in 22128 (78.6%) patients detecting also 2 "occult"
insulinomas, but had 2 false positive (7.1%). Only 51/65 patients (78.5%) had
typical single adenoma. Five (7.6%) had multiple adenomas and 5 had
hyperplasia or nesidioblastosis. In 26.1% of patients the tumor size was cm.
Two cases had liver metastases and in 2 patients the tumor was not found.
Excluding the cases with metastases, the outcome of the patients was as follows:
60163 (95.2%) were cured after surgery (1 of them recurred 3 years later); 2/63
(3.2%) were unchanged, and 2/63 developed diabetes after a near-total
pancreatectomy (including the case who recurred). Morbidity was 25% and the
hospital mortality was 5.5%. Only patient died after surgery from 1977
(51cases) for causes unrelated to surgery.
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ULTRASONOGRAPHIC EVALUATION OF THE COMMON
BILE DUCT IN BILIARYACUTE PANCREATITIS PATIENTS.A
COMPARISON WITH ENDOSCOPIC RETROGRADE
CHOLANGIOPANCREATOGRAPHY.
R. Pezzilli N. D’Imperio, B. Barakat, P. Billi, D. Baroncini, A.
Pfemontese.
Emergency Department, St. Orsola Hospital and Department of
Digestive Endoscopy, Bellaria Hospital, Bologna, Italy.
In patients with acute pancreatitis, evaluation of the morphology and
contents of the biliary tract is essential for diagnosis and optimal
management of the disease. The aim of this study was fo compare the
morphological findings pertinent to assessment of the common bile duct
by ultrasonography (US) and endoscopic retrograde
cholangiopancreatography (ERCP) in patients with biliary acute
pancreatitis. Thirty-one patients were studied (10 males, 21 females,
mean age 67 years, range 40-90); the diagnosis of acute pancreatitis was
made on the basis of characteristic abdminal pain associated with an
elevation of serum amylase and lipase. US was performed in all patients
on admission to the hospital and all subsequently underwent urgent
ERCP and endoscopic sphincterotomy within 24 hours. US was
.perfo.rmed with an Ansaldo AU 450 apparatus, using a 3.5 MHz
transaucer; ERCP was performed using a Fuji ED7-XU2 duodenoscope.
For the purpose of the study, the endoscopist was kept unaware of the
morphological details reported by the sonographer. US showed
choledocolithiasis in 2 patients and microlithiasis of the common bile
duct in 12. ERCP showed choledocolithiasis in 4 patients and
microlithiasis of the common bile duct was detected in 20. The mean of
the common bile duct diameters determined by US was 7.6 mm (range4-
12 mm), which was significantly smaller (P<0.001) than the value
obtained with ERCP (mean value 10.2 mm, range 4-17.5 mm). For this..
parameter, there was good correlation between the values obtained with
the two techniques (r=0.74, P<0.001). In 16 cases (52%) there was
concordance between US and ERCP in the detection of lithiasis and/or
microlithiasis of the common bile duct. The results show that in patients
with biliary acute pancreatitis: 1. Attendable values of the common bile
duct diameters can be obtained with either US or ERCP. The
significantly larger values given by ERCP are attributable to the
presence of contrast medium in the duct lumen. 2. US is the initial
technique of choice: it ig non-invasive and it is the preferred means for
demonstrating cholelithiasis. 3. ERCP shows a higher sensitivity than
US in detecting lithiasis or microlithiasis of the common bile duct.F174 F175
CT-SCAN ACCURACY IN THE DIFFERENTIAL DIAGNOSIS OF
PANCREATIC CYSTIC LESIONS.
R. Polverosi C. Sperti, C. Pasquali, E. Zanellato, # A. Caroli, S.
Pedrazzoli.
Radiology and # Medicine, Montebelluna Hospital -*Institute of Semeiotica
Chirurgica, University of Padua, Italy.
Preoperative differentiation of pancreatic cysts is important for appropriate
treatment. Cystic neoplasms of the pancreas are observed with increasing
frequency, often as incidental finding. CT-scan is the most common
radiologic investigation for preoperative detection of pancreatic lesions,
but misdiagnosis of pancreatic cysts is relatively frequent. We reviewed
our experience of CT-scan in 63 patients with 69 cystic lesions of the
pancreatic area, observed from May 1988 to March 1995. We evaluated
the accuracy of CT-scan to distinguish pancreatic or extrapancreatic
lesions, to differentiate between benign and malignant cysts, and to
identify different type of cysts. The final diagnosis included: 19
pseudocysts (28%), 6 serous cystadenomas, 20 mucinous neoplasms
(29%; 5 adenomas, 12 carcinomas,3 IHMN), 9 ductal carcinomas, 3
endocrine tumors, papillary cystic tumor, lymphoma, lleiomyo-
sarcoma, 2 solitary true cysts, 7 extrapancreatic lesions (10%).
CT findings correctly identified 5/7 extrapancreatic lesions, and 52/69
(75%) as benign or malignant pancreatic lesions. Sensitivity of CT-scan in
detecting benign pancreatic tumor was 79% and malignant was 73%.
Among different type of cyst CT correctly identified 15119 pseudocysts
(79%), 14/20 mucinous neoplasms (70%), 316 serous cystadenomas, 7/9
ductal carcinomas (78%). None of the other rare types of tumor was
correctly identified. In 8 % of cases the radiologic diagnosis was changed
when the clinical history of the patient was known.
In 25% of patients, with a cyst of the pancreatic area CT-scan in not able to
differentiate the type and the malignant nature of the cyst. In our series
12% of case’s were rare types of pancreatic lesion and in these patients
there is no chance to recognize the nature and behaviour of the cyst.
Study supported by the Italian National Research Council (C.N.R.),
contract nr. 94.01179.PF39.
ELECTROGASTROGRAPHIC AND pH-MONITORING OF
PATIENTS FOLLOWING CONVENTIONAL AND PYLORUS
PRESERVING PANCREATODUODENECTOMY.
Popiela T., Matyia A., Thor P., Herman R.M., Plebankiewicz S.,
Lorens K., Kawiorski W.,
Ist Dept. of General and GI Surgery Jagiellonian University,
Cracow, Poland.
Pylorus preserving pancreatoduodenectomy (PPP) has
been proposed as an alternative procedure to conventional
Whipple procedure (CWP).
The aim of this study was to evaluate the gastric motility
and Ph using modern methods of studies.
Patients: Two groups of patients, each consisted of 20
persons were examined before and after surgery group
patients following PPP and group II patients after CWP.
Methods: Transcutaneous electrogastrographic
examination and 24-hour Ph monitoring was performed in each
patients before and up to one year after surgery.The following
EGG patterns were evaluated in fasting and postprandial state:
slow waves time and space distribution, percentage of normal
slow waves, percentage of gastric dysarrhytmias. During the
24hr pH monitoring the number of reflux of jejunal contents
episodes and its duration were evaluated.
Results: In PPP the frequency of gastric dysarrhytmias is
lower than following CWP. The dominant frequency of SW
increased up to 10 + 2 cpm which occupied 56% of the
examination time. In CWP the significant decrease in SW
frequency occurred, although in symptomatic patients the aboral
propagation of jejunal pacemakers with frequency of 12 cpm
were observed.
Conclusion: EGG evaluation and continuous 24-h
.monitoring appeared to be useful methods in diagnosing and
monitoring of motility sequels following surgery. The frequency
of motility disturbances following PPP was significantly lower
than after CWP.
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THE FREY OPERATION FOR CHRONIC PANCREATITIS , D. Bizos, M. Lebos, J. Myburgh
Dept. of Surgery, Univ. of Witwatersrand, Johannesburg, South Africa
The surgical strategy used in treating symptomatic chronic pancreatitis,
namely drainage or resection, has generated much controversy. The
Fray modification of the Puestow procedure combines the principle of
wide drainage of the pancreatic duct with in situ resection of the head of
the pancreas. The aim of this study was to prospectively assess the
results of the Frey procedure in our patient population, this being the
procedure of choice since early 1992.
Between March 1992 and November 1995, 24 patients underwent the
Frey procedure for symptomatic chronic pancreatitis. There were 20
males and 4 females, mean age was 38.6 years (29-48). The aetiology
was alcohol in 21, and idiopathic in 3. Pain alone was the presenting
symptom in 17 (71%) patients, 6 had pain and jaundice, and one had
jaundice alone. Six patients (25%) had previous pancreatic surgery, 3
having a distal pancreatectomy, and 3 a Puestow procedure. Exocdne
insufficiency was present in 25% preoperatively, and 37% were diabetic.
The Frey procedure was performed alone in 12 patients (50%), 11 were
combined with biliary drainage (46%), and with distal pancreatectomy.
Significant morbidity.requiring reoperation occurred in two patients, one
an eady adhesive obstruction, and in another major bleeding from the
pancreatic bed occurred two weeks following surgery. Overall morbidity
was 42% and mostly minor, respiratory problems being the commonest.
One patient died of intra-abdominal sepsis following leakage of an
entero-enterostomy, an avoidable complication (mortality 4%).
Of the 23 survivors, 4 have been lost to follow-up. In the remaining 19
patients, mean follow-up time is 13.2 months (range 1-41). Relief of pain
has been good or excellent in 18 patients (95%), and poor in 1. No
recurrence ofjaundice has occurred in any of the patients. One of 12
patients seen at follow-up had developed new symptomatic exocdne
insufficiency. No new cases of diabetes were detected following the
surgery.
In conclusion, the eady results of the Frey procedure have been
promising. Sedous morbidity is low and the one death in the sedes was
avoidable. Although follow-up is short, very good relief of symptoms has
been achieved. No significant deterioration in exocdne or endocrine
function was detected following this operation.
CYSTIC TUMOURS OF THE PANCREAS
D. Rodriguez Romano, R. Gomez Sanz, A. Lopez Labrador, M. Manzanera, C.
Castellon, E. Moreno Gonzalez.
Introduction:
The cystic tumours ofthe pancreas are not very common. Must be done a differential
diagnosis with pseudocysts and the treatment is always surgical.
Material and Methods:
We reported on a retrospective trial of9 patients with CTP operated on during the last
10 years. Two were serosous cystoadet,rnas, 5 mucinous cystoadenomas and 2
cystoadenocarcinomas.Eight were females and was male, with a median age of47,2
years (28-72). The cystic character of the ,,-T was preoperatively diagnosed
(laparoscopy, ultrasonography CAT scanner) but not.even the fine needleaspiration
can establish a certain diagnosis.
Results:
Depending on the tumour localizationthe surgical treatment is performed, carrying out
6 distal pancreatectomies (in 2 cases with splenic preservation) and cephalic
duodenopancreatectomies(CDP). During the postoperative period one patient died, a
72 years old male with CDP due to cystadenocarcinoma,of caute renal insufficiency.
There were no complications in the postoperative period with the remaining patients.
After a follow-up, varying from 4 months and 10 years (3 years), there was.recurrence
in one case, the patient subsequently died. One patient died due to urdmown causes.
The remaining (6 cases) still alive.
Conclusiqns:
1) The cytological and radiological criteria are not enough to achieve a preoperative
diagnosis of the CPT.
2) These tumours must be treated surgically. It is curative in benign forms and offers
good results in malignant cases regarding non-cystic types of adenocarcinomas.
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TRAUMATIC INJURIES TO THE PANCREAS
MD Shahrudin & SM Noori
Department of Surgery, Faculty of Medicine
University of Malaya, 59100 Kuala Lumpur, MALAYSIA.
Pancreatic injuries from blunt trauma are infrequent,
and their diagnosis and management can be difficult.
Over the last 5 years we treated 13 patients with major
pancreatic injuries from blunt trauma. 12 were involved
in MVA, none of whom were wearing seat-belts. assault.
Only 5 patients had physical findings suggesting intra-
abdominal injury. Serum amylase were elevated in 7 of
the 9 patients tested. CT demonstrated injury in 3 of
4 patients scanned. diagnosed by u/s. 5 patients who
had DPL suffered other concomitant injuries that pro-
duced haemoperitoneum. Injuries were equally distribu-
ted throughout the pancreas.All patients underwent ce-
liotomy. 8 required no operative management other than
drainage. ISS averaged 28.5 2.6 & mean hospitalisa-
was 31 9.8 days. patient with delayed diagnosis of
pancreatic injury developed pseudocyst, but all other
complications and prolonged hospitalisations were due
to injuries to the head, chest, other abdominal organs
& extremities. All patients survived. The diagnosis of
pancreatic injury requires a high index of suspicion,
and diagnostic studies may demonstrate only subtle
signs of injury. Most injuries can be managed by loca-
lised resection and/or drainage. In contrast with pan-
creatic injuries from penetrating trauma, blunt pan-
creatic injuries are not associated with major vascular
injuries, and therefore have a lower mortality risk.
SERUM TUMOR MARKERS AND CYST FLUID ANALYSIS ARE USEFUL
FOR THE DIAGNOSIS OF PANCREATIC CYSTIC TUMORS.
C. Sperti, C. Pasquali, # P. Guolo, R. Polverosi, G. Liessi, S.
Pedrazzoli
Semeiotica Chirurgica, University of Padua, #Clinical Laboratory and
Radiology,^Montebelluna Hospital and Castelfranco V. Hospital, Italy.
Preoperative. differential diagnosis of cystic lesions of the pancreas may
be difficult because there are no reliable clinical or radiological cdteria to
assist in making the differentiation. The crucial point is to recognize
mucinous and/or malignant tumors, in which a surgical resection is
mandatory;Recently, analysis of aspirated cyst fluid for enzymes (amylase,
lipase), tu,mor markers and cytology has been used to provide a
preoperative diagnosis of pancreatic cysts.
Aim of the study was to evaluate the utility of serum and cyst fluid analysis.
for enzymes (amylase and lipase) and tumor markers (CEA, CA 19-9, CA
125, CA 72-4) in the differential diagnosis of pancreatic cystic lesions.
Serum and cyst fluid were obtained from 48 patients with pancreatic cyst
(21 pseudocysts, 14 mucinous cystic neoplasms, 6 ductal carcinomas, 7
serous cystadenomas), observed from 1089 to 1994. Preoperatively, a
basal sample of blood was collected and the serum was kept frozen until
assay. The cyst fluid was collected by percutaneous fine needle aspiration
in 20 cases, and by intraoperative aspiration in 28. The tumor markers
were measured using commercially available double antibody immuno-
assaies (CEA: n.v. < 5 ng/ml; CA 19-9: n.v. < 37 U/ml; CA 125 n.v. < 35
U/ml; CA 72-4, n.v. < 4 U/ml).
Serum CA 19-9 levels were significantly (p < 0.05) higher in ductal
carcinomas (all > 100 U/ml) and mucinous cystic neoplasms. CA 72-4 cyst
fluid levels were significantly higher in mucinous cystic tumors (p < 0.005)
with 95% specificity and 80 % sensitivity in detecting mucinous or
malignant cysts. Combined assay of serum CA 19-9 and cyst fluid Ca 72-4
correctly identified 19/20 (95 %) of (pre-)malignant lesions, with only one
(3.6 %) false positive. Cytology correctly classified all 21 pseudocysts as
inflammatory lesions. Mucin-containing epithelium were found in 8114
MCN and malignant cells in 316 ductal carcinomas. Cytology showed a
sensitivity of 48% and specificity of 100%.
Any pancreatic cyst with high serum CA 19-9 values, or positive cytology,
or high CA 72-4 in the fluid should be considered for resection.
Study supported by C.N.R., contract nr. 94.01179.PF39.
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A SCORING SYSTEM FOR EARLY DIFFERENTIATION OF ACUTE
PANCREATITIS ETIOLOGY
D.timac, M.Rubini, T.Lenac, D.Kova, A.Vev,D.Mileti
Clinical Medical Center Rijeka, Internal Clinic,
Gastroenterology Division, University of Rijeka,
Rijeka, Croatia
The purpose of this retrospective study was to
find a new scoring system for early differentiation of
the two most common acute pancreatitis etiologies:
biliary and alcoholic, because biliary pancreatitis
can be treated early by endoscopic sphyncterotomy,
whereas such treatment is unnecessary in alcoholics.
A hundred and forty-five patients (57 males and 88 fe-
males) with diagnosis of acute pancreatitis based on a
combination of clinical features, a typical case histo-
ry, elevation of serum pancreatic enzymes and confir-
mation with imaging studies (ultrasonography or con-
trast enhanced computed tomography), satisfied require
ments for participation in the study. Seven parameters
(serum amylase, aspartate aminotransferase /AST/,
alanine aminotransferase /ALT/, alkaline phosphatase
/ALP/, urine amylase, lipase/amylase ratio /L/A/and
erythrocyte mean corpuscular volume /MCV/ that differ
(statistically significant, p<0.001) between patients
with biliary and alcoholic pancreatitis were included
in the scoring system. Each parameter according to
its values was counted as 0 or i, so the patients
reached scores from 0 to 7. Score >4 differs biliary
pancreatitis from alcoholic with snsitivity of 92,92%,
specificity of 93,75%, positive predictive value of
98,11% and negative predictive value of 76,92%. We
conclude that our new scoring system calculated from
routine laboratory parameters could be important
support in early differentiation of acute pancreatitis
etiology because it is non-invasive, fast and
inexpensive.
EXPERIENCE WITH 59 CONSECUTIVE SOLITARY PANCREAS
TRANSPLANTS (PTX)
R,J. Stratta, R.J. Taylor, I.S. Gill, L.G. Weide, D. Sudan, R. Sindhi, P.
Castaldo, J.T. Jerius, K. Cushing, K. Frisbie, M.T. Grune, S.J. Radio
Department of Surgery, University of Nebraska Medical Center, Omaha,
Nebraska, USA
From 3/91 through 11/95, we performed 59 solitary PTXs (17 sequential
pancreas after kidney, 42 PTXs alone) in 54 adult Type diabetic
patients. Indications for solitary PTX were: 1) the presence of 2 or more
overt diabetic complications; and/or 2) glucose hyperlability with
hypoglycemic unawareness and impaired quality of life. The recipient
group consisted of 28 men and 26 women with a mean age of 38 years
(range 25-62) and a mean duration of diabetes of 27 years (range 14-
52). The recipient evaluation emphasized the documentation of diabetic
complications, as well as adequate cardiac and renal reserve. Organ
acceptance was restricted to ideal donors and mandated a minimum of
a 2 antigen match (mean ABDR match 2.5). The mean cold ischemia
time was 16.6 hours. Whole organ PTX was performed with bladder
drainage. Ten patients (17%) received pancreas retransplants. All pa-
tients received systemic anti-coagulation intra-operatively, anti-platelet
therapy post-operatively, and were managed with either triple or
quadruple immunosuppression. Monitoring included prospective urine
cytology as well as protocol and clinically indicated cystoscopic
transduodenal needle biopsies. Twenty-six cases were managed with
either FK506 induction (11) or rescue (15) therapy. The mean initial
length of hospital stay was 16.7 days, and mean hospital charges were
$100,664. The incidence of rejection, surgical complications, and major
infections was 71%, 47%, and 59%, respectively. Actuarial year
patient and graft survival is 90% and 62%, respectively. All patients with
functioning grafts have excellent metabolic control (mean
glycohemoglobin level 5.1%) and have achieved good rehabilitation
without major cardiovascular, renal, o( progressive diabetic problems.
Conclusion: Despite morbidity, solitary PTX can be performed with
improving success, enhances quality of life, and offers an opportunity
to arrest secondary diabetic complications.F182 F183
EXTENDED PANCREATIC RESECTION WITH INTRAOPERATIVE
RADIATION (IOR) AND PORTAL CATHETERIZ_TION (PC) FOR
PANCREATIC HEAD CANCER
.S. Takahashi, Y. Ikeda, E. Tamagawa, M. Tomikawa, T. Tsuzuki
M. Kitajima, Y. Ogata
Department of Surgery, Keio University School of Medicine, Tokyo, Japan
Pancreatic cancer is a disease with a poor therapeutic outcome. The frequency
oflocal recurrence and liver metastasis is highevenwhen extended resection
(D2) is performed. In this study we assessed the results of performing IOR to
prevent local reeunence andPC means ofpreventing liver metastasis.
The subjects of this study were 65 patients with cancer of the head of the
pancreas who underwent resectionbetween September 1985 and February
1995. The overall degree of progression was stage in 7 patients, stage II in
6, stage HI in 42, stage IV in 10 (pTNM, UICC). The surgical procedure
performed panereatoduodenectomy (PD) in 30 patients, PD + portal vein
resection in 20, total pancreatectomy (TP) in 2, andTP + portal vein
resection in 13.
We divided the patients into four groups, group surgery (D2) alone in 23
patients, group 2 surgery + IOR in 14, group 3 surgery + PC in 10, group
4 surgery + IOR + PC in 18, and assessed the sites of recurrence and survival
time retrospectively. Intraoperative radiation consisted ofadministering 20-30
Gy of electronbeam radiation retroperitoneally after performing resection,
while portal vein catheterization was used to continuously infuse 5FU, 250
mg/day, for two weeks through the recanalizedumbilical vein.
There was no significant difference in the stage distribution in these groups.
Investigation of sites of recurrence revealed the following, group local
87% (20/23), liver 74%(17/23), peritoneal dissemination 4%(1/23), group 2
79%(11/14), 57%(8/14), 29% (4/14), group 3 50%(5/10), 40%(4/10),
0%(0/10), group 4 61%(11/18), 22%(4/18), 33%(6/18). Comparison of the
rate of local recurrence in groupl and group 2, and in group and group 4,
failed to show a significant difference between either pair ofgroups (P=-0.50,
P=0.06, respectively), and no preventive effect ofintraoperative radiation on
local recunence was detected. Comparison of the rate of liver metastasis in
groupl and group 3, failed to show a significant difference (P=0.06), but
comparison of group and group4 revealed a significantly lower liver
metastasis rate in group 4 (P=0.001). Mean survival time was 11.8 months
in group 1, 9.7 months in group 2, 23.6 months in group 3 and 18.4 months
in group 4, and group 4 had significantly longer survival than group and 2.
There was local recurrence preventing effect and liver metastasis preventing
effect in the surgery (D2) + IOR + PC "group.
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DIVISION OF THE SPHINCTER OF ODDI FOR TREATMENT
OF DYSFUNCTION ASSOCIATED WITH RECURRENT
PANCREATITIS.
V Di Francesco, GTP Saccone& Kollias.
Gastrointestinal Surgical Unit, Department of Surgery, Flinders
Medical Centre, -Bedford Park, Adelaide, South
Australia,Australia.
Increasing evidence suggests that motility disorders of the
sphincter of Oddimay lead to episodes of recurrent pancreatitis
in a small percentage of patients who are given the diagnosis of
idiopathic recurrent pancreatitis. Over the course of 10 years, 35
patients have been identified and treated for this condition. The
aim of this study was to assess symptomatic outcome in these
patients. Following the exclusion of common causes of
pancreatitis the patients underwent sphincter of Oddi
manometry. Patients with manometric abnormalities and 3
patients with normal manometry underwent treatment.
Initially, patients were treated conservatively and in ten an
endoscopic sphincterotomy of the biliary part of the sphincter
was performed. Twenty six patients with persistent symptoms
underwent total division of the sphincter via an open
sphincteroplasty and septectomy. Patients were followed up
according to symptoms and classed as cured, mild symptoms or
no change. On a median follow up of 24 months (9 to 105), 15 of
the 26 patients (58%) were cured. Eight (31%) had only mild
symptoms which did not require medical treatment; 3 patients
remained unchanged. In the majority of patients having a good
clinical outcome, manometry had demonstrated sphincter of
Oddi stenosis.
Total sphincter of Oddi division is associated with a good
symptomatic outcome in patients with recurrent episodes of
pancreatitis and documented sphincter ofOddi stenosis.
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PANCREATIC ADENOCARCINOMA: OVER4DECADESOF SURGICAL
EXPERIENCE
H. Tan, Z. Kanacki, T. Kim, N. Azar, L. Juan, J. Smith, C. Garberoglio
tment of Surgery, Loma Linda University, Loma Linda, California,
U.S.A.
A retrospecfi.ve study of 348 patients (pts) with histologic diagnosis of
pancreaticadenocarcinomafm 1950o 1994 conducted. The median
ageand survival are 67.5 yrs and 7.5 mos. Sixty-three pts had curative
resections (RSCT), 201 pts had bypass (BYP) and 84 pts had exploratory
laparqtomy (EXPL). Tlie median and percent 5-yr.survival, pefioperative
mortality and morbidity of pts from ttie 1951Ys to the presentwho’had
curative resections, bypass and exploratory laparotomy are tabulated
below.
Median Median survival in mos (n)
AB,(yrs) Total 1950’s 1960’s 1970’s 1980’s 1990’s
RSC’T 64.3 8.7(63) 4.9(2) 7.0(20) 6.6(25) 17.4(16)*
BYP 70.3 4.5(201)2.0(14) 4.4(22) 4.2(94) 4.1(49) 5.5(22)
EXPL 66.7 3.3(84) 0.2(5) 1.9(5) 4.0(39) 3.7(31) 3.9(4)
05,yr survival in % (n)
Total 195 1960’s 1970’s 1980’s 1990’s
RSCT 9.4(5) 0.0(0) ’10.0(2) 8.0(2) 16.7(1)*
BYP 1.6(3) 0.0(0) 4.6(1) 1.1(1) 2.0(1) 0.0(0)
EXPL 0.0(0) 0.0(0) 0.0(0) 0.0(0) 0.0(0) 0.0(0)
Percent perioperative mortality (n)
Totil 1950’s 1960’s 1970’s 1980’s 1990’s
RSI 1’1.(7) 0.0(0) 5.0(1) 24.0(6) 0.0(0)
BYP 17.4(35)21.4(3) 13.6(3) 18.1(17)18.4(9) 13.6(3)
EXPL 23.8(20)60.0(3) 20.0(1) 20.5(8) 22.6(7) 25.0(1)
Percent perioperative morbidity* (n)
Total 1950’s 1960’s 1970’s 1980’s 1990’s
Rsf’ 49.i’1) 100.0(2’) 55.0(11)52.0(13) 31.2(5)
BYP 39.3(79) 35.7(5) 45.4(10) 44.7(42) 34.7(17) 22.7(5)
EXPL 35.7(30) 40.0(2) 0.0(0) 53.8(21) 22.6(7) 0.0(0)
"Morbidity defined having at least of the following: biliary pancreatic
fistula, gastric obstruction delayed gastric emptying, prolong ileus, hemorrhage
requiring than uPRBCs, sepsis, pulmonary emboli P<0.05
Our recent experience, as noted above, reveals a 0% perioperative mortality
rate in the 1990’s of the 16 patients who underwent curative resection with
median survival of 17.4 mos. and 5-yr survival of 16.7%. This is
consistent with previous recent reports that the Whipple operation is safe in
the 1990% with perioperative mortality of less than 1%. The resection of
pancreatic cancer does improve these patients’ five-year survival.
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MANAGEMENT OF NECROTIZING PANCREATITIS (NP) BY
REPEATED OPERATIVE NECROSECTOMY: FACTORS
AFFECTINGMORTALITY
G. Tsiotos. J. Soreide, and M. Sarr
Department of Surgery, Mayo Clinic, Rochester, MN, USA
Operative treatment ofnecrotizing pancreatitis at our institution has
evolved from open packing to repeated operative
necrosectomy/debridement every other day with delayed primary
wound closure over drains. We prospectively analyzed our results.
with operative management of72 patients (mean age 61 yr; range
20-93) withNP from 1983-1995. RESULTS Overall mortality
was 25%. Univariate analysis showed that mortality was increased
1) in patients over age 59 (p=0.06), 2) when the preop APACHE II
score was > 13 (p<0.005), 3) with pancreatic parenchymal versus
extrapancreatic necrosis (p=0.05), and 4) when the perioperative
course was complicated (13 patients) by intraabdominal
hemorrhage (p<0.01). In contrast, the number of operative
debridements (mean 3, range 0-21) or the development of
pancreatic and/or gastrointestinal fistulas (35%; 25 patients) and
recurrent intraabdominal abscesses (12 %; 9 patients, 5 ofwhom
were treated percutaneously) were not associated with increased
mortality. Multivariate analysis showed that APACHE II score and
perioperative hemorrhage maintained significance (p=0.05 and
0.03, respectively) as prognostic factors for mortality.
CONCLUSIONS: NP still carries very significant morbidity and
mortality. Planned reoperative necrosectomy with delayed primary
closure is associated with a very low incidence ofrecurrent
intraabdominal abscess. Peripancreatic tissue necrosis with
preservation ofthe viability ofthe pancreatic parenchyma, younger
age and especially APACHE-2 score <13 and absence of
hemorrhage are associated with more favorable outcome.F186 F187
BILIARYAND GASTRIC BYPASS SURGERY IN THE PALLIATION OF
PANCREATIC HEAD CARCINOMA; OUTCOME OF 126 PATIENTS.
B.A. van Wagensveld, P.P.L.O. Coene, T.M. van Gulik, H. Obertop and D.J.
Gouma. Department of Surgery, Academical Medical Center, Amsterdam,
the Netherlands.
Surgical palliation of unresectable pancreatic head carcinoma is commonly
associated with high morbidity and mortality, thus favoring the use of non-
surgical (endoscopical) procedures for palliation. More recent reports,
however, have shown improved results of surgical palliative treatment. This
prompted us to review the results of palliative biliary and gastric bypass
surgery in 126 patients who were found to have an unresectable tumor.
Patients: Between 1983 and 1994, 126 patients (m:f 64:62) with a median
age of 64 years (range: 39 to 90 years) underwent a biliary and gastric
bypass (n=118), a biliary bypass alone (n=6) or a gastric bypass alone (n=2).
Biliary bypass surgery in most cases consisted of Roux-and-Y hepatico-
jejunostomy (79%), and gastric bypass of gastro-jejunostomy (GJ). Surgical
palliation was undertaken when laparotomy revealed an unresectable tumor
(n=44), when endoscopical treatment failed (n=l 9), when gastric outlet
obstruction had occurred (GO0, n=28) or for miscellaneous reasons (n=35).
Seventy percent of patients had locally unresectable tumors and 30% had
metastatic disease. GJ was performed prophylactically in 92 patients
(76.6%). In 89 patients, preoperative, biliary drainage had occurred endosco-:
pically. Median tumor size was 4.3 cm (range: 1.5-12 cm).
Results: Postoperative morbidity consisted of local complications (17.5%),
general complications (9.5%) and delayed gastric emptying (14.3%). Thirty-
days mortality was 0.8% and overall hospital mortality was 2.4%. Median
hospital stay was 17 days (range: 5 to 80 days). Eighteen patients (14.3%)
werereadmitted with mostly a combination of problems: late GOO (n=8),
terminal care (n=8), recurrent jaundice (n=7), peritonitis carcinomatosa
(n=l) and pain management (n=l). Patients presenting with late GOO (n=8)
died within 14-19 days of terminal disease. Median overall postoperative
survival was 190 days (range: 14 to 830 days).
Conclusion: Roux-and-Y hepatico-jejunostomy combined with a (preventive)
gastro-jejunostomy, offers effective palliation for unresectable pancreatic
head cancer and can be performed with low mortality (< 2.5%) and accepta-
ble morbidity.
THEIN VITRO APPLICATION OF CHEMOTHERAPY INTHE
TREATMENT OFPANCREATIC CANCER
S.M. Vickers M. Rosenfeld, D. Rabem, L.K. Sampson, DT. Curiel
Departments ofSurgery and Biostatistics
University ofAlabama at Birmingham, Birmingham, AL
Adenocarcinoma ofthe pancreas comJnues to increase in frequency with a
current incidence of about 28,000 new cases per year. There has been
significant progress in the surgical management of the disease as well as
the molecular oncogenesis of pancreatic cancer (p53, K-ras). However,
little progress has been mad in the survival (overall survival < 8% at 2
years). Many strategies for gene therapy have been purposed to achieve
selective tumor toxicity and improve prognosis. Molecular chemotherapy
is one such approach, which is designed to achieve selective eradication of
tumor cells via toxin gene expression. Thus, we have applied this
principle to pancreatic cancer in the following study. Methods:
Pancreatic cell line (BxPc and Panc-1) were maintained under standard
cell culture conditions. These cells were transfected at 80-90%
confluency with the recombinant adenovirus, AdCMVLacZ (containing
the E. Coli 13 galactosidase gene) and AdCMVHSV-TK containing the
HSV-thymidine ldnase gene, at 100 plus/cell at 37 C. AdCMVLacZ
infected cells were evaluated by fluorescent activated cell sorting (FACS).
AdCMVHSV-TK transfected cells were treated with 20 lm ganciclovir
(GCV). Cell viability was determined by trypsin blue and MTT assay.
Results: Both cell lines demonstrated highly efficient transfection (55-
60%) with AdCMVLacZ by FACS. AdCMVHSV-TK transfected
cells were highly sensitized to the toxic effect of 20 tm GCV x 96
hours. When these cells were reconstituted with non-transfected cells
they demonstrated a "bystander effect". Conclusion: Human
pancreatic cancer cells can be transfected with a high efficiency with
recombinant adenovirus demonstrating marked cytotoxicity to 20 lm
GCV as well as having a bystander effect on non-transfected cells. This
may provide the basis for novel means oftreating pancreatic cancer.
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OVEREXPRESSION OF WILD-TYPE P53 IN CYTOLOGICAL SPECIMENS
FROM PANCREATIC JUICE:
IMPLICATIONS OF CHRONIC INFLAMMATION FOR THE PATHOGENESIS
OF PANCREATIC CANCER
I.Vogel, H.Maacke, A. Keller, W. Schmiegel, D. Henne-Bruns, B. Kremer,
H.Kalthoff
Department of Surgery, University of Kiel, Kiel, Germany
Pancreatic cancer is characterised by frequent mutations in the p53 gene,
leading to p53 overexpression. Detection of p53 overexpression strongly
correlates with neoplasia in many cytological specimens.
In order to test the usefullness of p53 assessment in detecting early stages of
pancreatic cancer we analysed cytological specimens of pancreatic juice
samples for p53 expression.
16 out of 27 cytological specimens from patients with pancreatitis (59%) and 10
out of 15 specimens from patients with pancreatic carcinoma (67%) were
positive for p53 expression. The wildtype (wt) p53 specific monoclonal antibody
PAb1620 was positive in 11 out of 27 specimens from patients with pancreatitis
and 10 out of 13 specimens from patients with pancreatic carcinoma.
The results clearly indicate, that p53 overexpression is observed in cytological
specimens of patients with pancreatic cancer as well as patients with
pancreatitis, whereas the expression of p53-protein could never be observed in
normal pancreatic tissue.
The expression of heat shock protein 70/72 was analysed in parallel:
8 out of 14 (pancreatitis) and 8 out of 13 (pancreatic carcinoma) specimens
showed a overexpression of HSP 70/72.
Double immunofluorescence analyses revealed a co-localisation of p53 and
HSP 70 in those cytological specimens. In vitro, wt p53 expression was
inducible in pancreatic adenocarcinoma cells by TNF-( treatment, followed by
apoptotic cell death as revealed by in situ "Terminal Transferase Test". A
corresponding result was achieved by analyzing cytological specimens from
patients with pancreatitis.
Our findings suggest, that TNF-( (increased levels during inflammation and
accompanied by a O- release) is a factor that stimultates p53 expression. This
might be one reason for wt p53 overexpression in cytological specimens of
pancreatic juice samples from patients with pancreatitis. Chronic inflammation
might therefore exhaust the function of wt p 53 as the "guardian of the genome"
and/or increase the risk of p53 mutations itself.
PANCREATIC DUCT OCCLUSION (PDO) WITH FIBRIN SEALANT
(FS) FOR THE PROTECTION OF THE PANCREATIC-DIGESTIVE
ANASTOMOSIS FOLLOWING PANCREATIC HEAD RESECTION
INPANCREAS CARCINOMA
Wacl,,w,i,czek n.w.
Ist Surg. Dept. and L.-Boltzmann-lnstitute for Exp./Gastroenterol. Surg.,
Landeskrankenanstalten Salzburg, A-5020 Salzburg, Austria
The pancreatic-digestive anastomosis is then highly endangered when a
normal lienat pancreatic tissue after pancreatic head dissection has to be
anastomosed with the jejunum. In the literature many procedmes for the
permanent as well as the temporary elimination of the exocrine
pancreatic secretion are known which in most cases is responsible for the
anastomosis-related complications. In animal experiments we could
show the efficiency of PDO with FS for the protection of this
anastomosis, in the meantime we could gain great experience with this
method in clinical trials.
Since 1987 87 patients underwent partial duodenopancreatectomies
(Whipple’s procedure) due to pancreatic head or peri-ampullary
carcinomas. After typical pancreatic head resection the duct of the
remaining lienal pancreas was intubated with a thin catheter and then
occluded with an average.of 2 (+/- 0.4) ml FS. A high concentration of
aprotinin (anthqbrinolytic substance) of 20.000 I.U./ml added to the
sealant is required to prevent a premature dissolution prior to the 5th
postoperative day. Then the remaining pancreas was anastomosed in
single-layer fashion.
Results: The postoperative lethality rate amounted to 2.4% (n 2) and
was not method-related. In cases bile fistulas occurred, in one a partial
liver necrosis and in another one a colonic necrosis, which required
relaparotomies. No pancreatic fistulas occurred. A remarkable fact is that
postoperatively only 5 of the patients suffered from exocrine and only 3
from endocrine, insulin-dependent insufficiencies.
Conclusion: ThePDO with FS represents a safe and effective method for
the protection of the pahcreatic-digestive anastomosis and can therefore
be recommended for Whipple’s procedure.
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A SPECIFIC DEFICIT IN ACINAR CELL SECRETORY POLE SECOND
MESSENGERCALCIUM SIGNALLINGDURING ACUTE
PANCREATITIS.
J. B, Ward, H. Morals, M. Hashtni, R. Sutton and O. H. Petersen.
Department of Surgery and The Physiological Laboratory, University of
Liverpool, UK.
Disruption of stimulus-secretion coupling may be an important event in acute
pancreatitis. Cytosolic free ionised calcium ([Ca2+]0 is a key second messenger
within the acinar cell, as secretory pole [Ca2+]i oscillations following
secretagogue stimlation initiate normal exocytosis. We have previously shown
that physiological oscillatory [Ca2+]i signals are lost during experimental
pancreatitis. This study examined the spatial aspects of [Ca2+]i signals and the
state of intracellular [Ca2]t pools during experimental pancreatitis.
Mice received hourly intraperitoneal injections of caerulein (501ag/kg) or saline
(paired controls). Pancreata were harvested after injections 1, 3, 5 and 7, and
acini isolated by collagenase digestion. Cells were loaded with fura-2 and the
pattern of [Ca2+] release in response to stimulation with 500nM acetylcholine
(ACh) assessed using digital imaging microfluorimetry. The intracellular pools
and pattern of [Ca2+] extrusion were also assessed by perifusion with the
endoplasmic reticulum (ER) Ca2+-ATPase inhibitor thapsigargin
Upon ACh stimulation the proportion of experimental cells maintaining a
normal polarised increase in [Ca2+]i progressively diminished: 16 of 17 after 1,
12 of 18 after 3, 6 of 13 after 5,and 3 of 6 after 7 injections respectively
(X2tre,,e=7.38, p<0.01). A high proportion of control cells maintained a normal
signal throughout. Following addition of thapsigargin there was no significant
difference between experimental and control cells in the amplitude of [Ca2+]i
increase: between 154+12.9nM (mean + SE) and 346+34;lnM in experimental
cells, and between 243+10.5nM and 382+17.6nM in controls, suggesting that
these stores were not depleted. Nor was there any difference in the rate Ca
extrusion.
These data suggest that during early caerulein hyperstimulation Ca reuptake
into the ER is preserved but there is a specific disruption of physiological
[ca2q signalling in the secretory pole of the acinar cell. These changes may
contribute to the disruption of secretion that occurs in the pathogenesis of acute
pancreatitis.
FUNCTIONAL RFULTS OF PANCREATOGASTROSTOMY AFTER
WHIPPLE PROCEDURE
A. Weimann, H. Dralle, J. Klempnauex, HJ. Balks*, K.F. Gratz**, V. Foek,
O. LOffge, R. Piehlmayr




Pancreatogastrostomy has been recommended as a feasible mode of
reconstruction after Whipple procedure in order to reduce anastomotie leakage
and postoperative mortality rate. Just a few reports are dealing with functional
results after Whipple procedure.
Patients and Methods
In our institution from 1988-1994 reconsmetion after Whipple operation was
performed in 61 eases by pancreatogastrostomy if’G) and in 76 by
pancreatojejunostomy (PJ). For follow-up after 14.3:t:13.3 months 19 patients
(PG: 11, 7 male, 4 female, median age: 55, 34-78yrs; PJ: 8, 4 male, 4 female,
median age 52, 17-73yrs) underwent assessment: nutritional status (body mass
index), resting energy expenditure, endocrine (glucose tolerance, HbAle, basal
serum level of insuline, C-peptid, glucagon and pancreatic polypeptid) and
exocrine (serum B-carotin, panereolauryl test) pancreatic function, gastric and
bowel transit (radionuelid tracer meal), bile flux (cholescintigraphy) as well as
Dumping symptoms (Sigstad-seore) and quality of life (GIQLI and Spitzer
index). In case of surgery for malignancy tumor recurrence was excluded by
diagnostic imaging and tumor markers. Statistics: Chi square- and Mann-
Witney U-test: p<0.05
Results:
Leakage of PG occured in 3/61 (4.9%) and PJ in 4/76 (5.3%) patients (n.s).
Functional results did not reveal any statistical differences between PG and PJ.
Nutritional status and quality of life were good in both groups. Endocrine
insufficiency of the pancreatic remnant could be avoided in most cases: just
one PG-patient with insulin-dependant diabetes. However, exocrine
insufficiency occured in both groups with a tendency to be more severe after
PG. PG patients showed a tendency for less dumping symptoms and higher
quality of life.
Conclusion:
Pancreatogastrostomy can be considexed an adequate functional option for
pancreatic anastomosis in patients undergoing Whipple procedure.
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AN ANALYSIS ON FAT DIGESTION IN THE UPPER S}/ALL INTESTINE
I) THE EFFECT OF PANCREATIC ENZY}/E SUBSTITUTION IN
PATIENTS WITH EXOCRINE PANCREATIC INSUFFICIENCY
N. Yamada, T. Nakamura, Y. Tando, Y. Arai, A. Terada, T. Suda
The Third Department of Internal l[edicine, University of
Hirosaki, Aomori, Japan
The patients with exocrine pancreatic insufficiency of
maldigestive state is sometimes severe and causes to
death. To clarify the mechanism of fat maldigestion in pa-
tients with exocrine pancreatic insufficiency, we analysed
upper small intestinal contents and investigated the ef-
fect of pancreatic enzyme on maldigestion.
Lipase activities, pH, and micellar lipids in the upper
small intestinal contents were studied after intragastric
infusion of test meal in 9 Japanese patients with exocrine
pancreatic insufficiency and 8 healthy subjects. As the
same. way, we infused the patients test meal with pancreatic
enzyme. The upper small intestinal pH was slightly less in
patients with exocrine pancreatic insufficiency than
healthy controls. Lipase activities and micellar lipids
were significantly decreased in patients with exocrine
pancreatic insufficiency compared with those in healthy
controls. There was a significant correlation between se-
rum cholesterol and micellar cholesterol concentrations.
In micellar lipids, the rate of monoglyceride was decreased
and triglyceride was increased.
Lipase activities and micellar lipids, especially monogly-
ceride were increased after the administration of pancre-
atic enzyme to the test meal.
The results suggest 1)that in patients with exocrine pan-
creatic insufficiency there is maldigestive state due to
decrease in lipase secretion, 2)that insufficiency of
lipase secretion disturbs hydrolysis of triglyceride, pre-
vents micelle formation and leads to decrease in uptake of
cholesterol into micellar phase, and 3)that such decrease
is reflected in serum cholesterol.
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KLATSKIN TUMOUR: ANALYSIS OF 78 CASES
s. Alfied, PF. Crueitti, GB Doglietto, O. Costamagna, F. Pacelli, M. Mutignani, C. Carriero, F. Crucitti
Department ofSurgery Catholic University Rome Italy
AIM of this study is to report short and long term results of series of patients with
Klatskin tumour (KT) treated with the same homogeneous preoperative investigations
and therapeutic approach. MATERIALS AND METHODS: Seventy eight patients with
KT consecutively observed in unit between November 1987 and July 1995.
There 48 and 30 women,, with a age of 66 years. To evaluate origin,
level and state of advancement of tumour spread, all patients routinely underwent US,
CT-scan and ERCP. Associated major pre-existing disease, advanced age and poor
general conditions were never considered contraindication of endoscopic procedure.
According to Bismuth modified classification, tumours distributed follow: 16
type I, 24 type II, 36 type HI and 2 type IV. With the exception of 4 patients,
preoperative drainage by endoscopic placement of more endoprostheses has been
always performed. Advanced aged (>75 years), poor general conditions, regional
metastases, bilateral involvement of the hepatic ducts beyond the secondary branches,
involvement of the main trunk of the hepatic artery, bilateral involvement of the portal
vein branches combination of vascular involvement to one side of liver with the
extensive chelangiographic involvement on the other, were considered contraindications
to resection. RESULTS On the basis of the above criteria, 10 patients out of 78
considered suitable for resection of the tumour. At laparotomy, resectability
confn’med in patients. Local excision of hilar turnout was performed in cases; local
excision plus liver resection was performed in other left hepatectomy
required in 2 Type mb cases and patient underwent right hepatectomy plus excision of
segment because there local disease spread suspected to this segment. In all
all loco-regional lymphatics and areolar tissue excised. The morbidity and
mortality rate 62% and 12% respectively. Macroscopic and microscopic tumour
clearance was obtained in patients. The overall survival was 21 months (range 3-
73); 4 patients still alive, disease free, 3,16,21 and 39 months respectively. For the
remaining 70 patients considered unresectable for cure stenting by endoscopic mean
the only palliative treatment performed but in 8 cases PTBD was associated to complete
endoscopic intrahepatie drainage. Most patients had placement of plastic endoprosthesis;
in 41% of patients drainage obtained with endoprosthesis, 54% of required
2 endoprosthesis while only in 4% of cases stents placed.The morbidity rate and
the direct procedure related mortality of 14% and 1% respectively with
survival of 10 months (rangel-24). CONCLUSION: from the present study is justifiable
to conclude that long term survival and potential cure can be achieved, in selected eases,
by radical surgical resection. Endoscopic insertion of single multiple endoprostheses
for patients unsuitable to surgery is safe procedure and provides good palliation.
EFFECTS OF ORAL ERYTHROMYCIN ON GALLBLADDER EMPTYING
FOLLOWINGTOTALORSUBTOTALGASTRECTOMY FORCANCER.
DF AItomare, L LupoS Farese, M Rina/di, L Caputi, V Memeo
Istituto di Clinica Chirurgica -Universit degli Studi di Bari
Gastric surgery increases the risk of cholelythiasisis due to
impaired gallbladder motility secondary to denervation and/or
loss of the coordination with gastro-duodenum motility.
Erythromycin, a macrolide antibiotic with powerfull prokinetic
effect on the GI tract has been shown to promote gallbladder
emptying in normal subjects and in those with gallstones.
We investigated the effect of oral Erythromycin on gallbladder
emptying in 15 patients (7M, 8F, median age 63y) subjected to
total (8) or subtotal (7) gastrectomy for cancer with a median
follow-up of 18 months and free of disease. Five healthy
subject, were considered as control.
After an overnight fasting, the gallbladder volume (GV) was
measured before and h after 500mg of Erythromycin and
before and h after a standardized meal. The GV was calculated
ultrasonographically using the 3 Dodds’ formula.
A wide variation in GVat fast was seen, particularly in totally
gastrectomized patients. After meal, the GV decreased
significantly in both groups of patients: from 36.4+21ml to
23.5+22ml (p=0.025) in patients with total gastrectomy and
from 43.4+_12ml to 19.1+13ml (p=0.018) in patients with
subtotal gastrectomy. In the controls the GV decreased from
25.2ml +_ to 6.5+_2ml. After Erythromycin the GV decreased
clearly in controls(from 23.3+/-10ml to 16+/-5.6ml), while in
patients with total gastrectomy did not change significantly from
41.8+/-31ml to 38.8+23ml, and in patients with subtotal
gastrectomy increased from 31+/-7ml to45+17ml (p=O.06).
Two patients in the group of total gastrectomy and one in the
group of subtotal gastrectomy had developed gallbladder stones
after gastric surgery. Gallbladder motility is only partially
impaired by the parasimpathetic denervation after total or
subtotal gastric removal for cancer since the gallbladder is still
able to empty in response to physiological stimuli. However it
does seem to become insensitive to the effects of oral
administration of Erythromycin within one hour.
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EXPERIENCE WITH CHOLEDOCHAL CYSTS
M.AZFAR, P. DHAR, A.SACHDEV, A.CHAUDHARY,
Deptt., of G.I. Surgery, G.B Pant Hospital,
New Delhi-ll02, INDIA.
Choledochal cysts are unusual lesions of the
biliary tract. Over the last 8 years
(1988-95), we treated 64 patients with bile
duct cysts, 25(39%) of these were children,
39(61%) adults, 47(73%) females and 17(27%)
males. The common presenting symptoms were
abdominal pain and jaundice. Adult patients
had a higher incidence of cholangitis. Eight
(13%) adult patients had undergone a cyst
related operation in the past. Sixty two
patients underwent an ERCP, and two T-tube
cholangiogram. The 38 patients (59%) had type
i cyst. Twenty five (39%) had type IVa cysts
and one(2%) had type IVb cysts. Though type I
cyst was commonest in both children and
adults,type IVa cysts were seen mainly in
adults. Fourteen (22%) patients, all adults,
had complications of choleduchal cyst like
cholangitis, portal hypertension,cystolithia-
sins, spontaneous perforation,liver abscess,
hemobilia and malignancy. Five patients had
emergency surgery beacause of cholangitis and
perforation and 59 had planned intervention.
Cyst excision and hepaticojejunostomy was done
in 61(95%) patients. The choledochal cyst could
not be excised in 3 patients each due to the
pesence of malignancy, portal hypertension and
pericystic adhesions. There was no mortality
and no major postoperative complications.
Choledochal cysts in adults have potential
for complications and in most cases excision
of the cyst is possible and gives the best
results. Choledochal cysts should be excised
son they ar deectd to prevent the eveloDmgt oz comDiicauions.
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INCIDENCE, MANAGEMENT AND OUTCOME OF SILENT COMMON BILE
DUCT STONES
C.ltianchl. MD. C.Garberoglio, MD and A.Robles, MD.
Department of Surgery, Loma Linda University Medical Center.
Loma Linda, California
The routine of intraoperative cholansiogram during laparoscopic surgery is still
controversial. Its in laparoscopic surgery at institution has been useful in
identifying bile duct stones in patients who had dinical, laboratory
ultrasonographic evidence of choledocholithlasts.
We have performed this retrospective study in effort to identify the incidence of
"silent bile.duct stones"
Methods: We have reviewed hundred and twenty patients that underwent
laparoscopic cholecystectomy since August 1990.
The inclusion criteria for "silent bile duct stones" l)the absence of
clinical features(jaundice, cholangitis) 2) Normal laboratory
(liver function test) 3) and suggestion ofcholedocholithiasis (stone dilation) by
ultrasound. Patients having any of the above indicators recorded in the category
"probable bile duct stones" and excluded for the purpose of this study.
Results:
The total prevalence of bile duct stones 11.52 96(83 patients)
Thirty two of these patients considered to have "silent bile duct stones"
and this represents 38.6% of all patients with choledocholithiasis in this series.
This review has established that three different approaches have been made at the time
of finding the stones in the intraoperative cholanglogram. (see the following table)
Total oat./ Aooroach Size Stone IOC Averaee follow ERCP Stone
retrlval %
7 Observation <4 13.5 months
F8
(*) Postop. ERCP <4 II months 37 %
II L 6 Postop.ERCP >4 11 months 66 %
(*) Flushing <4 11.2 months
m CBD explor. 4 34.5 months
(tmpacted)
4 CBD explor 4ram 10 months
Outcome of every group showed complications recurrent symptoms.
Conclusions:
"Silent bile duct stones" represent almost 40% ofcholedochollthiasts
Some patients(*)(stone 4 rout impacted) may have received unnecessary
intervention therefore increasing the total cost of
Observation only may be reasonable approach.
At the present time trying to elucidate this hypothesis by prospectiveF197 F198
ENDOCRINE RESPONSE TO CHOLECYSTECTOMY
COMPARATIVE STUDY BETWEEN STANDARD SURGICAL
MANAGEMENTAND V1DEOLAPAROSCOPY
FloraMB Bisinotti, HellerP Chaves, JoseAlves No.,EduardoCrema
From the Departments of Anesthesiology and Digestive Surgery of Hos-
pital Eseola of Faeuldade de Medicina do Triangulo Mineiro Uberaba-
MG- Brazil
Cholecystectomy through laparoscopy has become the first-choice for
procedures ofgallbladder and bile duet because of the rapid recovering of
patients, which may be associated to less anesthetic-surgical trauma. We
compared endocrine response in 30 patients undergoing operative
procedures for eholecystectomy using standard technique with subcostal
incision (n 16) and videolaparoseopy (n 14) through plasmatic dosages
of e’ortisol and adrenocorticotrophic hormone (ACTH) during surgery and
at early postoperative period.
Results showed that plasma concentrations of cortisol and ACTH showed
no significant differences between the two techniques during surgery and
at the first 6 hours postoperatively; only after 12 hours postoperatively
there was a trend to significance (0.05 < P < 0.10) relating to cortisol,
being greater in the standard group.
Analysis of different periods in each group showed significant increasing
of cortisol postoperatively compared to initial values for both groups; and
ACTH showed significant difference after extubation and 12 hours
postextubation for standard group; for videolaparoscopy group it was
evident 12 hours postoperatively.
Because these results shows that plasma concentrations of ACTH and
cortisol were not significantly different between both groups we concluded
that neuroendoerine stimulation induced for both procedures is similar.
Some elements are -likely to be involved and may be responsible for the
rapid recovering of patients undergoing cholecystectomy through
videolaparoscopy. Also, pneumoperitoneum and videosurgery were not
different from standard procedure relating to the endocrine changes studied.




Department of Surgery. Doee de Oetubre University Hospital,
Madrid, Spain.
Indications oflaparoscopie eholeeysteetomy (LC) are well established
and are not anymore object of controversy. The advantages ofLC are
evident. Our objetive is add the economical aspect as advantage ofLC
opposite to open eholeeysteetomy (OC).
MATER/AL AND METHODS. We compare 200 eholeeysteetomies,
100 LC and 100 OP. Both groul are homogeneous in relation to age,
sex, andpreoperative test. We analyse the cost ofprocedure, hospital
stay and temporary work incapacity.
RESULTS. The cost ofprocedure was upper in the LC group than in
the OC because the higest cost of disposable instruments in the LC
group, LC 821 US or 612 ECUs vs OC 89 US or 67 ECUs. The
hospital stay cost was LC 333 US x 1.3 days 434 US or 323 ECUs
and OC 333U$ x 5 days= 1667 US or 1242 ECUs. Duration of
temporary work incapacity was 14 days in the group LC and 40 days
in the OC group. The cost was 228 US or 170 UCUs and 650 US or
484 ECUs, respectively. Total cost was 1482 U$ or 1104 ECUs for
every LC and 2406 U$ or1794 UCUs for every OC. It mean that in
the LC group was save 92.304 US or 68.798 ECUs if we will
compare with the total amount ofthe OC group.
CONCLUSIONS. LC is more confortable than OC to the patient.
Relation cost/benefit was superior inLC group than inOC group, with
both lower hospital stay and temporary work incapacity in the first
group. If it was used reusable instruments, ecomomical differences
would be greater.
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SURGIgR OR ENDOSCOPIC SFJIINCTEROTOMY FOR
COMMON BILE DUCT STONgS ? A MULTICENTER
RANDOMI,?.IgD TRIAl...
B Sue, O Zeitotm, O Fourtanier, F Lacaine, J Escat and
French Surgical Rcse,arc,h Associations, 8 Avenue des Peupliers, 92270
Bois.Colombes.
Surgery and endoscopic otomy can both be proposed as
detlnitive treatmeat for patients with common bile duct stones.
floweret, the choice between the two procedures has not yet been well
establislg4. The aim of this randozed trial was to compare sursery
and endoscopic sphintcrotomy for common bile duct stones, with
Weaalra’ toopeve and short term results,
From 1989 to 19o.4, 204 patients (64 men and 140 wollll mes/l
67 *_ iS yer’, raa 2S.90) were indud in the stu. One
and -ven patients were opetttd on and 97 undawa endoscopic
sphincterotomy, Before treatment, th two Stoups ofpatients were not
silFdflca17 different as resards for rnc al sex ratio, ASA score,
’cvious ebole,cystectomy, jauntily, choiis, or Vancrtitis. In the
surgew group, ston(C)s were found in 72 % of csses, 10.: % of the
psfieats had a negative exploration of emnmon bile duct, In the
spincterotomy lpoup, llla was een/n all instra. Common bil(C)
ductetsm was pore’hie in9 %, anti sphinctotomy n 82% of
cas. Four post operative dths were reportl: on (1%) in the surgery group and 3 (3 %) in the phkerotomy tFoup. Medi
hospital st,xy was 6 days al 12 day. respectively (n$). P,nidual
stones were diagnosed early after treatme.t in 8 patiet of surgery
p’Otlp (7 %) and in 19 patients of spb/ncterotomy roup (20 %) p<0.02,. Early opemio, wasnec in :Z patient of ,,8ery 8ro,p (2 %) and in IS pents ofsphincterototw IFoup (20 %) -p<0.000} Although operative rnorudiry was not sisnificantly differem between the two procedures, surggry allowed a sijptificant lower ro0pe--mtion and residual stone rates than endoscopic sphincteotomy. This study xhowed that surgery should be prdered to endoscopic sphincterotomy, which should be restricted to patients with a sibmificant operative
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BLACK PIGMENT MICROSTONES FOUND WITHIN THE ROKITANSKY-
ASCHOFF SINUSES OF THE GALLBLADDER CAN FORM THE
PIGMENTED CENTRE. OF MIXED CHOLESTEROL STONES. A STUDY BY
SCANNING ELECTRON MICROSCOPY.
A. Cariati. *F. Cetta, op. Romano, F. Conti, D. Zaccheo.
Institute of Surgical Clinics, University of Genoa and *Siena. Institute of.Human
Anatomy and Institute of Pediatrics, University of Genoa. Italy.
Introduction. We have previously observed that: I) multiple black gallstones (GS)
are frequently associated with an increase in number and depth of the Rokitansky.
Aschoff (R-A) sinuses of the gallbladder (GB) (1): II) black mieronuclei can act as
initial nuclei for the formation of multiple cholesterol GS (2). The aim of this
study is to analyse by scanning electron microscopy (SEM) black pigment
microstones found within R-A sinuses and the pigmented center of the multiple
cholesterol GS which ,ere concomitantly pres( in the same gallbladder looking
at microstructural differences or analogies. Material and Methods. During the
prospective study of 168 consutive patients who had systematic stone and bile
analysis and histologic examination of GB wall, 32 patients were found with
adenomyomatosis (ADM), i. e., an increase in number and depth of R-A sinuses,
and black stones alone or in association with single cholesterol (n 7) or multiple
mixed (n= 4) stones. In 4 patients with intraparietal black microstones and
multiple mixed Cholesterol GS,.SEM analysis of stones and GB specimens were
performed. In addition to x-ray diffractometry, x-ray fluorescence elemental
analysis of stones also was performed in 2 of these cases. Results. SEM analysis
of GB specimens has demonstrated that: 1) both black pigment microstones
within the R-A sinuses and mixed cholesterol GS in the main lumen of GB can
grovth concomitantly in the same GB; 2) black pigment microstones are mostly
built up from granules of calcium bilirubinate rather than glassy masses of
bilirubinate. SEM analysis of the pigmented center of multiple cholesterol GS
showed the presence of a nidus of granules of calcium bilirubinate alone or in
association with calcium phosphate in all the observed stones. The presence of
calcium phosphate and other calcium salts in the pigmented center of mixed
cholesterol stones was also demonstrated by x-ray fluorescence elemental
analysis. Conclusions. It is suggested that: i) both black microstones and mixed
cholesterol GS can groWth together in the same GB; ii) microstructures of black
pigment microstones and of the pigmented center of mixed cholesterol stones are
similar and mainly consist of granules of calcium bilirubinate; iii) multiple
cholesterol stones can form by deposition of cholesterol cr).’stals over black
pigment nucleus.
1) F. Cetta, A. Cariati et al. Gastroenterol. 1993; 104: A 353. 2) F. Cetta et al.
Gastroenterol. 1993; 104: A356.F201 F202
DIAGNOSTIC YIELD OF ERCP AND INTRAOPERATIVE
CHOLANGIOGRAPHY IN 1847 PATIENTS UNDERGOING
LAIAROSCOPIC CHOLECYSTECTOMY. D.L.Carr-Lke,
T.C.K.Tham, J.Vandervoort, R.C.K.Wong, D.R.Lichtenste’.m, J.Van
Dam, F.Ruynm’m, F.Farraye, D.Brooks. Gastroenterology Division,
Brigham& Women’s Hospital, Harvard Medical School, Boston, MA.
With the advent of, laparoscopic cholecystectomy (LC), the optimal
management ofcommon bile duct stones remains controversial. AIM_.._dWe
report our experience of selective. ERCP and intraoperativc
cholangiography (IOC) in the management ofcommon bile duct stones in
a large series ofLC from a single center. METHODS 1847 consecutive
LC pefform&l .from 1990-1995 were analyzed in terms ofERCP and IOC
involvemznt. A high likelyhood for risk ofCBD stones was considered an
indicatiot for pro-operative ERCP and was defined as either presence of
bilirub >2mg%, alkaline phosphatase (ALP) >lSOU/I, present/recent
jaundicedpancreatitis or dilated CBD/stone on ultrasound or CT-scan.
Selective IOC was performed for intermediate risk based on either
bilirubin 1.5-2, ALP 110-150, ALT/AST greater than twice normal or
remote history of jaundice/pancreatitis. Post-operative ERCP was
performl in patients with suspected retained stones or bile duct injury.
RESULTS Pro-operative ERCP was performed in 143 (7.7%) of
patients; was successful in 141 (98.6%) and demonstrated CBD stones in
43 (30%) which were successfully extracted. Of 36 patients with mild
gallstone pancreatitis, stones were found only in 6 (17%). Selective IOC
was performed in 87 (5%) and stones were found in 4 (5%). Post-
operative ERCP was performed in 66(3.6%). Bile leaks were found in 21
(32%), stones in 20 (30%), ductal ihjury in 3 (4%), papillary stenosis in
3(4%) and pancreatic duct stricture in 2 (3%). Bile leaks, injuries and
stones wore all managed endoscopically. Complications were pancreatitis
in 6 (4.2%), bleeding in 2 (1.4%), fever in (0.7%) and all settled with
conservative treatment. CONCLUSIONS Even in selected patients
considered likely to have CBD stones, the positive diagnostic yield ofpre-
operative ERCP is low. Mild gallstone pancreatitis is associated with a
low incidence of CBD stones. There is a higher incidence of positive
findings with post-operative ERCP following selective IOC.
DIAGNOSTIC VALUEOFMR-CHOLANGIOGRAPHY FOR INVASION TOWARD
THE CAUDATE BILEDUCT BRANCH IN CARCINOMA OFTHE HEPATIC HILUM
M Cho, M. Ryu, T. Kinoshita, N. Kawano, M. Konishi, H. Tanizaki
Department of Surgery, National Cancer Center Hospital East, Chiba, Japan.
Objective: In order to identify intrahepatic bile ducts and their anatomical
modalities and to comprehend accurately the extent of bile duct cancer in each
segmental duct includ!ng caudate branches, we attempted to make 3
dimensional images of intrabepatic bile ducts which were reconstructed from
MR-cholangiography using maximum intensity projection (MIP).
Materials and Methods: 8 patients with hilar bile duct carcinoma underwent
imaging with aMR imager (Magneton H15 Siemens, Erlanger, Germany)
and a surface coil. A turbo spin echo pulse sequence (8000 msec/ 91 msec
TR TE) was used for data acquisition, with 35 seconds breath holding,
280 mm field of view, and a 120 256 matrix. These images sections were
processed by using a standard MIP algorithm to obtain views of the entire
hepatic biliary tree.
Result: Subsegmental bile ducts and their modalities could be visualized on
MR-cholangiography. Some caudate branches which could not be
visualized on conventional cholangiography because they were located
behind the hepatic hilum could be visualized on MR-cholangiography.
Other caudate branches which could not be filled ofcontrast medium because
of the invasion ofcancer also could be visualized.
Conclusion: MR-cholangiography provides a noninvasive technique. This is
useful for comprehesion of bile duct division and detection of the invasion
ofcancer because some bile ducts infiltrated by cancer and unfilled of
contrast medium can be visualized.
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"KLATSKINTUMOR: RESECTION ORNOT RESECTION?"
Ciferri E,, Bondanza G, Filauro M., Bagarolo C., Gazzaniga G.M.
1st Surg. Dept. S. Martino Hospital Genoa Italy
Most of updated literature shows an increase in resectability rate of
the Klatskin tumour. The problem of this pathologism is
represented by the preoperative work-up that is often not able to
settle the real staging of the neoplasm and to decide for a surgical or
not surgical approach. Between January 1970 and May 1995, 139
cases of Klatskin’ tumours were treated in our department. At
admittance clinical examination and biochemical data are assumed to
assess a risk score in jaundiced patients; then US B-mode liver
examination combined with echo-doppler on vascular structures of
hepatic pedicle and intrahepatic vessels are performed. Spiral CT
completes the diagnostic algorythm. PTC-PTBD are performed in
order to define biliary map, to obtain bile ducts decompression and
to reduce, if present, obstructive eholangitis. The exact
intraoperative staging of the neoplasm was established after a
careful histological examinations of the frozen sections of the
resected’biliary margins to evaluate the presence of microscopical
infiltration along the bile duct wall. All patients are staged according
Gazzaniga and coll. classification proposed in 1984: Ist stage 18
pts., Ilnd stage 18 pts., Illrd stage 4 pts., IVth 99 pts. Among 139
patients, 64 were operated; resectability rate was 46.5%, but radical
operations represented only 29.0%. Founy resections were.
performed with a curative aim (absence ofresidual neoplastic
tissue), 24 were palliative. Operative mortality rate was 9,5%. Post-
operative morbidity rate was 46%. Actuarial five years survival rate
for curative surgery was 18,9%. Palliative resections had maximum
survival of two years. The remaining 75 cases were treated as
follows: decompression ofthe bile duct with external-internal or
external PTBD (46 cases), pereutaneous self-blocking
endoprosthesis placement (6 eases); surgical palliation included 14
transtumoral stentings and 2 Soupault-Coinaud anastomoses;
explorative laparotomy (5 eases); no treatment (2 eases). Surgical
treatment, when it is possible, is the therapy of ehoise because of
sensible improvement of survival and quality of life.
Sequential treatment of Common Bile Duct and gallbladder Stones by
Endoscopic Sphyncterotomy and laparoscopic cholecystectom:
results of a prospective series of 420 patients.
G. Costamagna, D. Borzomati, V. Perri, M. Mutignani, M. Marciano,
F. Crucitti.
Istituto di Clinica Chirurgica Universita Cattolica del S. Cuore,
L.go A. Gemelli 8, 00168 Roma.
The sequential treatment -Endoscopic Sphyneterotomy (ES) and
Laparoscopic Cholecysteetomy (LC)- for patients with symptomatic
gallbladder and Common Bile Duet (CBD) Stones is a widespread and well
experienced therapeuthic strategy. From July 1990 through April 1995
indication for a LC was present in 420 symptomatic patients. Ninety-six
patients (22.8%) patients underwent a preoperative ERCP because of at
least one ofthe following criteria of suspected CBD Stones:
clinical history ofjaundice and/or acute cholangitis and/or acute biliary
pancreatitis;
increase (at least x2) oftotal bilirubin, ALT, AST, GGT and alk. phosp.;
US evidence ofCBD or intrahepatic stone/s and/or a CBD size >7mm;
Endoscopic cannulation of the Bile Duct was successful in every patient.
Fifty-two patients (i.e. 54% of those undergoing ERCP and 12.4% of the
whole group) underwent ES and extraction of stones and/or of biliary
sludge was executed in all patient but one. There was no mortality and the
morbidity rate was 0.2% (one case of mild acute panereatitis). All these
patients subsequently underwent LC at a mean interval time of 11.2 days
(min. 0 days, max 150 days), lntra Operative Cholangiography was never
performed. CBD injury, intra/postoperative major morbidity and
conversion rate were in 0.2%, 0.7% and 5.8% respectively. More than 95%
of all the patients have been followed up by a self-administered postal
questionnaire or telephonic interview. 0.4% (1 case of CBD and case of
intrahepatic stone) is the residual stone rate after a median follow-up of
21.4 months (range 1-44 months). These results support the safety and the
efficacy of the sequential treatment. The high number of negative
preoperative ERCP is counterbalanced by a very low rate of residual CBD
stone.
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IMMUNE SYSTEM CHANGES AFTER LAPAROSCOPIC AND OPEN
CHOLECYSTECTOMY. A PROSPECTIVE AND COMPARATIVE STUDY.
M. Cristaldi, S. Gerlinzani, B. Moh’eni, H. Kurihara, M. Mezzabotta, M. Rovati,
R. Gornati and A.M. Taschieri.
Departernent of Surgery. Univers#y ofMilan- I. Sacco Hospital, Milan, Italy.
Up to date it’s unclear laparoscopic surgery determine less immunosuppressive
effects than traditional laparotomic procedures. We determined in siries of 38 patients
affected by symptomatic gallstone disease and operated either by laparoscopic (Group
1) and by traditional open surgery (Group 2), the changes of lymphocyte subpopulations
in the postoperative, compared to preoperative period, different time point .up to day
30 after surgery. We collected 15 ml of blood from all patients in both group
and 2, day-1 (1 day before surgery) and postoperative day 1,7,15 and 30. A
single blood sample from control group (Group 3) formed by 56 healty volunteers
obtained. In the patients submitt to open cholecystectomy we observed significant fall
in total lymphocyte count in postoperative day 1. Basal levels of lymphocyte
subpopulations did not show any statistical significant difference (Wilcoxon test) between
study and control groups (results with P<O,O1 considered significant). No differences
were found in preoperative lymphocyte cell count between the two groups submitted to
cholecystectomy. Pan cell (CD3) showed marked statistically significant reduction
throughout the observation period. The count of helper (CD4), suppressor (CD8) and NK
(CD16) T cells reduced postoperative day 1, NK cell (CD16) count remaining
low until posfoperative day 30. B lymphocytes group showed postoperative
reduction. In patients submitted to laparoscopic cholecystectomy significant
postoperative fall of total lymphocytic count, CD3, CD4 and CD8 subpopulations
observed day only. No reduction of CD16 and CD19 subpopulations was noted.
A comparative statistical analysis between lymphocyte subpopulations inthe two groups
was carried out: in the open cholecystectomy group compared to laparoscopic group,
CD3, CD4, CD8 and CD16 lymphocyte subpopulations showed marked reduction
different time points. In particular, statistically significant differences were found in CD3
levels from postoperative day 30, in CD4 from day through day 7 and in CD8 and
CD 16 only day 1.
MORPHOLOGICAL FEATURES INFLUENCING PROGNOSIS
OF PATIENTS WITH BILE DUCT CARCINOMA.
A D’ERRICO, A. PRINCIPE, M.L. LUGARESI, E. BERTI, I. BICCHIERRI,
M.C. GALL0, A. CAVALLARI
Department of Surgical Pathology and Department of Surgery,
Bologna University, Italy.
Many discrepancies are reported in the literature about the clinico-
pathologic factors that can influence survival of patients with bile
duct carcinoma.
Material and Methods: We performed a revision of 37 bile duct
carcinomas surgically resected in the Department of Surgery,
Bologna University, from 1982. The 37 carcinomas were classified
as middle (5 cases, 13,5%), lower (11 cases, 29,7%) and hilar
(21 cases, 56,7%) bile duct carcinomas. In each case we evaluated
the following clinico-pathologic variables: age, sex, location of
primary tumor, serosal invasion, peritoneal dissemination, hepatic
metastasis, lymph-node metastasis, pancreatic invasion, duodenal
invasion, microscopic vessels involvement, perineural invasion,
resected proximal and distal margin involvement, histologic type
depth of cancer invasion and survival.
Results and follow-up: Lower bile duct carcinomas: All but two
pts died for neoplastic progression (mean survival 19,6 months),
two pts are alive and free of disease ms= 90 months). Middle bile
duct carcinomas: 3 pts died for neoplastic disease (ms= 15,3
months) and 2 pts are alive (ms= 96 months). Hilar bile duct
carcinomas: 2 pts died after surgery, 10 pts died for neoplastic
disease (ms= 11,8 months), 4 pts are alive at 13 months, 2 pts died
at 51,5 months (ms), and 3 pts are free of disease at 56 months
(ms). The main clinico-pathologic factors that seem to correlate
with .prognosis are location of primary tumor, size of tumor, depth
of cancer invasion, histologic type, lymphatic or perineural
invasion, lymph-node metastasis, hepatic or duodenal diffusion, and
pancreatic metastasis.
Conclusions: On the basis of this retrospective revision
morphological features seem to be closely related to the clinical
behaviour of bile duct carcinoma, and they can be evaluated only by
the mean of an accurate intraoperative staging.
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BILIARY DUCT INJURIES SECONDARY TO LAPAROSCOPIC
CHOLECYSTECTOMY: A NATIONAL SURVEY
E. de Santibaties, S. Perera, R. Sendin, J. Grondona.
HOB Surgery Section, General Surgery Service, Hospital Italiano,
Buenos Airas, ARGENTINA
A national survey of the surgical biliary duct injuries secondary to video
laparoscopic cholecystectomy was performed in the Argentine Republic. A
total of 116 cases were reported. Fifty one surgeons were surveyed, and 20 of
then sended the casuistic of 12 hospitalary centers and 31 the own
experience. Only the 50% of the surgeons who injured the biliary duct had
training in laparoscopic surgery. The 77% of the preoperative diagnosis
were cholelithiasis, and the lesion occurred in the 98% of the cases during a
simple cholecystectomy. Forty four percent of the injuries were advised and
56% passed innoted. Only in the 12% of the cases the intraoperative
colangiography was performed, and the intent of immediate repair were in
18 of the 116 patients (.5,51%). The main surgical procedures performed
choledoco-choledoco anastomosis with T-tube (19.82%), double
hcpaticoyeyunostomy (17,24%) and triple hepaticoyeyunostomy (4,3%). The
type of lesion on the Bismuth classification were: 21,51%;
II=26,72%;III=14,65%;IV=23,27%’,V=5,17% and unknown=8,62%. It is
mentioned that in Argentinean bibliography it is low the rate of injuries of
the biliary duct during laparoscopic cholecystectomy. We conclude that the
knowledge of the mechanisms of biliary duct injuries is the best way to
prevent then. The intraoperative cholangiography help the surgeon to
identify the biliary anomalies, but no substitute the carefully dissection and
the delineation of the anatomy. Further not prevent the lesion but advise
about it, avoid serious injuries and permit the intent of the immediate repair
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THE FEASIBILITY OF LAPAROSCOPIC CHOLECYSTECTOMY




Department of Surgery University Hospital B.A.- Argentina.
Dragones Clinic.
A retrospective study w.as carded in 1500 patients submitted to elective laparoscop-
ic cholecystectomy to ascertain its feasibility in patients with previous abdominal
surgery.
In 411 patients (27,4%) previous infraumbilical intraperitoneal surgery had been per-
formed, and 106 of them (7,06%) had 2 or more surgeries.
The most common was a cesarean operation. In this group the first trocar was placed
in the umbilicus.
Twenty five patients (1,66%) had previous supraumbilical intraperitoneal operations
(colonic resection, hidatic liver cysts, gastrectomies, etc.). Three of them had been
operated times. In this group the first trocar and pneumoperitoneum were per-
formed by open laparoscopy.
In 2 patients a Marlex mesh were present due previous surgery for supraumbilical
hernias.
Previous infraumbilical intraperitoneal surgery offered no inconvinience for per-
forming laparoscopic cholecystectomy, even in patients with several operations. No
morbidity was due to the Veres needle or.trocars.
In the 25 patients with infraumbilical intraperitoneal operations laparoscopic chole-
cystectomy was performed in 22.
In 3, adhesions to the abdominal wall, liver, etc. prevented the dissection of the gall-
bladder and the patients were converted.
The Marlex mesh in 2 patients because of adhesions to abdominal organs made nece-
sary to convert them to open surgery.
Conclusion: Previous intraperitoneal infralumbilical operations was not in our
patients contraindications to laparoscopic cholecystectomy and no morbidity was
related to them.
Supraumbilical intraperitoaeal surgery is no more a contraindication for laparoscop-
ic cholecystectomy. It should be performed by open laparoscopy and carefull disec-
tion. In some patients, specially those with reoperations for peritonitis, or hemoperi-
toneum, adhesions may prevent its performance, intraperitoneal Marlex meshes,
because of the adhesions they provoque may be a contraindication for laparoscopic
cholecystectomy.F209 F210
ROLE OFEXTENDEDLYMPH NODE DISSECTION FOR ADVANCED
GALLBLADDER CANCER
I, Endo, S. Togo, A. Nakano, H. Sekido, K. Gob, A. Takimoto, T.
Takahashi,, H. Shimada
Second Dept. of Surgery, Yokohama City Univ. School of Med. Yokohama,
Japan
The ,’tim of this study is to elucidate the role of extended lymph node
dissection for advanced gallbladder cancer. Forty-one consecutive patients
with advanced gallbladder cancer(tumor extended more than subserosal
layer) were underwent extended lymph node dissection combined with
hepatectomy and resection of bile duct. The range of lymph node dissection
covered N1, N2 of UICC and para-aortic region. Lymph node metastasis
found in 28 out of 41 patients(%). Metastatic rate of each regional lymph
node were 29%(cystic node), 45.2%(pericholedochal node), 45.2%
(posterosuperior pancreaticoduodenal node), 25.8%(retroportal node), 19.4%
(around the common hepatic artery). 8 out of 28 patients underwent para-
aortic lymph node dissection. Jumping metastasis(means N1 negative and N2
positive) was observed in 2 cases. Cumulative survival rates of patients
underwent curative resection were significantly higher than non-curative
cases. Overall survival rates at 1, 3 and 5 years were 87.1, 62.4 and 32.8%
respectively. There was statistical significant defferrence between the
survival rates of patients without metastasis and with N2 metastasis. There
which recurred in para-aortic reNgn in N1 positive patients. On
the other hand 7 out of 11 patients with N2 and para-aortic nodes metastasis
recurred in para-aortic region. Recurrence sites were out of the whitch
dissected previously such as retrocaval area and hilus of left kidney. Six out
of 11 patients with N2 and para-aortic nodes metastases survived than 2
years. We conclude that extended lymph node dissection is benefitial for
precise estimation of tumor extention and prolonged survival periods.
MR Cholanglopancreatography (MRCP)
In Failed or Incomplete ERCP
Joseph T. Ferrucci, m.D.
Department of Radiology
Boston University Medical Center
Boston, MA 02118
Purpose: To assess the value of MR cholangiopancreatography
(MRCP) in patients in whom ERCP fails to cannulate the biliary or
pancreatic ducts or does not provide complete delineation of ductal
abnormalities.
Methods: MRCP using a respiratory-triggered multi-slab three-
dimensional fast spin echo sequence was performed in 37 consecutive
patients referred during an 18 month period because of an
unsuccessful ERCP (n=20), presence of post-surgical biliary-entedc
anatomy (n=10) or evidence of complete pancreatic duct obstruction on
ERCP (n=7). MR examinations were acquired in the coronal plane on
a 1.5T system (Philips ACS Gyroscan II) using the following
parameters: TR 2500-5000 msec, TE 240 mSec, field of view 240 mm,
or 2 signal averages, matrix 186 x 256, echo train length 31, slice
thickness 2 mm. Eight or 10 slabs were obtained as part of the multi-
slab acquisition with 5 or 6 slices per slab (total slices 40 to 50).
Subsequent course and impact on clinical management was
determined.
Results: Satisfactory MRCP studies were obtained in 100% of patients.
Findings on MRCP were: normal biliary and pancreatic ducts (n=l 1),
bile duct dilatation without stones (n=12), changes consistent with
chronic pancreatitis (n=13), choledocholithiasis (n=4), pancreatic tumor
(n=2), isolated pancreatic duct stricture (n=l) and biliary stricture (n=l).
Multiple findings were present in 7 patients. Based on MRCP results,
patients subsequently underwent laparotomy (n=l 1), therapeutic ERCP
with precut papillotomy (n=3), therapeutic PTC (n=2), diagnostic PTC
(n=l) or ultrasound-guided biopsy (n=l). The 11 patients with normal
findings on MRCP required no intervention. The remaining 8 patients
had abnormalities detected on MRCP but were followed clinically.
Conclusion: MRCP plays an important role in the management of
patients when ERCP is unsuccessful or incomplete and in patients in
whom technical difficulties can be anticipated. Failed ERCP represents
one of the main clinical indications for performing MRCP.
F211 F212
GDER MOTILITY ANDGNE FORMATION DURING RAPID WEIGHT LOSS
INDUCED BY VERY LOW CALORIE DIETS: A PRESENT CONFIRMATION OFAN OLD CLINICAL
OBSERVATION.
D. Fti., M. Orsini*, A. Colecchia*, S. Sottili*, A. Sangermano*, G. Mazzella *, N.
Villanova*, ML. Petroni **, S. Pavesi **, E. Roda *.
Istituto di Fisiopatologia Medica, Universita’ G. D’Annunzio Chieti; Cattedra di
Gastroenterologia, Universita’ di Bologna; lstituto Scientifico Ospedale S. Giuseppe,
Centro Auxologico ltaliano, Piancavallo, Verbania; Italy.
Very low calorie diets (VLCD’s) have increasingly been used in the treatment of morbid
obesity; however, an increased risk of gallstone formation has been reported during rapid
weight loss. Impaired gallbladder motility is considered important pathogenetic factor
for gallstone development. Since diet composition modulates gallbladder contraction and
most VLCD’s are characterized by low fat content, this study aimed at evaluating
whether V1LT)’s with low and higher fat content might influence gallbladder motility and
consequence modify the risk of gallstone formation during weight loss. Sixteen obese
gallstone-free subjects (4 males, 12 females, age: 35.5+/-2.8 yrs, BMI: 41.3+/-1.4 kg/m2,
mean+/-SE) were studied. Gallbladder motility was evaluated by ultrasonographic technique
(US), three different days, in response to liquid test meal (375 kcal, 12 g fats) and to
two differentVLCs administred follow: dietA (515 kcal with g fats; breakfast 123
kcal, 1.6 g fats; lunch: 242 kcal, 1.1 g fats; dinner: 150 keal, 0.3 g fats); diet B (565 kcal
with 12.4 g fats; breakfast: 123 kcal, 1.6 g fats; lunch: 267 kcal, 5.8 g fats; dinner: 175 kcal,
g fats). DietA was administred to subjects for 45 days and diet B to the remaining 8
subjects, always for 45 days. At the end of the diet period, the appearance of gallstones
investigated by US and gallbladder motility study repeated at baseline. In the statistical
analysis Mann-Whitney test (independent samples) and Wilcoxon test (paired samples)
were used to comvare data. Results reported in the followintg table:
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In both groups, BMI significantly decreased atter VLCD’s. Three out of the 8 subjects
(37.5%) who followed diet A, but with diet B, developed asymptomatic gallstones.
DietA induced significantly lower gallbladder emptying in respect to diet B both before
and after the diet period. These results confirm the role of diet characteristics in influencing
gallbladder motility and suggest that higher fat content of VLCD could prevent gallstone
formation during weight loss.
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RESULTS OF 210 CONSECUTIVE LAPAROSCOPIC BILE
DUCT EXPLORATIONS
GA Fielding, NA O’Rourke, IS Bailey, M Rhodes, LK
Nathanson.
Royal Brisbane Hospital and Wesley Hospital, Brisbane,
Australia.
Experience with laparoscopic bile duct exploration is
slowly increasing. We report the results of 210
consecutive laparoscopic bile duct explorations
performed since August 1991. Utilising a variety of
techniques 185/210 (88%). patients bile duct was
cleared laparoscopically. Eleven patients were converted
to an open procedure, 14 had stones cleared by post-
operative ERCP and 7 had normal ERCP for post-
operative pain. One hundred and thirty-two patients had
transcystic exploration and 79 patients had
choledochotomy. One patient died during the post-
operative period. Eight of 46 (15%) of laparoscopic
choledochotomies closed with T tubes had T tube related
morbidity. One patient has had a bile duct stricture post-
operatively requiring reconstruction. Laparoscopic bile
duct exploration is technically satisfactory and
successful in 88% of patients with 0.5% mortality.and
relatively little morbidity.F213 F214
MOLECULAR BIOLOGICAL EXAMINATION IN
PANCREATICOBILIARY MALJLrNCTION
Funabiki. T-, Matsubara, T., Sasayama, Y., Hori, H., Hasegawa, S., Kamei,
K., Sakurai, Y., Marugami, Y., Oehiai, M.
Department of Surgery, Fujita Health University School of Medicine, Toyoake
Aiehi 470-11, JAPAN
Pancreaticobiliary maljunction (PBM) that was initially reported as a disease
accompanied by choledoehal dilatation has recently drawn an attention because
it appears to be frequently associated with biliary carcinoma. However, there are
little studies of carcinogenesis in PBM using molecular biological w,chniqucs.
In order to obtain an insight into the molecular biological aspect of the
carcinogenesis in PBM, wc investigated point mutation of K-raJ oncogenc and
the expression ofp53 protein in cancerous and noncancerous b’fliary epithelia of
patients with PBM.
MATERIALS AND METHODS: Twenty cases of patients with PBM (5 cases
associated with b’fliary carcinoma and 15 cases not associawA with carcinoma)
as well as 18 cases with gallbladder carcinoma without PBM and 7 cases with
slight c.holecystitis withoutPBM as control were examined. Point mutations of
K-ras oncogenc were examine.d in cancerous tissues and noncancerous bfliary
epithelium, hyperplasia, metaplasia, and inflammation, that were separately
scraped out from formalin-fixed paraffin-embedded histological sections, p53
protein in these tissues wcrc immunohistochemically stained using anti-p53
monocloclonal antibody.
RESULTS: Incidences of K-ras point mutation were 80% in b’fliary carcinoma
with PBM, 58% in hylxlasia/memplasia and 38% in inflammation in PBM,
while 53% in carcinoma without PBM and 0% in control gallbladder
epithelium. Positive rates of p53 protein were 100% in carcinoma with PBM,
18% in non-cacerous epithelium with PBM. while 92% in carcinoma without
PBM and 0% in control.
CONCLUSION: Biliary epithelium in cases with PBM may be in precancerous
state, which should bc considered for the treauncnt ofPBM.
LAPAROSCOPIC HEPATICOGASTROSTOMY FOR MALIGNANT
BILIARY OBSTRUCTION. M. Gaflner, MD, G. Soulez, MD, E.
Thdrasse, MD, E. Deslandres, MD, A. Pomp, MD. The
Cleveland Clinic Foundation, Cleveland, Ohio and HoteI-Dieu de
Montreal, Montreal, Quebec.
The purpose of this study was to evaluate the potential role
and benefit of laparoscopic biliar decompression in patients
with malignant biliary obstruction.
Since 1/92, 19 patients (14 F, 5 M) with a mean age of 65
(range 43-91), underwent laparoscopic hepaticogastr0stomy.
After transhepatic catheterization of a segment II or III bile duct,
the left lobe of the liver and the lesser curvature of. the stomach
were perforated under fluoroscopic and laparoscopic guidance
using three trocars. Anastomosis between the biliary tree and
the stomach was maintained with a gastrostomy tube placed
across the tract. After 2 weeks, the tube was removed and
patency of the tract was preserved with a metallic stent.
Two-thirds of the patients had a hilar level of obstruction, and
65% of patients had an unresectable cholangiocarcinoma or
pancreatic adenocarcinoma during laparoscopic staging. One-
fourth of patients palliated also had biliary obstruction due to
metastatic, colon adenocarcinoma, or gastric adenocarcinoma.
The total bilirubin fell from 271 to 32 (p<0.001) in less than
four weeks. The mean hospital stay was 17 days. After a
follow-up period of 47 months, the mean survival was 7-months
with 35% of patients surviving more than 12 months. Two
patients died of septicemia and pneumonia in the hospital. Early
complications were cholangitis (3), subcapsular hematoma (2),
and gastric outlet obstruction (1). No reintervention or
endoscopic procedures had to be performed. The recurrence of
jaundice was only seen in two patients due to liver failure.
A high level of malignant biliary obstruction can be palliated
effectively with the laparoscopic method with a relatively low
morbidity and mortality rate in this selected group of patients.
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CHANGES OF PMN-ELASTASE AND C-REAKTIVE PROTEIN FOLLOWING
TRADITIONALAND LAPAROSCOPIC CHOLECYSTECTOMY
L. Luntos*, E. R6th*
Dept. of Surgery, Bugfit P61 Hosp. GyOngyOs, Dept. of Experimental Surgery,Univ.
Med. School ofP6es* Hungary
The magnitude of metabolic response to injury has been shown to be proportional to
the degree of magical trauma. For this reason many investigatior have henceforth tried
to find ways of reducing the metabolic response to surgery. Laparoscopic surgery is a
minimal invasive procedure becoming the operation ofchoice in many field of surgery.
In this study of patients undergoing open cholecystectomy (OC) and laparoscopic
cholecystectomy (LC) we aimed to determine, whether or not there are any indications
of postoperative inflammatory reaction by measuring serum concentration of C-
reaktive protein (CRP) and polymorphonuclear leukocytes (PMN) elastase as the
most sensitive biochemical markers of the granulocyta stimulation. An unselected
number of patients (pts) were investigated and divided into two groups. Group I.
contained 15 pts operated by OC; Group II. involved 15 pts with LC. The indication
for surgery was chronic cholecystitis in all cases. Anaesthetic and operative procedures
were standardised in both groups. Venous blood samples were taken hours before
surgical intervention and every day for 4 days following the operation. CRP level was
measured by immonological assay (CRP-latex a88utination slide test), the PMN-
elastase vas measured by heterogeneous enzyme immunoassay (Reagent kit,
MERCK) to specific determine its complex formatione with cl-proteinase
inhibitor.The postoperative CRP concentration rose markedly following OC, and
reached peak of 84,1+!4,32 ng/ml on the second day. This elevation was hishly
significant (p<0,001), while in the LC group only a moderate increase to 52,7+17,70
ng/l was shown, which was not statistically significant. The level ofCRP in the OC
group remained higher during the whole observation period, while in the LC group it
decreased to the starting value 19+4,93 n8/l by the 4th day. Our results owed
significant PMN-elastase elevation in both groups on the fn-st postoperative day
(135,1:L-9,1 n8/l, p<0,001; 150,5:E24,8 ng/l p<0,05 respectively), ttowever there was
marked difference between the two groups by the 3rd postoperative day. While the
value of PMN-elastase in the LC group decreased considerably (! 16,5:E20,9 ng/l) it
maintained a high level in OC group (164,6+18,9 ng/l; p<0,01). Following the 4th
postoperative day we still found an elevated enzyme level in the OC group (! 52,8-9,3
ng/lg p<0,0 ), while in the LC group a continuous fall towards the baseline value was
noted (87,2+!0,5 ng/l).These results provide us with biochemical evidence supporting
the clinical observation that LC is far less traumatic to the patients than OC.
EXPERIENCE OF THE 100 OPERATIONS WITHOUT
STENTING FORBENIGN (BISMUTH
3-5 TYPE) HEPATIC DUCT STRICTURE
E.Galperin, N.Kuzovlev, A.Chevokin
Department ofHepatic Surgery, Moscow Medical
Academy,Russia.
100 surgical repairs without stenting were performed for benign
bile duct strictures (Bismuth 3-5 types) from 1987 through 1994.
There were 78 women and 22 men with ages ranging from 23 to
69 years. The most common cause ofthe stricture (85,7% ofthe
patients) was the iatrogenic trauma during cholecystectomy or
-resection ofthe stomach. Manycfour patients had undergone
previously 3, 4 and 5 operations on the bile ducts, and suffered
from long-term jaundice and cholangitis (69% ofthe patients). 25
patients had the stricture below the bifurcation ofthe hepatic duct(
less then cm), 49 patients had the stricture ofthe confluence, 19
patients had biductal stricture, and 7 patients had monoductal
stricture. Performing high mucosa-to-mucosa biliary enteral
anastomosis, we tried to free the hepatic ducts above the stricture.
In our report we shall present some van’ation ofthe "platform of
the duct branches" for biliary enteral anastomosis. No fatal
outcome was noted and the 17 complications were: subphrenic
abscess case, temporary biliary fistulae 6 cases,
intraabdominal bleeding 3 cases, gastrointestinal.bleeding 6
cases, intestinal liens case. Two patients had been. operated
over the long-term follow-up period from 6 months to 9 years):
recurrent stricture case, intrahepatic cholangiolitias -1 case.
Our experience shows, that in benign biliary (type 3 5) stricture
thorough dissection of the bile ducts above the stricture permits
precise anastomosis to be constructed without stenting.
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BILIARY TRACT INJURY (BTI)
LAPAROSCOPIC CHOLECYSTECTOMY
RESULTS OF A NATIONAL SURVEY.
DURING
(LC)
J.F. Gigot and the Belgian Group for Endoscopic Surgery
(BGES)
Department of Digestive Surgery, Louvain Medical School
A retrospective anonymous survey was conducted in
Belgium in a multicentric group of general surgeons about
9959 LC. The incidence of BTI was 0.5 %. The
prevalence is 1.3 % below 50 cases of experience
compared to 0.35 % (p < 0.0001) over 50 cases of
experience. 36% of these BTI have been performed by a
surgeon with more than 100 cases of experience.
Predisposing local risk factors were present in 61%.
Severe BTI occured in 42 %. Intraoperative detection of
BTI occured in 44 %, mainly related to the performance of
intraoperative cholangiography. In patients with biliary
peritonitis, the overall mortality and late biliary stenosis
were 19 % and 38 % respectively, compared to 4 % and
12 % in patients with intraoperative detection of BTI.
Hospital mortality was related to the occurrence .of biliary
peritonitis, while late biliary stenosis was related to the
occurrence of postoperative biliary complications after
initial biliary repair.
In conclusion, mortality and morbidity of BTI during LC are
high. Intraoperative detection mainly with the use of IOC
is an essential factor to improve outcome.
MODIFIED MINI-CHOLECYSTECTOMY: A MINIMALLY
INVASIVE PROCEDURE, EXPERIENCE WITH 250
CONSECUTIVE CASES
I. Hamdi, A. Khamag, J.Faitori
Department of Surgery, Arab Medical Universi.ty, Benghazi, Libya
Minimally invasive surgery is being increasingly employed and extended to
various procedures, it reduces hospital stay and shorten recovery interval,
with excellent cosmetic results. Short incisions tend to be associated with
less post-operative pain. Tissue destruction is minimised and the risk of
wound complications is probably diminished result.
We report the results ofmodified mini-cholecystectomy 250 patients (212
xvomen, 38 men). The age ofthe patients 39 years (range 16-72
years), while the weight 80.2 kg (range 61-135 kg). Eighty
percent of patients were overweight (5-98% in of standard chart based
height and weight). The incisions used to 4 long, and the
procedure carried out employing selected laparoscopic instruments.
Forty-two patients had mucocele and 17 had empymatous gall bladders. The
incision had to be extended in 22 patients due to obscured anatomy (10
patients) tbr unanticipated exploration ofthe common duct (12 patients).
Nasogastric tubes not employed, peritoneal drainage instituted for
with infected gall bladder. All patients allowed oral intake after
hours fi’om operation. The period of hospital stay 1.9 days
(range 1-5 days). The operative time ranged lbr 20-82 minutes, generally
tending to get shorter towards the end of the study period, presumably
reflection of the learning-curve effect. No major postoperativecomplications
encountered in any of patients during the tbllow-up period (3-31
months.
We conclude that modified mini-cholecystectomy is simple and safe
procedure. In estimate the operation is applicable to 95% of




H. Hara.K. Okajima,H. Isozaki,S. Morita,T. Ishibashi,S. Sako, K. Fujii
Department of Surgery,Osaka Medica College,JAPAN
Purpose: The present study designed to review the clinicopathological
items of pancreaticobiliary maljunction in adults and children. Patients and
methods In sixty four patients (42 patients of adults, 22 patients of children),
who surgically treated during the past 16 years in the department of surgery,
Osaka Medical College, the following items reviewed: 1) morphological
classification, 2) operative method, 3) postoperative complications, 4) cell
kinetics (proliferating cell nuclear antigen (PCNA) of the epithelium of bile duct
and gallbladder). Results: [Morphological classification TOTANI’s
Classification) of congenital biliary dilatation] Type Ia found in patients,
type Ib in one, type Ic in 10, type IV-A in 18, type IV-B in one, and dilatation
in 7 of 42 adult patients and type Ia in 5, type Ic in 11, and type IV-A in 6 in 22
children.Cancer observed in 9 patients in adults (6 patients of gallbladder
cancer, patients of bile duct cancer) .Operative method: In the cancer-free
adults, biliary reconstruction after resection of extrahepatic bile duct
performed by 1)choledochoduodenostomy in 8, 2) Roux-en-Y’s fashion in 16, 3)
jejunal interposition in 8, and 4) panceraticoduodenectomy in 1. In children,
choledochoduodenostomy performed in 17, Roux-en-Y’s fashion in 3, jejunal
interposition in 2. In patients with gallbladder cancer, 2 patients underwent
cholecystectomy with lymph node dissection (LN), patients underwent
cholecystectomy with LN with partial hepatectomy, and the other
nonresectable. In patients with bile duct cancer, underwent
pancreaticoduodenectomy with portal vein resection and LN, underwent
extrahepatic bile duct resection with LN, one nonresectable. Five of 6
patients with gallbladder alive, but all the three patients with bile duct
have already died. Postoperative complications: Postoperative
cholangitis observed in 7 patients (6 patients in adults, patient in child).
In 6 adult patients with postoperative cholangitis, 4 patients were mildly ill, but,
2 severely ill, requiring surgical treatment with jejunal interposition.one
child patient with postoperative cholangitis mildly ill without surgical
treatment. Cell kinetics (PCNA of the epithelium of bile duct and gallbladder)
Labelling index of PCNA higher in adults than in children. Conclusion:
The incidence rate of carcinogenesis and postoperative cholangitis were higher in
adults than in children. 2) The earlier detection and treatment of
pancreaticobiliary maljunction should be desirable, especially in childhood.
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EFFECTIVENESS OF BILE CYTOLOGY IN THE DIAGNOSIS
OF GALLBLADDER CARCINOMA
LA Hidalgo_, JM Badia, R Muns*, C Admella*, J Feliu, A Bianchi,
JM Gubem.
Department of Surgery and Department of Pathology*.
Consorci Sanitari de Matar6. Matar6, Barcelona, Spain.
Non-advanced gallbladder carcinoma (GC) usually remains
unsuspected at operation and diagnosis is made postoperatively by the
pathologist. However, the entire organ is not included for pathological
examination in a macroseopically normal gallbladder.
Aim: To. analyze the value of bile cytology in the diagnosis of
gallbladder carcinoma.
Methods: Bile samples obtained intraoperatively by fine needle
aspiration (FNA) from 311 patients were studied (99 men, 215
women; mean age 65 years, range 27-95). All the patients were
operated either by laparotomic or laparoscopic approach for
gallbladder disease (mainly cholelithiasis). Ultrasonography was
suspicious of GC in 4 patients. Sample A was obtained through
aspiration of 5 mL of gallbladder bile. Sample B was obtained after
infusion of 5 mL of physiologic saline in the gallbladder lumen and
subsequent aspiration. Early cytologic diagnosis was done
intraoperatively (Dif-quiek stain), but definitive diagnosis was delayed
until a Papanieolau technique was performed. Routine pathologic
examination of the gallbladder was carried out by the pathologist
without previous knowledge of the cytologic result.
Results: Cytologic examination was positive for malignant cells (GC)
in 11 patients. The 4 cases of preoperative suspicion of carcinoma
were- confirmed., There was a false positLve in- a case- of chronic
reactive dysplasia. The remaining 6 cases of GC were deemed chronic
or acute cholecystitis by surgeons at operation. No differences were
observed between bile samples A and B, neither between Dif-quik and
Papanicolau methods. Pathologists were unable to identify 2 cases of
GC in situ in the first microscopic examination. The diagnosis was
made in a second evaluation after the cytologic results were disclosed.
Conclusions: 1) Intraoperative bile cytology obtained by FNA of the
gallbladder allows an early diagnosis of GC; 2) Routine pathologic
examination of the gallbladder can miss,a small number of GC cases
that can be diagnosed by bile cytology; and 3) lntraoperative bile
cytology is indicated when macroscopic appearance of the
gallbladder suggests GC.F221 F222
EXTERNAL AND INTRA-LUMINAL RADIATION
TI-RAPY (ILRT) FOR PROXIMAL BILE DUCT
CARCINOMA- LONG TERM RESULT
YY Jan, MF Chen, WM Leung*
Department of Surgery, Department ofRadiation Therapy*,
Chang Gung Memorial Hospital, Taipei, Taiwan
Between January 1985 and June 1995, 16 patients with hilar
cholangiocarcinoma were treated by external or/with intraluminal
radiation therapy (ILRT). The mode of radiation therapy were:
external radiation only in 6 patients, external + ILRT in 9
patients and another one ILRT only. The clinical status of 16
patients with hilar carcinoma are: unresectable or unsuitable
resection in 9 patients, post-resection residual tumor in 3 and
pos,toperative recurrent cancer in another 4. Radiation effects
were assessed on the basis of clinical respone, cholangiographic
change, choledochoscopic finding and survival times.
Clinical response after radiation are: subsided ofmucinous
substance from bile duct in 3 patients, general condition
deteriorated in two patients and other eleven patients with
stationary condition after radiation. Post-treatment.
cholangiogram revealed patency of bile duct, decrease size or
diminished the filling defect ofbile duct in six patients (37.5%).
Post-treatment choledochoscopic finding revealed nodular or
papillary tumor necrosis with decreased tumor size in six patients
(6/13;. 46.1%), tumor necrosis only in 4 patients and dutal
fibrosis in another 3. The survival times of 16 patients with
hilar carcinoma after complete radiative therapy are ranged from
3 to 112 months (mean 29.8M, median 15.5 M) with l-y, 3-y
and 5-y survival rates are 56.2%, 37.5% and 25% respectively.
TRANSFERRIN,IRONAND CHOLESTEROL GALLSTONE
PATHOGENESIS.
S.M, Johnston, M.K. Fox-Talbot, S.A. Martin, P.A.Lipsett, K.D.Lillemoe,
H.A.Pitt. Department of Surgery, The Johns Hopkins Medical Institutions.
Baltimore ,MD.
Transferrin is anonmucin glycoprotein which binds and transfers iron.
We have recently reported that the 84kDa nonmucin glycoprotein which is a
potent nucleator ofcholesterol crystals, is biliary transferrin (Hepatology 1995;
16:110A ). However, no data are available on the levels oftransferrin or iron in
patients with or without cholesterol gallstones. Therefore, we tested the
hypothesis that biliary transferrin and iron levels are elevated in patients with
cholesterol gallstones. Gallbladder bile was collected from 13 control patients
without gallstones and 23 patients undergoing cholecystectomy for
symptomatic, multiple, cholesterol gallstones. Control and gallstone patients
were similar with respect to age, gender and race. Neither the controls nor the
patients had acute cholecysfitis or abnormal liver function tests. Biliary
transferrin (Tf) levels were measured by a serial radial immune diffusion assay.
Total protein (TP) was measured by a Peterson Lowery assay. Biliary total iron
and unbound iron binding capacity levels were measured by a
spectrophotometric assay modified to prevent interference by bilirubin. Percent
iron saturation (SAT) was calculated from these measurements. Results were:
Tf Tf/ TP Total Iron SAT
N ,g/ml % /g/dl
CONTROL 13 1104.39 1.64-0.6 1714-64 384-7
CHOLESTEROL 23 293+44* 6.2+1.7* 3904.107’ 70-:8*
*p<0.01, tp<0.02 ,*p<0.05 vs Control
These data suggest that patients with multiple cholesterol gallstones
have significant increases in gallbladder bile transferrin, percent transferfin, total
iron ,and percent iron saturation. We conclude that an alteration in iron
metabolism may be linked to the pathogenesis ofmultiple cholesterol gallstones.
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BILIO-BILIARY FISTULA AND CONFLUENCE STONE WITH OR
WITHOUT CARCINOMA
.J.. Kamiya, Y. Nimura, N. Hayakawa, S. Kondo, M. Nagino, M. Kanai,
M. Miyachi
The First Department of Surgery, Nagoya University School of Medicine,
Nagoya, Japan
Stones in the gallbladder with inflammation or carcinoma make bilio-biliary
fistula (BBF) or confluence stone (CS) in some cases. Although the
differentiation of malignant and benign lesions in the gallbladder is important for
a rational treatment, it is not easy to achieve a definite diagnosis due to
interference of the stone in or around the fistula.
In our clinic, percutaneous transhepatic biliary drainage (PTBD) has been
performed for patients with obstructive jaundice routinely since 1975 in order t6
obtain high quality cholangiograms for diagnostic purposes and to relieve
jaundice. Furthermore, since 1977, we have adopted percutaneous transhepatic
cholangioscopy (PTCS) to obtain a more accurate preoperative diagnosis. In
the following, we review our experiences with BBF and CS.
1. BBF and CS in patients with gallbladder carcinoma
One hundred patients with gallbladder carcinoma underwent PTBD, 49 of them
did PTCS. Five had BBF, one CS. Five of six cases had gallstones.
Preoperative diagnosis of BBF or CS was achieved in all cases and
cholangioscopic biopsy from the gallbladder through the fistula verified
carcinoma in four cases. Carcinoma was highly suspected by the imaging
diagnosis in the other two cases, though large stones made it impossible to take
biopsy of the gallbladder. All cases underwent curative resection.
2. BBF without carcinoma
Seven patients with benign stenosis at the proximal bile duct underwent PTCS
(excluding patients with primary sclerosing cholangitis). All had stones in the
gallbladder. Three had BBF, two of which were revealed by PTCS. The
cholangioscopic biopsy of the gallbladder through the fistula was useful in these
two cases.
3. CS without carcinoma
One hundred and forty-eight patients with bile duct stone underwent PTCS.
Ten cases (6.7%) were CS. Cholangioscopic lithotomy were successful in all
patients. After lithotomy cholangioscopic biopsy of the gallbladder showed no
carcinoma in any case. Cholecystectomy was not indicated in nine cases
because the gallbladder shdnked remarkably after PTCS.
In conclusion, it is recommended that PTCS should be used for definitive
diagnosis and non-surgical treatment ofBBF and CS.
CHANGES IN THELEVELS OF BILE ENDOTOXINAND CYTOKINESAFTER
BILIARY DRAINAGE.FOR ACUTE CHOLANGITIS
A, KANAZAWA, H. KINOSHITA, K. HIROHASHI, S. KUBO,
T. TSUKAMOTO, T. SHUTO
Second Department of Surgery, Osaka City University
Medical School, Osaka, Japan
To assess the effects of bile endotoxin on the
pathophysiologyof acute cholangitis (AC), we investigated
changes in the levels of bile endotoxin and serum cytokines
after biliary drainage for obstructive jaundice with or
without AC. Patients who underwent percutaneous
transhepatic cholangiodrainage (PTCD) for obstructive
jaundice were classified as those with AC (group A; n
5); those with a history of AC (group B; n 4); and those
without a history of.AC (group C; n i0). The
concentrations of bile and serum endotoxin, the serum
inflammatory cytokines interleukin 6 (IL-6), and IL-8,
and IL-I receptor antagonist (IL-Ira) were measured
before PTCD, 5 h after, and i, 3, 5, 7, 10, and 14 days
after. Endotoxin was assayed by the Endospecy method.
The levels of IL-6, IL-8, and IL-ira were measured with
kits for enzyme-linked immunosorbent assays. Results
for serum endotoxin were positive (at above the cut-off
value of pg/ml) in patients in group A, one patient
in group B, and 2 patients in group C. The median
concentration of bile endotoxin was higher in groups A and
B than in group C. Serum endotoxin levels, if high,
decreased to below the cut-off value after PTCD. Bile
endotoxin levels in group C, if high, had decreased by
5 hours. This concentration ingroup A, if high, decreased
slowly or stayed high after PTCD. In patients with poor
drainage, bile endotoxin decreased only transiently.
Intestinal flora including Escherichia coli and
Enterococcus were isolated from the bile in all patiehts
in groups A and B. The median serum levels of IL-6 and
IL-8 before PTCD were higher in group A than groups B and
C. These levels in group A increased after PTCD, peaking
before 1 day, and then decreased. The serum levels of
IL-6 were significantly correlated to the concentration
of bile endotoxin at 5 hours. The median serumlevels of
IL-ira before PTCD were higher in group A than in groups
B or C. Increases in bile endotoxin and serum cytokines
may be important in the pathophysiologyof AC. Biliary
drainage eventually decreases the concentrations of these
substances.
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THE EFFECT OF COMMON BILE DUCT OBSTRUCTION ON BACTERIAL
TRANSLOCATION FROM BILIARY TRACT TO BLOODSTREAM AND
LYMPHATIC SYSTEM
T.M.Karsten T.v.Gulik, L.Spanjaard, A.Bosma, P.Dankert, D.Gouma
Depts. of Surgery and Bacteriology, AMC, Amsterdam, The Netherlands.
Background: Prolonged biliary obstruction results in bile duct
proliferation and disruption of the hepatocyte tight-junction at the level
of the bile canaliculi. Aim: To evaluate the respective roles of biliary
obstruction and intrabiliary pressure in passage of bacteria from the
biliary tract to the bloodstream and lymphatic system.
M&M: 37 male Wistar rats underwent distal common bile duct (= CBD)
ligation or a sham operation. After 2 weeks a laparotomy was performed
and the CBD, the caval vein and the thoracic duct were canulated. Next,
a broth containing 108 bacteria/ml of a specific pathogenous E.coli strain
was retrogradely infused in the CBD at 5 or 20 cm H20 above baseline
biliary pressure. After 5 minutes perfusion, blood and lymph samples
were collected for quantitative culture analysis. Subsequently the liver
was fixed for light microscopy. The infused E.coli could be visualized in
the liver sections by immunohistological staining with specific
monoclonal antibodies. Results: A higher biliary infusion pressure
resulted in more colony forming units E.coli per ml blood in both the
sham operated rats (5 cm H20, n 10, mean 1.99 x104 vs 20 cm H20,
n 9, mean 11400 xl 04 ;p 0.0015, MannWhitney(MW)) and the bile
duct ligated rats (5 cm HO, n=9, mean 3.5 xl05 vs 20 cm HO,
n=9, mean 330 105; p=0.034, MW). Bile duct obstructed rats
showed, at infusion pressures of 5 cm HO, more bacterial reflux to the
bloodstream as compared to the sham operated rats (n 10, mean 1.99
104 vs n =9, mean 35 x104 ;p=0.0092, MW). However, at 20 cm
HO infusion pressure, there was no significant difference between the
two groups (n 9, mean 1.14 108 vs n 9, mean 33.2 108 ;p 0.7,
MW). At 20 cm H20 infusion pressure, 2 of 9 lymph cultures were
positive in the sham operated group and of 9 in the CBD ligated
group. None of the lymph cultures showed growth at 5 cm H20 infusion
pressure in both groups.
Conclusion: This study confirms the increase of translocation of bacteria
from biliary tract to bloodstream with higher intrabiliary pressures.
Increased translocation, however, is also present at low intrabiliary
pressures after a period of biliary obstruction. Bacterial migration to the
lymphatic system is of no major significance in the early phase of
bacterial infusion in the biliary tract.
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RESULTS OF PROSPECTIVE STUDY OF AGGRESSIVE SURGERY FOR ADVANCED
CARCINOMA OF THE GALLBLADDER
S Kaw.amoto, T. Hiraoka, Y. Kamimoto, K. Kanemitsu, K. Tabaru
and *S. Tashiro
1st Dept of Surgery, Kumamoto University, Kumamoto, Japan
*1st Dept of Surgery, Tokushima University, Tokushima, Japan
We have adopted the radical resection for the patients with
gallbladder carcinoma according to strategy, corresponded to
modes of spread of the carcinoma since 1985. We present results
of prospective study.
A total of 101 patients who underwent the resection from 1965
to 1995 divided into non-protocol group (A) (n=60) and
protocol group (B) (n-41). The age of the patients 61
years-old in both group. In group B, intraoperatlvE.
ultrasonography adopted for the diagnosis of the tumor spreid
in depth of the wall and the invasion into the liver according
to TNM system. In the protocol, wedge resection of the li.er
with reglonal lymphadenectomy for Tlb, wedge resection and
duct resection with regional and paraaortic lymphadenectomy for
T2 adopted. A segmentectomy of the liver including $5 and
S4b added to the with the direct invasion into the
within 20mm. A pancreatoduodenectomy (PD) performed the
with regional nodal involvement diagnosed by the froze]
biopsy. In overall, 30 of segmentectomy, 6 of extended right
lobectomy and 23 of PD performed. Tumor follow, in
group A and B; pTla, and 1; pTlb, 3 and 2; pT2, 14 and 10; T3,
23 and 12; pT4, 14 and 16.
In pT2 patients, 10 of group A died from recurrence (8 local
and 2 distant hepatic metastases), whereas only
died form distant hepatic metastases in 14 of group @. Th 5-
year survival rate of pT2 tumr 21% in group A, and 88% in
group B (P=0.006). In pT3 tumor, the 3 and 5-year survival rates
23% and 15% in group A, and 38% and 28% in group B,
respectively. Six of 8 patients with recurrence in group B died
from the blood-borne disease; distant hepatic (4) and lung (2)
metastases without any recurrences at the hepatic resection
margin. In pT4 tumor, there survival than 2 years
in group B, in which three patients died in hospital and the
modes of various. In patients with the extended
lymphadenectomy for pT2 and pT3 tumor, half of patients with
involvement of nodes in the hepatoduodenal llgament had the
Involvement of distant lymph nodes, such retropancreatlc
paraaortlc nodes.
In conclusion, radical resection according to protocol
adequate for pT2 and pT3 tumor. A bile duct resection wlt,
reglonal lymphadenectomy should be indicated for the with
involvement only involvement of pericholedochal nodes. An
extended surgery includlng PD is necessary for the with
involvement of nodes in the hepatoduodenal llgament. Majority
of blood-borne in pT3 tumor imply possibility of the
adjuvant chemotherapy to improve the survival. An aggressive
surgery should not be indicated for pT4 tumor.
F228
BILIARY ENDOPROSTHESIS WITH POLYURETHANE-COVERED
METALLIC STENTS FOR MALIGNANT BILIARY STRICTURES.
Y.Kawase, H.Kawa, T.Mori, T.Suzuki, N. Igaki,
T.Yamasaki, H.Kitamura and M.Fukuda.
Department of Internal Medicine and Radiology,
Public Shiso County Hospital, Hyogo, Japan
Recent reports on implantation of metal]ic stents
for malignant biliay strictures have shown
favorable results. But the problem of stent
occlusion by tumor ingrowth has not been
completely solved. e report our experience with
polyurethane-covered metallic stents and uncovered
metallic stents for malignant biliary strictures.
PATIENTS AND METHODS:Thirty-one patients(13 males,
18 females, mean age 71) with malignant biliary
strictures have been treated by implantation of
polyu’ethane-covered metallic stents(6 Z stents,
13 tantalum Strecker stents, 2 nitinol Strecker
slents, allstent) and uncovered metallic stents
(8 Z stents, tantalum Strecker stents). Causes
of obstruction were pancreatic carcinoma(6/31,19Z)
and. biliary neoplasm(25/31,81Z). We designed
home-made polyurethane membrane for metaltic
stents. RESULTS:Stent placement was technically
successful in all patients. None of procedure
-related complication was confirmed. Thirty day
mortality was identical ior both groups(0). 25
weeks survival rates were 60 of polyurethane
-covered and uncovered metallic stents. Stent
obstruction prior to death or last follow up
occurred in 4/10(40Z) of uncovered metallic stents
with a median time to obstruction of 24 weeks and
0/11(0) of polyurethane-covered metallic stents.
The causes of obstruction of uncovered metallic
stents included tumor ingrowth, confirmed by
cholangioscopy. CONCLUSION: The polyurethane-
covered metallic stentis effective alternative to
palliation of malignant biliary strictures.
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MODE OF THE LYMPHATIC SPREAD IN
CARCINOMA OF THE GALLBLADDER
Kazuhiro Tsukada, Isao Kurosaki, Yoshio Shirai, Katsuyuki
Uchida, Tetsuya Ootani, Yasuhiro Oohashi, Katsuyoshi
Hatak.eyama.
The First Department of Surgery, Niigata University School
of Medicine, Niigata City, Japan
Purpose: To evaluate the mode of lymphatic spread of the
advanced gallbladder carcinoma and to determine standard
lymph node dissection are the purpose of this study.
Method s: The resected specimen, intraoperative findings
and prognosis in 107 patients who underwent radical
surgery were studied clinicopathologically using
modification of the pTNM stage ofAJCC. Primary tumor was
classified into threestage of pTl(N=16), pT2(N=46)and pT3-
4(N=45). Paraaortic lymph node belonged to pN2 group.
Results: The frequency of nodal involvement (0% in pT1,
48% in pT2, and 73 % in pT3-4) was significantly different
among three groups based on the stage of primary tumor.
Distribution of the lymph node metasases was more widely
in pT3-4. The paraao rtic node metastasis was recogn ized as
a 12% in patients with pT2 and a 23% in patients with pT3-4
and other clinicopathlogical findings were positive in most
patients with pT3-4 and some patients with pT2. The
patients with pN2 metastases had significantly poorer
survival (16 % of 5 year) than those with pN0 (65 %) or pN1
metastases (55 %). However, 5 patients with pN2
metastases survived more than 36 months. Conclusions:
Understanding the characteristics of the mode of lymphatic
spread is very helpful for achieving the approp date
dissection of the lymph nodes. Dissection of regional lymph
nodes including the paraaortic lymph node is recommended
for T2-4 carcinoma ofthe gallbladder.F229 F230
FIFTEEN CONSECUTIVE HEPATIC RESECTION FOR HILAR
CHOLANGIOCARCINOMA WITHOUT MORTALITY
S.W. Kim, S. Huh, K.S. Suh, Y.H. Park
Department of Surgery, Seoul National University College of
Medicine, Seoul, Korea
Without hepatic resection, curative surgery for hilar
cholangiocarcinoma is difficult due to invasion of perihilar soft
tissues and adjacent main vascular structures and extensive
metastasis to regional lymphnodes. But high postoperative
mortality and morbidity rates have been reported with such an
extensive operation, and the operator should select patient and
determine reasonable extent of resection. In this study, we analyzed
the short-term results of hepatic resection for hilar
cholangiocarcinoma and tried to establish rational preoperative
assessment to determine resectability and extent of resection. From
October 1993 to October 1995, 15 patients had undergone hepatic
resection for hilar cholangiocarcinoma. CT and cholangiography
were done as preoperative assessment of tumors. In some
patients, angiography and/or choledochoscopy were added. In 13
patients, jaundice had relieved preoperatively with percutaneous
transhepatic biliary drainage. In 4 cases of Bismuth type IIIA, 3
extended right lobectomies and rigfit lobectomy were performed
and in 8 cases of Bismuth type IIIB, left lobectomies were done. In 3
cases of-Bismuth type IV, 2 left lobectomies with portal vein
resections and left lobectomy were carried out. Among these 15
cases, 13 caudate lobectomies were combined. Early postoperative
complications developed in 7 cases including case with arterial
bleeding and case with portal vein thrombosis, which were
managed operatively. Others were controlled with conservative
managements and all the complicated cases had improved without
any sequalae. To summarize, hepatic resections were performed in 15
consecutive patients with Bismuth type III and IV hilar
cholangiocarcinomas without operative mortality. In 2 cases, proximal
resection margins were postive microscopically and in another 2
cases, disease recurred at 10 and 14 postoperative months,
respectively. In case, anastomotic site obstruction developed as a
late complication and reanastomosis was performed without evidence
of recurrence. All the patients are alive(mean follow-up of 13
months) and disease free survivors(13/15) have good quality of life.
In conclusion, lobectomy or extended lobectomy with caudate
lobectomy is safe for most hilar cholangiocarcinomas with Bismuth
type III and even Bismuth type IV in selected cases, and more
extensive surgery for advanced hilar cholangiocarcinoma should be
considered whenever resection is feasible.
THE EFFECT OF RECOMBINANT BPI2, ON THE ENDOTOXIN
INDUCED MORTALITY IN RATS WITH BILE DUCT LIGATION.
A.N.Kimmings1’2 S.J.H.van Deventer2, H.Obertop1, D.J.Gouma Department of
Surgery and Inflammation Kesearch2, Academic Medical Center, Amsterdam,
the Netherlands.
Surgery in patients with obstructivejaundice (OJ) is associated with higher
morbidity than in non-jaundiced .patients, due to increased susceptibility to
endotoxin (LPS) resulting in the inflammatory cascade. Different interventions
have been studied to reduce endotoxemia and cytokine induction and the resulting
complications. Bactericidal/permeability increasing protein (BPI) is a naturally
occurring endotoxin binding and neutralizing protein, released from the primary
granules of neutrophils. It binds endotoxin, neutralizing the activity and therefore
inhibiting cytokine production by mononuclear cells. In animal studies and in
healthy human volunteers BPI has a protective effect in experimental
endotoxemia.
The aim ofthis study is to determine ifBPI can protect against the increased
endotoxin sensitivity in rats with OJ and, by that, reduce mortality.
Male Wistar rats were used, weighing approximately 250g. A dose of 2.0 mg/kg
intraperitoneal E-coli 0111 B4 LPS was chosen, given week after Sham
operation or bile duct ligation (BDL). Three groups of rats were studied Sham,
BDL with saline, and BDL with recombinant BPI21 (recombinant 21 kD protein).
All BDL rats were clearly jaundiced, as shown by bilirubin levels (mean + SEM)
week after operation of 186 tmol/l (10), with no difference between BDL rats
without 178 (25) or with BPI intervention 193 (17) (p=0.59). Levels remained
<1 xmol/1 in Sham rats (p=0.027). Endotoxin levels, estimated by the Limuius
assay, were 3.4 pg/ml (0.5) in Shams and 3.1 pg/ml (0.5) in BDLs with or
without BPI just before LPS administration (ns). Two hours after LPS
administration levels were + 800 ng/ml (390) in Shams and BDLs with saline,
and appeared reduced in BDLs with BPI to 40 ng/ml (34) (19= 0.09). 24 hour
mortality was 1/6 in Sham rats (15%) versus 8/11 in BDL rats (75%). BPI
intervention directly after LPS administration, reduced the mortality to 1/12 BDL
rats (8%) (p=0.003).
Conclusions: Intraperitoneal recombinant BPI21 treatment in BDL rats reduced
the endotoxin induced mortality from 75% to 8%, a mortality rate comparable to
that in non-jaundiced rats. BPI could be an interesting perioperative treatment
possibility in olinical OJ.
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TREATMENT OF POLYPOID LESIONS OF THE GALLBLADDER IN
I’HE.ERA OF LAPAROSCOpIC CHOLECYSTECTOMY
K. Kubota, Y. Bandai, T. Noie, Y. Ishizaki, M. Makuuchi
Second Department of Surgery, University of Tokyo, Tokyo, Japan.
A retrospective study was carried out to define definitive criteria
for choosing the most appropriate treatment for each type of
polypoid lesion of the gallbladder (PLG). The shapes and sizes of
PLGs were evaluated using ultrasound in 82 patients who had
undergone surgery. Histologic examinations showed cholesterol
polyps in 55 patients, adenomas in 9, cancers in 16, an
inflammatory polyp in and a hyperplastic polyp in 1. The
diameters of 58% of the benign PLGs were less than 10 mm,
whereas those of 88% of the cancers were more than 10 mm; 78%
of the former were pedunculated and 56% of the latter were
sessile. 7 of 8 early-stage cancers had diameters less than 18 mm,
whereas those .of all 8 advanced cancers were greater than 18 mm.
5 of the 8 early-stage cancers were pedunculated, and 6 of the
more advanced cancers were sessile. Cholecystectomies with or
without full-thickness dissection (removal of the entire
connective tissue layers of the gallbladder bed to expose the liver
surface) were main surgical procedures used to resect benign
PLGs and early-stage cancers, whereas cholecystectomy with
partial liver resection was used for more advanced cancers.
Laparoscopic cholecystectomy was performed in the recent 42
patients, 4 ofwhom had early-stage cancers. In 17 of the 42
patients, the procedure with full-thickness dissection was
performed. 8 patients with early-stage cancer and 5 with more
advanced cancers were alive with no signs of recurrence after
respective observation periods of 1.8 to 17.5 years and 1.8 to 16.5
years. In conclusion, a PLG with a diameter of less than 18 mm is
a potential early-stage cancer and therefore can be resected by
laparoscopic cholecystectomy with full-thickness dissection.
.However, when cancer invades the subserosal layer or beyond, a
second-look operation is necessary. A PLG with a diameter of
greater than 18 mm may be an advanced cancer and should be
removed by cholecystectomy with partial liver resection or a more
extended procedure with lymph node dissection.
CYTOLOGYOF MALIGNANTBILIARYSTRICTURESIN RELATIONTO
TUMOUR TYPEAND DIFFERENTIATION
.Kurzawinski TR, Ahmed SW, Distante V, Decry A, Dooley JS, Hobbs KEF,
Davidson BR.
University Department of Surgery, Royal .Free Hospital, London, UK.
Cytology despite becoming standard method for diagnosing the malignant
nature of biliary strictures, has never been correlated with tumour type and
differentiation. The aim of the study was to compare cytology results with
tumour type and differentiation.
The study included 79 patients with biliary strictures (50 M, 29 F, median age
65yrs, range 19-85), who had both biliary cytology (92 samples taken at ERCP)
and tissue biopsy for histology. Cytology ,eported as positive or negative
for malignant cells. Tumour type and differentiation obtained by histology
of resected specimen (n 30), percutaneous intraoperative biopsy (45) or post
mortem examination (4).
23 patients had pancreatic, 29 bile duct, 20 ampullary and 6 gallbladder cancer.
In case histology of resected bile duct showed no malignant, but cytological
examination was positive for malignant cells. Cancers were graded as well (20),
moderately (27) and poorly differentiated (1 carcinoma in situ, 9 differentiation
not known).
Overall sensitivity of cytology was 55% (43/78) and positive predictive value
98 %. There was no association between positive biliary cytologyand the degree
oftumour differentiation. Sensitivity of cytology for well, moderately and poorly
differentiated tumours was 65% (13/20), 52% (14/27) and 48% (10/21)
respectively (chi square test, p>0.5). However, there was an association
between tumour type and positive cytology (p> 0.02). Sensitivity for bile duct
and ampullary cancer was 59% and 80% for pancreatic and gallbladder cancer
30% and 50%.
Sensitivity of biliary cytology depends on tumour type and is highest for
ampullary and bile duct cancer, but unexpectedly not on degree of tumour
differentiation.
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ENDOSCOPIC ULTRASONOGRAPHY AND IIILIARY LITHIASIS
IN THE ERA OF LAPAROSCOPIC CHOLECYSTECTOMY
PROGRESSOR FASHION ?
F. ,Laeaine, T. Monlariol, M-J. Boudet, C. Roy,. A. Chadier, A,Fiagerhut,
J-M. Hay and the French Associations for Surgical Research,
8 Alike des Peupliers, 92270 Bois Colombes, France.
Ifoperative eholangiography (OC) was a widely accepted and leasable
method, there would be no need for a preoperative exam to aeertain
the presence or absence of a common bile duet (CBD.) stone. In the
era of taparoseopic choleeystetomy, as this exam Is not 100 %
leasable and/or interpretable, preoperative endoscopic ultrasonograpy
(EU) has been proposed to detect CBD stones. Because of its
drawbacks (cost and need of general anesthesia), use of EU is still
controversial.The aim of this multieentrie prospective study was
determine the place of EU in patients for whom laparoscopie
eholecysteetomy is planned.
Patients operated on for eholelithiasis were selected on the basis of a
preoperative score to be at risk of having CBD stones. Preoperative
EU was performed within 10 days before the operation and compared
with OC.-Presence of CBD stones on one of these exams was
systematically confirmed (or infirmed) by operative exploration.
Two hundred and fifty patients were included in the study. EU and
OC were feasab|e in 99 % and 91% of cases, respectively. Of 225
eases available for analysis, 206 were concordant (92 %) and .19 were.
discordant (8 %). When both exams were in favor ofCBD stones, the
presence of stones was confirmed operatively in each case (n=45).
When both exams were not in favor of CBD stones, follow up.
confirmed the absence (n=161). In 12 instances, EU was in favor of
CBD stones and OC was not 10 were EU false positive for CBD
stbne diagnosis and 2 were OC false negative. In 7 instances, OC was
in favor ofCBD stones and EU was not 6 wereEU false negative for
CBD stone diagnosis and was OC false positive.
In our study t/EUs more otten feasable than OC 2/in pntients
at risk of having CBD stones, performance ofEU was very similar to
OC 3/if any, its use should decrease with the feasabitity of OC in
laparoseopic eholeeysteetomy.
RELIABILITY OF PREOPERATIVE BIOPSY IN THE DIAGNOSIS
OFAMPULLARY MALIGNANCY
B. Launois, A. Dorandeu, B. Meunier, B. Chareton, C. Stasik, G.
S.piliopoulos, J.F. Bretagne, M. Gosselin.
Department of Digestive Surgery and Transplant Unit, CHR
Pontchaillou, Rue Henri Le Guilloux, 35033 Rennes, France
The choice treatment of malignant ampulloma is
pancreaticoduodenectomy. Before engaging in such major surgery,
some clinicians prefer to have histological confirmation of malignancy.
In case of negative biopsies, surveillance, ampullectomy and
endoscopic sphincterotomy have been advocated.
Patients and methods 35 patients with adenocarcinomas of the
Ampulla of Vater confirmed by pathological analysis of the surgical
specimens (3 ampullectomies, 31 pancreaticoduodenectomies, total
pancreatectomy) underwent preoperative endoscopic biopsy. There
were 22 males and 13 females with a mean age of 62.5+/-9.5 years.
Jaundice, abdominal pain, poor general health status and
gastrointestinal bleeding were present in 19, 21, 22 and 8 patients
respectively.
Results Specimens showed protuberant and hemorrhagic papillary
tumor (n 17), a pseudovillous tumor (n 2), an enlarged papilla (n
5), a common bile duct dilatation (n 4), a common bile duct nodule
(n 4) and a papillary obstruction (n 1). Data was not available for 2
patients. 17 of 35 biopsies showed infiltrating adenocarcinoma,
biopsy having been obtained only after sphincterotomy. Biopsies
showed an adenovillous tumor suspect of malignant transformation, an
unspecified suspect lesion and a positive smear in case each. Other
biopsies showed mild (n 1), medium (n 2), or severe dysplasia (n
4), benign tumors (n 4), inflammation (n 1) and hyperplasia (n
1). No anomalies were noted in 2 patients.
Conclusion In some patients preoperative endoscopic biopsies are
capable of ascertaining malignancy for tumors of Vater’s ampulla.
However the possibility of malignancy should not be discarded in the
presence of a negative biopsy and patients should be denied the
benefits of resective surgery solely on the basis of a negative biopsy.
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CURATIVE SURGICAL MANAGEMENT OF KLATSKIN TUMORS
THE PLACE OF LIVER RESECTION
B. Launois, J. Terblanche, JM. Catheline, JP. Campion, E. Bardaxoglou,
B. Chareton, O. Azzis, S. Landen
Department of Digestive Surgery and Transplant Unit, CHR
Pontchaillou, Rue Henri le Guilloux, 35033, FRANCE
The .place of liver resection in the management of Klatskin tumors
remains controversial with some authors suggesting that liver resection
should be the rule. We assess this attitude in the light of our personal
experience with Klatskin tumors.
Patients and methods Between 1974 and 1993, 40 patients underwent
resections for Klatskin tumors." The group comprised 23 males and 17
females with a mean age of 60 years (range 34-81 years). The
majority of tumors were stage T3 (n 24) and 25 presented with type
III biliary extension. The resectability rate was 42.5%. Surgical
procedures included 11 tumor resections, and 27 combined tumor and
liver resections. The latter included 7 extended right hepatectomies and
in 8 cases resections were supplemented by regional vascular
resections. There were also 4 liver transplantations of which 2 were
preceded by organ cluster-type resections.
Results: There was no operative mortality among patients having
undergone tumor resections, combined tumor, liver and vascular
resections, or transplantation. There were 4 hospital deaths in the group
having had combined tumor and liver resections. Following resections
considered to be curative, the median time of survival was 23 months.
When the site of the tumor was considered, mean survival was greatest
for type II lesions (52 months). When TNM staging was considered,
mean survival was 5 years for Tis and T1 lesions. Survival was as high
as 26.7 months for type III lesions. When surgical procedures were
considered, 5-year survival was excellent following tumor resection
(27%) but was poor following liver resection (7%) although the latter
increased resectability.
Conclusions: Resectability of Klatskin tumors is increased by adding
liver resection. Median survival time for "curative" procedures is 23
months. Mean survival for Tis and T1 lesions is excellent (beyond 5
years) and remains good for T3 and type II lesions. However, long-
term results of liver resection are disappointing when compared to
those achieved by simple tumor resections.
PANCREATODUODENECTOMY(PD) FOR PERIAMPULLARY CARCINOMA -320
CASES EXPERIENCE.
Yong-feng Liu, Li-ming Wang, Jian Liang zhang,san-Guang He
Department of surgery, First University Hospital
China Medical University, Shenyang 110001 ,P. R. China.
There were 1200 patients of periampullary carcinoma who had laparotomy
from 1962 to 1994 in our department. 320 cases of them underwent PD, the
resection rate was 25.8%, hospital mortality were 23 cases,and the mortality
rate was 7.19%, hospital morbidity were 69 cases, the morbidity rate was
21.9%, Of the 320 PD, 214 were male, 106 female, The ages of the patients
ranged from 26 to 73 years .with a median of 52.9 years. The lesions ofthe 320
cases were that carcinoma in the head ofpancreas were 81 cases, in common
bile duct were 85, in ampulla of Vater were 104, in duodenum were 50. The
method of resection we preferred is to follow the order of gallbladder, bile
duct stomach proximal jejunum and" duodenum initially and leave the
pancreas at last, this method provides excellent exposure of uncinate process
and controls bleeding easily .Gastrojejunual anastomosis was retrocolic
procedure The end of the jejunum is brought into upper abdomen in a
retrocolic position, but anterior to the mesenteric vessels. Pancreatic fistula is
a common and severous complication following PD. From 1962 to 1970, 43
PD with end-to-side anastomosis without pancreatic drainage were performed,
the fistula occurred in 10 patients 6 deaths after that. So we change the
method to end-to-end anastomosis between the pancreas and jejunum 14
patients with internal drainage by using of short tube ,fistula occurred
in 2 cases, then we changed to a long catheter external drainage for 237 cases,
fistula only occurred in 3 cases. PPPD were performed in 28 cases, gastric
stasis occurred in 5 patients, it was cured by nasogastric drainage and drugs
within a week. From our data shows that postoperative survival rate is poor for
pancreatic carcinoma, one year survival rate is no more than half, and the three
years is only 13.58%, but for carcinoma of ampulla of Vater and common
bile duct, the result is better, five years survival rate for carcinoma ofampulla
ofVater is 41.54 % which is the best.
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BODY WATER DISTRIBUTION IN OBSTRUCTIVE JAUNDICE PATIENTS
ASSESSED BY BIO-IMPENDENCE ANALYSIS BIA
L. Lulo. O. Pannarale, P. Ricci, L. Caputi, A Panebianco, V. Memeo
Istituto di Clinica Chirurgica, Universit di Bari, Italy
Renal dysfunction frequently occurs in patients with obstructive
jaundice (OJ) and changes of the total volume and distribution of
body water are probably involved in its pathogenesis and were
detectedby invasive methodsz. Bio-impedence analysis BIA was
reported as a reliable and non invasive method to assess the total
bodywater TBW ), the intracellular (ICW) and the extracellular
(ECW) distribution in normal and pathologic conditions, by
measuring the body resistance (R) and reactance (Xc) 3,4.
This studywas undertaken to determine the total body water and its
distribution in patients with OJ Bilirubin > 200 mol/I for >
week with no evidence of renal dysfunction Creatinine < 20
lmol/I ). Three repeated measurements were taken at steady state
in 5 cancer OJ patients before treatment and in 5 control subjects
matched for sex, ageand weight.
Results Significantly different values of R and Xc were found
between OJ patients and controls: R: 602 (498-652) v._s 437
(425-468), p< 0.001; Xc: 52 (47-84) v_.s 43 (41-50), p<
0.001. TBW was reduced in OJ patients compared to controls: 33.7
28.7- 38.9 v_s 46.5 37.2- 48 ), p<0.02 median value and
range; Mann Whitney U test ). The depletion was present in both
compartments: ECW 13.7 11.7 17.4 v__s 18.9 17.1 21.5 ),
p<0.02 andlCW 19.8 15- 23.4 v_s 26.5 20.1 27.6 ), p<
0.03, with no change of the lCW/ECW ratio.
In conclusion, the mesurement of body water in OJ patients by BIA
gave results similar to those obtained with invasive methods and
confirmed the alterations of water volume and distribution in these
patients.
1. Br.J.Surg. 1995, 82:877 2. Br.J.Surg. 1992, 79:553
3. J ofTrauma 1992, 33:665 4. Am.J.Clin Nutr 1994, 60:159
LPAROSCOPCANDNZNILAPARO’I’ONYCfIOLBCYSTC’I’ONY:
PIfYSIOLOGICALANDNICTABOLICP,SPONSES.
A.Nonaco, C.Vrn_a+, G.MoncellJ, L.Gastald G.VJbert"
.la*, .tmrcocch, .FJaccavento’and N.Vajo
Dpt of Surgery, Servs of Anesthesia and Laboratory*,
Giaveno H.,Turin; II Dpt of Surgery+, Asti H., Italy
Though laparoscoplc cholecystectomy has become the
operation of choice for uncomplicated gallstones, mini-
laparotomy is shorter, without the disadvantages of the
carbon dioxide pneumoperltoneum, and with a more rapid
postoperative recovery compared with use of a standard
incision (Surg.1994;1151533-9 and Br.J.Surg. 1992;79:
1061-4). The aim of this study is to compare the two me-
thods evaluating respiratory and metabolic functions in
patients (pts) undergoing electlve laparoscopic (group I
=30) in the Giaveno Hospital and mlnilaparotomy (group
II=30) cholecystectomy in the Giaveno and Asti Hospitals
for symptomatic cholelithiasis. Hinilaparotomy was per-
formed by use of the smallest feasible transverse sub-
costal incision (7-12 cm.) depending on the habitus of
the patient. Arterlal blood gases" full blood count; se-
rum cortisol" urinary vanillylmandelic acid (VHA), epi-
nephrine (EN), norepinephrine (NEN) and cateeholamine
(CCA); serum C-reactive protein (CRP), fibrinogen, ery-
throcyte sedimentation rate (ESR) and serum electrolytes
(Na+, K+ and Ca++) were assessed in the preoperative and
the immediate postoperative time and 24 hs afterwards.
The data were analyzed by "t"student test. Blood gas da-
ta demonstrated a more significant decrease in arterial
oxlgen pressure in pts of group II compared with those
of group I, 24 hs later (P(0.000), reflecting poorer
respiratory performance. Serum fibrinogen, electrolytes
and cortsol dosages showed no significant dfferences
in both groups, while urinary VA, EN NEN CCA were
sJgnlficantly less for pts of group I P(O.4; P(0.04;
P(O.01 and P(O.OOg,respect.). Also acute-phase responses
were greatest in patients undergoing minilaparotomy as
determined by ESR and CRP levels (P(O.01 and P(O.01,
respect.). Horeover, the-decrease in hospltal stay after
surgery, could be observed in the group I. These
findings suggest that laparoscopic cholecystectomy may
result in a reduced risk of postoperative complications.
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SURGICAL TREATMENT OF ClCATRICIAL BILIARY STRICTURES
J.E.Monteiro da Cunha, M.C.C. Machado, P.Herman, T. Bacchella,
S.Penteado, E.Abdo, J. Jukemura, A Montagnini. H. W. Pinotti
Department of Gastroenterology, Surgical Division, Sto Paulo University
Medical School. Sio Paulo, Brazil.
BACKGROUND: Cicatricial biliary strictures are usually associated with
high morbidity and mortality rates, frequently related to technical
difficulties of the surgical repair, mainly in the hilar lesions and those
complicated with portal hypertension. Extended follow-up is needed to
adequately evaluate results achieved with appropriate surgical repair
techniques.
METHODS: The medical records of 45 patients surgically treated for
cicatdcial biliary strictures between January 1984 and July 1992 were
reviewed and the immediate and long term results retrospectively
analyzed
RESULTS: There were 34 females and 11 males. The average age was
42.7 years (11-72). The cause of the biliary lesion was: cholecystectomy in
18; cholecystectomy with duct exploration or reoperations for biliodigestive
anastomosis in 25 and trauma in two. Thirty-seven patients. (82.2%)
presented episodes of jaundice after the lesion and 31 (68.8%) presented
cholangitis. Plasma bilirrubin levels were high in 31 patients. (68.8%) and
alkaline phosphatase was elevated in 37 (82.2%). Diagnosis was possible
by ecography in 25/33 cases with a sensitivity (S) of 75.7%, by ERCP in
10/11 (S=90.9%) and by transhepatic cholangiogram in 21/22 (S=95.4%).
In 24 cases (53.3%) the stricture was located at the upper third of the bile
duct, in 20 (44.4%) at the middle third and in one case (2.2%) it was low.
All patients were submitted to Roux-en-Y hepaticojejunostomy with
mucosa apposition. No transanastomotic stents were used. Six patients
(13.3%) presented eight postoperative complications: biliary fistula (3);
duodenal fistula (1) and wound infection (4). Average hospital stay was
10.8 days and there was no mortality. Only three patients developed
secondary biliary cirrhosis, one with ascites, after a follow-up period of two
to 10.5 years (average three years). There were no episodes of cholangitis
in the late postoperative pedod.
CONCLUSION: Roux-en-Y hepaticojejunostomy with mucosa apposition
without transanastomotic stent is a safe and efficient method for the
surgical treatment of cicatdcial biliary strictures.
MANAGEMENT OF EARLY GALLBLADDER CARCINOMA IN
THE LAPAROSCOPIC ERA.
M.Morino,C.Miglietta,C.Garrone,V.Festa,G.Cavuoti.
Istituto di Clinica Chirugica I,University of Turin.
Laparoscopic cholecystectomy (LC) is actually considered the treatment
of choice for gallbladder lithiasis. Since 1991 many cases of inapparent
gallbladder carcinoma (GBC) discovered after LC have been reported.
Abdominal wall metastases, expecially at the port sites, and peritoneal
metastatic diffusion have been described as complications of this new
technique.
From March 1990 to October 1995 11 cases of inapparent GBC have
been observed: out of 1492 LC personally performed for cholelithiasis
(0.2%) and 8 referred to our institution by other surgeons. At the time of
the first operation patients were classified stade I, stade II and stade
III. The median interval between LC and re-exploration was 211 days
at this time 6 patients (2 stade 1,3 stade II and stade III) were submitted
to a 4th-5th bisegmentectomy with radical pedicle lymphadenectomy and
umbilical resection. The others patients (1 stade I, 2 stade II and 2
stade III) had unresectable tumor and received a palliative treatment: 2
had diffused liver metastasis, 2 had an invasion of the common bile duct,
had a peritoneal carcinosis. Among the 6 resected patients one (stade I)
developed a peritoneal carcinosis and died of recurrence 6 months after
the hepatic resection. A second patient (stade II) developed a cutaneous
metastases on the surgical limb. After the removal of this seeding he’s
alive without tumor recurrence 40 months after LC. 4 patients are alive
20,9,7 and 6 months after hepatectomy without recurrence. In the group
with unresectable tumor median survival time was 8 months.
We suppose that LC may be involved in the early appearance of
abdominal and cutaneous recurrences: to confirm this hypothesis we
have organized a multicentric group to study gallbbladder carcinoma and
the consequence of laparoscopic procedure.
At present, according to the literature and to our personal experience: 1.
we avoid to perform LC if a GBC is suspected preoperatively; 2. we
abandon laparoscopy if a GBC is diagnosed intraoperatively; 3. we
perform a 4th-5th bisegmentectomy, a radical pedicle lymphadenectomy





Nakeeb,S.,M. Radosevich, 1LH. Hruban, Y. Gusev, W.C. Dooley,.
P.A. Lipsett, K.D. Lillemoe, H.A. Pitt. Department of Surgery, The Johns
Hopkins Medical Institutions, Baltimore, MD, USA
In the hamster diisopropanolnitrosamine (DIPN) induces papillary
hyperplasia in the biliary epithelium which progresses to eholangioearcinoma.
In rodent models ofcolon cancer diets high in cholie acid,have been shown to
promote carcinogenesis. However, the effect of dietary cholic acid in the
pathogenesis ofcholangiocarcinoma has not been investigated. Therefore, we
tested the hypothesis that dietary eholic acidwould increase the incidence ofbile
duct hyperplasia in DIPN treated hamsters. Eight week old male Syrian Golden
hamsters were fed either a control chow(CHOW) or a 0.5% cholic acid enriched
(CA) diet. In each group, ammals underwent weekly subcutaneous injection
with either normal saline (NS), or DIPN (500 mg/kg) for 10 weeks. At thirty
weeks, livers were harvested, hepatic bile and serum were collected. The
incidence of bile duet papillary hyperplasia, the liver function tests, and the
percent ofglychocholic acid in hepatic bile were:
Papillary AST ALT AIR Phos Glycocholic
N Hyperplasia (IU/L) (IU/L) (IU/L) acid
CHOW NS 11 0 24+4 265 47+4 28%+9
CA NS 11 9% 30-:7 29-J:7 72.-t:71" 41%+7
CHOW DIPN 13 15% 506"1" 28+31:1: 51 +8 39%+7
CA DIPN 9 77%* 51 +71" 12531:1: 75+51" 62%+EP
*p<0.0I vs others, t p<0.05 vs CHOW+NS,
p<0.05 vs CHOW+NS,CA+NS, <0.05 vs others
These data suggest that 1) a cholic acid enriched diet significantly
increases the incidence ofpapillary biliary hyperplasia in DIPN treated hamsters,
2) DIPN causes hepatotoxicity, and 3) cholic acid results in biliary stasis. We
conclude that cholestasis caused by cholic acid promotes nitrosamine induced
cholangiocarcinoma.
PREVELANCE OFPORT SITE METASTASES AFTERDIAGNOSTIC
LAPAROSCOPY IN GASTROINTESTINAL MALIGNANCIES.
E,J.M.Nieveen van Dijkum, L.Th.de Wit, H.Obertop, D.J.Gouma. Department of
Surgery, Academic Medical Center, Amsterdam, The Netherlands.
Diagnostic laparoseopy and laparoscopic ultrasonography is increasingly used for
staging of gastrointestinal malignancies. Recently many reports on port site
metastases after laparoscopic colonreseetions and laparoscopic eholecystectomies fox
occult galbladder carcinoma were published and induction ofport site metastases
after diagnostic laparoscopy is also suggested. Therefore the prevelance ofport site
metastases after diagnostic laparoscopy was assessed in this study.
Patients and Methods: All records ofpatients, who underwent diagnostic
laparoscopy between January 1992 and July 1995 for staging ofa gastrointestinal
malignancy, were retrospectively analysed for the appearence ofport site metastases
in the trocar-scars. Included were 250 patients; patients with an esophageal tumor
(n=66), periampullairy tumor (n=121), proximal bile duct tumor (n=26), a
livertttmor (n=24) or other intra-abdominal malignancies (n=l 3).
Results: Seven patients (2,8%) were lost from follow up. Four patients developed
port site metastases, one with neuro-endocrine tumor, one with proximal bile duct
tumor and two with pancreatic head tumors, respectively 2, 3, 5 and 10 months after
diagnostic laparoscopy. Two patients had atypical, but no malignant cells in the
peritoneal lavage fluid ofthe diagnostic laparoscopy and during the procedure
biopsies were taken in 2 patients to prove irresectable disease. None ofthe 4 patients
underwent tumor resection, the 2 patients with pancreatic head malignancies both
underwent laparotomy with palliative bypass. These patients did not develop
metastases in their laparotomy scars. All 4 patients were in an end stage of their
disease and underwent only palliative treatment. One patient is still alive one month
after detection ofhis port site metastases, the other patients died within months
after development ofport site metastases.
Conclusion: Port site metastases occured in 1,6% (4/250 patients) as late
complication ofdiagnostic laparoscopy for gastrointestinal malignancies. Remarkable
is the fact that no metastases were found in the laparotomy scars, indicating that not
only dissiminated intra-abdominal disease but also laparoscopy related-factor, for
instance the pneumoperitoneum, must be responsible for this phenomenon. Although
the precise mechanism for this complication is unclear, the occurence in potentially
curable disease should be prevented. Therefore during laparoscopy biopsies should
only be taken to prove incurable disease and resectable tumors should not be
biopsied.
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Laparoscopic treatment of residual stones after cholecystectomy.
L. Novellino; M. Longoni; M. Vitellaro; L. Spinelli; A. Casati; M. Andretta;
G. Faillace; A.. Piazzini Albani; G. Perrucchini; L. Campanati.
Dep gral Mhdma-InvatveSurgy Ztngonla(BERGAMO)
Cholecystectomy carried out with the video-laparoscopic technique, today
considered tested and codified operation, not only has the merit of having
introduced method in the field of surgery, but, above all, ofhaving proposed
way ofinterpreting and dealing with surgery: mini-invasive surgery or, it has
been also called, "respectful" surgery, could in the next few years be increasingly
performed and have wder and important application
When bile stone is encountered after laparoscopic cholecystectomy, two
options available to the surgeon: to perform ERCP-PTSE surgical treatment.
In the period between February 1992 and October 1995, 1041 consecutive
laparoscopic cholecystectomies performed. In four patients were found
choledochal calculosis after surgical treatment and underwent ERCP choice that
still consider optimal when is sufficient.
In two patients not possible to the stones by endoscopic tecnique and
underwent the patients to laparoscopic choledochotomy.
Direct laparoscopic choledochotomy, after laparoscopic cholecystectomy, requires
very carefully dissection to define the anterior common duct wall, usually
fibrotic tissue be found. Then, longitudinal incision is made in the
duct for distance of about cm, and exploration proceed. At the conclusion of
the exploration, T-tube is placed and the duct is securely closed with
intracorporeal suturing techniques. It is racommended that small drain be placed
in the region of Morrison’s pouch to control any liquid collection.
The patients had regular post-operative course; intracholedochal drainage
removed 13 days aRer the operation, aRer x-ray check-up; this patient
dismissed eighteen days aRer the operation.
At present believe that the laparoscopic cholecystectomy be considered the
"gold standard"; if residual choledochal calculosis appear the patient be
candidate to endoscopic treatment and in of failure laparoscopic
choledochotomy be performed.
ENDOSCOPIC RESECTION OF TUMORS IN THE PAPILLA OF VATER
K.Ohhashl, T.Furukawa
Department of Gastroenterolgy, Alcht Cancer Center
Hospital, Nagoya, JAPAN
(Purpose)
This study aims to reveal clinical benefits of endoscopic
resection of turaors In papilla of Vater.
(SubJect and Method)
A total of 12 cases of tumor In papilla of Vater was
endoscoplcally resected. Indication was decided by
duodenoscopic findings, biopsy, ERCP, hypotonlc
duodenography and Intraductal ultrasonography(IDUS).
Tumor resection was performed only In the case of adenoma
or carcinoma limited In mucosal layer by using snare and
high-frequency current under endoscopic control. Clinical
follow-up including pain, GI tract bleeding and
laboratory data was cont!nued untll recovery.
(Result)
Tumor consisted of adenocarclnoma and 11 adenomas
ranging 40mm to 8mm in size as a result of pathological
study. Repeated endoscopy showed complete removal of the
tumor in a11 cases. In cases, GI bleeding necessitated
blood transfusion was noted. Transient elevation of serum
amyl.ase continued for few days. In case, post
operative jaundice occured and subsided spontaneously a
week later. No other complication was noted.
(Conclusion)
Endoscopic resection of tumor (adenoma and carcinoma in
mucosal layer) In papilla of Vater indicates safe and less
invaslve procedure compared wlth surgical
pancreatoduodenectomy.
63F245 F246
CAN THE NEGATIVE ERCP RATE IN PATIENTS
UNDERGOING CHOLECYSTECTOMY BE REDUCED?
R.Oodit, PC Bomman, J.Krige, J.Terblanche, MEC van Wyk
Department of Surgical Gastroenterology, Groote. Schuur
Hospital, University of Cape Town, South Afdca.
Despite a selective approach to preoperative ERCP only 31%
are positive in our expedence.A retrospective study was done
on all patients who had successful ERCP’S preoperatively
between 01 December 1990 and 30 June 1995 one. The
indication for ERCP was based on either one or a
combination of the following "markers":- an elevated total
bilirubin and/or alkaline phophatase and ultrasound features of
a dilated commom bile duct (CBD) >6mm and/or the presence
of CBD stones. Patients were grouped according to their pre-
operative diagnosis :- biliary colic(BC), gall stone pancreatitis
(GSP) and acute cholecystitis (AC). The results were analysed
using and Fisher tests.There were 167 patients :-115 with
BC, 33 GSP, 19 AC. The age ranged from 16 to 93, mean
49.3.There were 135 (81%) females and 32 males. 531167
(31%) had positive ERCP’s. 44 in the BC, 4 in the AC and 5 in
those with GSP. The most useful predictor of CBD stones
(CBDS) in the biliary colic group was the presence of a dilated
CBD on ultrasound :- 43 of 45 patients with dilated ducts had
CBDS confirmed at ERCP.(positive predictor value 88,
negative predictor value 98) and a sensitivity of 98% and
specifity of 92%. In conclusion the presence of a dilated CBD
in those with biliary colic is an accurate marker of CBDS and
this could be used to reduce the rate of negative ERCP’s in
this subgroup of patients. None of the other "markers", either
in isolation or combination, proved to be reliable predictors of
CBD stones in any of the other subgroups.
MANAGEMENT OF MALIGNANT HILAR BILIARY
OBSTRUCTION- EXPERIENCE IN 58 CASES
RTA Padbury,A Loh, GW Dyke, TG Wilson, R Davies* and J Toouli.
Departments. of Hepatobiliary Surgery and Radiology*, Hinders
Medical Centre, Bedford Park, SA 5042
Palliation ofjaundice caused by malignant high bile duct obstruction
remains a clinical dilemma. A retrospective analysis of 58 patients
treated over a 7 year period (1987-1994) is presented. The median age
was 66 years (range 43 to 92 yrs) with 23 men and 35 women. The
median survival for all patients was 5 months.
The primary diagnostic morality was endoscopic retrograde
eholangiography (ERC) in 55 patients and percutaneous transhepatie
cholangiography (FI’C) in 3. Endoscopic stenting was attempted in 39
patients with technical success in 25. 11 stents failed due to blockage,
incomplete drainage or infection or infection requiring either a
pereutaneous drainage procedure (8) or surgical bypass (3). Thus,
endoscopic stenting alone was successful in 36% of those in whom it
was attempted. A variety ofpercutaneous transhepatie biliary drainage
(PTBD) procedures (external drains, internal/external drains and
internal Wall stents) were employed, successfully in 30 patients (52%).
20 patients had not undergone a previous decompression procedure and
10 had PTBD for failed endoscopic stents or recurrence after surgical
bypass. Surgical bypass was performed in 8 patients (median survival
-14 months); 2 required percutaneous procedures for recurrentjaundice
at a later date. The most effective modality for relief ofjaundice was
surgical bypass. Normal bilirubin levels were rarely obtained (12% of
patients) after.endoscopic stenting.
In conclusion, malignant hilar obstruction is best managed by a
multidisciplinary team utilising endoscopic, radiological and surgical
approaches. Endoscopic stenting .alone was successful in a quarter
(14/58) of patients. Percutaneous techniques can be considered for
first line management or for rescue following endoscopic or surgical
procedures. Hepatieojejunostomy in selected patients may give better
palliation for potential longer term survivors.
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FEASIBILITY, SAFETYAND EFFICACY OFLAPAROSCOPIC
CHOLECYSTECTOMY AND COMMON BILE DUCT (CBD)
EXPLORATION IN UNSELECTED PATIENTS
A. Paganini, F. Feliciotti, *F. Carlei, *D. Lomanto, M. Guerrieri,
*M. Nardovino *M. Sottili, A. Tamburini,
Istituto di Scienze Chirurgiche, Universiti di Ancona. *I.N.I.
Canistro, L’Aquila. Italy
Feasibility, success rates, safety and short-term results were
prospectively evaluated in a consecutive series of unselected patients
undergoing laparoscopic cholecystectomy (LC) and common, bile
duct exploration (LCBDE) atthe same operative session. Routine
intraoperative cholangiography demonstrated CBD stones in 155
patients (97 females, 58 males, mean age 55.1 years, age range 12-
94 years) out of 1300 with gallstones undergoing LC. CBD stones
were unsuspected in 68 patients (5.2% of 1300; 43.8% of 155).
Thirty-two patients had been referred for surgery after failed
endoscopic sphincterotomy (ES) performed elsewhere.
Laparoscopic trans-cystic ductCBD exploration was attempted first
in all patients. When this was not feasible, laparoscopic
choledochotomy was resorted to. Biliary tubes were employed
selectively. Laparoscopic treatment ofCBD stones was completed in
151 patients (97.4% success rate), by the trans-cystie route in 102
(no biliary drainage employed in 75) and after choledochotomy in 49
(biliary drainage in 48). Four patients were converted to open
surgery (2.6%), 2 of whom were among the first 5 patients of the
series. Retained stones were observed in 10 patients and were
treated by ES in 3 cases and by percutaneous endo/fluoroscopic
lithotripsy in 6 (with ESWL in 1). Minor morbidity included biloma
(2), port site infection (2), hyperamylasemia (3) and subumbilical
hematoma (1) (5.2%). Major morbidity was cystic.duct bile leakage
and haemoperitoneum in 3 cases each (3.9%), the latter requiring
reoperation in 2 cases (laparoscopic 1). Mortality was observed in
(0.6%) elderly, ASA 4 patient referred for cholangitis after several
failed attempts of endoscopic clearance, who died from cardiogenic
shock 3 days after successful laparoscopic treatment. LCBDE during
LC was feasible, safe and effective with short-term results that are
not worse than those reported after ERCP/ES and LC.
LAPAROSCOPIC CHOLECYSTECTOMY IN CIRRHOTIC
LIVER
C. PALANIVELU MS Mch.. P S Rajan, S V Sivakumar,
K Sendhilkumar, R Parthasarathi, Dept. of Surgical
Gastroenterology, Coimbatore Medical College and Hospital,
INDIA.
Liver cirrhosis which was considered as a relative contraindication to
Laparoscopic Cholecystectomy is now being successfully managed
by the same. Since July 1991, over 1950 LC’s have been performed
among which 94 were cirrhotics. 40 patients presented with features
of acute cholecystitis and 54 with chronic cholecystitis. By avoiding
Cholecystostomy andopenconversion, morbidityhasbeenverymuch
reduced. The average duration of hospital stay was 2-3 days,
Problems encountered 1) Difficult Liver retraction 2) Deeply
placed hilum due to nodular hypertrophy of Liver 3) Increased
abnormal vessels due to portal hypertension 4) Hard, fibrotic liver
bed 5)Extensive inflammatoryphlegmon and adhesions 6) Extreme
laterally placed gallbladder due to shrunken right lobe.
Proceduresadopted: 1) Adequate exposure ofhilum was obtainedby
using additionaltrocars for lifting of liver with dipping retractors (28)
anddownward traction (50) ofduodenumandomentum. 2) Modified
subtotal eholecysteetomy Type LC was performed in cases of
nodular liver bed where posterior wall of gall bladder was left intact
with the liver after mucosectomy orelectrocoagulation ofthe mucosa
and thus avoiding uncontrollable haemorrhage. Type II LC was
performed in the presenceofPHT, extensive pericholecystic fibrosis,
increasedphlegmonanddeeplyplacedhilum. Here, theinfundibulum
was divided circumferentiallyand muscular flapwas sutured to cover
the cystic stump after mucosectomy, thus avoiding undue bleeding
and injury toCBD orduodenum 3) Retrogradecholeeysteetomy was
performed in cases of difficult or inadequate hilar exposure.
Conclusion Laparoscopic Cholecystectomy either standard or its
modificationsmay be safely performed in cirrhotic patients. Policyof
keeping awayfrom the danger zone makes the procedure safer and
avoids undue bleeding andCBD injury.
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MORPHOMETRIC EVIDENCE OF GUTMUCOSAL INJURY
IN OBSTRUCTIVE JAUNDICE
RW Parks, WDB Clements, C Gannona, C Pope, BJ Rowlands,
T Diamond.
Departments of Surgery and Pathology The Queen’s University
ofBelfast, Northern Ireland.
Gut banier dysfunction has been implicated in the development of
the complications seen with obstructivejaundice. Physical injury
ofthe gut mucosa may promote bacterial translocation (BT). This
study investigates histological changes ofthe small and large
bowel mucosa in relation to BT in obstructivejaundice. Three
groups ofWistar rats were studied {controls, sham operation, bile
duct ligation (BDL)}. After one week, bacteriological cultures of
portal blood, mesenteric lymph nodes, liver and spleen were
performed. Segments ofjejunum, ileum, caecum and colon were
assessed morphometrically using a computerised image analysis
system. Significant BT [68.8% BDL vs 6.3% Sham vs 0%
Control; P<0.001)] was demonstrated following BDL. There was
no significant alteration ofthe jejunal or large bowel mueosa,
however morphometric evidence of ileal mucosal injury was
demonstrated. Results are expressed as mean (SEM).
Ileal measurements
Mueosal Villous Crypt depth
thickness height
Control 744 (95) 559 (79) 183’ (19)
Sham 731 (27) 515 (18) 193 (11)
BDL 650 (23)" 451 (20)" 180. (8)
laP<0.02, Mann-WhitneyU test]. These data demonstrate
morphometrie evidence of ileal mueosal injury and BT following
BDL, supporting the hypothesis ofgut barrier dysfunction in
obstructive jaundice.
COMBINED ENDOSCOPIC AND LAPAROSCOPIC APPROACH TO
CHOLELITHIASIS AND CHOLEDOCHOL1THIASIS.
D. Parolini, L. Giangreco, S. Spagnolo, M. Pansera, L. Fanti, E.
Masi, C. Staudacher
Dept. of Emergency Surgery, Dept. of Endoscopy, S. Raffaele
Hospital, University of Milan, Milan, Italy
The treatment of cholelithiasis with concomitant choledocholithiasis
(CCL) has recently completely changed, thanks to development of
laparoscopic and operative retrograde endoscopic techniques on the
biliary system. Aim of our study was to compare combined
endoscopic and laparoscopic treatment (CT) with traditional surgical
treatment.
Between June 93 and August 95 we observed 37 patients with CCL
(moan age 53.1+17.3, range 17-84). All these patients were
candidated to CT, but one out of them had a severe necrotizing acute
pancreatitis post-E.RCP and underwent cholecystectomy during
laparotomy for pancreatic necrosis debridement. All the other 36
patients underwent CT which consists of ERCP with common bile
duct (CBD) stones removal and laparoscopic cholecystectomy. We
compared them with a second group of 53 patients with CCL
previously admitted and treated with open surgery (mean age
62.8+14.6 years, range 28-89), with particular regard to hospital
stay and complications. In the second group cholecystectomy was
assooiated to transcystic removal of CBD stones in 16 cases,
choledochotomy in 16 cases, transduodenal sphincterotomy in 17
cases and biliary-enteric by pass in 4 cases. External drainage of
the CBD was provided in 30 patients. Complication rate of the first
group was 2.7% (1 case of hemobilia without need of blood
transfusions), and mean hospital stay was 11.5+5.2 days. Seven out
of the second group patients had complications (13.2% p=0.005): 5
had residual CBD stones, had wound infection and had
oedematous pancreatitis. Mean hospital stay was 18.3+._6.7 "days
(p=0.0001). In conclusion CT represents the gold standard of
treatment of CCL. It provide a significative lower rate of
complications, shorter hospital stays and postoperative recovery
than surgical traditional treatment.
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Unsuspected gallbladder cancer and laparoscopic
cholecystectomy
J.Pekoli. A. Aldet, R. Sendin, J.Sivod, M.Ciardullo, E. de Santibafies
HPB Surgery Section, General Surgery Service, Hospital Italiano,
Buenos Aires, ARGENTINA.
Laparoscopic cholecystectomy (LC) is the "Gold Standard" of the
treatments for symptomatic gallstones, and its contraindications has
sharply decreased. Nevertheless, gallbladder carcinoma (GC) is still
a formal contraindication. Its incidence is 1,5 2 % among the
patients operated for gallstones, and the preoperative diagnosis is
routinly difficult, except in advanced cases.
We reviewed 13 patients with GC and LC treated between
september 1991, and november 1995. Ten were of our sede, among
1231 LC (0,8%), and 3 were sended from other hospitals. Eight were
female, and the mean age was 63,5 years 50 88 ). No case was
diagnosed before LC. One was suspected after initial laparoscopic
exploration, and other after LC, in =ex situ" exploration of the
gallbladder was confirmed by frozen section. In all the restant cases,
the diagnosis was performed after delayed microscopic study.
In tree cases was performed resection of segments IV B and V of the
liver, lymph, nodes and trocar sites. In four cases a paliative
procedure was done. In one, only exploratory laparotomy was
performed. In five cases no other procedure than LC was realized. In
four cases tumor recurrence in pert sides were observed. In tree, the
recurrences were excised.One was reexcised after recurrence in the
scar of subcostal incision for liver resection. In two cases was not
evidence of extense disease and are still alive after 6 and 11
months of follow up.
Conclusion: The GC and LC, is still a not resolved problem, because
the preoperative diagnosis is uncommon feature. However ifGC is
suspected, open cholecystectomy must be performed. The
recurrences in trocar sites are a "new" complication, and does not
mean in all the cases a sign of diffuse metastasis or incurable stage.
The resection of recurrences is the treatment to resolve the local pain
and discomfort; and is the way in wich we can somewhat extend the
survival time.
Laparoscopic transcystic choledocholithotomy (LTC)
J.Pekol|, R Sendin, A. Aldet, J.Sivori, E. de Santibafies.
HPB Surgery Section, General Surgery Service, Hospital Italiano
Buenos Aires ARGENTINA.
Since the introduction of laparoscopic cholecystectomy (LC), there has
been widespread debate about the best treatment for common bile duct
stones (CBDS), associated to gallstones. Different surgical sedes
demostrated a high effectiveness of the laparoscopic approach for the
treatment of CBDS, and the transcystic access is the most accepted.
Between september 1991 and november 1995, we peiform 1231 LC,
with sistematic indication for intraoperative cholangiogram. It was
possible in 96% and were diagnosticated 98 cases 8 %) of CBDS (39
unsuspected, and 59 suspected). The LTC was considered the first
option, combining flushing extraction with Dormia baskets under
radioscopic guide, mechanical lithotdpsy and selective
choledodochoscopy. We retrospectively revised two sedes. Serie 1:
from september 1991 to march 1994, with 33 patients 20
unsuspected, and 13 suspected).The first 4 cases were coverted to
perform open exploration,.and of the remnant 29, in 23 (80%), the
stones were resolved with LTC.ln one patient was performed a
laparoscopic choledochotomy with trascystic drainage, and 5 open CBD
explorations. In this pedod, the aplicability of LTC was 23 %. $erie 2:
from apdl 1994 to november 1995, with 64 cases 19 unsuspected,
and 45 suspected). The LTC was effective in 93% 95 % for
unsuspected, and 92 % for suspected). The aplicability was 70%. In 5
cases (6 %) laparoscopic choledochotomy without T tube (LCWTT) was
performed, and open exploration was necessary. In the last 6 months,
90 % of CBDS were resolved by laparoscopic approach.The morbidity
of LTC was 6,6 % (2 bile leaks, perforation of CBD, residual stone,
pancreatitis, hemopedtoneum), and was not mortality. The mean
hospital,stay was 1.8 days (1-24).
Cgnclusic,n: LTC is a technically feasible procedure, with high
effectiveness and low complication, mortality and length hospital stay
rates. It require adequate selection of patients, training in vadety of
techniques and equipment. In the unsuccessful and unapplicable cases
of LTC the LCWTT is our treatment before the open procedure.
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PATHOPHYSIOLOGY OF ACUTE ACALCULOUS CHOLECYSTITIS
F.M. Polignano, S. Ferrarese
Cattedra di Fisiopatologia Chirurgica Clinica Chirurgica Universi di Bad
We report 12 patients suffering from AAC, observed between 1987 and 1994. These
represented 9.4% of all acute eholecystitis and 1.5% of all admissions for biliary-
related pathologies in the same period. There wer 7 men and women, whose
average age was 64.3 years (range 31 to 89). APACHE 1I score, for assessment ofthe
severity in patients with serous intra-abdominal sepsis, was. evaluated on admission,
before any therapeutic intervention had been performed. Scores ranged from 6 to 27
(average 13.1). 7 patients admitted with diagnosis ofAAC; were admitted
with unrelated diagnosis and had symptoms develop while in the hospital.
Temperature was higher than normal in 7, leukocytosis was present in 10 and
leukopenya in (suffering from myelodysplasic syndrome); serurn bilirubin level was
abnormal in (greater than rag% in 2) and serum amylase in 4 (greater than 1000
in 3). On admission to the hospital patients were so ill that they were brought
to operatory room immediately after resuscitation. On the opposite, reidratation and
antibiotics caused quick resolution ofsymptoms and ofultrasonographie findings in
patients (2 with associated inoperable colon cancer with liver metastasis and with
acute partial thrombosis of portal and superior mesentede veins); they were
monitored by means of real time ultrasonography and operation was postposed.
Diagnosis was obtained by US in patients and by CT in (2 having serum amylase
level greater than 1000 UI/L). Most common ultrasonographie findings were the
presence of sludge, distension, thick wall, pericholecystic fluid. Underlying,
associated pathologies had been: cancer and metastasis (3), severe cardiopathy (3),
diabetes (3), thrombosis of abdominal or periferic vessels (2), history of gastric
resection for complicated ulcer (2), neurologic disturbance with syncope (1),
haematologic disease (1), cirrhosis (1), rupture of aortic aneurysm (1), anastomotic
bleeding ulcer (1), peritonitis due to gunshot multiple bowel laceration (1). Potential
etiologic factors had been: shock (3) and massive blood transfusion (3), parenteral
hyperalimentation (1), acute renal failure (2). Activation of factor XII had been
reasonable hypotesys which might have occurred in out of 12 patients. Gangrenous
cholecystitis with perforation of the gallbladder occurred in (average APACHE II
score 15.8) out of patients which underwent undelayed surgery, testifying the quick
evolution of this condition and its dangerousness. Operative treatment consisted of
cholecystectomy in 6 patients and of cholecystostomy in (2 perforated and
empiematous average APACHE II score 14.6). The overall mortality rate was 8.3%
(1 patient out of 12, whose APACHE score the highest) and that limited to those
operated was 11.1%.
KLATSKIN’S TUMOR: ASSESSMENT OF RESECTABILITY AND
THERAPEUTIC ALTERNATIVES
A. Principe, M.L. Lugaresi, M.C. Gallo, I. Biechierfi, B. Nardo A. Mazziotti, A.
Cavallari
2 Department of Surgery- Polielinico S.Orsola- University ofBologna- ITALY
The severe prognosis of Klatskin’s tumor is strictly correlated with it’s site and
it’s extensive diffusion. The purpose of this study is to analyse the results
obtained after adoption ofan accurate pre and perioperative diagnostic algorhytm
in order to localize the. site of the tumor, achieve a correct staging and determine
reseetability. Material and Methods- Since 1982, 72 patients have been
observed. The preoperative work-up was carded out in all eases through US, CT,
and only in 17 eases with, Angiography. PTC and/or ERCP allowed
decompression of the bile ducts and identification of the exact site of the tumor
(Bismuth classification). Two patients were excluded from this study because of
death, before intervention, due to hepato-renal insufficiency, despite transhepatic
biliary drainage. Preoperative staging was modified during operation in 23 cases
(33%) because perioperative US and frozen sections of the margins demonstrated
unexpected diffusion. A curative resection was possible only in 21 cases (R.I.
30%). Five patients were submitted to tumor resection. Of the other 16 pts, 8
were treated with a simple Hepatectomy, and with an extended Hepatectomy,
associated in 7 eases with resection of the caudate lobe and in case with
resection of the vena porte. The remaining 49 patients (70 %), were treated
following three different palliative modalities: 11 patients with an Intrahepatic
Bilio-Digestive-Anastomosis (IBDA), and 18 with a Surgical Biliary Drainage
(SBD), externally and 10 transtumorally. On 20 patients no surgical
intervention was possible and they were reclosed with the Non Surgical Biliary
Drainage (NSBD), positioned before surgery. Results- Curative procedures: there
were 2 p.o. death (mortality rate 9.5%) (St II and IVa). Eleven pts (1 St.I; 4 St.II;
6 St.IVa) are currently alive (mean FU 42 months; Range 6-156 too). The
remaining pts (6 St.IVa; 2 St.IVb) had a mean FU of 19 months.(Range 2-55
mo). Palliative ,nracaduras operative mortality rate was 12.2 % (6 pts). Mean
survival according to the type of biliary derivation was: 7 months for IBDA
(Range 1-18 too.); months for external SBD (Range 1-30 too) and 10 months
for internal SBD (Range 2-38 too); 4 months for NSBD. (range 1-9 too).
Survival between curative versus palliative pl’ocedures was statistically different
(p=0.0005). Conclusions- The results suggest that extensive diffusion of the
tumor is not often evidenced by the preoperative work-up (33%). Curative
resection, with can only planed with intraoperative staging, must be as wide as
possible in order to achieve significant survival. Surgical transtumoral biliary
intubation is the better therapeutic alternative to improve survival and quality of
life in these patients.
F255
RESULTS AND COMPLICATIONS OF LAPAROSCOPIC
CHOLECYSTECTOMY FOR ACUTE CHOLECYSTITIS
$, Ramacciato, A.M. Balesh, W. Clazzer
I Department of Surgery, University of Rome
"La Sapienza," Rome, Italy
The purpose of the present study was to
evaluate the benefits and effectiveness of
laparoscopic cholecystect0my (LC) for acute
cholecystitis (AC). A total of 800 patients,
60 of whom affeced by AC, underwent the
procedure from July 1991-June 1995. Average
age was 53 years (range 25-76). Successful LC
was performed in 79.2% cases. Average
operative time significantly increased when AC
was present (180+/-20 min) vs. in its absence
(100+/-20 min) (p<0.01). AC also significantly
lengthened postoperative hospital stay (3.5+/-1
days, range 1-18), in keeping with that
reported by Lujan et al. (i), vs. in its
absence (2.5+/-1 days, range 1-7). A conversion
rate of 20.8% occurred in cases of AC, with
the most frequent cause of conversion being
technically difficult dissection of Calot’s
triangle due to pericholecystitis. Injury to
the principal bile duct system occurred in
3.3% (2/60) cases of LC for AC vs.
significantly lower incidence in elective LC
(0.3%, 2/740). In the former cases, injury was
immediately discernible and involved
detachment of the cystic duct from the
principal bile duct system. In conclusion, the
effectiveness of LC for AC must be weighed
against a high conversion rate, with the
balance appearing to tip in favor of LC.
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OCTREOTIDE INCREASES BILE LITHOGENITY IN TPN-
FEEDED RABBITS
Rodriguez, J, Targarona, EM*, Martinez, J,* Poca, E+, Vela, M+, Ros, E,+
Mass6*, E, Nadal, J#,Marco, C, Trias, M+. *Serv. of Surgery, +Gastroenterology
and#Pathology, Hosp. Clinic. Serv. of Surgery, Hosp Mutua de Terrassa, Univ
of Barcelona. Barcelona, Spain
The development of gallstones is a well recognized complication of long-term
treatment with Octreotide (SMS). Also, parenteral nutrition (TPN) is associated
with several hepatobiljaxy complications including cholestasi,s, jaundice, biliary
sludge or stones. The association of both treatments has been proposed for
treatment of digestives fistulaes, but the biliary effects has not been evaluated.
AIM To study the modifications of bile composition during treatment with TPN
plus SMS. 32 New Zealand rabbits were studied. Fourteen served
as controls (Group I), and 6 received SMS (Group II) (ltg/kg tid sc), NPT (190
cc/kg/d, 340 Kcal/d) (Group III), or SMS + NPT (Group IV) for 2 weeks.
Gallbladder bile was obtained and phospholipids, cholesterol, bile salts, total
bilirrubin, total protein, and total calcium, were measured.
RESULTS Control SMS TPN TPN+SMS
Phospholip. 10.4+_3.9 36.3+3.8* 17.6+_4.7 36.4+_4.2*#
Cholesterol 0.6_+0.1 0.6+0.10 1.7+_0.1 2.6+0.5
Bile salts 11.5+2.5 57.0+6.1 26.5+_7. 15.1+_2.2
Bilirrubin 10.2+-2.3 8.6+_0.7 23.7+1.6 29.9+3.9
Proteins 14.3+2.8 8.2+._0.4 19.6+_2.6" 22.3+7.0
Total calcium 44.6+-.12.4 79.3+-7.0* 185.9+_20.2 91.4+17.8
(X SE), *<.05 control, +<.05 SMS, #<.05 TPN
SMS induced a significant rise of phos, bile salts and Ca, and TPN was associated
with an increase of chol, bile salts, bi and, Ca. The simultaneous administration
of both treatments enhnaced increase of phos, chol, bi, Ca and decreased bile
salts levels...ONCLUSION: 1. This studyconfirms that SMS or TPN
administered alone, induce significative changes of gallbladder bile composition.
2. The associated administration of SMS enhances the lithogenic changes induced
by TPN. 3. Biliary function must be monitored in patients receiveing both
treatments in order to prevent biliary complications.F257 F258
UTILITY OFE)OSCOPIC CONPEN BILE DUCT STENTING IN PATIENTS WITH
SUSPECTED SPHINCTER ODDI DYSFUNCTION
P. Rolny
Department of Medicine, stra Hospital, Gothenburg, Sweden
Intretien. As Endoscopic sphincterotomy (ES) for sphincter of
Oddi dysfunction .is relatively risky (SOD) only patients who are
likely to benefit should be selected for the procedure. Endoscopic
sphincter of Oddi (SO) manometry is at present an established tool
for that purpose. H6wever the method is neither universally
accurate, nor generally available. In contrast endoscopic stent
placement (ESP) .into the conmon bile duct .is feasible .in most
hospitals. Here, we explored the utility of ESP as an alternative
for selection of patients with suspected sphincter of Oddi dysfunc-
tion for ES. Patients md methods: The paper comprises 23 post-
cholecystectomy patients aged 37-68 (mean 45) years, all byt two
women who suffered from symptoms consistent with SOD and in whom
alternative causes for symptoms were excluded. All patients under-
went SO manometry (SO pressure > 40 nmHg is abnormal), followed by
ESP and finally by ES. The patients were then followed up in the
outpatients clinic for 6-16, median 12 months. Improvement was
defined as complete freedom from analgetic drugs. Results. After
ESP 17 (75,6) of the 23 patients were improved and after subsequent.
ES eleven (65,6) remained pain free long term, whereas in 6 the
synptoms recurred. However, three of these have had the stent for
only < 11 weeks (as opposed to 12-16 weeks in the remainder) and
two had relapse of pain during stenting. Six patients had no pain
relief after ESP and none of these benefited from ES. All patients
with elevated SO pressure improved on ESP and they with one exeption
also benefi-.ed from ES. The 5 Patients with normal SO pressures who
had a sustained improvment during ESP were also long term .improved
after ES. Stmmry and conclusion. Most of the patients with
sustained response to ESP were irrespected of SO pressure rendered
symptom-free after ES. If confirmed .in larger trials ESP could be
useful for selection of patients with suspected SOD for ES.
RELATIONSHIP BE’INVEEN LYMPHNODE METASTASIS AND MODE
OF RECCURENCE, PROGNOSIS IN CANCER OF THE BILE DUCT.
-Lymphnode metastasis is related to postoperative liver metastasis-
R. Sasaki. S. Kanno*, H. Nitta, M. Murakami, Y. Hayakawa, Y. Shimada,
H. Kawamura, T. Suto and K. Saito
Department ..of Surgery I, lwate Medical University, Morioka and
Department of Surgery, lwate prefectural Kuji Hospital*, Kuji, Japan
In order to reveal the relationship between lymphnode metastasis and mode
of reeeurence, prognosis in cancer of the bile duet, the number and degree of
lymphnode metastasis were investigated about the relation to mode of
receurence and prognosis in sixty-nine rese.ct patients of bile duet cancer.
RESULTS:
1) Lymplmode metastasis was observed in 24 of 69 patients (34.8%). There
was significant correlation between the number of lymphnode metastasis and
degree of lymphnode metastasis (p<0.05, ehi-square test).
2) Postoperative reeeurence oceured 15 of 45 cases (33.3%) in patients with
no lymplmode metastasis (n(-)). The site of receurence was liver metastasis
in 7 eases (15.6%), peritoneal dissemination and lymphnode receurence in 4
cases (8.9%), local receurence and metastasis at abdominal wall in one ease
(2.2%), respectively. On the other hand, in patients with lymphnode
metastasis ((n(+)), reeeurence oeeured in 13 of 24 eases (54.2%). The mode
of receurence was liver metastasis in 10 eases (41.7%), peritoneal
dissemination in 3 (12.5%), lymphnode reeeurence, bone metastasis, brain
metastasis and pleural metastasis in one case (4.2%), respectively.
Postoperative liver metastasis oeeured more frequently in n(+) patients than
n(-) patients (p<0.05, ehi-square test).
3) Five years survival rate was 54.6% in n(-) patients. Three years survival
rate was 11.5% and no 5 years survivor in n(+) patients. Prognosis in n(+)
pattients was significantly worse than in n(-) patients (p<0.0001, log
lank test ). According to the number of positive lymphnode, mean survival
period was, one positive lymphnode: 575.9:t:121.7 days, 2 to 7:
658.54-174.4 days and more than 8:356.3+/-167.8 days and nl: 625.5.99.8
days, n2:726.7+263.2 days n3:408.0:.80.7 days and n4:361.4+/-117.4
days according to the degree of lymph node metastasis. So, prognosis in
n(+) patients was poor, even if the number of lymphnode metastasis was
one or degree of lymphnode metastasis was nl.
CONCLUSION: These results suggest that postoperative liver metastasis
OCOLred frequently and prognosis was poor in patients with lymplmode
metastasis, it is necessary to do the postoperative adjuvant therapy against




GALLBLADDER CARCINOMA: LONG-TERM RESULTS
Y Shirai. K. Tsukada, T. Ohtani, K.Hatakeyama
Department of Surgery, Niigata University School of Medicine,
Niigata City, Japan
BACKGR0UND: The aim of this retrospective analysis was to
clarify the role of pancreaticoduodenectomy (PD) in the management
of gallbladder carcinoma (GBC) in a 5-year study. METHODS:
Between 1983 and 1993, 19 consecutive patients with GBC
underwent a classical Whipple PD combined with extended
cholecystectomy. To analyze the long-term results, 17 patients who
had such surgery before December 1990 were included in this study.
PD was indicated for direct invasion of the pancreaticoduodenal region
and/or peripancreatic nodal disease. Hepatic resection was performed
in all: resection of the gallbladder bed in 15 and extended right hepatic
lobectomy in 2. The 17 patients were divided into two groups; 12
with invasion of the extrahepatic bile duct and 5 without such
invasion. RESULTS: Thirteen patients had Stage IVB disease.
Overall, 5 patients (29%), ofwhom 4 had Stage 1VB disease with
positive peripancreatic nodes, survived 5 years after surgery. Five
patients (42%) in the group without bile duct invasion survived 5 years
with median survival of 57mo, compared with no 5-year survivors
with median survival of 15 mo in the group with bile duct invasion
(P<0.01). A 5-year survival of45% in those undergoing a potentially
curative (R0) resection (median survival, 57 mo) was significantly
higher (P<0.01) than 0 % in those undergoing a palliative resection
(median survival, 11 mo). CONCLUSIONS: PD provides long-
term palliation for selected patients with advanced GBC with
peripancreatic nodal disease. The absence of bile duct invasion and R0
resection are prerequisites for long-term survival. The results justify
the use of PD in selected patients with advanced GBC.
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GALLBLADDER EMPTYING PRESSURE IN PATIENTS WITH
ACALCULOUS GALLBLADDER PAIN AND IN PATIENTS WITH
NORMAL GALLBLADDERS.
RiChard S Stubbs and MichaelWC Booth. The Wakefield Clinic for
Gastrointestinal Diseases, Wakefield Hospital, Wellington, New
Zealand.
Introduction: Chronic acalculous gallbladder pain (CAGBP) is a
controversial entity. This study was undertaken to compare the GB
pressures observed during emptying of normal gallbladders with that
of patients believed to be suffering from CAGBP. Methods: GB
pressures were measured directly in anaesthetised patients
immediately prior to GB removal in 15 patients undergoing lap thole
for CAGBP and in 10 patients who were having open removal of a
normal GB at the time of major hepatic surgery for metastatic cancer
(controls). Baseline pressures were recorded prior to bolus IV injection
of CCK-OP (sincalide) 2.5 Ixg given over minute. Pressures were
recorded at 30 see intervals commencing at the completion of the
CCK injection (0 time) and continuing for a total of 10 minutes. The
maximum pressure rise over baseline was calculated for each patient
(AP1) as was the change in pressure from baseline at the 10 minute
period (AP2). CAGBP patients were divided into responders (those
whose problem was resolved by cholecystectomy, n 11) and non-
responders (whose problem was unchanged by cholecystectomy, n
4). AP1 of responders was compared with controls and with non-
responders using a two tailed Wilcoxan Signed Rank test. AP2 values
were similarly compared. Results: Mean 5: SE (mmHg) AP1 and AP2
were as follows:- controls, 4.50 5:0.51 and 0.15 5: 0.68; re,ponders,
9.27 + 1.43 and 4.36 + 1.23; non-responders, 5.50 + 0.65 and 2.75 +
0.48. The difference between mean AP1 in responders and controls
was significant (p 0.015). Similarly the difference between mean
AP2 in responders and controls was significant (p 0.044). The
differences between these measurements in the non-responders and
responders or controls was not significant. Conclusion: To our
knowledge this is the first data to be collected of this kind and the
findings lend support to the existence of CAGBP as an entity and
provide support for the hypothesis that the pain is due to increased
resistance to GB emptying.F261 F262
PROSPECTIVE COMPARISON OF ENDOSCOPIC
SPHINCTEROTOMY (ES) WITH GALLBLADDER ’in situ’,
OPEN SURGERY AND ES plus LAP. CHOLECYSTECTOMY
FOR TREATMENT OF BILE DUCT STONES IN HIGH RISK
PATIENTS. EM Targarona, RM Perez-Ayuso, JM Bordas, ERos, C Balagu&
Martinez, Pros, Ter6s, M Tffas. Serv.of Surgery, Gastroenterology and
Endoscopy. Hosp. Clinic. Univ.of Barcelona
Lap cholecystectomy (LC) has. modified the approach to bile duct stones (BDS).
During last decade. ES with gallbladder ’in situ’(EE-GiS) has been used as
alternative to surgeryin the high risk patient, but symptoms up to 30% during
f-up has been reported and it has never been compared with open surgery.
ES+LC is the most accepted therapy for BDS in the laparoscopic era. AIM: To
compare the efficacy of open surgery with EE-GiS or ES+LC for treatment of
BDS in the high risk patient. MATERIAL AND METHODS: From set-91
to set-94, 100 patients suspected to harbour duct stones were randomly allocated to
open surgery (Group I, n: 48) or EE-GiS (Group II, n: 50). From set-94 to
nov 95.54 consecutive patients were treated with ES-LC (Group 111) Criteria for
suspicion of BDS were gallstones+jaundice, cholangitis or pancreatitis+dilated
bile duct. High risk factors were: age > 70 or severe disease (cardiac, pulmonary.
cirrhosis or limited mobilization). RESULTS:
Open surgery
Age (y) 80 + 7
Technical success 94 %
Morbidity 23 %
Mortality 4 %
Postop stay (d) II + 8
FOLLOW UP (months) 18 + 10
Late biliary morbidity 6.5 %
S+LC a
79 + 9 79+7 ns
90% 98 % ns
16% 10 % ns
6% 2% ns
5 + 4 4 + 4 .001
15+ 11 7+4
20 % 4 % .002
Conversion rate was 11%. CONCLUSION: ES+LC is safe and effective
alternative to open surgery or EE-GiS for treatment of bile duct stones in the
elderly or high risk patient.
PROGNOSTIC VALUE OF NUCLEAR DNA CONTENTAND CELL
PROLIFERATION (Ki-67) IN RESECTABLE DISTAL BILE DUCT
CARCINOMA
A.Umezawa*, T.M.van Gulik, A.Bosma**, K.Koyama*, G.J.A.Offerhaus**,
H.Obertop, D.J.Gouma.
Dept.of Surgery, Akita University Hospital, Akita, Japan (*), Depts.of
Surgery and Pathology(**), Academic Medical Center, University of
Amsterdam, Amsterdam, The Netherlands.
In 33 patients (age 31-73y, mean 60y) who had undergone subtotal
pancreatoduodenectomy for distal bile duct carcinoma (DBDC), tumor
DNA content and the cell cycle-associated antigen Ki-67 were studied in
relation with survival time. Methods: Of each pancreato-duodenectomy
specimen, 1-5 samples were selected from the cancer-containing tissue
blocks. As controls, non-tumor areas of the distal bile duct were analyzed
in 12 patients. For assessment of nuclear DNA content, a nuclear
suspension was prepared from 50p sections of each sample and stained
with propidium iodide. DNA content was measured with a flowcytometry
FACScan and the data of 20.000 nuclei of each sample were analyzed.
Tumor ploidy was classified as diploid or aneuploid on the basis of the
resulting DNA histograms. Ki-67 was detected by immunohistochemical
staining of 4p tumor sections with a new antibody: MIB-I. MIB-1
expression was recorded as the ratio of positive nuclei (%) in 1000 tumor
cells (MIB-1 index). Results: 19 pats. had a radical resection, 14 resections
were microscopically non-radical. 22. pats. were found to have diploid
tumors and 11 pats. had aneuploid tumors. Median survival of patients
with diploid and aneuploid tumors was 13mths and. 10mths, respectively.
No correlation of DNA ploidy with survival time was found, neither after
stratification for radicality of the resection. Of the 12 non-tumor areas, 10
cases were diploid and 2 cases aneuploid. Mean MIB-1 index in tumor
cases was 17.6%, whereas in benign areas mean MIB-1 index was
significantly lower, i.e. 3.6% (p=0.0007). Univadate survival analysis of the
whole group of patients showed that MIB-1 index of >20% was associated
with decreased survival time, i.e. <12 months (log rank test, p=0.005) (dsk
ratio 2.86). Conclusions: 1) Assessment of DNA content has no prognostic
value in distal bile duct carcinoma 2) Mean MIB-1 index (reflecting Ki-67
expression) greater than 20%, is associated with poor survival <12
months) in resectable distal bile duct carcinoma.
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GROWTH HORMONE TREATMENT REDUCES BACTERIAL
TRANSLOCATION IN OBSTRUCTIVE JAUNDICE
C Vaglanos, S Koureleas, A Arvanltl, CD Sopa, T Alaxandrldls,
M StavropouIos
Departments of Surgery and Internal Medicine and Laboratories
of MIcrobiology and Pathology, University of Patra$, Patras,
Greece
Septic complications in the presence of obstructive jaundice may be
related to increased bacterial translocation (BT) from the gut. This may
be due to the lack of bile salts and their trophic effect on intestinal
mucosa. We investigated the effect of Growth Hormone (GH) in
maintaining intestinal mucosal integrity and reducing BT in jaundiced rats.
Method.. Male Wistar rats were used divided randomly into four Groups:
(n=21), controls; (n=21), sham operated; III (n=22), ligation and division
of the common bile duct (CBDL) and IV (n=15) CBDL and treatment with
Growth Hormone (GH). Laparotomies were performed on day 0, under
sterile conditions. GH (250 IJg/kg BW) was given s.c. once daily until
sacrifice. On day 10 all animals were sacrificed. Blood bilirubin was
determined, mesenteric lymph nodes (MLN) and liver specimens were
cultured aerobically, as well as bile from the ligated CBD stump. By
washing the colon with 2 ml of saline, 0.5 aliquots were obtained and the
total aerobic flora was determined. Samples from the terminal ileum were
removed for histologic examination and DNA meaurements.
Results: Bilirubin was significantly increased in Groups III and IV (p<0.01).
77% of the animals in Group III had positive MLN and 36% positive liver
cultures (p<0.05 vs Groups and II). GH treatment decreased positive
cultures to 35% and 0 respectively and this was statistically significant
(p<0.05 vs Group III). All cultured bacteria were enteric in origin. The bile
was sterile in all animals subjected to CBDL. Aerobic colonic flora was
the same in all Groups (p>0.05). Histology revealed insignificant mucosal
atrophy, while intestinal DNA content was significantly decreased in
Group III (p<0.05 vs groups and II). These returned to normal after GH
treatment.
Conclusion: Obstructive jaundice promotes BT both to MLN and liver.
This may be partly due to desruption of intestinal mucosal integrity,
following the lack of the trophic effect of bile salts. GH preserves mucosa,
probably by treating atrophy, although immunological factors can not be
excluded. This may have interesting clinical applications in patients with
obstructive jaundice.
FEASIBILITY OF BILEDUCT STONES EXTRACTION
VIA THE CYSTIC DUCT; ANATOMICAL CONSIDERA-
TION.
J. Vracko
Department of Gastroenterological Surgery, University Medi-
cal Centre, Ljubljana, Slovenia
Inner diameter of the cystic duct and the size of the largest
common bile duct stones have been prospectively measured in
a consecutive series of 30 patients undergoing open choledo-
cholithotripsy, out of 250 patients referred to our department
for laparoscopic cholecystectomy, to asses whether anatomy of
the cystic duct ascertains bile duct stone extraction via the cystic
duct. Average inner diameter of tht cystic ducts, measured
ostoperatively on intraoperative cholangiograms, was 5.233 +_.
.373 mm, range 2 -10 mm, and was significantly wider as
compared with the average size of largest common bile duct
stones which measured 3.666 _
2.475 mm, range 0.5 10 mm
(p<0.05). In 14 (47%) patients bile duct stones were smaller
and in 9 (30%) patients they were of equal size as compared
with the concomitant diameter of the cystic duct, indicating
feasibility of transcystic bile duct stones extraction in 3/4 of
patients with common bile duct stones. In 7 (23%) patients bile
duct stones were larger as compared with concomitant cystic
duct caliber; in five patients their were lmm and in two patients
they were 2 and 4 mm larger. Therefor, anatomy of the cystic
duct ascertains bile duct stone extraction via the cystic duct in
3/4 of bile duct stone patients. In 1/4,.cystic duct dilatation
and/or laser lithotripsy should be used. These features strongly
support the concept of laparoscopic common bile duct stone
extractions via the cystic duct and confirm that the transcystic
access to bile duct stones is a logical way of bile duct clearance.
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GUT BARRIER FAILURE IN OBSTRUCTIVE JAUNDICE
F. Welsh, CW. Ramsden, K. MaeLennan, M. Sheridan, GR. Barclay,
PJ. Guillou and JV. Reynolds.
Academic Surgical Unit, St. James’s University Hospital, Leeds, UK.
Endotoxaemia and bacterial translocation may underlie the high incidence
of septic complications in thejaundiced patient. The degree of intestinal
permeability in obstructivejaundice has not been quantified. Altered
mucosal immunitymay also contribute. This study aimed to examine the
effect of obstructivejaundice on intestinal permeability and immunological
cellular infiltration. Thirty three patients were studied, 18 jaundiced
(median plasma bilirubin 303molL"1) and 15 non-ieteric matched controls.
Gut permeability was measured by the lactulose-mannitolabsorbance test.
Endoscopic biopsies ofthe second part ofthe duodenum were stained and
morphological and immunohistochemical features graded from + to +4 by
and independent blinded pathologist. The results (median and interquartile
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There was no difference in morphologybetween groups.
The results show a significant increase, in intestinal permeability, in
association with local intestinal immunological activation injaundiced
patients. These results show intestinal barrier function to be impaired in the
jaundiced patient. This may underlie the high risk of sepsis in this group.
BENIGNAND MALIGNANTGALLBLADDER LESIONS:
SURGICAL RESULTS OF LAPAROSCOPIC TREATMENT INTHE
PROSPECTIVE SALTS-STUDYON LAPAROSCOPIC
CHOLECYSTEC’IMY
.K. Z’raggen, HU. Baer. S. Birrer, E Holzinger, L. Krihenbiihl,
C. Klaiber*
Department ofVisceral and Transplantation Surgery, Inselspital
University of Bern, Bern and Department of Surgery, Spital Aarberg*,
Switzerland
Since 1992 the Swiss Association of Laparoseopic and Thoraeoscopic
Surgery (SALTS) performed a prospective multiinstitutional study on
laparoscopic cholecystectomy (LC) including approximatly 50% of all
cholecystectomies done in Switzerland. 10724 patients entered the
study, and 0.97% (104 patients) were operated for benign (66 pat.) or
malignant (38 pat.) gallbladder tumors.
In gallbladder carcinoma LC was successfully peff in
60.5% (23/38), Prinmy conversion rate to an open pmcedme was
21.1% (8 cases), 7 cases(18.4%) had to be converted for intraoperative
complications in 13.3% and for inflammatory changes or unclear
anatomy in 10%. LC in benign gallbladder tumors was suocessfull in
100%. lntraoperative complication rate was 30% in ganbladder
carcinoma and 16.6% in benign gallbladder lesions. Morbidity was
18.4% in malignant and 3% in benign lesions. Reoperation rate in
gallbladder cancer was 15.8% (10.5% for liver resection, 5.3% for
complicafims), in benign gallbladder lesions 0%. 30-day mortality was
0 in both groups.
Conclusions: LC is the treatment of choice for suspected benign
gallbladder lesions with a 0% conversion rate, a 0% reoperation rate
and low morbidity. Laparoscopic treatment for malignant or suspected
malignant gallbladder lesions leads to a high primary and seconda
conversion rate, a high morbidity and to reoperation in 15.8%. We
therefore recommend an open approach in alltively suspected
orknown gallbladder cancerand a primm3’ or secondary conversion aflgr
laparoscopic diagnosis of malignant gallbladder lesions. Wether more
extended resectional wocedures are indicated remains open for
discussion
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EXPERIMENTAL AND CLINICAL BASIS FOR THE TARGETED
DELIVERY OF ANTIBIOTICS IN BILIARY SURGERY
Zh. Sh. Zhumadilov
Semipalatinsk Medical Institute, Kazakstan
The possibility of the use and effectiveness of
targeted delivery of antibiotics by autological
erythrocyte ghosts has been studied experimentally
on 20 noninbred dogs and applied clinically in 200
patients with acute complicated cholecystitis and
high risk of urgent,operation, in 21 patients with
biliary abscesses of the liver, in 45 patients with
acute cholangitis. The control group of 65 patients.
received traditional therapy. We studied the effect
of the new method on the immune,clinical and bio-
chemical status of patients. We infused intra-
venously ghosts containing single dose of anti-
biotic twice daily. It was found that the new
method made it possible to provide a high concen-
tration of antibiotic for prolonged periods in the
liver and biliary ducts, in comparison with tra-
ditional methods. No septic complications of dis-
ease or urgent operation was noted in patients with
acute cholecystitis. Our method resulted in a
threefold reduction in the duration of treatment of
patients with biliary abscesses of the liver. The
amelioration of immunological and clinical states
was more. marked in patients receiving targeted de-
livery of antibiotic.. On the basis of this anal-
ysis, we conclude that the new method is effective,
economical, and will increase the quality of
bil iary surgery.
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